Community Health Systems, Inc.
Subject to completion, as filed with the Securities and
Exchange Commission on September 24, 2007
Registration
No. 333-
UNITED STATES SECURITIES AND
EXCHANGE COMMISSION
Washington, D.C.
20549
Form S-4
REGISTRATION
STATEMENT
UNDER
THE SECURITIES ACT OF
1933
CHS/Community Health Systems,
Inc.
(Exact Name of Registrant as
Specified in Its Charter)
|
|
|
|
|
Delaware
(State of
Incorporation)
|
|
8062
(Primary Standard
Industrial
Classification Code Number)
|
|
76-0137985
(I.R.S. employer
identification number)
|
4000 Meridian Boulevard
Franklin, Tennessee 37067
(615) 465-7000
(Address, Including Zip Code,
and Telephone Number, Including Area Code, of Registrants
Principal Executive Offices)
Rachel A. Seifert
CHS/Community Health Systems, Inc.
Senior Vice President, Secretary and General Counsel
4000 Meridian Boulevard
Franklin, Tennessee 37067
(615) 465-7000
(Name, Address, Including Zip
Code, and Telephone Number, Including Area Code, of Agent for
Service)
Copy to:
Joshua N. Korff, Esq.
Kirkland & Ellis LLP
Citicorp Center
153 East
53rd
Street
New York, New York 10022
(212) 446-4800
Approximate date of commencement of proposed sale to the
public: The exchange will occur as soon as
reasonably practicable after the effectiveness of this
registration statement.
If the securities being registered on this form are being
offered in connection with the formation of a holding company
and there is compliance with General Instruction G, check
the following box. o
If this form is filed to register additional securities for an
offering pursuant to Rule 462(b) under the Securities Act,
please check the following box and list the Securities Act
registration statement number of the earlier effective
registration statement for the same
offering. o
If this form is a post-effective amendment filed pursuant to
Rule 462(d) under the Securities Act, check the following
box and list the Securities Act registration statement number of
the earlier effective registration statement for the same
offering. o
CALCULATION OF REGISTRATION FEE
|
|
|
|
|
|
|
|
|
|
Proposed Maximum
|
|
|
|
Title of Each Class of
|
|
|
Aggregate
|
|
|
Amount of
|
Securities to be Registered(1)
|
|
|
Offering Price(1)
|
|
|
Registration Fee
|
87/8% Senior
Notes due 2015
|
|
|
$3,021,331,000
|
|
|
$92,755
|
Guarantees(2)
|
|
|
N/A
|
|
|
N/A
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
Estimated solely for the purpose of calculating the registration
fee in accordance with Rule 457(o) promulgated under the
Securities Act of 1933, as amended (the Securities
Act). |
|
(2) |
|
No separate consideration will be received for the guarantees,
and no separate fee is payable, pursuant to Rule 457(n)
under the Securities Act.
|
The Registrants hereby amend this Registration Statement on
such date or dates as may be necessary to delay its effective
date until the Registrants shall file a further amendment which
specifically states that this Registration Statement shall
thereafter become effective in accordance with Section 8(a)
of the Securities act of 1933, as amended, or until this
Registration Statement shall become effective on such date as
the commission, acting pursuant to said Section 8(a), may
determine.
ADDITIONAL
REGISTRANTS
|
|
|
|
|
|
|
|
|
|
|
|
|
State or Other
|
|
Primary Standard
|
|
|
|
|
Address, Including Zip Code, and
|
|
|
Jurisdiction of
|
|
Industrial
|
|
|
|
|
Telephone Number, Including
|
Exact Name of Registrant as
|
|
Incorporation or
|
|
Classification Code
|
|
|
I.R.S. Employer
|
|
Area Code, of Registrants
|
Specified in its Charter
|
|
Organization
|
|
Number
|
|
|
Identification No.
|
|
Principal Executive Offices
|
|
Centre Hospital Corporation
|
|
AL
|
|
|
8062
|
|
|
20-4370931
|
|
4000 Meridian Blvd. Franklin, TN
37067
615-465-7000
|
Cullman Hospital Corporation
|
|
AL
|
|
|
8062
|
|
|
63-1157234
|
|
4000 Meridian Blvd. Franklin, TN
37067
615-465-7000
|
Foley Hospital Corporation
|
|
AL
|
|
|
8062
|
|
|
62-1811413
|
|
4000 Meridian Blvd. Franklin, TN
37067
615-465-7000
|
Fort Payne Hospital
Corporation
|
|
AL
|
|
|
8062
|
|
|
20-4370870
|
|
4000 Meridian Blvd. Franklin, TN
37067
615-465-7000
|
Greenville Hospital Corporation
|
|
AL
|
|
|
8062
|
|
|
63-1134649
|
|
4000 Meridian Blvd. Franklin, TN
37067
615-465-7000
|
Forrest City Arkansas Hospital
Company, LLC
|
|
AR
|
|
|
8062
|
|
|
20-4217095
|
|
4000 Meridian Blvd. Franklin, TN
37067
615-465-7000
|
Forrest City Clinic Company, LLC
|
|
AR
|
|
|
8062
|
|
|
20-5624608
|
|
4000 Meridian Blvd. Franklin, TN
37067
615-465-7000
|
Forrest City Hospital Corporation
|
|
AR
|
|
|
8062
|
|
|
20-4216978
|
|
4000 Meridian Blvd. Franklin, TN
37067
615-465-7000
|
Phillips Hospital Corporation
|
|
AR
|
|
|
8062
|
|
|
75-2976342
|
|
4000 Meridian Blvd. Franklin, TN
37067
615-465-7000
|
Payson Hospital Corporation
|
|
AZ
|
|
|
8062
|
|
|
86-0874009
|
|
4000 Meridian Blvd. Franklin, TN
37067
615-465-7000
|
Chesterfield/Marlboro, L.P.
|
|
DE
|
|
|
8062
|
|
|
59-3303026
|
|
4000 Meridian Blvd. Franklin, TN
37067
615-465-7000
|
CHHS Holdings, LLC
|
|
DE
|
|
|
8062
|
|
|
20-2189938
|
|
4000 Meridian Blvd. Franklin, TN
37067
615-465-7000
|
Cleveland Regional Medical Center,
L.P.
|
|
DE
|
|
|
8062
|
|
|
59-3215798
|
|
4000 Meridian Blvd. Franklin, TN
37067
615-465-7000
|
Community GP Corp.
|
|
DE
|
|
|
8062
|
|
|
62-1648466
|
|
4000 Meridian Blvd. Franklin, TN
37067
615-465-7000
|
Community Health Investment
Corporation
|
|
DE
|
|
|
8062
|
|
|
76-0152801
|
|
4000 Meridian Blvd. Franklin, TN
37067
615-465-7000
|
Community Health Systems,
Inc.
|
|
DE
|
|
|
8062
|
|
|
13-3893191
|
|
4000 Meridian Blvd. Franklin, TN
37067
615-465-7000
|
Community LP Corp.
|
|
DE
|
|
|
8062
|
|
|
62-1648206
|
|
4000 Meridian Blvd. Franklin, TN
37067
615-465-7000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
State or Other
|
|
Primary Standard
|
|
|
|
|
Address, Including Zip Code, and
|
|
|
Jurisdiction of
|
|
Industrial
|
|
|
|
|
Telephone Number, Including
|
Exact Name of Registrant as
|
|
Incorporation or
|
|
Classification Code
|
|
|
I.R.S. Employer
|
|
Area Code, of Registrants
|
Specified in its Charter
|
|
Organization
|
|
Number
|
|
|
Identification No.
|
|
Principal Executive Offices
|
|
Fallbrook Hospital Corporation
|
|
DE
|
|
|
8062
|
|
|
91-1918215
|
|
4000 Meridian Blvd. Franklin, TN
37067
615-465-7000
|
Hallmark Healthcare Corporation
|
|
DE
|
|
|
8062
|
|
|
63-0817574
|
|
4000 Meridian Blvd. Franklin, TN
37067
615-465-7000
|
Hospital of Barstow, Inc.
|
|
DE
|
|
|
8062
|
|
|
76-0385534
|
|
4000 Meridian Blvd. Franklin, TN
37067
615-465-7000
|
Lancaster Hospital Corporation
|
|
DE
|
|
|
8062
|
|
|
57-1010381
|
|
4000 Meridian Blvd. Franklin, TN
37067
615-465-7000
|
National Healthcare of Cleveland,
Inc.
|
|
DE
|
|
|
8062
|
|
|
62-1281627
|
|
4000 Meridian Blvd. Franklin, TN
37067
615-465-7000
|
National Healthcare of Cullman,
Inc.
|
|
DE
|
|
|
8062
|
|
|
63-0928788
|
|
4000 Meridian Blvd. Franklin, TN
37067
615-465-7000
|
National Healthcare of Decatur,
Inc.
|
|
DE
|
|
|
8062
|
|
|
63-0928790
|
|
4000 Meridian Blvd. Franklin, TN
37067
615-465-7000
|
National Healthcare of Hartselle,
Inc.
|
|
DE
|
|
|
8062
|
|
|
63-0928787
|
|
4000 Meridian Blvd. Franklin, TN
37067
615-465-7000
|
National Healthcare of Leesville,
Inc.
|
|
DE
|
|
|
8062
|
|
|
95-4066162
|
|
4000 Meridian Blvd. Franklin, TN
37067
615-465-7000
|
National Healthcare of Mt. Vernon,
Inc.
|
|
DE
|
|
|
8062
|
|
|
58-1622971
|
|
4000 Meridian Blvd. Franklin, TN
37067
615-465-7000
|
National Healthcare of Newport,
Inc.
|
|
DE
|
|
|
8062
|
|
|
71-0616802
|
|
4000 Meridian Blvd. Franklin, TN
37067
615-465-7000
|
NWI Hospital Holdings, LLC
|
|
DE
|
|
|
8062
|
|
|
20-8398145
|
|
4000 Meridian Blvd. Franklin, TN
37067
615-465-7000
|
Pennsylvania Hospital Company, LLC
|
|
DE
|
|
|
8062
|
|
|
06-1694707
|
|
4000 Meridian Blvd. Franklin, TN
37067
615-465-7000
|
Phoenixville Hospital Company, LLC
|
|
DE
|
|
|
8062
|
|
|
20-1055060
|
|
4000 Meridian Blvd. Franklin, TN
37067
615-465-7000
|
Pottstown Hospital Company, LLC
|
|
DE
|
|
|
8062
|
|
|
06-1694708
|
|
4000 Meridian Blvd. Franklin, TN
37067
615-465-7000
|
Ruston Hospital Corporation
|
|
DE
|
|
|
8062
|
|
|
20-8066937
|
|
4000 Meridian Blvd. Franklin, TN
37067
615-465-7000
|
Ruston Louisiana Hospital Company,
LLC
|
|
DE
|
|
|
8062
|
|
|
20-8066999
|
|
4000 Meridian Blvd. Franklin, TN
37067
615-465-7000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
State or Other
|
|
Primary Standard
|
|
|
|
|
Address, Including Zip Code, and
|
|
|
Jurisdiction of
|
|
Industrial
|
|
|
|
|
Telephone Number, Including
|
Exact Name of Registrant as
|
|
Incorporation or
|
|
Classification Code
|
|
|
I.R.S. Employer
|
|
Area Code, of Registrants
|
Specified in its Charter
|
|
Organization
|
|
Number
|
|
|
Identification No.
|
|
Principal Executive Offices
|
|
Watsonville Hospital Corporation
|
|
DE
|
|
|
8062
|
|
|
91-1894113
|
|
4000 Meridian Blvd. Franklin, TN
37067
615-465-7000
|
Webb Hospital Corporation
|
|
DE
|
|
|
8062
|
|
|
20-0167530
|
|
4000 Meridian Blvd. Franklin, TN
37067
615-465-7000
|
Webb Hospital Holdings, LLC
|
|
DE
|
|
|
8062
|
|
|
20-0167590
|
|
4000 Meridian Blvd. Franklin, TN
37067
615-465-7000
|
Fannin Regional Hospital,
Inc.
|
|
GA
|
|
|
8062
|
|
|
76-0350464
|
|
4000 Meridian Blvd. Franklin, TN
37067
615-465-7000
|
Anna Hospital Corporation
|
|
IL
|
|
|
8062
|
|
|
36-4431843
|
|
4000 Meridian Blvd. Franklin, TN
37067
615-465-7000
|
Galesburg Hospital Corporation
|
|
IL
|
|
|
8062
|
|
|
37-1485782
|
|
4000 Meridian Blvd. Franklin, TN
37067
615-465-7000
|
Granite City Hospital Corporation
|
|
IL
|
|
|
8062
|
|
|
36-4460625
|
|
4000 Meridian Blvd. Franklin, TN
37067
615-465-7000
|
Granite City Illinois Hospital
Company, LLC
|
|
IL
|
|
|
8062
|
|
|
36-4460628
|
|
4000 Meridian Blvd. Franklin, TN
37067
615-465-7000
|
Marion Hospital Corporation
|
|
IL
|
|
|
8062
|
|
|
37-1359605
|
|
4000 Meridian Blvd. Franklin, TN
37067
615-465-7000
|
Red Bud Hospital Corporation
|
|
IL
|
|
|
8062
|
|
|
36-4444121
|
|
4000 Meridian Blvd. Franklin, TN
37067
615-465-7000
|
Red Bud Illinois Hospital Company,
LLC
|
|
IL
|
|
|
8062
|
|
|
36-4443919
|
|
4000 Meridian Blvd. Franklin, TN
37067
615-465-7000
|
Waukegan Hospital Corporation
|
|
IL
|
|
|
8062
|
|
|
20-3978400
|
|
4000 Meridian Blvd. Franklin, TN
37067
615-465-7000
|
Waukegan Illinois Hospital
Company, LLC
|
|
IL
|
|
|
8062
|
|
|
20-3978521
|
|
4000 Meridian Blvd. Franklin, TN
37067
615-465-7000
|
Hospital of Fulton, Inc.
|
|
KY
|
|
|
8062
|
|
|
61-1218106
|
|
4000 Meridian Blvd. Franklin, TN
37067
615-465-7000
|
Hospital of Louisa, Inc.
|
|
KY
|
|
|
8062
|
|
|
61-1238190
|
|
4000 Meridian Blvd. Franklin, TN
37067
615-465-7000
|
Jackson Hospital Corporation
|
|
KY
|
|
|
8062
|
|
|
61-1285331
|
|
4000 Meridian Blvd. Franklin, TN
37067
615-465-7000
|
Farmington Hospital Corporation
|
|
MO
|
|
|
8062
|
|
|
20-4795037
|
|
4000 Meridian Blvd. Franklin, TN
37067
615-465-7000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
State or Other
|
|
Primary Standard
|
|
|
|
|
Address, Including Zip Code, and
|
|
|
Jurisdiction of
|
|
Industrial
|
|
|
|
|
Telephone Number, Including
|
Exact Name of Registrant as
|
|
Incorporation or
|
|
Classification Code
|
|
|
I.R.S. Employer
|
|
Area Code, of Registrants
|
Specified in its Charter
|
|
Organization
|
|
Number
|
|
|
Identification No.
|
|
Principal Executive Offices
|
|
Farmington Missouri Hospital
Company, LLC
|
|
MO
|
|
|
8062
|
|
|
20-4795132
|
|
4000 Meridian Blvd. Franklin, TN
37067
615-465-7000
|
Kirksville Hospital Corporation
|
|
MO
|
|
|
8062
|
|
|
36-4373298
|
|
4000 Meridian Blvd. Franklin, TN
37067
615-465-7000
|
Moberly Hospital, Inc.
|
|
MO
|
|
|
8062
|
|
|
43-1651906
|
|
4000 Meridian Blvd. Franklin, TN
37067
615-465-7000
|
Williamston Hospital Corporation
|
|
NC
|
|
|
8062
|
|
|
62-1749107
|
|
4000 Meridian Blvd. Franklin, TN
37067
615-465-7000
|
Salem Hospital Corporation
|
|
NJ
|
|
|
8062
|
|
|
22-3838322
|
|
4000 Meridian Blvd. Franklin, TN
37067
615-465-7000
|
Deming Hospital Corporation
|
|
NM
|
|
|
8062
|
|
|
85-0438008
|
|
4000 Meridian Blvd. Franklin, TN
37067
615-465-7000
|
Roswell Hospital Corporation
|
|
NM
|
|
|
8062
|
|
|
74-2870118
|
|
4000 Meridian Blvd. Franklin, TN
37067
615-465-7000
|
San Miguel Hospital
Corporation
|
|
NM
|
|
|
8062
|
|
|
74-2930034
|
|
4000 Meridian Blvd. Franklin, TN
37067
615-465-7000
|
CHS Holdings Corp.
|
|
NY
|
|
|
8062
|
|
|
13-3936167
|
|
4000 Meridian Blvd. Franklin, TN
37067
615-465-7000
|
Hallmark Holdings Corp.
|
|
NY
|
|
|
8062
|
|
|
13-3936166
|
|
4000 Meridian Blvd. Franklin, TN
37067
615-465-7000
|
Kay County Hospital Corporation
|
|
OK
|
|
|
8062
|
|
|
20-4052833
|
|
4000 Meridian Blvd. Franklin, TN
37067
615-465-7000
|
Kay County Oklahoma Hospital
Company, LLC
|
|
OK
|
|
|
8062
|
|
|
20-4052936
|
|
4000 Meridian Blvd. Franklin, TN
37067
615-465-7000
|
CHS Berwick Hospital Corporation
|
|
PA
|
|
|
8062
|
|
|
23-2975836
|
|
4000 Meridian Blvd. Franklin, TN
37067
615-465-7000
|
Clinton Hospital Corporation
|
|
PA
|
|
|
8062
|
|
|
90-0003715
|
|
4000 Meridian Blvd. Franklin, TN
37067
615-465-7000
|
Coatesville Hospital Corporation
|
|
PA
|
|
|
8062
|
|
|
23-3069798
|
|
4000 Meridian Blvd. Franklin, TN
37067
615-465-7000
|
Northampton Hospital Corporation
|
|
PA
|
|
|
8062
|
|
|
52-2325498
|
|
4000 Meridian Blvd. Franklin, TN
37067
615-465-7000
|
Sunbury Hospital Corporation
|
|
PA
|
|
|
8062
|
|
|
20-3346421
|
|
4000 Meridian Blvd. Franklin, TN
37067
615-465-7000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
State or Other
|
|
Primary Standard
|
|
|
|
|
Address, Including Zip Code, and
|
|
|
Jurisdiction of
|
|
Industrial
|
|
|
|
|
Telephone Number, Including
|
Exact Name of Registrant as
|
|
Incorporation or
|
|
Classification Code
|
|
|
I.R.S. Employer
|
|
Area Code, of Registrants
|
Specified in its Charter
|
|
Organization
|
|
Number
|
|
|
Identification No.
|
|
Principal Executive Offices
|
|
West Grove Hospital Corporation
|
|
PA
|
|
|
8062
|
|
|
25-1892279
|
|
4000 Meridian Blvd. Franklin, TN
37067
615-465-7000
|
Brownsville Hospital Corporation
|
|
TN
|
|
|
8062
|
|
|
42-1557534
|
|
4000 Meridian Blvd. Franklin, TN
37067
615-465-7000
|
Cleveland Hospital Corporation
|
|
TN
|
|
|
8062
|
|
|
62-1587878
|
|
4000 Meridian Blvd. Franklin, TN
37067
615-465-7000
|
Dyersburg Hospital Corporation
|
|
TN
|
|
|
8062
|
|
|
42-1557536
|
|
4000 Meridian Blvd. Franklin, TN
37067
615-465-7000
|
Hospital of Morristown, Inc.
|
|
TN
|
|
|
8062
|
|
|
62-1528689
|
|
4000 Meridian Blvd. Franklin, TN
37067
615-465-7000
|
Jackson Hospital Corporation
|
|
TN
|
|
|
8062
|
|
|
42-1557525
|
|
4000 Meridian Blvd. Franklin, TN
37067
615-465-7000
|
Jackson, Tennessee Hospital
Company, LLC
|
|
TN
|
|
|
8062
|
|
|
42-1557540
|
|
4000 Meridian Blvd. Franklin, TN
37067
615-465-7000
|
Lakeway Hospital Corporation
|
|
TN
|
|
|
8062
|
|
|
62-1564360
|
|
4000 Meridian Blvd. Franklin, TN
37067
615-465-7000
|
Lexington Hospital Corporation
|
|
TN
|
|
|
8062
|
|
|
42-1557533
|
|
4000 Meridian Blvd. Franklin, TN
37067
615-465-7000
|
Martin Hospital Corporation
|
|
TN
|
|
|
8062
|
|
|
42-1557527
|
|
4000 Meridian Blvd. Franklin, TN
37067
615-465-7000
|
McKenzie Hospital Corporation
|
|
TN
|
|
|
8062
|
|
|
42-1557531
|
|
4000 Meridian Blvd. Franklin, TN
37067
615-465-7000
|
McNairy Hospital Corporation
|
|
TN
|
|
|
8062
|
|
|
42-1557530
|
|
4000 Meridian Blvd. Franklin, TN
37067
615-465-7000
|
Shelbyville Hospital Corporation
|
|
TN
|
|
|
8062
|
|
|
20-2909388
|
|
4000 Meridian Blvd. Franklin, TN
37067
615-465-7000
|
Sparta Hospital Corporation
|
|
TN
|
|
|
8062
|
|
|
62-1587742
|
|
4000 Meridian Blvd. Franklin, TN
37067
615-465-7000
|
Big Bend Hospital Corporation
|
|
TX
|
|
|
8062
|
|
|
75-2717545
|
|
4000 Meridian Blvd. Franklin, TN
37067
615-465-7000
|
Big Spring Hospital Corporation
|
|
TX
|
|
|
8062
|
|
|
75-2574581
|
|
4000 Meridian Blvd. Franklin, TN
37067
615-465-7000
|
Granbury Hospital Corporation
|
|
TX
|
|
|
8062
|
|
|
75-2682017
|
|
4000 Meridian Blvd. Franklin, TN
37067
615-465-7000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
State or Other
|
|
Primary Standard
|
|
|
|
|
Address, Including Zip Code, and
|
|
|
Jurisdiction of
|
|
Industrial
|
|
|
|
|
Telephone Number, Including
|
Exact Name of Registrant as
|
|
Incorporation or
|
|
Classification Code
|
|
|
I.R.S. Employer
|
|
Area Code, of Registrants
|
Specified in its Charter
|
|
Organization
|
|
Number
|
|
|
Identification No.
|
|
Principal Executive Offices
|
|
Jourdanton Hospital Corporation
|
|
TX
|
|
|
8062
|
|
|
74-3011840
|
|
4000 Meridian Blvd. Franklin, TN
37067
615-465-7000
|
NHCI of Hillsboro, Inc.
|
|
TX
|
|
|
8062
|
|
|
74-2425482
|
|
4000 Meridian Blvd. Franklin, TN
37067
615-465-7000
|
Weatherford Hospital Corporation
|
|
TX
|
|
|
8062
|
|
|
20-5694260
|
|
4000 Meridian Blvd. Franklin, TN
37067
615-465-7000
|
Weatherford Texas Hospital
Company, LLC
|
|
TX
|
|
|
8062
|
|
|
20-5694301
|
|
4000 Meridian Blvd. Franklin, TN
37067
615-465-7000
|
Tooele Hospital Corporation
|
|
UT
|
|
|
8062
|
|
|
87-0619248
|
|
4000 Meridian Blvd. Franklin, TN
37067
615-465-7000
|
Emporia Hospital Corporation
|
|
VA
|
|
|
8062
|
|
|
54-1924866
|
|
4000 Meridian Blvd. Franklin, TN
37067
615-465-7000
|
Franklin Hospital Corporation
|
|
VA
|
|
|
8062
|
|
|
52-2200240
|
|
4000 Meridian Blvd. Franklin, TN
37067
615-465-7000
|
Petersburg Hospital Company, LLC
|
|
VA
|
|
|
8062
|
|
|
02-0691413
|
|
4000 Meridian Blvd. Franklin, TN
37067
615-465-7000
|
Russell County Medical Center,
Inc.
|
|
VA
|
|
|
8062
|
|
|
54-1594711
|
|
4000 Meridian Blvd. Franklin, TN
37067
615-465-7000
|
Virginia Hospital Company, LLC
|
|
VA
|
|
|
8062
|
|
|
02-0691406
|
|
4000 Meridian Blvd. Franklin, TN
37067
615-465-7000
|
Oak Hill Hospital Corporation
|
|
WV
|
|
|
8062
|
|
|
27-0003893
|
|
4000 Meridian Blvd. Franklin, TN
37067
615-465-7000
|
Evanston Hospital Corporation
|
|
WY
|
|
|
8062
|
|
|
83-0327475
|
|
4000 Meridian Blvd. Franklin, TN
37067
615-465-7000
|
QHG of Enterprise, Inc.
|
|
AL
|
|
|
8062
|
|
|
63-1159023
|
|
5800 Tennyson Parkway
Plano, TX 75024
214-473-7000
|
QHG of Jacksonville, Inc.
|
|
AL
|
|
|
8062
|
|
|
62-1637909
|
|
5800 Tennyson Parkway
Plano, TX 75024
214-473-7000
|
QHG of Springdale, Inc.
|
|
AR
|
|
|
8062
|
|
|
62-1755664
|
|
5800 Tennyson Parkway
Plano, TX 75024
214-473-7000
|
Triad-El Dorado, Inc.
|
|
AR
|
|
|
8062
|
|
|
62-1628508
|
|
5800 Tennyson Parkway
Plano, TX 75024
214-473-7000
|
Abilene Hospital, LLC
|
|
DE
|
|
|
8062
|
|
|
46-0496920
|
|
5800 Tennyson Parkway
Plano, TX 75024
214-473-7000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
State or Other
|
|
Primary Standard
|
|
|
|
|
Address, Including Zip Code, and
|
|
|
Jurisdiction of
|
|
Industrial
|
|
|
|
|
Telephone Number, Including
|
Exact Name of Registrant as
|
|
Incorporation or
|
|
Classification Code
|
|
|
I.R.S. Employer
|
|
Area Code, of Registrants
|
Specified in its Charter
|
|
Organization
|
|
Number
|
|
|
Identification No.
|
|
Principal Executive Offices
|
|
Abilene Merger, LLC
|
|
DE
|
|
|
8062
|
|
|
46-0496918
|
|
5800 Tennyson Parkway
Plano, TX 75024
214-473-7000
|
Arizona DH, LLC
|
|
DE
|
|
|
8062
|
|
|
91-2065656
|
|
5800 Tennyson Parkway
Plano, TX 75024
214-473-7000
|
ARMC, LP
|
|
DE
|
|
|
8062
|
|
|
46-0496933
|
|
5800 Tennyson Parkway
Plano, TX 75024
214-473-7000
|
Birmingham Holdings, LLC
|
|
DE
|
|
|
8062
|
|
|
20-3320362
|
|
5800 Tennyson Parkway
Plano, TX 75024
214-473-7000
|
Bluffton Health System, LLC
|
|
DE
|
|
|
8062
|
|
|
62-1792272
|
|
5800 Tennyson Parkway
Plano, TX 75024
214-473-7000
|
Brownwood Hospital, L.P.
|
|
DE
|
|
|
8062
|
|
|
62-1762521
|
|
5800 Tennyson Parkway
Plano, TX 75024
214-473-7000
|
Brownwood Medical Center, LLC
|
|
DE
|
|
|
8062
|
|
|
62-1762523
|
|
5800 Tennyson Parkway
Plano, TX 75024
214-473-7000
|
Carlsbad Medical Center, LLC
|
|
DE
|
|
|
8062
|
|
|
62-1762526
|
|
5800 Tennyson Parkway
Plano, TX 75024
214-473-7000
|
Claremore Regional Hospital, LLC
|
|
DE
|
|
|
8062
|
|
|
62-1757649
|
|
5800 Tennyson Parkway
Plano, TX 75024
214-473-7000
|
Clarksville Holdings, LLC
|
|
DE
|
|
|
8062
|
|
|
20-3320418
|
|
5800 Tennyson Parkway
Plano, TX 75024
214-473-7000
|
College Station Hospital,
L.P.
|
|
DE
|
|
|
8062
|
|
|
62-1762360
|
|
5800 Tennyson Parkway
Plano, TX 75024
214-473-7000
|
College Station Medical Center, LLC
|
|
DE
|
|
|
8062
|
|
|
62-1762359
|
|
5800 Tennyson Parkway
Plano, TX 75024
214-473-7000
|
College Station Merger, LLC
|
|
DE
|
|
|
8062
|
|
|
62-1771861
|
|
5800 Tennyson Parkway
Plano, TX 75024
214-473-7000
|
CP Hospital GP, LLC
|
|
DE
|
|
|
8062
|
|
|
20-3904557
|
|
5800 Tennyson Parkway
Plano, TX 75024
214-473-7000
|
CPLP, LLC
|
|
DE
|
|
|
8062
|
|
|
20-3904614
|
|
5800 Tennyson Parkway
Plano, TX 75024
214-473-7000
|
Crestwood Hospital LP, LLC
|
|
DE
|
|
|
8062
|
|
|
62-1762369
|
|
5800 Tennyson Parkway
Plano, TX 75024
214-473-7000
|
Crestwood Hospital, LLC
|
|
DE
|
|
|
8062
|
|
|
62-1769644
|
|
5800 Tennyson Parkway
Plano, TX 75024
214-473-7000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
State or Other
|
|
Primary Standard
|
|
|
|
|
Address, Including Zip Code, and
|
|
|
Jurisdiction of
|
|
Industrial
|
|
|
|
|
Telephone Number, Including
|
Exact Name of Registrant as
|
|
Incorporation or
|
|
Classification Code
|
|
|
I.R.S. Employer
|
|
Area Code, of Registrants
|
Specified in its Charter
|
|
Organization
|
|
Number
|
|
|
Identification No.
|
|
Principal Executive Offices
|
|
CSMC, LLC
|
|
DE
|
|
|
8062
|
|
|
62-1762362
|
|
5800 Tennyson Parkway
Plano, TX 75024
214-473-7000
|
CSRA Holdings, LLC
|
|
DE
|
|
|
8062
|
|
|
20-5111915
|
|
5800 Tennyson Parkway
Plano, TX 75024
214-473-7000
|
Deaconess Holdings, LLC
|
|
DE
|
|
|
8062
|
|
|
47-0890490
|
|
5800 Tennyson Parkway
Plano, TX 75024
214-473-7000
|
Deaconess Hospital Holdings, LLC
|
|
DE
|
|
|
8062
|
|
|
20-2401268
|
|
5800 Tennyson Parkway
Plano, TX 75024
214-473-7000
|
Desert Hospital Holdings, LLC
|
|
DE
|
|
|
8062
|
|
|
20-8111921
|
|
5800 Tennyson Parkway
Plano, TX 75024
214-473-7000
|
Detar Hospital, LLC
|
|
DE
|
|
|
8062
|
|
|
62-1764943
|
|
5800 Tennyson Parkway
Plano, TX 75024
214-473-7000
|
Dukes Health System, LLC
|
|
DE
|
|
|
8062
|
|
|
52-2379885
|
|
5800 Tennyson Parkway
Plano, TX 75024
214-473-7000
|
Gadsden Regional Medical Center,
LLC
|
|
DE
|
|
|
8062
|
|
|
63-1102773
|
|
5800 Tennyson Parkway
Plano, TX 75024
214-473-7000
|
Greenbrier VMC, LLC
|
|
DE
|
|
|
8062
|
|
|
75-2887493
|
|
5800 Tennyson Parkway
Plano, TX 75024
214-473-7000
|
GRMC Holdings, LLC
|
|
DE
|
|
|
8062
|
|
|
20-8112090
|
|
5800 Tennyson Parkway
Plano, TX 75024
214-473-7000
|
Hobbs Medco, LLC
|
|
DE
|
|
|
8062
|
|
|
62-1769641
|
|
5800 Tennyson Parkway
Plano, TX 75024
214-473-7000
|
Las Cruces Medical Center, LLC
|
|
DE
|
|
|
8062
|
|
|
75-2905434
|
|
5800 Tennyson Parkway
Plano, TX 75024
214-473-7000
|
Lea Regional Hospital, LLC
|
|
DE
|
|
|
8062
|
|
|
62-1760149
|
|
5800 Tennyson Parkway
Plano, TX 75024
214-473-7000
|
Longview Merger, LLC
|
|
DE
|
|
|
8062
|
|
|
62-1769639
|
|
5800 Tennyson Parkway
Plano, TX 75024
214-473-7000
|
LRH, LLC
|
|
DE
|
|
|
8062
|
|
|
62-1762421
|
|
5800 Tennyson Parkway
Plano, TX 75024
214-473-7000
|
Lutheran Health Network of
Indiana, LLC
|
|
DE
|
|
|
8062
|
|
|
62-1762363
|
|
5800 Tennyson Parkway
Plano, TX 75024
214-473-7000
|
Massillon Health System, LLC
|
|
DE
|
|
|
8062
|
|
|
34-1840860
|
|
5800 Tennyson Parkway
Plano, TX 75024
214-473-7000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
State or Other
|
|
Primary Standard
|
|
|
|
|
Address, Including Zip Code, and
|
|
|
Jurisdiction of
|
|
Industrial
|
|
|
|
|
Telephone Number, Including
|
Exact Name of Registrant as
|
|
Incorporation or
|
|
Classification Code
|
|
|
I.R.S. Employer
|
|
Area Code, of Registrants
|
Specified in its Charter
|
|
Organization
|
|
Number
|
|
|
Identification No.
|
|
Principal Executive Offices
|
|
Medical Center of Brownwood, LLC
|
|
DE
|
|
|
8062
|
|
|
62-1762425
|
|
5800 Tennyson Parkway
Plano, TX 75024
214-473-7000
|
MMC of Nevada, LLC
|
|
DE
|
|
|
8062
|
|
|
42-1543617
|
|
5800 Tennyson Parkway
Plano, TX 75024
214-473-7000
|
Navarro Hospital, L.P.
|
|
DE
|
|
|
8062
|
|
|
62-1762428
|
|
5800 Tennyson Parkway
Plano, TX 75024
214-473-7000
|
Navarro Regional, LLC
|
|
DE
|
|
|
8062
|
|
|
62-1762429
|
|
5800 Tennyson Parkway
Plano, TX 75024
214-473-7000
|
NRH, LLC
|
|
DE
|
|
|
8062
|
|
|
62-1762431
|
|
5800 Tennyson Parkway
Plano, TX 75024
214-473-7000
|
Oregon Healthcorp, LLC
|
|
DE
|
|
|
8062
|
|
|
62-1769632
|
|
5800 Tennyson Parkway
Plano, TX 75024
214-473-7000
|
Palmer-Wasilla Health System, LLC
|
|
DE
|
|
|
8062
|
|
|
62-1762371
|
|
5800 Tennyson Parkway
Plano, TX 75024
214-473-7000
|
Quorum Health Resources, LLC
|
|
DE
|
|
|
8062
|
|
|
62-1742954
|
|
5800 Tennyson Parkway
Plano, TX 75024
214-473-7000
|
Regional Hospital of Longview, LLC
|
|
DE
|
|
|
8062
|
|
|
62-1762464
|
|
5800 Tennyson Parkway
Plano, TX 75024
214-473-7000
|
Russellville Holdings, LLC
|
|
DE
|
|
|
8062
|
|
|
62-1771866
|
|
5800 Tennyson Parkway
Plano, TX 75024
214-473-7000
|
SACMC, LLC
|
|
DE
|
|
|
8062
|
|
|
62-1762472
|
|
5800 Tennyson Parkway
Plano, TX 75024
214-473-7000
|
San Angelo Community Medical
Center, LLC
|
|
DE
|
|
|
8062
|
|
|
62-1762473
|
|
5800 Tennyson Parkway
Plano, TX 75024
214-473-7000
|
San Angelo Hospital,
L.P.
|
|
DE
|
|
|
8062
|
|
|
62-1762476
|
|
5800 Tennyson Parkway
Plano, TX 75024
214-473-7000
|
San Angelo Medical, LLC
|
|
DE
|
|
|
8062
|
|
|
62-1769697
|
|
5800 Tennyson Parkway
Plano, TX 75024
214-473-7000
|
Southern Texas Medical Center, LLC
|
|
DE
|
|
|
8062
|
|
|
62-1769737
|
|
5800 Tennyson Parkway
Plano, TX 75024
214-473-7000
|
St. Joseph Health System, LLC
|
|
DE
|
|
|
8062
|
|
|
51-0382045
|
|
5800 Tennyson Parkway
Plano, TX 75024
214-473-7000
|
Tennyson Holdings, Inc.
|
|
DE
|
|
|
8062
|
|
|
20-3943816
|
|
5800 Tennyson Parkway
Plano, TX 75024
214-473-7000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
State or Other
|
|
Primary Standard
|
|
|
|
|
Address, Including Zip Code, and
|
|
|
Jurisdiction of
|
|
Industrial
|
|
|
|
|
Telephone Number, Including
|
Exact Name of Registrant as
|
|
Incorporation or
|
|
Classification Code
|
|
|
I.R.S. Employer
|
|
Area Code, of Registrants
|
Specified in its Charter
|
|
Organization
|
|
Number
|
|
|
Identification No.
|
|
Principal Executive Offices
|
|
Triad Holdings III, LLC
|
|
DE
|
|
|
8062
|
|
|
75-2821745
|
|
5800 Tennyson Parkway
Plano, TX 75024
214-473-7000
|
Triad Holdings IV, LLC
|
|
DE
|
|
|
8062
|
|
|
62-1766957
|
|
5800 Tennyson Parkway
Plano, TX 75024
214-473-7000
|
Triad Holdings V, LLC
|
|
DE
|
|
|
8062
|
|
|
51-0327978
|
|
5800 Tennyson Parkway
Plano, TX 75024
214-473-7000
|
Triad Healthcare Corporation
|
|
DE
|
|
|
8062
|
|
|
75-2816101
|
|
5800 Tennyson Parkway
Plano, TX 75024
214-473-7000
|
Triad of Alabama, LLC
|
|
DE
|
|
|
8062
|
|
|
62-1762412
|
|
5800 Tennyson Parkway
Plano, TX 75024
214-473-7000
|
Triad of Oregon, LLC
|
|
DE
|
|
|
8062
|
|
|
62-1761990
|
|
5800 Tennyson Parkway
Plano, TX 75024
214-473-7000
|
Triad-ARMC, LLC
|
|
DE
|
|
|
8062
|
|
|
46-0496926
|
|
5800 Tennyson Parkway
Plano, TX 75024
214-473-7000
|
Triad-Denton Hospital GP, LLC
|
|
DE
|
|
|
8062
|
|
|
75-2887764
|
|
5800 Tennyson Parkway
Plano, TX 75024
214-473-7000
|
Triad-Denton Hospital, L.P.
|
|
DE
|
|
|
8062
|
|
|
75-2887765
|
|
5800 Tennyson Parkway
Plano, TX 75024
214-473-7000
|
Triad-Navarro Regional Hospital
Subsidiary, LLC
|
|
DE
|
|
|
8062
|
|
|
62-1681610
|
|
5800 Tennyson Parkway Plano, TX
75024
214-473-7000
|
VHC Medical, LLC
|
|
DE
|
|
|
8062
|
|
|
62-1769671
|
|
5800 Tennyson Parkway
Plano, TX 75024
214-473-7000
|
Vicksburg Healthcare, LLC
|
|
DE
|
|
|
8062
|
|
|
62-1752111
|
|
5800 Tennyson Parkway
Plano, TX 75024
214-473-7000
|
Victoria Hospital, LLC
|
|
DE
|
|
|
8062
|
|
|
62-1760818
|
|
5800 Tennyson Parkway
Plano, TX 75024
214-473-7000
|
Victoria of Texas, L.P.
|
|
DE
|
|
|
8062
|
|
|
62-1754940
|
|
5800 Tennyson Parkway
Plano, TX 75024
214-473-7000
|
WHMC, LLC
|
|
DE
|
|
|
8062
|
|
|
62-1762551
|
|
5800 Tennyson Parkway
Plano, TX 75024
214-473-7000
|
Willamette Valley Medical Center,
LLC
|
|
DE
|
|
|
8062
|
|
|
62-1762552
|
|
5800 Tennyson Parkway
Plano, TX 75024
214-473-7000
|
Women & Childrens
Hospital, LLC
|
|
DE
|
|
|
8062
|
|
|
62-1762556
|
|
5800 Tennyson Parkway
Plano, TX 75024
214-473-7000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
State or Other
|
|
Primary Standard
|
|
|
|
|
Address, Including Zip Code, and
|
|
|
Jurisdiction of
|
|
Industrial
|
|
|
|
|
Telephone Number, Including
|
Exact Name of Registrant as
|
|
Incorporation or
|
|
Classification Code
|
|
|
I.R.S. Employer
|
|
Area Code, of Registrants
|
Specified in its Charter
|
|
Organization
|
|
Number
|
|
|
Identification No.
|
|
Principal Executive Offices
|
|
Woodland Heights Medical Center,
LLC
|
|
DE
|
|
|
8062
|
|
|
62-1762558
|
|
5800 Tennyson Parkway
Plano, TX 75024
214-473-7000
|
Woodward Health System, LLC
|
|
DE
|
|
|
8062
|
|
|
62-1762418
|
|
5800 Tennyson Parkway
Plano, TX 75024
214-473-7000
|
QHG Georgia Holdings, Inc.
|
|
GA
|
|
|
8062
|
|
|
58-2386459
|
|
5800 Tennyson Parkway
Plano, TX 75024
214-473-7000
|
QHG Georgia, L.P.
|
|
GA
|
|
|
8062
|
|
|
58-2387537
|
|
5800 Tennyson Parkway
Plano, TX 75024
214-473-7000
|
Frankfort Health Partner,
Inc.
|
|
IN
|
|
|
8062
|
|
|
35-2009540
|
|
5800 Tennyson Parkway
Plano, TX 75024
214-473-7000
|
IOM Health System, L.P.
|
|
IN
|
|
|
8062
|
|
|
35-1963748
|
|
5800 Tennyson Parkway
Plano, TX 75024
214-473-7000
|
QHG of Bluffton, Inc.
|
|
IN
|
|
|
8062
|
|
|
62-1792274
|
|
5800 Tennyson Parkway
Plano, TX 75024
214-473-7000
|
QHG of Clinton County, Inc.
|
|
IN
|
|
|
8062
|
|
|
35-2006952
|
|
5800 Tennyson Parkway
Plano, TX 75024
214-473-7000
|
QHG of Fort Wayne, Inc.
|
|
IN
|
|
|
8062
|
|
|
35-1946949
|
|
5800 Tennyson Parkway
Plano, TX 75024
214-473-7000
|
QHG of Warsaw, Inc.
|
|
IN
|
|
|
8062
|
|
|
62-1764509
|
|
5800 Tennyson Parkway
Plano, TX 75024
214-473-7000
|
QHG of Forrest County, Inc.
|
|
MS
|
|
|
8062
|
|
|
62-1704095
|
|
5800 Tennyson Parkway
Plano, TX 75024
214-473-7000
|
QHG of Hattiesburg, Inc.
|
|
MS
|
|
|
8062
|
|
|
62-1704097
|
|
5800 Tennyson Parkway
Plano, TX 75024
214-473-7000
|
River Region Medical Corporation
|
|
MS
|
|
|
8062
|
|
|
62-1576702
|
|
5800 Tennyson Parkway
Plano, TX 75024
214-473-7000
|
NC-DSH, Inc.
|
|
NV
|
|
|
8062
|
|
|
88-0305790
|
|
5800 Tennyson Parkway
Plano, TX 75024
214-473-7000
|
QHG of Barberton, Inc.
|
|
OH
|
|
|
8062
|
|
|
31-1472381
|
|
5800 Tennyson Parkway
Plano, TX 75024
214-473-7000
|
QHG of Massillon, Inc.
|
|
OH
|
|
|
8062
|
|
|
31-1472380
|
|
5800 Tennyson Parkway
Plano, TX 75024
214-473-7000
|
SouthCrest, L.L.C.
|
|
OK
|
|
|
8062
|
|
|
62-1723864
|
|
5800 Tennyson Parkway Plano, TX
75024
214-473-7000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
State or Other
|
|
Primary Standard
|
|
|
|
|
Address, Including Zip Code, and
|
|
|
Jurisdiction of
|
|
Industrial
|
|
|
|
|
Telephone Number, Including
|
Exact Name of Registrant as
|
|
Incorporation or
|
|
Classification Code
|
|
|
I.R.S. Employer
|
|
Area Code, of Registrants
|
Specified in its Charter
|
|
Organization
|
|
Number
|
|
|
Identification No.
|
|
Principal Executive Offices
|
|
Triad-South Tulsa Hospital
Company, Inc.
|
|
OK
|
|
|
8062
|
|
|
62-1678883
|
|
5800 Tennyson Parkway
Plano, TX 75024
214-473-7000
|
QHG of South Carolina, Inc.
|
|
SC
|
|
|
8062
|
|
|
62-1587267
|
|
5800 Tennyson Parkway
Plano, TX 75024
214-473-7000
|
QHG of Spartanburg, Inc.
|
|
SC
|
|
|
8062
|
|
|
57-1040117
|
|
5800 Tennyson Parkway
Plano, TX 75024
214-473-7000
|
Name, address, including zip code, and telephone number,
including area code, of agent for service
Rachel A.
Seifert
CHS/Community Health Systems, Inc.
Senior Vice President, Secretary and General Counsel
4000 Meridian Boulevard
Franklin, Tennessee 37067
(615) 465-7000
The
information in this prospectus is not complete and may be
changed. We may not sell these securities until the registration
statement filed with the Securities and Exchange Commission is
effective. The prospectus is not an offer to sell these
securities and is not soliciting an offer to buy these
securities in any state where the offer or sale is not
permitted.
|
SUBJECT TO COMPLETION, DATED
SEPTEMBER 24, 2007
PROSPECTUS
$3,021,331,000
CHS/Community Health Systems,
Inc.
Exchange Offer for
87/8% Senior
Notes due 2015
Offer for outstanding
87/8% Senior
Notes due 2015, in the aggregate principal amount of
$3,021,331,000 (which we refer to as the Old Notes)
in exchange for up to $3,021,331,000 in aggregate principal
amount of
87/8% Senior
Notes due 2015 which have been registered under the Securities
Act of 1933, as amended (which we refer to as the Exchange
Notes and, together with the Old Notes, the
notes).
Terms of
the Exchange Offer:
|
|
|
|
|
Expires 5:00 p.m., New York City
time, ,
2007, unless extended.
|
|
|
|
Not subject to any condition other than that the exchange offer
does not violate applicable law or any interpretation of the
staff of the Securities and Exchange Commission.
|
|
|
|
We can amend or terminate the exchange offer.
|
|
|
|
We will exchange all
87/8% Senior
Notes due 2015 that are validly tendered and not validly
withdrawn.
|
|
|
|
We will not receive any proceeds from the exchange offer.
|
|
|
|
The exchange of notes will not be a taxable exchange for
U.S. federal income tax purposes.
|
|
|
|
You may withdraw tendered outstanding Old Notes any time before
the expiration of the exchange offer.
|
Terms of
the Exchange Notes:
|
|
|
|
|
The Exchange Notes will be general unsecured obligations and
will rank equally in right of payment with all existing and
future unsecured senior debt, senior in right of payment to all
existing and future senior subordinated debt and effectively
subordinated in right of payment to secured indebtedness to the
extent of the value of the assets securing such indebtedness,
including all borrowings under senior secured credit facilities.
|
|
|
|
The Exchange Notes mature on July 15, 2015. The Exchange
Notes will bear interest semi-annually in cash in arrears on
January 15 and July 15 of each year, commencing on
January 15, 2008.
|
|
|
|
We may redeem the Exchange Notes in whole or in part from time
to time. See Description of Exchange Notes.
|
|
|
|
We may also redeem up to 35% of the aggregate principal amount
of the Exchange Notes using the proceeds of certain equity
offerings completed before July 15, 2010. See
Description of Exchange Notes.
|
|
|
|
The terms of the Exchange Notes are identical to our outstanding
Old Notes except for transfer restrictions and registration
rights.
|
For a discussion of specific risks that you should consider
before tendering your outstanding
87/8% Senior
Notes due 2015 in the exchange offer, see Risk
Factors beginning on page 14.
There is no public market for the Old Notes or the Exchange
Notes, However, you may trade the Old Notes in the Private
Offering Resale and Trading through Automatic Linkages, or
PORTALtm,
market.
Each broker-dealer that receives Exchange Notes pursuant to the
exchange offer must acknowledge that it will deliver a
prospectus in connection with any resale of the Exchange Notes.
A broker dealer who acquired Old Notes as a result of market
making or other trading activities may use this exchange offer
prospectus, as supplemented or amended, in connection with any
resales of the Exchange Notes.
Neither the Securities and Exchange Commission nor any state
securities commission has approved or disapproved of the
Exchange Notes or determined if this prospectus is truthful or
complete. Any representation to the contrary is a criminal
offense.
The date of this prospectus
is ,
2007
You should rely only on the information contained in this
prospectus. We have not authorized anyone to provide you with
information different from that contained in this prospectus.
The selling noteholders are offering to sell, and seeking offers
to buy,
87/8% Senior
Notes due 2015 only in jurisdictions where offers and sales are
permitted. The information contained in this prospectus is
accurate only as of the date of this prospectus, regardless of
the time of delivery of this prospectus or of any sale of our
87/8% Senior
Notes due 2015.
TABLE OF
CONTENTS
i
The following summary should be read in conjunction with, and
is qualified in its entirety by, the more detailed information
and financial statements (including the accompanying notes)
appearing elsewhere in this prospectus or incorporated by
reference herein. You should carefully read this prospectus and
the information incorporated by reference herein, including the
section entitled Risk Factors and the pro forma
financial data, which gives effect to our acquisition of Triad,
the offering of the Old Notes, the additional debt financings to
fund the purchase price for the acquisition of Triad and certain
other transactions.
Unless otherwise indicated or the context requires otherwise,
references in this prospectus to CHS,
we, our, us and the
Company refer to Community Health Systems, Inc. and its
consolidated subsidiaries, including CHS/Community Health
Systems, Inc., the issuer of the Notes, both before and after
the consummation of the Merger, as defined below. References to
the Issuer refer to CHS/Community Health Systems,
Inc. alone, and references to Holdings refer to
Community Health Systems, Inc. alone. Triad refers
to Triad Hospitals, Inc. and its consolidated subsidiaries
unless the context otherwise requires. Financial information
identified in this prospectus as pro forma gives
effect to the closing of the Transactions. See Unaudited
Pro Forma Condensed Financial Statements.
Our
Company
We are the largest non-urban provider of general hospital
healthcare services in the United States in terms of number of
facilities and net operating revenues. As of July 25, 2007,
prior to the acquisition of Triad, we owned, leased or operated
79 hospitals, geographically diversified across 23 states,
with an aggregate of 9,550 licensed beds. We generate revenues
by providing a broad range of general hospital healthcare
services to patients in the communities in which we are located.
Services provided by our hospitals include emergency room
services, general surgery, critical care, internal medicine,
obstetrics and diagnostic services. As part of providing these
services, we also own physician practices, imaging centers, home
health agencies and ambulatory surgery centers. Our net
operating revenues for the year ended December 31, 2006 and
for the six months ended June 30, 2007 were
$4,366 million and $2,453 million, respectively.
Historically, we have grown by acquiring hospitals and by
improving the operations of our facilities. We targeted
hospitals in growing, non-urban healthcare markets for
acquisition because of their favorable demographic and economic
trends and competitive conditions. Because non-urban service
areas have smaller populations, there are generally fewer
hospitals and other healthcare service providers in these
communities and a lower level of managed care presence in these
markets. We believe that smaller populations support less direct
competition for hospital-based services. Over the past several
years, we also have expanded our focus beyond these non-urban
markets, acquiring larger facilities in more urban markets.
Based on our experience and our observations about our industry,
we have recognized that more rapid growth opportunities exist
for a skillful and disciplined operator in selected larger
markets.
On July 25, 2007, we acquired Triad, a publicly-owned
hospital company. Triad provides a broad range of general
hospital healthcare services to patients in non-urban and
mid-size markets located primarily in the southern, midwestern
and western United States. As of July 25, 2007, Triad
owned, leased or operated 50 hospitals in 17 states,
with an aggregate of approximately 9,600 licensed beds. Upon
closing of the acquisition, we became the largest publicly-owned
provider of hospital services, operating 129 hospitals in
28 states with an aggregate of approximately 19,200
licensed beds. Pro forma for the Triad acquisition, our net
operating revenues for the year ended December 31, 2006 and
for the six months ended June 30, 2007 would have been
$9,903 million and $5,429 million, respectively. In
connection with the consummation of the merger the Company
obtained $7,215 million of senior secured financing under a
new credit facility (the New Credit Facility) and
its wholly-owned subsidiary, CHS/Community Health Systems, Inc.
issued the Old Notes at the closing of the merger. We also refer
to the acquisition of Triad as the Merger. See Unaudited
Pro Forma Condensed Financial Statements.
1
We believe the Triad acquisition will:
|
|
|
|
|
complement our non-urban market presence with mid-size markets
having greater population growth than non-urban markets and less
competition than major metropolitan markets;
|
|
|
|
increase the scale of our operations, enabling us to realize
corporate overhead efficiencies and purchasing savings;
|
|
|
|
increase our operating growth and profitability as we centralize
certain functions and standardize best practices across these
facilities; and
|
|
|
|
increase our presence in 12 states and expand into five new
states.
|
Our
Strengths
We believe the following strengths will allow us to continue to
improve our operations and profitability:
Leading local market provider. We are a
leading provider of acute care services in the markets we serve.
As of June 30, 2007, we are one of three or fewer providers
in approximately 98% of our markets, and we are the sole
provider in approximately 85% of our markets. We have focused on
non-urban markets with strong demographic growth and underserved
medical populations. In general, reimbursement is more favorable
in these markets than in markets with more direct competition
for hospital-based services. In some of our markets, we receive
higher reimbursement rates from Medicare for designated sole
community hospitals. Additionally, our leading market position
enables us to achieve a strong return on investments in facility
expansion and physician recruitment. As of June 30, 2007,
pro forma for the Triad acquisition, we are one of three or
fewer providers in approximately 86% of our markets and the sole
provider in approximately 65% of our markets.
Geographic diversity and operating scale. We
operated 79 hospitals in 23 states as of July 25,
2007, prior to the acquisition of Triad. With our acquisition of
Triad, we have expanded into five new states and operate 129
hospitals across 28 states. Pro forma for the Triad
acquisition, our 2006 revenue exposure to any one state is less
than 13% (as compared to less than 21% for us prior to the
acquisition). Our geographic diversity helps to mitigate risk
associated with fluctuating state regulations related to
Medicaid reimbursement and state-specific economic conditions.
Furthermore, we believe our current operations, together with
those we acquired from Triad, will enable us to realize the
benefits of economies of scale, purchasing power and increased
operating efficiencies.
Strong presence in attractive markets. The
underserved non-urban markets, on which we have historically
focused, provide an attractive environment for our operations.
With fewer hospitals and healthcare providers and generally a
lower level of managed care penetration, these markets allow us
to profitably provide much needed acute care services. We
believe the Triad acquisition expands our presence in non-urban
markets and complements our non-urban focus, as Triads
mid-size markets have greater population growth than non-urban
markets. Triads facilities also enjoy strong patient and
physician loyalty and have less direct competition than
hospitals in major metropolitan markets.
Emphasis on quality of care. We have developed
significant expertise in implementing a variety of programs to
ensure continuous improvement in the quality of care provided at
our hospitals. This is an evolving aspect of our business, as
payors and accrediting agencies expand their views of quality to
include measurement, reporting and continual improvement of the
timeliness, safety, effectiveness, efficiency and
patient-centeredness of clinical care. We understand that high
levels of clinical care are only achieved when
quality is a company-wide leadership focus that
embraces patient, physician and employee satisfaction and
continual, systematic improvements. Seeking the highest levels
of improvement typically yields the best results for patients,
reduces risk and improves our financial performance. We have
developed and implemented programs to support and monitor
quality of care improvement that include:
|
|
|
|
|
standardized data and benchmarks to assist and monitor hospital
quality improvement efforts;
|
|
|
|
recommended policies and procedures based on the best medical
and scientific evidence;
|
2
|
|
|
|
|
hospital-based training and coaching to achieve success with
respect to expectations of accrediting agencies;
|
|
|
|
training programs for hospital management and clinical staff
regarding regulatory and reporting requirements, as well as
skills in leadership, communications and service;
|
|
|
|
sharing of best practices for regulatory compliance and
performance improvement; and
|
|
|
|
evidence-based tools for improving patient, physician and staff
satisfaction.
|
Strong history of generating revenue growth and improving
profitability. Since 2001, we have grown from 57
to 79 hospitals and have increased revenue from
$1,657 million to $4,366 million, and income from
continuing operations from $44.7 million to
$171.5 million for the year ended December 31, 2006
(2001 numbers are not restated for insignificant discontinued
operations). We have improved profitability by recruiting
primary care physicians and specialists, expanding our service
offerings to include more complex care, optimizing our emergency
room strategy across our portfolio of hospitals and selectively
making capital investments in projects that generate a high
return on investment. Upon closing of the Triad acquisition, we
believe that a significant opportunity exists to continue to
improve profitability, as approximately 30% of the combined
companys facilities have been acquired within the past
four years.
Experienced management team with a proven track
record. We have a strong and committed management
team that has substantial industry knowledge and a proven track
record of operations success in the hospital industry. Our chief
executive officer and chief financial officer each have over
30 years of experience in the healthcare industry and have
worked together since 1973. Our management team has successfully
acquired and integrated 55 hospitals, and we believe this
experience positions us well to integrate and improve the
operations of the Triad facilities in addition to successfully
executing our business strategy.
Our
Strategy
We intend to continue to grow our business and improve our
financial performance by implementing our business strategy, the
key elements of which are to:
Increase revenues at our facilities. We intend
to increase revenues at our facilities by providing a broader
range of services in a more attractive care setting. Our primary
method of expanding medical services is recruiting additional
primary care physicians and specialists. We intend to continue
to expand the breadth of services offered at our hospitals
through targeted capital expenditures to support the addition of
more complex services, including orthopedics, cardiovascular
services and urology. We also provide the capital to invest in
technology and the physical plant at our facilities,
particularly in our emergency rooms, surgery/critical care
departments and diagnostic services. For example, as part of our
successful and ongoing emergency room enhancement strategy, we
have implemented a standardized management system across all of
our facilities. Emergency rooms represent approximately 60% of
our hospital admissions, and we believe the Triad acquisition
presents an additional growth opportunity as Triad has not
pursued a similar emergency room enhancement strategy.
Additionally, we believe a number of our standardized practices,
including centralized physician recruiting, managed care
contracting, facilities management and resource and case
management programs, can be successfully applied to Triads
facilities.
Increase operating efficiencies to improve
profitability. We continually focus on improving
operating efficiency to increase our operating margins. We seek
to reduce costs and enhance efficiency through various methods
and across the broad spectrum of our operations, including:
|
|
|
|
|
standardizing and centralizing our methods of operation and
management;
|
|
|
|
improving quality of care and patient, physician and staff
satisfaction;
|
|
|
|
implementing management and healthcare industry best practices,
which drive efficiencies in areas as diverse and wide-ranging as
adjusting staffing levels to patient volume and acuity, and
adopting drug formularies;
|
3
|
|
|
|
|
utilizing our proven case and resource management program, which
guides our hospitals in the allocation and application of
resources, which assists in optimizing clinical care and, in
turn, containing expenses;
|
|
|
|
capitalizing on our participation in a wide range of group
purchasing arrangements by monitoring and ensuring compliance by
our hospitals with the terms of those purchasing
arrangements; and
|
|
|
|
utilizing standardized management information systems
appropriate for the size and complexity of a particular hospital.
|
Complete successful integration of Triad. We
have successfully acquired and integrated 55 hospitals since
1996 and our focus over the next two years will be to
successfully integrate the acquisition of Triad. We have an
established, experienced and dedicated team to manage the
integration of Triad. We believe that, in the first year
following the acquisition of Triad, we will realize
approximately $28 million of annual cost savings related to
cash expenses from the elimination of certain head count
reductions and the elimination of certain duplicate overhead
costs. We anticipate that we will realize additional savings
from improved pricing opportunities under our purchasing
contracts, the elimination of certain other duplicate corporate
overhead costs and the implementation of other cost saving
initiatives that management has identified. Additionally, we
intend to continue to pursue a disciplined approach in making
capital investments that generate a high return on investment,
and will apply this focus to our acquired hospitals. Over the
last four years, Triad has invested approximately
$1,573 million (or approximately 9% of revenues) into its
facilities. We believe we can leverage these already
well-capitalized facilities and increase operating efficiencies
and profitability.
Deleverage balance sheet. Historically, we
have generated relatively strong and stable cash flow which has
allowed us to fund our growth-related investments while
maintaining reasonable leverage levels. From March 31, 2000
(prior to the June, 2000 initial public offering of our common
stock) to June 30, 2007, our debt as a percentage of total
capitalization decreased from 86.6% to 51.8%. We intend to
continue our strategy of utilizing cash flows from our combined
operations to service debt and to fund our future growth
initiatives. We will also consider issuing equity or
equity-related securities or divesting selected hospital
facilities to deleverage our balance sheet.
Our
Industry
The U.S. healthcare industry is large and growing. The
Centers for Medicare and Medicaid Services, or CMS, reported
that in 2005, total U.S. healthcare expenditures grew by
6.9% to $2.0 trillion. It also projected total
U.S. healthcare spending to grow by 6.8% in 2006 and by an
average of 6.9% per year through 2015. By these estimates,
healthcare expenditures will account for approximately $3.9
trillion, or 19.2% of the total U.S. gross domestic
product, by 2015.
Hospital services, the market in which we operate, is the
largest single category of healthcare at 31% of total healthcare
spending in 2005, or $611.6 billion, as reported by CMS.
CMS projects the hospital services market to grow by an average
of 7.0% per year through 2015. It expects growth in hospital
healthcare spending to continue due to the aging of the
U.S. population and consumer demand for expanded medical
services. As hospitals remain the primary setting for healthcare
delivery, CMS expects hospital services to remain the largest
category of healthcare spending.
We believe that we are well-positioned to benefit from the
expected growth in hospital spending as well as shifts in
demographics in the United States. According to the
U.S. Census Bureau, there are approximately
36.9 million Americans age 65 or older in the United
States, who comprise approximately 13% of the total
U.S. population. By the year 2030, the number of elderly is
expected to climb to 71.5 million, or 20% of the total
population. Due to the increasing life expectancy of Americans,
the number of people aged 85 years and older is also
expected to increase from 4.3 million to 9.6 million
by the year 2030. This increase in life expectancy will increase
demand for healthcare services and, as importantly, the demand
for innovative, more sophisticated means of delivering those
services. Hospitals, as the largest category of care in the
healthcare market, will be among the main beneficiaries of this
increase in demand. Based on data compiled for us, the
populations of the service areas where our current hospitals are
located grew 19.6% from 1990 to 2005, and
4
are expected to grow 4.9% from 2005 to 2010. The number of
people aged 55 or older in these service areas grew 25.8% from
1990 to 2005, and is expected to grow 12.7% from 2005 to 2010.
We believe that the aging of the population will benefit both
non-urban and mid-size markets, particularly in the southern
regions in which we operate.
The acute care hospital sector is characterized by a stable
Medicare reimbursement and commercial pricing environment. In
the United States, general acute care hospitals are instrumental
to the delivery of quality healthcare and represent a critical
element of the overall healthcare infrastructure. Approximately
82% of these hospitals are owned and managed by not-for-profit
or government entities that, according to the American Hospital
Association, or the AHA, tend to have lower operating margins
than investor-owned hospitals. We believe that Medicare, which
accounts for approximately 30% of total hospital spending, will
continue to provide appropriate pricing increases that will
enable hospitals to provide high quality clinical care. For
fiscal 2007, Medicare has budgeted a total payment increase of
$3,400 million for acute care inpatient services, which we
believe is consistent with recent historical experience. CMS
forecasts Medicare hospital spending to nearly double over the
next 10 years.
Commercial pricing has also been stable for hospital providers,
and we believe that commercial payors typically offer rate
increases that exceed those offered by Medicare. With respect to
commercial reimbursement, based on our experience,
well-positioned hospital companies generally have been
successful at receiving mid- to high single-digit private pay
increases over the past few years, and we expect this trend to
continue.
Our
Corporate Information
Community Health Systems, Inc. was incorporated in Delaware on
June 6, 1996. CHS/Community Health Systems, Inc. was
incorporated in Delaware on March 25, 1985. Our principal
executive offices are located at 4000 Meridian Boulevard,
Franklin, Tennessee 37067, and our telephone number is
(615) 465-7000.
Our website is www.chs.net. Information on our website shall
not be deemed part of this prospectus.
The
Transactions
On July 25, 2007, we acquired Triad, a publicly-owned
hospital company. Triad provides a broad range of general
hospital healthcare services to patients in non-urban and
mid-size markets located primarily in the southern, midwestern
and western United States. As of July 25, 2007, prior to
the acquisition, Triad owned, leased or operated 50 hospitals in
17 states, with an aggregate of approximately 9,600
licensed beds. Upon closing of the acquisition, we have become
the largest publicly-owned provider of hospital services,
operating 129 hospitals in 28 states with an aggregate of
approximately 19,200 licensed beds. Pro forma for the Triad
acquisition, our net operating revenues for the year ended
December 31, 2006 and for the six months ended
June 30, 2007 would have been $9,903 million and
$5,429 million, respectively. See Unaudited Pro Forma
Condensed Financial Information.
5
Purpose
of the Exchange Offer
On July 25, 2007, we sold, through a private placement
exempt from the registration requirements of the Securities Act,
$3,021,331,000 of our
87/8% Senior
Notes due 2015, all of which are eligible to be exchanged for
Exchange Notes. We refer to these notes as Old Notes
in this prospectus.
Simultaneously with the private placement, we entered into a
registration rights agreement with the initial purchasers of the
Old Notes. Under the registration rights agreement, we are
required to use our reasonable best efforts to cause a
registration statement for substantially identical Notes, which
will be issued in exchange for the Old Notes, to be filed within
90 days and to become effective on or within 210 days
of issuance of the Old Notes. We refer to the Notes to be
registered under this exchange offer registration statement as
Exchange Notes and collectively with the Old Notes,
we refer to them as the Notes in this prospectus.
You may exchange your Old Notes for Exchange Notes in this
exchange offer. You should read the discussion under the
headings Summary of the Exchange Offer,
The Exchange Offer and Description of Exchange
Notes for further information regarding the Exchange Notes.
We did not register the Old Notes under the Securities Act or
any state securities law, nor do we intend to after the exchange
offer. As a result, the Old Notes may only be transferred in
limited circumstances under the securities laws. If the holders
of the Old Notes do not exchange their Old Notes in the exchange
offer, they lose their right to have the Old Notes registered
under the Securities Act, subject to certain limitations. Anyone
who still holds Old Notes after the exchange offer may be unable
to resell their Old Notes.
Summary
of the Exchange Offer
The
Exchange Offer
|
|
|
Securities Offered |
|
$3,021,331,000 aggregate principal amount of
87/8% Senior
Notes due 2015. |
|
The Exchange Offer |
|
We are offering to exchange the Old Notes for a like principal
amount at maturity of the Exchange Notes. Old Notes may be
exchanged only in integral principal multiples of $1,000. This
exchange offer is being made pursuant to a registration rights
agreement dated as of July 25, 2007 which granted the
initial purchasers and any subsequent holders of the Old Notes
certain exchange and registration rights. This exchange offer is
intended to satisfy those exchange and registration rights with
respect to the Old Notes. After the exchange offer is complete,
you will no longer be entitled to any exchange or registration
rights with respect to your Old Notes. |
|
Expiration Date; Withdrawal of Tender
|
|
The exchange offer will expire 5:00 p.m., New York City
time,
on ,
2007, or a later time if we choose to extend this exchange
offer. You may withdraw your tender of Old Notes at any time
prior to the expiration date. All outstanding Old Notes that are
validly tendered and not validly withdrawn will be exchanged.
Any Old Notes not accepted by us for exchange for any reason
will be returned to you at our expense as promptly as possible
after the expiration or termination of the exchange offer. |
|
Resales |
|
We believe that you can offer for resale, resell and otherwise
transfer the Exchange Notes without complying with the
registration and prospectus delivery requirements of the
Securities Act if: |
|
|
|
you acquire the Exchange Notes in the ordinary
course of business;
|
6
|
|
|
|
|
you are not participating, do not intend to
participate, and have no arrangement or understanding with any
person to participate, in the distribution of the Exchange Notes;
|
|
|
|
you are not an affiliate of ours, as
defined in Rule 405 of the Securities Act; and
|
|
|
|
you are not a broker-dealer.
|
|
|
|
If any of these conditions is not satisfied and you transfer any
Exchange Notes without delivering a proper prospectus or without
qualifying for a registration exemption, you may incur liability
under the Securities Act. We do not assume, or indemnify you
against, this liability. |
|
|
|
Each broker-dealer acquiring Exchange Notes issued for its own
account in exchange for Old Notes, which it acquired through
market-making activities or other trading activities, must
acknowledge that it will deliver a proper prospectus when any
Exchange Notes issued in the exchange offer are transferred. A
broker-dealer may use this prospectus for an offer to resell, a
resale or other retransfer of the Exchange Notes issued in the
exchange offer. |
|
Conditions to the Exchange Offer |
|
Our obligation to accept for exchange, or to issue the Exchange
Notes in exchange for, any Old Notes is subject to certain
customary conditions relating to compliance with any applicable
law, or any applicable interpretation by any staff of the
Securities and Exchange Commission, or any order of any
governmental agency or court of law. We currently expect that
each of the conditions will be satisfied and that no waivers
will be necessary. See The Exchange Offer
Conditions to the Exchange Offer. |
|
Procedures for Tendering Notes Held in the Form of
Book-Entry Interests
|
|
The Old Notes were issued as global securities and were
deposited upon issuance with U.S. Bank National Association
which issued uncertificated depositary interests in those
outstanding Old Notes, which represent a 100% interest in those
Old Notes, to The Depositary Trust Company. |
|
|
|
Beneficial interests in the outstanding Old Notes, which are
held by direct or indirect participants in the Depository
Trust Company, are shown on, and transfers of the Old Notes
can only be made through, records maintained in book-entry form
by The Depository Trust Company. |
|
|
|
You may tender your outstanding Old Notes by instructing your
broker or bank where you keep the Old Notes to tender them for
you. In some cases you may be asked to submit the BLUE-colored
Letter of Transmittal that may accompany this
prospectus. By tendering your Old Notes you will be deemed to
have acknowledged and agreed to be bound by the terms set forth
under The Exchange Offer. Your outstanding Old Notes
will be tendered in multiples of $1,000. |
7
|
|
|
|
|
A timely confirmation of book-entry transfer of your outstanding
Old Notes into the exchange agents account at The
Depository Trust Company, under the procedure described in
this prospectus under the heading The Exchange Offer
must be received by the exchange agent on or before
5:00 p.m., New York City time, on the expiration date. |
|
United States Federal Income Tax Considerations
|
|
The exchange offer should not result in any income, gain or loss
to the holders of old notes or to us for United States Federal
Income Tax Purposes. See Certain U.S. Federal Income Tax
Considerations. |
|
Use of Proceeds |
|
We will not receive any proceeds from the issuance of the
Exchange Notes in the exchange offer. We used the net proceeds
from the sale of the Old Notes, together with borrowings under
our New Credit Facility, to fund the Transactions, to pay fees
and expenses and for general corporate purposes. See Use
of Proceeds. |
|
Exchange Agent |
|
U.S. Bank National Association is serving as the exchange agent
for the exchange offer. |
|
Shelf Registration Statement |
|
In limited circumstances, holders of Old Notes may require us to
register their Old Notes under a shelf registration statement. |
8
Description
of the Exchange Notes
|
|
|
Issuer |
|
CHS/Community Health Systems, Inc. |
|
Notes Offered |
|
$3,021,331,000 aggregate principal amount of
87/8%
Exchange Notes due 2015. |
|
Maturity Date |
|
July 15, 2015. |
|
Interest Payment Dates |
|
January 15 and July 15 of each year, commencing on
January 15, 2008. |
|
Guarantees |
|
The Exchange Notes will be unconditionally guaranteed on a
senior basis by Holdings and certain of our current and future
domestic subsidiaries. |
|
|
|
On a pro forma basis, our non-guarantor subsidiaries would have
accounted for approximately $2,006 million, or 37%, of our
total revenue for the six months ended June 30, 2007, and
approximately $4,370 million, or 33%, of our total assets,
and approximately $1,397 million, or 12%, of our total
liabilities, in each case as of June 30, 2007. To the
extent that the purchase price allocation changes the valuation
of guarantor and non-guarantor assets and liabilities, the ratio
of non-guarantor assets and liabilities to total assets and
liabilities could change. |
|
Ranking |
|
The Exchange Notes and guarantees thereof will: |
|
|
|
be effectively subordinated to all of our and the
guarantors obligations under all secured indebtedness,
including any borrowings under our New Credit Facility to the
extent of the value of the assets securing such obligations, and
be effectively subordinated to all obligations of each of our
subsidiaries that is not a guarantor of the Exchange Notes;
|
|
|
|
rank pari passu in right of payment with all
of our and the guarantors existing and future unsecured
senior indebtedness; and
|
|
|
|
rank senior in right of payment to all of our and
the guarantors future subordinated indebtedness.
|
|
|
|
As of June 30, 2007, on a pro forma basis after giving
effect to the Transactions, we would have had approximately
$6,133 million aggregate principal amount of senior secured
indebtedness outstanding, and an additional $1,150 million
that we would have been able to borrow under our New Credit
Facility, to which the Exchange Notes would have been
effectively subordinated to the extent of the value of the
collateral. |
|
Optional Redemption |
|
Prior to July 15, 2011, we may redeem some or all of the
Exchange Notes at a redemption price equal to 100% of the
principal amount of the Exchange Notes plus accrued and unpaid
interest and additional interest, if any, to the applicable
redemption date plus the applicable make-whole
premium set forth in this prospectus. |
|
|
|
We may redeem some or all of the Exchange Notes at any time and
from time to time on or after July 15, 2011, at the
redemption |
9
|
|
|
|
|
price set forth in this prospectus. In addition, at any time
prior to July 15, 2010, we may redeem up to 35% of the
aggregate principal amount of the Exchange Notes with the
proceeds of certain equity offerings. See Description of
the Exchange Notes Optional Redemption. |
|
Change of Control |
|
If a change of control occurs, each holder of Exchange Notes
will have the right to require us to purchase all or a portion
of its Exchange Notes at 101% of the principal amount of the
Exchange Notes on the date of purchase, plus any accrued and
unpaid interest to the date of repurchase. See Description
of the Exchange Notes Change of Control. |
|
Certain Covenants |
|
The indenture governing the Exchange Notes contains covenants
that, among other things, limit our ability and the ability of
our restricted subsidiaries to: |
|
|
|
incur or guarantee additional indebtedness;
|
|
|
|
pay dividends or make other restricted payments;
|
|
|
|
make certain investments;
|
|
|
|
create or incur certain liens;
|
|
|
|
sell assets and subsidiary stock;
|
|
|
|
transfer all or substantially all of our assets or
enter into merger or consolidation transactions; and
|
|
|
|
enter into transactions with our affiliates.
|
|
|
|
However, these limitations are subject to a number of important
qualifications and exceptions. See Description of the
Exchange Notes Certain Covenants. |
|
Use of Proceeds |
|
We will not receive any proceeds from the issue of the Exchange
Notes. We used the net proceeds from the sale of the Old Notes,
together with borrowings under our New Credit Facility, to fund
the Transactions to pay fees and expenses and for general
corporate uses. See Use of Proceeds. |
Risk
Factors
Investing in the Exchange Notes involves substantial risk. See
Risk Factors for a discussion of certain factors
that you should consider before investing in the Exchange Notes.
10
SUMMARY
HISTORICAL AND PRO FORMA FINANCIAL AND OTHER DATA
COMMUNITY
HEALTH SYSTEMS, INC.
The following table sets forth a summary of our selected
consolidated historical financial data as of and for the periods
presented. The summary historical financial information, except
for Other Financial Data and Operating
Data, as of December 31, 2005 and 2006, and for each
of the fiscal years ended December 31, 2004, 2005 and 2006,
have been derived from our audited consolidated financial
statements incorporated by reference in this prospectus. The
consolidated balance sheet and statement of operations data as
of and for the years ended December 31, 2002 and 2003 were
derived from our audited consolidated financial statements, not
included herein, giving effect to adjustments for discontinued
operations. The summary historical financial information, except
for Other Financial Data and Operating
Data, for the six month periods ended June 30, 2006
and June 30, 2007, have been derived from our unaudited
interim condensed consolidated financial statements incorporated
by reference in this prospectus. In the opinion of management,
the unaudited interim financial data includes all adjustments,
consisting of only normal non-recurring adjustments, considered
necessary for a fair presentation of this information. The
results of operations for interim periods are not necessarily
indicative of the results that may be expected for the entire
year. The following data should be read in conjunction with our
consolidated financial statements and related Exchange Notes,
Managements Discussion and Analysis of Financial
Condition and Results of Operations and other financial
information included or incorporated by reference in this
prospectus.
The summary unaudited pro forma financial data as of and for the
six months ended June 30, 2007 have been prepared to give
effect to the Transactions in the manner described under
Unaudited Pro Forma Condensed Financial Information
and the Exchange Notes thereto as if they had occurred on
January 1, 2006, in the case of the summary unaudited pro
forma condensed income statement, and on June 30, 2007, in
the case of the summary unaudited pro forma condensed balance
sheet. The pro forma adjustments are based upon available
information and certain assumptions that we believe are
reasonable. The summary unaudited pro forma financial and other
data are for informational purposes only and do not purport to
represent what our results of operations, balance sheet data or
other financial information actually would have been if the
Transactions had occurred at any other date, and such data do
not purport to project the results of operations for any future
period or our financial condition as of any future date.
The summary historical and unaudited pro forma financial and
other data should be read in conjunction with Unaudited
Pro Forma Condensed Financial Information, Selected
Historical Financial Data, Managements
Discussion and Analysis of Financial Condition and Results of
Operations and our audited and unaudited consolidated
financial statements and related Exchange Notes appearing
elsewhere or incorporated by reference in this prospectus.
11
SUMMARY
HISTORICAL AND PRO FORMA FINANCIAL AND OTHER DATA
COMMUNITY
HEALTH SYSTEMS, INC.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Pro Forma
|
|
|
Pro Forma
|
|
|
|
|
|
|
Six Months Ended
|
|
|
Six Months Ended
|
|
|
Year Ended
|
|
|
|
Year Ended December 31,
|
|
|
June 30,
|
|
|
June 30,
|
|
|
December 31,
|
|
|
|
2004
|
|
|
2005
|
|
|
2006
|
|
|
2006
|
|
|
2007
|
|
|
2006
|
|
|
2007(1)
|
|
|
2006
|
|
|
|
(Dollars in thousands)
|
|
|
Income Statement Data:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net operating revenues
|
|
$
|
3,203,507
|
|
|
$
|
3,738,320
|
|
|
$
|
4,365,576
|
|
|
$
|
2,087,616
|
|
|
$
|
2,453,125
|
|
|
$
|
4,834,881
|
|
|
$
|
5,429,035
|
|
|
$
|
9,903,476
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Salaries and benefits
|
|
|
1,279,136
|
|
|
|
1,486,407
|
|
|
|
1,741,223
|
|
|
|
827,815
|
|
|
|
981,421
|
|
|
|
1,959,312
|
|
|
|
2,230,381
|
|
|
|
4,012,202
|
|
Provision for doubtful accounts
|
|
|
324,643
|
|
|
|
377,596
|
|
|
|
547,781
|
|
|
|
223,295
|
|
|
|
284,360
|
|
|
|
472,169
|
|
|
|
587,924
|
|
|
|
1,124,681
|
|
Supplies
|
|
|
389,584
|
|
|
|
448,210
|
|
|
|
510,351
|
|
|
|
248,520
|
|
|
|
286,541
|
|
|
|
720,270
|
|
|
|
792,303
|
|
|
|
1,468,251
|
|
Rent
|
|
|
76,986
|
|
|
|
87,210
|
|
|
|
97,104
|
|
|
|
46,628
|
|
|
|
54,240
|
|
|
|
101,400
|
|
|
|
116,888
|
|
|
|
213,918
|
|
Other operating expenses
|
|
|
639,037
|
|
|
|
765,697
|
|
|
|
897,091
|
|
|
|
426,156
|
|
|
|
503,815
|
|
|
|
893,983
|
|
|
|
1,049,240
|
|
|
|
1,840,275
|
|
Minority interest in earnings
|
|
|
2,494
|
|
|
|
3,104
|
|
|
|
2,795
|
|
|
|
1,068
|
|
|
|
818
|
|
|
|
11,052
|
|
|
|
13,649
|
|
|
|
24,795
|
|
Equity in earnings of
unconsolidated subsidiaries
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(19,824
|
)
|
|
|
(23,608
|
)
|
|
|
(43,500
|
)
|
Depreciation and amortization
|
|
|
149,155
|
|
|
|
164,563
|
|
|
|
188,771
|
|
|
|
89,689
|
|
|
|
104,619
|
|
|
|
210,067
|
|
|
|
235,858
|
|
|
|
434,571
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total operating costs and expenses
|
|
|
2,861,035
|
|
|
|
3,332,787
|
|
|
|
3,985,116
|
|
|
|
1,863,171
|
|
|
|
2,215,814
|
|
|
|
4,348,429
|
|
|
|
5,002,635
|
|
|
|
9,075,193
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from operations
|
|
|
342,472
|
|
|
|
405,533
|
|
|
|
380,460
|
|
|
|
224,445
|
|
|
|
237,311
|
|
|
|
486,452
|
|
|
|
426,400
|
|
|
|
828,283
|
|
Interest expense, net
|
|
|
75,256
|
|
|
|
94,613
|
|
|
|
102,299
|
|
|
|
45,657
|
|
|
|
61,559
|
|
|
|
350,169
|
|
|
|
363,042
|
|
|
|
710,601
|
|
Loss from early extinguishment of
debt
|
|
|
788
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations
before income taxes
|
|
|
266,428
|
|
|
|
310,920
|
|
|
|
278,161
|
|
|
|
178,788
|
|
|
|
175,752
|
|
|
|
136,283
|
|
|
|
63,358
|
|
|
|
117,682
|
|
Provision for income taxes
|
|
|
104,071
|
|
|
|
120,782
|
|
|
|
106,682
|
|
|
|
69,165
|
|
|
|
67,665
|
|
|
|
53,104
|
|
|
|
34,072
|
|
|
|
46,344
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations
|
|
|
162,357
|
|
|
|
190,138
|
|
|
|
171,479
|
|
|
|
109,623
|
|
|
|
108,087
|
|
|
$
|
83,179
|
|
|
$
|
29,286
|
|
|
$
|
71,338
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Discontinued operations, net of
taxes
|
|
|
(10,924
|
)
|
|
|
(22,594
|
)
|
|
|
(3,216
|
)
|
|
|
(3,216
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
$
|
151,433
|
|
|
$
|
167,544
|
|
|
$
|
168,263
|
|
|
$
|
106,407
|
|
|
$
|
108,087
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Statement of Cash Flows
Data:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash flows provided by operating
activities
|
|
$
|
325,750
|
|
|
$
|
411,049
|
|
|
$
|
350,255
|
|
|
$
|
207,046
|
|
|
$
|
215,988
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash flows used in investing
activities
|
|
|
(318,479
|
)
|
|
|
(327,272
|
)
|
|
|
(640,257
|
)
|
|
|
(295,767
|
)
|
|
|
(309,270
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash flows (used in) provided by
financing activities
|
|
|
58,896
|
|
|
|
(62,167
|
)
|
|
|
226,460
|
|
|
|
8,770
|
|
|
|
74,073
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other Financial Data:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Capital expenditures
|
|
|
164,286
|
|
|
|
188,365
|
|
|
|
224,519
|
|
|
|
94,194
|
|
|
|
108,849
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating Data:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of hospitals at end of period
|
|
|
66
|
|
|
|
69
|
|
|
|
77
|
|
|
|
74
|
|
|
|
79
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of licensed beds at end of
period(2)
|
|
|
7,358
|
|
|
|
7,974
|
|
|
|
9,117
|
|
|
|
8,546
|
|
|
|
9,550
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Beds in service(3)
|
|
|
5,960
|
|
|
|
6,476
|
|
|
|
7,341
|
|
|
|
6,871
|
|
|
|
7,777
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Admissions(4)
|
|
|
267,390
|
|
|
|
291,633
|
|
|
|
326,235
|
|
|
|
157,214
|
|
|
|
175,763
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Adjusted admissions(5)
|
|
|
493,776
|
|
|
|
538,445
|
|
|
|
605,511
|
|
|
|
290,305
|
|
|
|
326,960
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Patient days(6)
|
|
|
1,091,889
|
|
|
|
1,204,001
|
|
|
|
1,334,728
|
|
|
|
654,822
|
|
|
|
717,654
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Average length of stay (days)(7)
|
|
|
4.1
|
|
|
|
4.1
|
|
|
|
4.1
|
|
|
|
4.2
|
|
|
|
4.1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Occupancy rate (beds in service)(8)
|
|
|
51.2
|
%
|
|
|
52.9
|
%
|
|
|
53.0
|
%
|
|
|
54.5
|
%
|
|
|
52.8
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
Net inpatient revenues as a
percentage of total net operating revenues
|
|
|
50.5
|
%
|
|
|
50.9
|
%
|
|
|
50.0
|
%
|
|
|
50.3
|
%
|
|
|
49.2
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
Net outpatient revenues as a
percentage of total net operating revenues
|
|
|
48.1
|
%
|
|
|
47.8
|
%
|
|
|
48.7
|
%
|
|
|
48.4
|
%
|
|
|
49.6
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance Sheet Data (end of
period):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Working capital
|
|
$
|
453,090
|
|
|
$
|
476,806
|
|
|
$
|
446,101
|
|
|
$
|
405,857
|
|
|
$
|
521,289
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Property and equipment
|
|
|
1,484,548
|
|
|
|
1,610,991
|
|
|
|
1,986,577
|
|
|
|
1,757,218
|
|
|
|
2,089,142
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents
|
|
|
82,498
|
|
|
|
104,108
|
|
|
|
40,566
|
|
|
|
24,157
|
|
|
|
21,357
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total assets
|
|
|
3,632,608
|
|
|
|
3,934,218
|
|
|
|
4,506,579
|
|
|
|
4,178,660
|
|
|
|
4,793,111
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total debt
|
|
|
1,831,735
|
|
|
|
1,667,624
|
|
|
|
1,941,177
|
|
|
|
1,677,604
|
|
|
|
1,999,997
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other long-term obligations
|
|
|
225,390
|
|
|
|
283,738
|
|
|
|
301,842
|
|
|
|
289,592
|
|
|
|
346,880
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders equity
|
|
$
|
1,239,991
|
|
|
$
|
1,564,577
|
|
|
$
|
1,723,673
|
|
|
$
|
1,698,299
|
|
|
$
|
1,860,967
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
The pro forma results include the historical results for
Holdings adjusted to include the historical results of Triad and
other pro forma adjustments to give effect to the Transactions
as previously described. |
12
|
|
|
(2) |
|
Licensed beds are the number of beds for which the appropriate
state agency licenses a facility which may vary in some
instances from beds actually available for patient use. |
|
(3) |
|
Beds in service are the number of beds that are readily
available for patient use. |
|
(4) |
|
Admissions represent the number of patients admitted for
inpatient treatment. |
|
(5) |
|
Adjusted admissions is a general measure of combined inpatient
and outpatient volume. We computed adjusted admissions by
multiplying admissions by gross patient revenues and then
dividing that number by gross inpatient revenues. |
|
(6) |
|
Patient days represent the total number of days of care provided
to inpatients. |
|
(7) |
|
Average length of stay (in days) represents the average number
of days inpatients stay in our hospitals. |
|
(8) |
|
We calculated occupancy rate percentages by dividing the average
daily number of inpatients by the weighted-average of beds in
service. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Pro Forma
|
|
|
|
|
|
|
|
|
|
|
|
|
Six Months
|
|
|
Pro Forma
|
|
|
|
|
|
|
Six Months
|
|
|
Ended
|
|
|
Year Ended
|
|
|
|
Year Ended December 31,
|
|
|
Ended June 30,
|
|
|
June 30,
|
|
|
December 31,
|
|
|
|
2002
|
|
|
2003
|
|
|
2004
|
|
|
2005
|
|
|
2006
|
|
|
2006
|
|
|
2007
|
|
|
2007
|
|
|
2006
|
|
|
Ratio of Earnings to Fixed
Charges
|
|
|
3.21
|
x
|
|
|
3.58
|
x
|
|
|
3.74
|
x
|
|
|
3.61
|
x
|
|
|
3.13
|
x
|
|
|
4.03
|
x
|
|
|
3.25
|
x
|
|
|
1.14
|
x
|
|
|
1.14
|
x
|
13
You should carefully consider the risk factors set forth
below, as well as the other information contained in this
prospectus. This prospectus contains forward-looking statements
that involve risk and uncertainties. Any of the following risks
could materially and adversely affect our business, financial
condition or results of operations. Additional risks and
uncertainties not currently known to us, or those we currently
view to be immaterial, may also materially and adversely affect
our business, financial condition or results of operations. In
such a case, you may lose all or part of your original
investment.
Risks
Related to the Exchange Notes
We may
not be able to generate sufficient cash to service all of our
indebtedness, including the notes, and we may be forced to take
other actions to satisfy our obligations under our indebtedness,
which may not be successful.
Our ability to make scheduled payments or to refinance our debt
obligations depends on our financial and operating performance,
which is subject to prevailing economic and competitive
conditions and to financial, business and other factors beyond
our control. We cannot assure you that we will maintain a level
of cash flows from operating activities sufficient to permit us
to pay the principal, premium, if any, and interest on our
indebtedness. See Forward-Looking Statements and
Managements Discussion and Analysis of Financial
Condition and Results of Operations Liquidity and
Capital Resources.
If our cash flows and capital resources are insufficient to fund
our debt service obligations, we may be forced to reduce or
delay capital expenditures, including those required for
operating our existing hospitals, for integrating our historical
acquisitions, including the Triad acquisition, or for future
acquisitions. We also may be forced to sell assets or
operations, seek additional capital or restructure or refinance
our indebtedness, including the notes. We cannot assure you that
we would be able to take any of these actions, that these
actions would be successful and permit us to meet our scheduled
debt service obligations, or that these actions would be
permitted under the terms of our existing or future debt
agreements, including our New Credit Facility and the indenture
governing the notes. For example, our New Credit Facility and
the indenture governing the notes restrict our ability to
dispose of assets and use the proceeds from any dispositions. We
may not be able to consummate those dispositions, and any
proceeds we receive may not be adequate to meet any debt service
obligations then due. See Description of Certain
Indebtedness and Description of the Exchange
Notes.
We are
a holding company and may not have access to sufficient cash to
make payments on the notes.
We are a holding company with no direct operations. Our
principal assets are the equity interests we hold in our
operating subsidiaries. As a result, we are dependent upon
dividends and other payments from our subsidiaries to generate
the funds necessary to meet our outstanding debt service and
other obligations. Our subsidiaries may not generate sufficient
cash from operations to enable us to make principal and interest
payments on our indebtedness, including the notes. In addition,
any payments of dividends, distributions, loans or advances to
us by our subsidiaries could be subject to legal and contractual
restrictions. Our subsidiaries are permitted under the terms of
our indebtedness, including the indenture governing the notes,
to incur additional indebtedness that may restrict payments from
those subsidiaries to us. The agreements governing the current
and future indebtedness of our subsidiaries may not permit those
subsidiaries to provide us with sufficient cash to fund payments
on the notes when due.
Our subsidiaries are separate and distinct legal entities, and
they may have (except to the extent of the guarantees) no
obligation, contingent or otherwise, to pay amounts due under
the notes or to make any funds available to pay those amounts,
whether by dividend, distribution, loan or other payment.
14
Our
variable rate indebtedness subjects us to interest rate risk,
which could cause our debt service obligations to increase
significantly.
Our borrowings under the New Credit Facility are expected to be,
at variable rates of interest, and expose us to interest rate
risk. If interest rates increase, our debt service obligations
on the variable rate indebtedness would increase even though the
amount borrowed remained the same, and our net income would
decrease.
Our pro forma cash interest expense, net, for the six months
ended June 30, 2007, would have been $365.8 million.
At June 30, 2007, pro forma for the Triad acquisition, a
fluctuation in interest rates of 0.125% on the New Credit
Facility would have resulted in a fluctuation in our cash
interest expense of approximately $3.9 million for the six
months ended June 30, 2007.
If we
default on our obligations to pay our indebtedness, we may not
be able to make payments on the notes.
Any default under the agreements governing our indebtedness,
including a default under our New Credit Facility that is not
waived by the required lenders, and the remedies sought by the
holders of indebtedness as a result of a default, could render
us unable to pay principal, premium, if any, and interest on the
notes and substantially decrease the market value of the notes.
If we are unable to generate sufficient cash flow and are
otherwise unable to obtain funds necessary to meet required
payments of principal, premium, if any, and interest on our
indebtedness, or if we otherwise fail to comply with the various
covenants, including financial and operating covenants, in the
instruments governing our indebtedness, including covenants in
the indenture governing the notes and our New Credit Facility,
we could be in default under the terms of the agreements
governing this indebtedness, including our New Credit Facility
and the indenture governing the notes. In the event of any
default, the holders of this indebtedness could elect to declare
all the funds borrowed to be due and payable, together with
accrued and unpaid interest, the lenders under our New Credit
Facility could elect to terminate their commitments under this
facility, cease making further loans and institute foreclosure
proceedings against our assets, and we could be forced into
bankruptcy or liquidation. If our operating performance
declines, we may in the future need to obtain waivers from the
required lenders under our New Credit Facility to avoid being in
default. If we breach our covenants under our New Credit
Facility and seek a waiver, we may not be able to obtain a
waiver from the required lenders. If this occurs, we would be in
default under our New Credit Facility, the lenders could
exercise their rights, as described above, and we could be
forced into bankruptcy or liquidation. See Description of
Certain Indebtedness and Description of the Exchange
Notes.
Your
ability to receive payments on these notes is junior to those
lenders who have a security interest in our assets to the extent
of the value of those assets.
Our obligations under the notes are unsecured, but our
obligations under the New Credit Facility are secured by an
interest in substantially all of our assets. CHS is a borrower
under the New Credit Facility and Holdings and certain of its
existing and future domestic and foreign subsidiaries have
guaranteed obligations under the New Credit Facility on a senior
secured basis. If we are declared bankrupt or insolvent, or if
we default under the New Credit Facility, the lenders could
declare all of the funds borrowed thereunder, together with
accrued interest, immediately due and payable. If we are unable
to repay such indebtedness, the lenders could foreclose on the
pledged assets to the exclusion of holders of the notes, even if
an event of default exists under the indenture at such time. In
such event, because the notes will not be secured by any of our
assets, it is possible that there would be no assets remaining
from which claims of the holders of notes could be satisfied or,
if any assets remained, they might be insufficient to satisfy
such claims fully. See Description of Certain
Indebtedness.
Claims
of holders of the notes will be structurally subordinated to
claims of creditors of our subsidiaries that do not guarantee
the notes.
As of the issue date, the notes will be guaranteed by certain of
our subsidiaries. Claims of holders of the notes will be
structurally subordinated to the claims of creditors of our
subsidiaries that do not guarantee the
15
notes, including trade creditors. All obligations of these
subsidiaries will have to be satisfied before any of the assets
of such subsidiaries would be available for distribution, upon a
liquidation or otherwise, to us or creditors of us, including
the holders of the notes.
We estimate, on a pro forma basis, our non-guarantor
subsidiaries would have accounted for approximately
$2,006 million, or 37%, of our total revenue for the
6 months ended June 30, 2007, and approximately
$4,370 million, or 33%, of our total assets, and
approximately $1,397 million, or 12%, of our total
liabilities, in each case as of June 30, 2007. To the
extent that the purchase price allocation changes the valuation
of guarantor and non-guarantor assets and liabilities, the ratio
of non-guarantor assets and liabilities to total assets and
liabilities could change.
We may
not be able to satisfy our obligations to holders of the notes
upon a change of control.
Upon the occurrence of a change of control, as
defined in the indenture governing the notes, the holders of the
notes will be entitled to require us to repurchase the
outstanding notes at a purchase price equal to 101% of the
principal amount of the notes plus accrued and unpaid interest,
if any, to the date of repurchase. Failure to make this
repurchase would result in a default under the indenture. Also,
our New Credit Facility may effectively prevent the purchase of
the notes by us if a change of control occurs and these lenders
do not consent to our purchase of the notes, unless all amounts
outstanding under the New Credit Facility are repaid in full.
Our failure to purchase or give a notice of purchase of the
notes would be a default under the indenture, which would in
turn be a default under the New Credit Facility. In addition, a
change of control may constitute an event of default under the
New Credit Facility. A default under the New Credit Facility
would result in a default under the indenture if the lenders
accelerate the debt under the New Credit Facility. Any future
credit agreements or other agreements to which we become a party
may contain similar restrictions and provisions. The exercise by
holders of the notes of their right to require us to repurchase
the notes could cause a default under our other debt agreements
due to the financial effect of these repurchases on us, even if
the change of control itself does not cause a default under the
indenture.
In the event of a change of control, we may not have sufficient
funds to repurchase the notes and to satisfy our other
obligations under the notes and any other indebtedness. The
source of funds for any purchase of notes would be available
cash or cash generated from other sources, which may not be
available. Upon the occurrence of a change of control, we could
seek to refinance our indebtedness or obtain a waiver from our
lenders, but it is possible that we would not be able to obtain
a waiver or refinance our indebtedness on commercially
reasonable terms, if at all. On the other hand, the provisions
in the indenture governing the notes regarding a change of
control could make it more difficult for a potential acquiror to
obtain control of us. See Description of the Exchange
Notes Change of Control.
The change of control provisions in the indenture governing the
notes may not protect you in the event we consummate a highly
leveraged transaction, reorganization, restructuring, merger or
other similar transaction, unless such transaction constitutes a
change of control under the indenture. Some of these
transactions may not involve a change in voting power or
beneficial ownership or, even if they do, may not involve a
change of the magnitude required under the definition of change
of control in the indenture to trigger our obligation to
repurchase the notes. Except as described above, the indenture
does not contain provisions that permit the holders of the notes
to require us to repurchase or redeem the notes in the event of
a takeover, recapitalization or similar transaction. Therefore,
if an event occurs that does not constitute a change of control
as defined under the indenture governing the notes, we will not
be required to make an offer to repurchase the notes, and you
may be required to hold your notes despite the event. See
Description of Certain Indebtedness and
Description of the Exchange Notes Change of
Control.
Subsidiary
guarantors will be automatically released from their obligations
under the New Credit Facility in a variety of circumstances,
which may cause those subsidiary guarantors to be released from
their guarantees of the notes.
While any obligations under the New Credit Facility remain
outstanding, any subsidiary guarantee of the notes may be
released without action by, or consent of, any holder of the
notes or the trustee under the
16
indenture governing the notes, if such subsidiary guarantor is
no longer a guarantor of obligations under the New Credit
Facility or any other indebtedness. See Description of
Certain Indebtedness and Description of the Exchange
Notes. Upon the closing of any asset sale permitted under
the New Credit Facility consisting of the sale of all of the
equity interests of any subsidiary guarantor, the obligations of
such subsidiary guarantor under the New Credit Facility will be
automatically discharged and released. In addition, if any
shares of a subsidiary guarantor are subject to certain
permitted interest transfers under the New Credit Facility,
including transfers of such shares in connection with permitted
joint ventures or permitted syndication transactions under the
New Credit Facility, the obligations of such subsidiary
guarantor under the New Credit Facility will be automatically
discharged and released. You will not have a claim as a creditor
against any subsidiary that is no longer a guarantor of the
notes, and the indebtedness and other liabilities, including
trade payables, whether secured or unsecured, of those
subsidiaries will effectively be senior to claims of noteholders.
Holdings
and some of our subsidiaries will guarantee the notes. Federal
and state statutes allow courts, under specific circumstances,
to void guarantees and require note holders to return payments
received from guarantors.
Under the terms of the indenture governing the notes, the notes
will be guaranteed by Holdings and certain of our subsidiaries
at the time of issuance. If Holdings or one of the subsidiaries
that is a guarantor of the notes becomes the subject of a
bankruptcy case or a lawsuit filed by unpaid creditors of any
such guarantor, the guarantees entered into by these guarantors
may be reviewed under the federal bankruptcy law and comparable
provisions of state fraudulent transfer laws. Under these laws,
a guarantee could be voided, or claims in respect of a guarantee
could be subordinated to other obligations of a guarantor, if,
among other things, the guarantor, at the time it incurred the
indebtedness evidenced by its guarantee:
|
|
|
|
|
received less than reasonably equivalent value or fair
consideration for entering into the guarantee; and
|
|
|
|
either:
|
|
|
|
|
|
was insolvent or rendered insolvent by reason of entering into
the guarantee; or
|
|
|
|
was engaged in a business or transaction for which the
guarantors remaining assets constituted unreasonably small
capital; or
|
|
|
|
intended to incur, or believed that it would incur, debts or
contingent liabilities beyond its ability to pay such debts or
contingent liabilities as they become due.
|
In such event, any payment by a guarantor pursuant to its
guarantee could be voided and required to be returned to the
guarantor, or to a fund for the benefit of the guarantors
creditors, under those circumstances.
If a guarantee of a guarantor were voided as a fraudulent
conveyance or held unenforceable for any other reason, in all
likelihood holders of the notes would be creditors solely of
CHS/Community Health Systems, Inc. and those guarantors whose
guarantees had not been voided. The notes then would in effect
be structurally subordinated to all liabilities of the guarantor
whose guarantee was voided.
The measures of insolvency for purposes of these fraudulent
transfer laws will vary depending upon the law applied in any
proceeding to determine whether a fraudulent transfer has
occurred. Generally, however, a guarantor would be considered
insolvent if:
|
|
|
|
|
the sum of its debts, including contingent liabilities, was
greater than the fair saleable value of all of its
assets; or
|
|
|
|
the present fair saleable value of its assets was less than the
amount that would be required to pay its probable liability on
its existing debts, including contingent liabilities, as they
become absolute and mature; or
|
|
|
|
it could not pay its debts or contingent liabilities as they
become due.
|
17
We cannot assure you as to what standard a court would use to
determine whether or not a guarantor would be solvent at the
relevant time, or regardless of the standard used, that the
guarantees would not be subordinated to any guarantors
other debt.
If a court held that the guarantees should be voided as
fraudulent conveyances, the court could void, or hold
unenforceable, the guarantees, which could mean that you may not
receive any payments under the guarantees, and the court may
direct you to return any amounts that you have already received
from any guarantor. Furthermore, the holders of the notes would
cease to have any direct claim against the applicable guarantor.
Consequently, the applicable guarantors assets would be
applied first to satisfy the applicable guarantors other
liabilities, before any portion of its assets could be applied
to the payment of the notes. Sufficient funds to repay the notes
may not be available from other sources, including the remaining
guarantors, if any. Moreover, the avoidance of a guarantee could
result in acceleration of such debt (if not otherwise
accelerated due to our or our guarantors insolvency or
other proceeding).
Each guarantee contains a provision intended to limit the
guarantors liability to the maximum amount that it could
incur without causing the incurrence of obligations under its
guarantee to be a fraudulent transfer. This provision may not be
effective to protect the guarantees from being voided under
fraudulent transfer law, or may reduce or eliminate the
guarantors obligation to an amount that effectively makes
the guarantee worthless.
Risks
Related to Our Indebtedness
Our
level of indebtedness could adversely affect our ability to
raise additional capital to fund our operations, limit our
ability to react to changes in the economy or our industry, and
prevent us from meeting our obligations under the agreements
relating to our indebtedness.
We are significantly leveraged. After the Merger was completed,
we had total debt of approximately $9,154 million. The New
Credit Facility and the indenture governing the notes contains,
and our future debt agreements will contain, covenants and
events of default that may limit our ability to raise additional
capital, react to changes or meet our obligations under our
financing agreements. See Use of Proceeds,
Description of the Exchange Notes and
Description of Certain Indebtedness.
Our leverage could have important consequences for you,
including the following:
|
|
|
|
|
it may limit our ability to obtain additional debt or equity
financing for working capital, capital expenditures, debt
service requirements, debt service prepayments and general
corporate or other purposes;
|
|
|
|
a substantial portion of our cash flows from operations will be
dedicated to the payment of principal and interest on our
indebtedness and will not be available for other purposes,
including our operations, capital expenditures and future
business opportunities;
|
|
|
|
the debt service requirements of our indebtedness could make it
more difficult for us to satisfy our financial obligations;
|
|
|
|
some of our borrowings, including borrowings under our New
Credit Facility, will be at variable rates of interest, exposing
us to the risk of increased interest rates;
|
|
|
|
it may limit our ability to adjust to changing market conditions
and place us at a competitive disadvantage compared to our
competitors that have less debt; and
|
|
|
|
we may be vulnerable in a downturn in general economic
conditions or in our business, or we may be unable to carry out
capital spending that is important to our growth.
|
Despite
current indebtedness levels, we may still be able to incur
substantially more debt. This could further exacerbate the risks
described above.
We, our subsidiaries and any of our future subsidiaries may be
able to incur substantial additional indebtedness in the future.
The terms of the indenture governing the notes do not fully
prohibit us from doing
18
so, and all of this additional debt may be senior to the notes.
For example, under the indenture for the notes, we or our
subsidiaries may incur up to $7,815 million pursuant to a
credit facility or a qualified receivables transaction, less
certain amounts repaid with the proceeds of asset dispositions.
If we incur any additional indebtedness, including trade
payables, that ranks equally with the notes, the holders of that
debt will be entitled to share ratably with you in any proceeds
distributed in connection with any insolvency, liquidation,
reorganization, dissolution or other
winding-up
of us. This may have the effect of reducing the amount of
proceeds paid to you. Additionally, upon consummation of the
Transactions, our New Credit Facility will provide for
commitments of up to $7,215 million in the aggregate. We
also have the ability to amend our New Credit Facility to
provide for one or more additional tranches of term loans in
aggregate principal amount of up to $600.0 million. All
borrowings under our New Credit Facility would be secured senior
indebtedness. If new debt is added to our current debt levels,
the related risks that we and our subsidiaries now face could
intensify. See Description of the Exchange Notes and
Description of Certain Indebtedness.
Restrictive
covenants in our debt agreement will limit our flexibility in
operating our business.
The indenture governing the notes contains various covenants
that limit our ability
and/or our
restricted subsidiaries ability to:
|
|
|
|
|
incur, assume or guarantee additional indebtedness;
|
|
|
|
issue redeemable stock and preferred stock;
|
|
|
|
repurchase capital stock;
|
|
|
|
make restricted payments, including paying dividends and making
investments;
|
|
|
|
redeem debt that is junior in right of payment to the notes;
|
|
|
|
create liens without securing the notes;
|
|
|
|
sell or otherwise dispose of assets, including capital stock of
subsidiaries;
|
|
|
|
enter into agreements that restrict dividends from subsidiaries;
|
|
|
|
merge, consolidate, sell or otherwise dispose of substantially
all our assets;
|
|
|
|
enter into transactions with affiliates; and
|
|
|
|
guarantee indebtedness.
|
In addition, our New Credit Facility also contains restrictive
covenants and requires us to maintain specified financial ratios
and satisfy other financial condition tests. Our ability to meet
those financial ratios and tests can be affected by events
beyond our control, and we cannot assure you that we will meet
those tests. A breach of any of these covenants could result in
a default under our New Credit Facility
and/or the
notes. Upon the occurrence of an event of default under our New
Credit Facility, the lenders could elect to declare all amounts
outstanding under our New Credit Facility to be immediately due
and payable and terminate all commitments to extend further
credit. If we were unable to repay those amounts, the lenders
under our New Credit Facility could proceed against the
collateral granted to them to secure that indebtedness. We have
pledged a significant portion of our assets as collateral under
our New Credit Facility. If the lenders under our New Credit
Facility accelerate the repayment of borrowings, we cannot
assure you that we will have sufficient assets to repay our New
Credit Facility and our other indebtedness, including the notes.
See Description of Certain Indebtedness.
Risks
Related to Our Business
We may
not be able to successfully integrate our acquisition of Triad
or realize the potential benefits of the acquisition, which
could cause our business to suffer.
We may not be able to combine successfully the operations of
Triad with our operations and, even if such integration is
accomplished, we may never realize the potential benefits of the
acquisition. The integration of
19
Triad with our operations requires significant attention from
management and may impose substantial demands on our operations
or other projects. In addition, a significant number of
Triads corporate officers, who are covered by change of
control arrangements, did not continue their employment with us
beyond the date of the Merger. The integration of Triad also
involves a significant capital commitment, and the return that
we achieve on any capital invested may be less than the return
that we would achieve on our other projects or investments. Any
of these factors could cause delays or increased costs of
combining the companies could adversely affect our operations,
financial results and liquidity.
Certain of Triads joint venture partners have put or call
rights, the exercise of which could affect our available cash
and/or
operating results. Triad entered into a number of joint venture
transactions that entitle its joint venture partners to require
Triad to purchase the partners interest or to require
Triad to sell its interest to the partner. Some of these rights
are triggered by Triads change in control as a result of
the Merger and others by the passage of time. The consideration
provided for in these contracts may not be at an advantageous
amount vis-à-vis the Merger consideration. If these rights
are exercised, we may be required to make unanticipated
payments, our operations at these facilities may be adversely
affected, or we may be required to divest the facility.
If we
fail to improve the operations of future acquired hospitals, we
may be unable to successfully execute our growth
strategy.
Most of the hospitals we have acquired or will acquire had or
may have significantly lower operating margins than we do
and/or
operating losses prior to the time we acquired them. In the
past, we have occasionally experienced temporary delays in
improving the operating margins or effectively integrating the
operations of these acquired hospitals. In the future, if we are
unable to improve the operating margins of acquired hospitals,
operate them profitably, or effectively integrate their
operations, we may be unable to successfully execute our growth
strategy. We acquired 50 hospitals in the Merger. In the past we
have not acquired this many hospitals at one time. We may
experience delays or difficulties in improving the operating
margins or effectively integrating the operations of these
acquired hospitals. In addition, we have and will incur other
significant transaction-related costs.
Given the number of hospitals being acquired, senior management
may need to devote a significant amount of time to integration
of the acquired hospitals, which may detract from the ability of
senior management to execute our business strategy.
If the
hospitals we acquire have unknown or contingent liabilities, we
could be liable for material obligations.
Hospitals that we acquire may have unknown or contingent
liabilities, including liabilities for environmental matters and
failure to comply with healthcare laws and regulations. Although
we seek indemnification from sellers covering these matters, we
may nevertheless have material liabilities for past activities
of acquired hospitals.
In addition, we have assumed all of Triads potential
liabilities, including liabilities relating to pending or
threatened litigation matters and government investigations,
which, if adversely decided, could have a material adverse
effect on our future results
and/or
operations. We do not have any rights of indemnification with
respect to the Merger.
State
efforts to regulate the construction, acquisition or expansion
of hospitals could prevent us from constructing or acquiring new
hospitals, renovating our facilities or expanding the breadth of
services we offer.
Some states require prior approval for the construction or
acquisition of healthcare facilities and for the expansion of
healthcare facilities and services. In giving approval, these
states consider the need for new or expanded healthcare
facilities or services. In some states in which we operate, we
are required to obtain certificates of need, or CONs, for
capital expenditures exceeding a prescribed amount, changes in
bed capacity or services, and some other matters. Other states
may adopt similar legislation. We may not be able to obtain
20
the required CONs or other prior approvals for new or expanded
facilities in the future. In addition, at the time we acquire a
hospital, we may agree to replace or expand the facility we are
acquiring. If we are not able to obtain required prior
approvals, we would not be able to acquire or construct new
hospitals and expand the breadth of services we offer.
If we
are unable to effectively compete for patients, local residents
could use other hospitals.
The hospital industry is highly competitive. In addition to the
competition we face for acquisitions and physicians, we must
also compete with other hospitals and healthcare providers for
patients. The competition among hospitals and other healthcare
providers for patients has intensified in recent years. In
approximately 85% of our current markets, we are the sole
provider of general healthcare services. After the Merger was
consummated, this percentage decreased to approximately 65%. In
our other markets, the competitors are typically not-for-profit
hospitals. These not-for-profit hospitals generally differ in
each jurisdiction. In addition, some competing hospitals are
owned by tax-supported governmental agencies or not-for-profit
entities supported by endowments and charitable contributions.
These hospitals can make capital expenditures without paying
sales, property and income taxes. We also face competition from
other specialized care providers, including outpatient surgery,
orthopedic, oncology and diagnostic centers. However, our
hospitals also face competition from hospitals outside of their
primary service area, including hospitals in major metropolitan
areas that provide more complex services. These facilities
generally are located some distance from our facilities, but
patients in our primary service areas may travel to these other
hospitals for a variety of reasons. These reasons include
physician referrals or the need for services we do not offer.
Patients who seek services from these other hospitals may
subsequently shift their preferences to those hospitals for the
services we provide.
We expect that these competitive trends will continue. Our
inability to compete effectively with other hospitals and other
healthcare providers could result in local residents using other
hospitals.
The
failure to obtain our medical supplies at favorable prices could
cause our operating results to decline.
In March 2005, we entered into a five-year participation
agreement with automatic renewal terms of one year each with
HealthTrust Purchasing Group, L.P., or HealthTrust, a Group
Purchasing Organization, or GPO, which replaced a similar
arrangement with another GPO. Triad has a similar relationship
with this GPO. GPOs attempt to obtain favorable pricing on
medical supplies with manufacturers and vendors who sometimes
negotiate exclusive supply arrangements in exchange for the
discounts they give. In the past, exclusive relationships have
been the subject of challenge by excluded vendors and inquiry by
regulators. To the extent these exclusive supply arrangements
are challenged or deemed unenforceable, we could incur higher
costs for our medical supplies currently obtained through
HealthTrust. These higher costs could cause our operating
results to decline. There can be no assurance that our
arrangement with HealthTrust will provide the discounts we
expect to achieve.
If the
fair value of our reporting units declines, a material non-cash
charge to earnings from impairment of our goodwill could
result.
At June 30, 2007, we had approximately $1,345 million
of goodwill recorded on our books, and on a pro forma basis at
June 30, 2007, we would have had $4,279 million of
goodwill. On an ongoing basis, we evaluate, based on the fair
value of our reporting units, whether the carrying value of our
goodwill is impaired. If a test of our goodwill for impairment
indicates that impairment has occurred, we are required to
record an impairment charge for the difference between the
carrying value of the goodwill and the implied fair value of the
goodwill in the period in which the determination is made. If we
make changes in our business strategy or if market or other
conditions adversely affect our business, we may be forced to
record an impairment charge, which would lead to a decrease in
our assets and a reduction in our net income or an increase in
our net losses.
21
Risks
Related to Our Industry
If
federal or state healthcare programs or managed care companies
reduce the payments we receive as reimbursement for services we
provide, our net operating revenues may decline.
On a pro forma basis, assuming the completion of the
Transactions on January 1, 2006, 41.7% of our net operating
revenues would have come from the Medicare and Medicaid
programs. In recent years, federal and state governments made
significant changes in the Medicare and Medicaid programs,
including the Medicare Prescription Drug, Improvement, and
Modernization Act of 2003. Some of these changes have decreased
the amount of money we receive for our services relating to
these programs.
In recent years, Congress and some state legislatures have
introduced an increasing number of other proposals to make major
changes in the healthcare system, including an increased
emphasis on the linkage between quality of care criteria and
payment levels, such as the submission of patient quality data
to the Secretary of Health and Human Services. Future federal
and state legislation may further reduce the payments we receive
for our services. For example, the Governor of the State of
Tennessee implemented cuts in the third quarter of 2005 in
TennCare by restricting eligibility and capping specified
services.
In addition, insurance and managed care companies and other
third parties from whom we receive payment for our services
increasingly are attempting to control healthcare costs by
requiring that hospitals discount payments for their services in
exchange for exclusive or preferred participation in their
benefit plans. We believe that this trend may continue and may
reduce the payments we receive for our services.
If we
fail to comply with extensive laws and government regulations,
including fraud and abuse laws, we could suffer penalties or be
required to make significant changes to our
operations.
The healthcare industry is required to comply with many laws and
regulations at the federal, state and local government levels.
These laws and regulations require that hospitals meet various
requirements, including those relating to the adequacy of
medical care, equipment, personnel, operating policies and
procedures, maintenance of adequate records, compliance with
building codes, environmental protection, health and safety, and
privacy. These laws include the Health Insurance Portability and
Accountability Act of 1996, or HIPAA, and a section of the
Social Security Act known as the anti-kickback
statute. If we fail to comply with applicable laws and
regulations, including fraud and abuse laws, we could suffer
civil or criminal penalties, including the loss of our licenses
to operate and our ability to participate in the Medicare,
Medicaid and other federal and state healthcare programs, and we
may be subject to claims for damages brought by governmental or
private parties.
In addition, there are heightened coordinated civil and criminal
enforcement efforts by both federal and state government
agencies relating to the healthcare industry, including the
hospital segment. The ongoing investigations relate to various
referral, cost reporting and billing practices, laboratory and
home healthcare services, and physician ownership and joint
ventures involving hospitals.
In the future, different interpretations or enforcement of these
laws and regulations could subject our current practices to
allegations of impropriety or illegality or could require us to
make changes in our facilities, equipment, personnel, services,
capital expenditure programs and operating expenses.
We
continue to be affected by an industry-wide shortage of
qualified healthcare professionals and by increasing labor
costs.
We and other healthcare providers have had and continue to have
difficulties in retaining qualified personnel to staff our
healthcare facilities, particularly nurses and pharmacists, and
in such situations we may be required to use temporary
employment agencies to provide additional personnel. The labor
costs are generally higher for temporary employees than for
full-time employees. In addition, some states in which we
operate have increased minimum staffing standards. As minimum
staffing standards are increased, we may be required to retain
additional staffing. In addition, in recent years we have
experienced increases in our labor costs primarily due to higher
wages and greater benefits required to attract and retain
qualified personnel and to increase staffing levels in our
healthcare facilities. Although we have undertaken strategic and
structural
22
initiatives to address these issues, if these initiatives are
unsuccessful, our financial condition, results of operations and
cash flows could be adversely affected.
If we
become subject to significant legal actions, we could be subject
to substantial uninsured liabilities or increased insurance
costs.
In recent years, physicians, hospitals and other healthcare
providers have become subject to an increasing number of legal
actions alleging malpractice, product liability, negligent
credentialing, over-charging or related legal theories. Many of
these actions involve large claims and significant defense
costs. To protect us from the cost of these claims, we maintain
professional malpractice liability insurance and general
liability insurance coverage in excess of those amounts for
which we are self-insured, in amounts that we believe to be
sufficient for our operations. However, our insurance coverage
does not cover all claims against us or may not continue to be
available at a reasonable cost for us to maintain adequate
levels of insurance. If the costs of malpractice and other
liability insurance rise rapidly or uninsured claims are
incurred, our profitability could decline. For a further
discussion of our insurance coverage, see our discussion of
professional liability insurance claims in the section entitled
Managements Discussion and Analysis of Financial
Condition and Results of Operations in our Annual Report
on Form 10-K for the year ended December 31, 2006,
incorporated by reference in this prospectus.
If we
experience growth in self-pay volume and revenue, our financial
condition or results of operations could be adversely
affected.
Like others in the hospital industry, we have experienced an
increase in our provision for bad debts as a percentage of net
operating revenue due to a growth in self-pay volume and
revenue. If we experience growth in self-pay volume and revenue,
our results of operations could be adversely affected. Further,
our ability to improve collections for self-pay patients may be
limited by statutory, regulatory and investigatory initiatives,
including private lawsuits directed at hospital charges, and
collection practices for uninsured and underinsured patients.
23
FORWARD-LOOKING
STATEMENTS
This prospectus contains forward-looking statements
within the meaning of the federal securities laws, which involve
risks and uncertainties. Statements that are predictive in
nature, that depend upon or refer to future events or
conditions, or that include words such as expects,
anticipates, intends, plans,
believes, estimates, thinks
and similar expressions are forward-looking statements. These
statements involve known and unknown risks, uncertainties and
other factors that may cause our actual results and performance
to be materially different from any future results or
performance expressed or implied by these forward-looking
statements. These factors include, but are not limited to, the
following:
|
|
|
|
|
general economic and business conditions, both nationally and in
the regions in which we operate;
|
|
|
|
our ability to successfully integrate any acquisitions or to
recognize expected synergies from such acquisitions;
|
|
|
|
risks associated with our substantial indebtedness, leverage and
debt service obligations;
|
|
|
|
demographic changes;
|
|
|
|
existing governmental regulations and changes in, or the failure
to comply with, governmental regulations;
|
|
|
|
legislative proposals for healthcare reform;
|
|
|
|
the impact of the Medicare Prescription Drug, Improvement, and
Modernization Act of 2003, which includes specific reimbursement
changes for small urban and non-urban hospitals;
|
|
|
|
our ability, where appropriate, to enter into managed care
provider arrangements, and the terms of these arrangements;
|
|
|
|
changes in inpatient or outpatient Medicare and Medicaid payment
levels;
|
|
|
|
increases in the amount and risk of collectibility of patient
accounts receivable;
|
|
|
|
increases in wages as a result of inflation or competition for
highly technical positions, and rising supply cost due to market
pressure from pharmaceutical companies and new product releases;
|
|
|
|
liability and other claims asserted against us, including
self-insured malpractice claims;
|
|
|
|
competition;
|
|
|
|
our ability to attract and retain qualified personnel, key
management, physicians, nurses and other healthcare workers;
|
|
|
|
trends toward treatment of patients in less acute or specialty
healthcare settings including ambulatory surgery centers or
specialty hospitals;
|
|
|
|
changes in medical or other technology;
|
|
|
|
changes in generally accepted accounting principles;
|
|
|
|
the availability and terms of capital to fund any acquisitions
or replacement facilities;
|
|
|
|
our ability to successfully acquire and integrate additional
hospitals (including the hospitals acquired from Triad);
|
|
|
|
our ability to obtain adequate levels of general and
professional liability insurance;
|
|
|
|
potential adverse impact of known and unknown government
investigations; and
|
|
|
|
timeliness of reimbursement payments received under government
programs.
|
Some of the other important factors that could cause actual
results to differ materially from our expectations are disclosed
under Risk Factors and elsewhere in this prospectus,
including, without limitation, in conjunction with the
forward-looking statements included in this prospectus. Although
we believe that these
24
statements are based upon reasonable assumptions, we can give no
assurance that our goals will be achieved. Given these
uncertainties, prospective investors are cautioned not to place
undue reliance on these forward-looking statements. These
forward-looking statements are made as of the date of this
filing. All subsequent written and oral forward-looking
statements attributable to us, or to persons acting on our
behalf, are expressly qualified in their entirety by these
cautionary statements. We do not undertake any obligation to
publicly update or revise any forward-looking statement as a
result of new information, future events or otherwise, except as
otherwise required by law.
The data included in this prospectus regarding markets and
ranking, including the size of certain markets and our position
and the position of our competitors within these markets, are
based on reports of government agencies, published industry
sources and other sources we believe to be reliable. While we
believe that these studies and reports and our own research and
estimates are reliable and appropriate, neither we nor the
initial purchasers have independently verified such data and
neither we nor the initial purchasers make any representations
as to the accuracy of such information.
On July 25, 2007, we acquired Triad, a publicly-owned
hospital company. Triad provides a broad range of general
hospital healthcare services to patients in non-urban and
mid-size markets located primarily in the southern, midwestern
and western United States. As of July 25, 2007, prior to
the acquisition, Triad owned, leased or operated 50 hospitals in
17 states, with an aggregate of approximately 9,600
licensed beds. Upon closing of the acquisition, we became the
largest publicly-owned provider of hospital services, operating
129 hospitals in 28 states with an aggregate of
approximately 19,200 licensed beds. On a pro forma basis, our
net operating revenues for the year ended December 31, 2006
and for the six months ended June 30, 2007 would have been
$9,903 million and $5,429 million, respectively.
25
The registration rights agreement requires that we register the
Exchange Notes with the SEC and offer to exchange the registered
Exchange Notes for the outstanding Old Notes. This exchange
offer is intended to satisfy our obligations under the
registration rights agreement. We will not receive any cash
proceeds from the issuance of the Exchange Notes. In
consideration for issuing the Exchange Notes contemplated in
this prospectus, you will receive outstanding securities in like
principal amount, the form and terms of which are the same as
the form and terms of the Exchange Notes except as otherwise
described in this prospectus. The Old Notes surrendered in
exchange for Exchange Notes will be retired and canceled.
Accordingly, no additional debt will result from the exchange.
We have agreed to bear the expense of the exchange offer.
We used the net proceeds from the issuance of the Old Notes, in
addition to our cash on hand and cash at Triad, and borrowings
under our New Credit Facility described under Description
of Certain Indebtedness New Senior Secured Credit
Facilities, to complete the acquisition of Triad and
certain related transactions and repay certain of our debt and
the debt of Triad. See our unaudited pro forma financial
information included elsewhere in this prospectus. The sources
and uses of funds in connection with such transactions are as
follows:
Sources
of Funds
|
|
|
|
|
|
|
(Dollars in millions)
|
|
|
New Senior Secured Revolving
Credit Facility(1)
|
|
$
|
|
|
New Senior Secured Delayed Draw
Term Loan Facility(1)
|
|
|
|
|
New Senior Secured Term Loan
Facility
|
|
|
6,065
|
|
The Notes(2)
|
|
|
3,000
|
|
|
|
|
|
|
Total Sources
|
|
$
|
9,065
|
|
|
|
|
|
|
Uses
of Funds
|
|
|
|
|
Equity Purchase Price
|
|
$
|
4,973
|
|
Refinance Existing Triad Debt
|
|
|
1,688
|
|
Refinance Existing CHS Debt
|
|
|
1,942
|
|
Redemption Tendering Fees
|
|
|
59
|
|
Severance and Termination Costs
|
|
|
90
|
|
Breakup Fees and Expenses
|
|
|
39
|
|
Working Capital(3)
|
|
|
15
|
|
Other Fees and Expenses
|
|
|
259
|
|
|
|
|
|
|
Total Uses
|
|
$
|
9,065
|
|
|
|
|
|
|
|
|
|
(1) |
|
We do not have any outstanding borrowings under our new
$750.0 million senior secured revolving credit facility, or
our $400.0 million New Senior Secured delayed draw term
loan facility, immediately following the consummation of the
Transactions. |
|
(2) |
|
Notes are net of discount of $21.3 million. |
|
(3) |
|
Working capital will be used for general corporate uses. |
26
The following table sets forth our capitalization as of
June 30, 2007:
|
|
|
|
|
on an actual basis; and
|
|
|
|
after giving pro forma effect to the issuance of the notes, our
acquisition of Triad and the financing thereof and the other pro
forma transactions. SeeUnaudited Pro Forma Condensed
Financial Statements for a description of the pro forma
transactions and the financing of our acquisition of Triad.
|
|
|
|
|
|
|
|
|
|
|
|
As of June 30, 2007
|
|
|
|
Actual
|
|
|
Pro Forma
|
|
|
|
(Dollars in millions)
|
|
|
Cash and Cash Equivalents
|
|
$
|
21
|
|
|
$
|
99
|
|
|
|
|
|
|
|
|
|
|
Debt:
|
|
|
|
|
|
|
|
|
New Senior Secured Revolving
Credit Facility(1)
|
|
$
|
|
|
|
$
|
|
|
New Senior Secured Term Loan
Facility(1)
|
|
|
|
|
|
|
6,065
|
|
New Senior Secured Delayed Draw
Term Loan Facility(1)
|
|
|
|
|
|
|
|
|
Capital Leases and Other
|
|
|
58
|
|
|
|
68
|
|
Existing Secured Debt
|
|
|
1,642
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Secured Debt
|
|
|
1,700
|
|
|
|
6,133
|
|
The Notes(2)
|
|
|
|
|
|
|
3,000
|
|
|
|
|
|
|
|
|
|
|
Total Senior Debt
|
|
|
1,700
|
|
|
|
9,133
|
|
Senior Subordinated Notes
|
|
|
300
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Debt
|
|
|
2,000
|
|
|
|
9,133
|
|
Shareholders Equity(3)
|
|
|
1,861
|
|
|
|
1,829
|
|
|
|
|
|
|
|
|
|
|
Total Capitalization
|
|
$
|
3,861
|
|
|
$
|
10,962
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
We do not have any outstanding borrowings under our
$750.0 million new senior secured revolving credit facility
or our $400.0 million new senior secured delayed draw term
loan facility. |
|
(2) |
|
Notes are net of discount of $21.3 million. |
|
(3) |
|
Pro forma shareholders equity reflects the non-cash
write-off of deferred loan costs associated with the refinancing
of existing indebtedness of both us and Triad. See the notes to
our unaudited pro forma condensed financial information for
additional discussion. |
27
UNAUDITED
PRO FORMA CONDENSED FINANCIAL STATEMENTS
On March 19, 2007, Holdings and a wholly-owned subsidiary
of CHS/Community Health Systems, Inc., which subsidiary we refer
to as Merger Sub, entered into a definitive Agreement and Plan
of Merger, or the Merger Agreement, with Triad. On July 25,
2007, pursuant to the Merger Agreement, Merger Sub merged with
and into Triad, with Triad continuing as the surviving
corporation and a wholly-owned subsidiary of the Issuer. We
refer to this business combination as the Merger. In connection
with entry into the Merger Agreement, Holdings entered into a
debt financing for up to $7,215 million of senior secured
financing and issued $3,021 million of the Old Notes, which
financing we collectively refer to herein as the Debt Financing.
The Merger Agreement and related documents effectuated the
occurrence of the following events, which we collectively refer
to as the Transactions:
|
|
|
|
|
the Merger;
|
|
|
|
the entering into by CHS of the New Credit Facility, consisting
of a $6,065 million senior secured term loan, a
$750 million senior secured revolving credit facility and a
$400 million delayed draw senior secured term loan, of
which $6,065 million was drawn on the closing date;
|
|
|
|
the issuance by CHS of up to $3,021 million
($3,000 million, net of discount) of Old Notes;
|
|
|
|
the refinancing of certain of our existing indebtedness and that
of Triad, which together totaled approximately
$3,630 million as of June 30, 2007;
|
|
|
|
the merger of Merger Sub with and into Triad, with Triad as the
surviving corporation, and the payment of approximately
$6,915 million as merger consideration, including the
refinancing or assumption of Triads then outstanding
debt; and
|
|
|
|
the payment of approximately $448 million of fees and
expenses, including severance costs, related to the foregoing
transactions.
|
The following unaudited pro forma condensed financial statements
are based on our historical financial statements and those of
Triad after giving effect to the Transactions. The effects of
the Merger have been prepared using the purchase method of
accounting and applying the assumptions and adjustments
described in the accompanying notes.
We derived the following unaudited pro forma condensed financial
statements by applying pro forma adjustments to our historical
consolidated financial statements incorporated by reference in
this prospectus, and Triad historical consolidated financial
statements incorporated by reference in this prospectus.
The unaudited pro forma condensed statements of operations data
for the periods presented give effect to the Transactions as if
they had been consummated on January 1, 2006. The unaudited
pro forma condensed balance sheet data give effect to the
Transactions as if they had occurred on June 30, 2007. We
describe the assumptions underlying the pro forma adjustments in
the accompanying notes, which should also be read in conjunction
with these unaudited pro forma condensed financial statements.
You should also read this information in conjunction with the:
|
|
|
|
|
Separate unaudited historical financial statements of CHS as of
and for the six month period ended June 30, 2007,
incorporated by reference in this prospectus;
|
|
|
|
Separate historical financial statements of CHS as of and for
the fiscal year ended December 31, 2006, incorporated by
reference in this prospectus;
|
|
|
|
Separate unaudited historical financial statements of Triad as
of and for the six month period ended June 30, 2007,
incorporated by reference in this prospectus; and
|
|
|
|
Separate historical financial statements of Triad as of and for
the fiscal year ended December 31, 2006, incorporated by
reference in this prospectus.
|
The pro forma adjustments related to the purchase price
allocation and financing of the Transactions are preliminary and
based on information obtained to date by management, and are
subject to revision as
28
additional information becomes available as to, among other
things, the fair value of acquired assets and liabilities as
well as any pre-acquisition contingencies and finalization of
acquisition-related costs. The actual adjustments described in
the accompanying notes may differ from those reflected in these
unaudited pro forma condensed financial statements. Revisions to
the preliminary purchase price allocation and financing of the
Transactions may have a significant impact on the pro forma
amounts of total assets, total liabilities and
stockholders equity, operating expense and costs,
depreciation and amortization and interest expense.
The unaudited pro forma condensed financial statements do not
reflect non-recurring charges that will be incurred in
connection with the (i) write-off of certain deferred
financing costs, (ii) tender premiums on our previously
outstanding Senior Subordinated Notes and (iii) certain
other non-recurring Merger costs, such as cash expenditures for
restructuring and integration activities and retention bonuses,
which cannot be reasonably estimated at this time.
The unaudited pro forma condensed financial statements should
not be considered indicative of actual results that would have
been achieved had the Transactions been consummated on the date
or for the periods indicated, and do not purport to indicate
consolidated balance sheet data or results of operations as of
any future date or any future period.
The unaudited pro forma condensed financial statements should be
read in conjunction with the information contained in
Selected Historical Financial Data,
Managements Discussion and Analysis of Financial
Condition and Results of Operations and the consolidated
financial statements and accompanying notes incorporated by
reference in this prospectus.
29
COMMUNITY
HEALTH SYSTEMS, INC. AND SUBSIDIARIES
UNAUDITED
PRO FORMA CONDENSED BALANCE SHEET
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of June 30, 2007
|
|
|
|
CHS
|
|
|
|
|
|
|
|
|
|
|
|
|
as Reported
|
|
|
Triad
|
|
|
Adjustments
|
|
|
Pro Forma
|
|
|
|
(Dollars in thousands)
|
|
|
ASSETS
|
Current assets:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents
|
|
$
|
21,357
|
|
|
$
|
63,200
|
|
|
$
|
(5,217,358
|
)(a)
|
|
$
|
99,156
|
|
|
|
|
|
|
|
|
|
|
|
|
(3,833,043
|
)(b)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
9,065,000
|
(b)
|
|
|
|
|
Patient accounts receivable
|
|
|
876,523
|
|
|
|
979,400
|
|
|
|
|
|
|
|
1,855,923
|
|
Supplies
|
|
|
121,964
|
|
|
|
152,700
|
|
|
|
|
|
|
|
274,664
|
|
Deferred income taxes
|
|
|
13,249
|
|
|
|
41,600
|
|
|
|
|
|
|
|
54,849
|
|
Prepaid expenses and taxes
|
|
|
36,287
|
|
|
|
48,900
|
|
|
|
|
|
|
|
85,187
|
|
Other current assets
|
|
|
62,933
|
|
|
|
100,900
|
|
|
|
|
|
|
|
163,833
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total current assets
|
|
|
1,132,313
|
|
|
|
1,386,700
|
|
|
|
14,599
|
|
|
|
2,533,612
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Property and equipment:
|
|
|
2,809,988
|
|
|
|
4,510,100
|
|
|
|
500,000
|
(a)
|
|
|
7,820,088
|
|
Less accumulated depreciation and
amortization
|
|
|
(720,846
|
)
|
|
|
(1,341,100
|
)
|
|
|
|
|
|
|
(2,061,946
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Property and equipment, net
|
|
|
2,089,142
|
|
|
|
3,169,000
|
|
|
|
500,000
|
|
|
|
5,758,142
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Goodwill
|
|
|
1,344,956
|
|
|
|
1,365,800
|
|
|
|
(1,365,800
|
)(a)
|
|
|
4,279,314
|
|
|
|
|
|
|
|
|
|
|
|
|
2,934,358
|
(a)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Investment in and advances to
unconsolidated affiliates
|
|
|
|
|
|
|
260,200
|
|
|
|
|
|
|
|
260,200
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other assets
|
|
|
226,700
|
|
|
|
197,500
|
|
|
|
5,000
|
(a)
|
|
|
581,545
|
|
|
|
|
|
|
|
|
|
|
|
|
183,956
|
(b)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(31,611
|
)(c)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total assets
|
|
$
|
4,793,111
|
|
|
$
|
6,379,200
|
|
|
$
|
2,240,502
|
|
|
$
|
13,412,813
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
LIABILITIES AND
STOCKHOLDERS EQUITY
|
Current liabilities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Current maturities of long-term debt
|
|
$
|
25,757
|
|
|
$
|
26,900
|
|
|
$
|
(16,900
|
)(b)
|
|
$
|
35,757
|
|
Accounts payable
|
|
|
257,730
|
|
|
|
245,100
|
|
|
|
|
|
|
|
502,830
|
|
Current income taxes payable
|
|
|
49,010
|
|
|
|
39,500
|
|
|
|
|
|
|
|
88,510
|
|
Accrued liabilities
|
|
|
278,527
|
|
|
|
347,700
|
|
|
|
(19,587
|
)(b)
|
|
|
606,640
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total current liabilities
|
|
|
611,024
|
|
|
|
659,200
|
|
|
|
(36,487
|
)(b)
|
|
|
1,233,737
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Long-term debt
|
|
|
1,974,240
|
|
|
|
1,670,600
|
|
|
|
5,452,400
|
(b)
|
|
|
9,097,240
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Deferred income taxes
|
|
|
141,472
|
|
|
|
172,200
|
|
|
|
192,500
|
(a)
|
|
|
506,172
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other long-term liabilities
|
|
|
205,408
|
|
|
|
201,800
|
|
|
|
|
|
|
|
407,208
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Minority interests in equity of
consolidated entities
|
|
|
|
|
|
|
339,100
|
|
|
|
|
|
|
|
339,100
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders equity:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Preferred stock
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common stock
|
|
|
959
|
|
|
|
900
|
|
|
|
(900
|
)(a)
|
|
|
959
|
|
Additional paid-in capital
|
|
|
1,215,321
|
|
|
|
2,450,800
|
|
|
|
(2,450,800
|
)(a)
|
|
|
1,215,321
|
|
Treasury stock, at cost
|
|
|
(6,678
|
)
|
|
|
(3,200
|
)
|
|
|
3,200
|
(a)
|
|
|
(6,678
|
)
|
Unearned stock compensation
|
|
|
|
|
|
|
(5,200
|
)
|
|
|
5,200
|
(a)
|
|
|
|
|
Accumulated other comprehensive
income
|
|
|
15,622
|
|
|
|
(7,100
|
)
|
|
|
7,100
|
(a)
|
|
|
15,622
|
|
Retained Earnings
|
|
|
635,743
|
|
|
|
900,100
|
|
|
|
(900,100
|
)(a)
|
|
|
604,132
|
|
|
|
|
|
|
|
|
|
|
|
|
(31,611
|
)(c)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total stockholders equity
|
|
|
1,860,967
|
|
|
|
3,336,300
|
|
|
|
(3,367,911
|
)
|
|
|
1,829,356
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total liabilities and
stockholders equity
|
|
$
|
4,793,111
|
|
|
$
|
6,379,200
|
|
|
$
|
2,240,502
|
|
|
$
|
13,412,813
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The accompanying notes are an integral part of these unaudited
pro forma condensed financial statements.
30
COMMUNITY
HEALTH SYSTEMS, INC. AND SUBSIDIARIES
UNAUDITED
PRO FORMA CONDENSED STATEMENTS OF INCOME
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31, 2006
|
|
|
|
CHS
|
|
|
Triad
|
|
|
|
|
|
|
|
|
|
as Reported
|
|
|
as Reported
|
|
|
Adjustments
|
|
|
Pro Forma
|
|
|
|
(Dollars in thousands)
|
|
|
Net operating revenues
|
|
$
|
4,365,576
|
|
|
$
|
5,537,900
|
|
|
|
|
|
|
$
|
9,903,476
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating costs and expenses:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Salaries and benefits
|
|
|
1,741,223
|
|
|
|
2,233,100
|
|
|
|
49,700
|
(f)
|
|
|
4,012,202
|
|
|
|
|
|
|
|
|
|
|
|
|
(11,821
|
)(j)
|
|
|
|
|
Provision for bad debts
|
|
|
547,781
|
|
|
|
576,900
|
|
|
|
|
|
|
|
1,124,681
|
|
Supplies
|
|
|
510,351
|
|
|
|
957,900
|
|
|
|
|
|
|
|
1,468,251
|
|
Rent
|
|
|
97,104
|
|
|
|
|
|
|
|
116,814
|
(g)
|
|
|
213,918
|
|
Other operating expenses
|
|
|
897,091
|
|
|
|
1,069,800
|
|
|
|
(116,814
|
)(g)
|
|
|
1,840,275
|
|
|
|
|
|
|
|
|
|
|
|
|
(6,000
|
)(h)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(3,802
|
)(k)
|
|
|
|
|
Reimbursable expenses
|
|
|
|
|
|
|
49,700
|
|
|
|
(49,700
|
)(f)
|
|
|
|
|
Minority interest in earnings
|
|
|
2,795
|
|
|
|
22,000
|
|
|
|
|
|
|
|
24,795
|
|
Equity in earnings of
unconsolidated affiliates
|
|
|
|
|
|
|
(43,500
|
)
|
|
|
|
|
|
|
(43,500
|
)
|
Depreciation and amortization
|
|
|
188,771
|
|
|
|
229,800
|
|
|
|
15,000
|
(e)
|
|
|
434,571
|
|
|
|
|
|
|
|
|
|
|
|
|
1,000
|
(i)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total operating costs and expenses
|
|
|
3,985,116
|
|
|
|
5,095,700
|
|
|
|
(5,623
|
)
|
|
|
9,075,193
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from operations
|
|
|
380,460
|
|
|
|
442,200
|
|
|
|
5,623
|
|
|
|
828,283
|
|
Interest expense, net
|
|
|
102,299
|
|
|
|
95,300
|
|
|
|
513,002
|
(d)
|
|
|
710,601
|
|
ESOP expense
|
|
|
|
|
|
|
12,500
|
|
|
|
(12,500
|
)(l)
|
|
|
|
|
Gain on sales of assets
|
|
|
|
|
|
|
(6,000
|
)
|
|
|
6,000
|
(h)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations
before income taxes
|
|
|
278,161
|
|
|
|
340,400
|
|
|
|
(500,879
|
)
|
|
|
117,682
|
|
Provision for income taxes
|
|
|
106,682
|
|
|
|
132,500
|
|
|
|
(192,838
|
)(m)
|
|
|
46,344
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations
|
|
$
|
171,479
|
|
|
$
|
207,900
|
|
|
$
|
(308,041
|
)
|
|
$
|
71,338
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations
per common share:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
$
|
1.81
|
|
|
$
|
2.41
|
|
|
|
|
|
|
$
|
0.75
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted
|
|
$
|
1.78
|
|
|
$
|
2.38
|
|
|
|
|
|
|
$
|
0.74
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted-average number of shares
outstanding:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
|
94,983,646
|
|
|
|
86,306,434
|
|
|
|
|
|
|
|
94,983,646
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted
|
|
|
96,232,910
|
|
|
|
87,153,019
|
|
|
|
|
|
|
|
96,232,910
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The accompanying notes are an integral part of these unaudited
pro forma condensed financial statements.
31
COMMUNITY
HEALTH SYSTEMS, INC. AND SUBSIDIARIES
UNAUDITED
PRO FORMA CONDENSED STATEMENTS OF INCOME
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Six Months Ended June 30, 2006
|
|
|
|
CHS
|
|
|
|
|
|
|
|
|
|
|
|
|
as Reported
|
|
|
Triad
|
|
|
Adjustments
|
|
|
Pro Forma
|
|
|
|
(Dollars in thousands)
|
|
|
Net operating revenues
|
|
$
|
2,087,616
|
|
|
$
|
2,747,265
|
|
|
|
|
|
|
$
|
4,834,881
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating costs and expenses:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Salaries and benefits
|
|
|
827,815
|
|
|
|
1,111,382
|
|
|
|
25,954
|
(f)
|
|
|
1,959,312
|
|
|
|
|
|
|
|
|
|
|
|
|
(5,839
|
)(j)
|
|
|
|
|
Provision for bad debts
|
|
|
223,295
|
|
|
|
248,874
|
|
|
|
|
|
|
|
472,169
|
|
Supplies
|
|
|
248,520
|
|
|
|
471,750
|
|
|
|
|
|
|
|
720,270
|
|
Rent
|
|
|
46,628
|
|
|
|
|
|
|
|
54,772
|
(g)
|
|
|
101,400
|
|
Other operating expenses
|
|
|
426,156
|
|
|
|
525,430
|
|
|
|
(54,772
|
)(g)
|
|
|
893,983
|
|
|
|
|
|
|
|
|
|
|
|
|
(614
|
)(h)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(2,217
|
)(k)
|
|
|
|
|
Reimbursable expenses
|
|
|
|
|
|
|
25,954
|
|
|
|
(25,954
|
)(f)
|
|
|
|
|
Minority interest in earnings
|
|
|
1,068
|
|
|
|
9,984
|
|
|
|
|
|
|
|
11,052
|
|
Equity in earnings of
unconsolidated affiliates
|
|
|
|
|
|
|
(19,824
|
)
|
|
|
|
|
|
|
(19,824
|
)
|
Depreciation and amortization
|
|
|
89,689
|
|
|
|
112,378
|
|
|
|
7,500
|
(e)
|
|
|
210,067
|
|
|
|
|
|
|
|
|
|
|
|
|
500
|
(i)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total operating costs and expenses
|
|
|
1,863,171
|
|
|
|
2,485,928
|
|
|
|
(670
|
)
|
|
|
4,348,429
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from operations
|
|
|
224,445
|
|
|
|
261,337
|
|
|
|
670
|
|
|
|
486,452
|
|
Interest expense, net
|
|
|
45,657
|
|
|
|
47,414
|
|
|
|
257,098
|
(d)
|
|
|
350,169
|
|
ESOP expense
|
|
|
|
|
|
|
6,099
|
|
|
|
(6,099
|
)(l)
|
|
|
|
|
Gain on sales of assets
|
|
|
|
|
|
|
(614
|
)
|
|
|
614
|
(h)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations
before income taxes
|
|
|
178,788
|
|
|
|
208,438
|
|
|
|
(250,943
|
)
|
|
|
136,283
|
|
Provision for income taxes
|
|
|
69,165
|
|
|
|
80,552
|
|
|
|
(96,613
|
)(m)
|
|
|
53,104
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations
|
|
$
|
109,623
|
|
|
$
|
127,886
|
|
|
$
|
(154,330
|
)
|
|
$
|
83,179
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations
per common share:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
$
|
1.14
|
|
|
$
|
1.49
|
|
|
|
|
|
|
$
|
0.87
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted
|
|
$
|
1.13
|
|
|
$
|
1.48
|
|
|
|
|
|
|
$
|
0.85
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted-average number of shares
outstanding:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
|
96,158,575
|
|
|
|
85,958,229
|
|
|
|
|
|
|
|
96,158,575
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted
|
|
|
97,536,815
|
|
|
|
86,665,173
|
|
|
|
|
|
|
|
97,536,815
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The accompanying notes are an integral part of these unaudited
pro forma condensed financial statements.
32
COMMUNITY
HEALTH SYSTEMS, INC. AND SUBSIDIARIES
UNAUDITED
PRO FORMA CONDENSED STATEMENTS OF OPERATIONS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Six Months Ended June 30, 2007
|
|
|
|
CHS
|
|
|
|
|
|
|
|
|
|
|
|
|
as Reported
|
|
|
Triad
|
|
|
Adjustments
|
|
|
Pro Forma
|
|
|
|
(Dollars in thousands)
|
|
|
Net operating revenues
|
|
$
|
2,453,125
|
|
|
$
|
2,975,910
|
|
|
|
|
|
|
$
|
5,429,035
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating costs and expenses:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Salaries and benefits
|
|
|
981,421
|
|
|
|
1,230,591
|
|
|
|
24,582
|
(f)
|
|
|
2,230,381
|
|
|
|
|
|
|
|
|
|
|
|
|
(6,213
|
)(j)
|
|
|
|
|
Provision for bad debts
|
|
|
284,360
|
|
|
|
303,564
|
|
|
|
|
|
|
|
587,924
|
|
Supplies
|
|
|
286,541
|
|
|
|
505,762
|
|
|
|
|
|
|
|
792,303
|
|
Rent
|
|
|
54,240
|
|
|
|
|
|
|
|
62,648
|
(g)
|
|
|
116,888
|
|
Other operating expenses
|
|
|
503,815
|
|
|
|
610,284
|
|
|
|
(62,648
|
)(g)
|
|
|
1,049,240
|
|
|
|
|
|
|
|
|
|
|
|
|
388
|
(h)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(2,599
|
)(k)
|
|
|
|
|
Reimbursable expenses
|
|
|
|
|
|
|
24,582
|
|
|
|
(24,582
|
)(f)
|
|
|
|
|
Minority interest in earnings
|
|
|
818
|
|
|
|
12,831
|
|
|
|
|
|
|
|
13,649
|
|
Equity in earnings of
unconsolidated affiliates
|
|
|
|
|
|
|
(23,608
|
)
|
|
|
|
|
|
|
(23,608
|
)
|
Depreciation and amortization
|
|
|
104,619
|
|
|
|
123,239
|
|
|
|
7,500
|
(e)
|
|
|
235,858
|
|
|
|
|
|
|
|
|
|
|
|
|
500
|
(i)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total operating costs and expenses
|
|
|
2,215,814
|
|
|
|
2,787,245
|
|
|
|
(424
|
)
|
|
|
5,002,635
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from operations
|
|
|
237,311
|
|
|
|
188,665
|
|
|
|
424
|
|
|
|
426,400
|
|
Interest expense, net
|
|
|
61,559
|
|
|
|
48,225
|
|
|
|
253,258
|
(d)
|
|
|
363,042
|
|
ESOP expense
|
|
|
|
|
|
|
7,504
|
|
|
|
(7,504
|
)(l)
|
|
|
|
|
Loss on sales of assets
|
|
|
|
|
|
|
388
|
|
|
|
(388
|
)(h)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations
before income taxes
|
|
|
175,752
|
|
|
|
132,548
|
|
|
|
(244,942
|
)
|
|
|
63,358
|
|
Provision for income taxes
|
|
|
67,665
|
|
|
|
60,710
|
|
|
|
(94,303
|
)(m)
|
|
|
34,072
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations
|
|
$
|
108,087
|
|
|
$
|
71,838
|
|
|
$
|
(150,639
|
)
|
|
$
|
29,286
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations
per common shares:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
$
|
1.16
|
|
|
$
|
0.82
|
|
|
|
|
|
|
$
|
0.31
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted
|
|
$
|
1.14
|
|
|
$
|
0.80
|
|
|
|
|
|
|
$
|
0.31
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted-average number of shares
outstanding:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
|
93,373,357
|
|
|
|
87,379,366
|
|
|
|
|
|
|
|
93,373,357
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted
|
|
|
94,422,000
|
|
|
|
89,340,770
|
|
|
|
|
|
|
|
94,422,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The accompanying notes are an integral part of these unaudited
pro forma condensed financial statements.
33
NOTES TO
UNAUDITED PRO FORMA
CONDENSED
FINANCIAL STATEMENTS
(Dollars in thousands)
The total purchase price of the acquisition of Triad is as
follows:
|
|
|
|
|
Cash paid for shares outstanding
or issuable
|
|
$
|
4,972,812
|
|
Repayment or assumption of
Triads debt obligations
|
|
|
1,697,500
|
|
Estimated direct transaction costs
|
|
|
244,546
|
|
|
|
|
|
|
Total
|
|
$
|
6,914,858
|
|
|
|
|
|
|
Under the purchase method of accounting, the total purchase
price as shown in the table above will be allocated to
Triads tangible and intangible assets based upon their
estimated fair value as of July 25, 2007, the date of
completion of the transaction. Any excess of the purchase price
over the estimated fair value of the tangible and intangible
assets will be recorded as goodwill. Based upon the purchase
price and assumptions regarding valuations of acquired assets
and liabilities, the purchase price allocation is as follows (in
thousands):
|
|
|
|
|
Current assets
|
|
$
|
1,386,700
|
|
Property and equipment
|
|
|
3,669,000
|
|
Goodwill
|
|
|
2,934,358
|
|
Other long-term assets
|
|
|
457,700
|
|
Amortizable intangible assets
|
|
|
5,000
|
|
Current liabilities
|
|
|
(632,300
|
)
|
Other long-term liabilities
|
|
|
(566,500
|
)
|
Minority interest
|
|
|
(339,100
|
)
|
|
|
|
|
|
|
|
$
|
6,914,858
|
|
|
|
|
|
|
Goodwill will not be amortized but will be tested for impairment
on an annual basis and whenever events or circumstances occur
indicating that the goodwill may be impaired. The preliminary
purchase price allocation for Triad is subject to revision as
more detailed analysis is completed and additional information
on, among other things, the fair values of Triads assets
and liabilities, any preacquisition contingencies and
finalization of acquisition-related costs, becomes available.
Any change in the fair value of the assets and liabilities of
Triad will change the amount of the purchase price allocable to
goodwill. The final purchase price allocation may differ
materially from the allocation presented here.
Pro forma adjustments are necessary to reflect the purchase
price, to adjust amounts related to Triads assets and
liabilities to an estimate of their fair values, to reflect
financing transactions associated with the transaction, to
reflect changes in depreciation and amortization expense
resulting from the fair value adjustments to tangible and
intangible assets, to reflect other transactions directly
related to the transaction, and to reflect the income tax
effects related to the pro forma adjustments. There were no
intercompany transactions between us and Triad. Certain pro
forma adjustments were made to conform Triads accounting
policies and presentation to our accounting policies and
presentation.
34
NOTES TO
UNAUDITED PRO FORMA
CONDENSED
FINANCIAL STATEMENTS (Continued)
The accompanying unaudited pro forma condensed financial
statements have been prepared as if the transaction was
completed on June 30, 2007 for balance sheet purposes and
on January 1, 2006 for income statement purposes, and
reflect the following adjustments:
(a) To record the transaction:
Cash payments for:
|
|
|
|
|
Purchase of Triad outstanding
shares
|
|
$
|
4,835,908
|
|
Triad stock option costs and other
equity-based instruments
|
|
|
136,904
|
|
Transaction costs
|
|
|
244,546
|
|
|
|
|
|
|
|
|
$
|
5,217,358
|
|
|
|
|
|
|
Included in transaction costs are severance costs of
$90 million, primarily resulting from change in control
provisions, direct transaction costs of $116 million, which
primarily include estimated investment banker fees,
attorneys fees and accounting fees,
break-up
fees and expenses of $39 million.
Elimination of existing Triad stockholders equity:
|
|
|
|
|
Common stock
|
|
$
|
900
|
|
Capital in excess of par value
|
|
|
2,450,800
|
|
Treasury stock, at cost
|
|
|
(3,200
|
)
|
Unearned stock compensation
|
|
|
(5,200
|
)
|
Retained earnings
|
|
|
900,100
|
|
Accumulated other comprehensive
income
|
|
|
(7,100
|
)
|
|
|
|
|
|
|
|
$
|
3,336,300
|
|
|
|
|
|
|
The difference between the preliminary estimated fair value of
assets acquired based on managements estimates of fair
value and Triads historical net book value of property and
equipment:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Historical
|
|
|
Estimated
|
|
|
|
|
|
|
Net Book
|
|
|
Fair
|
|
|
Estimated
|
|
|
|
Value
|
|
|
Value
|
|
|
Increase
|
|
|
Land
|
|
$
|
214,000
|
|
|
$
|
414,000
|
|
|
$
|
200,000
|
|
Buildings and improvements
|
|
|
1,624,791
|
|
|
|
1,924,791
|
|
|
|
300,000
|
|
Equipment
|
|
|
872,809
|
|
|
|
872,809
|
|
|
|
|
|
Construction in progress
|
|
|
457,400
|
|
|
|
457,400
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
3,169,000
|
|
|
$
|
3,669,000
|
|
|
$
|
500,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The final fair value amounts will be determined based upon
managements final best estimate of fair value. Deferred
income tax liabilities will increase by an estimated $192,500 to
reflect the impact of the pro forma purchase price adjustments
related to the increase in fair value of Triads property
and equipment. Estimate of additional goodwill and identifiable
intangibles as a result of the purchase price allocation are
detailed in footnote 1 to these unaudited pro forma condensed
financial statements.
35
NOTES TO
UNAUDITED PRO FORMA
CONDENSED
FINANCIAL STATEMENTS (Continued)
(b) To record the payments made from the proceeds of the
new indebtedness:
|
|
|
|
|
Sources
|
|
|
|
|
New Senior Secured Term Loan
Facility
|
|
$
|
6,065,000
|
|
The Notes
|
|
|
3,021,331
|
|
Notes discount
|
|
|
(21,331
|
)
|
|
|
|
|
|
Subtotal
|
|
|
9,065,000
|
|
|
|
|
|
|
Uses
|
|
|
|
|
Cash payments for Triad stock and
transaction costs:
|
|
|
|
|
Purchase Triad outstanding shares
|
|
|
(4,835,908
|
)
|
Triad stock option costs and other
equity-based compensation
|
|
|
(136,904
|
)
|
Transaction costs
|
|
|
(244,546
|
)
|
|
|
|
|
|
Subtotal
|
|
|
(5,217,358
|
)
|
|
|
|
|
|
Cash payments related to
refinancing and debt repayment:
|
|
|
|
|
Triad Term Loan A
|
|
|
(487,500
|
)
|
Triad 7% Senior Notes
|
|
|
(600,000
|
)
|
Triad 7% Senior Subordinated
Notes
|
|
|
(600,000
|
)
|
CHS Term Loans
|
|
|
(1,642,000
|
)
|
CHS Senior Subordinated Notes
|
|
|
(300,000
|
)
|
Accrued Interest
|
|
|
(19,587
|
)
|
Financing fees(1)
|
|
|
(183,956
|
)
|
|
|
|
|
|
Subtotal
|
|
|
(3,833,043
|
)
|
|
|
|
|
|
Working Capital(2)
|
|
|
(14,599
|
)
|
|
|
|
|
|
Total uses
|
|
$
|
(9,065,000
|
)
|
|
|
|
|
|
|
|
|
(1) |
|
Financing fees will be capitalized as deferred loan costs and
amortized into interest expense. |
|
(2) |
|
Working capital will be used for general corporate uses. |
(c) To reflect the non-cash write-off of deferred loan
costs associated with the refinancing of existing indebtedness
of both us and Triad:
|
|
|
|
|
|
|
Deferred
|
|
|
|
Loan Costs
|
|
|
CHS $1,200 million Term Loan
|
|
$
|
6,897
|
|
CHS $400 million Term Loan
|
|
|
1,962
|
|
CHS
61/2%
Senior Subordinated Notes
|
|
|
5,370
|
|
Triad Term Loan A
|
|
|
4,066
|
|
Triad 7% Senior Notes
|
|
|
3,245
|
|
Triad 7% Senior Subordinated
Notes
|
|
|
10,071
|
|
|
|
|
|
|
|
|
$
|
31,611
|
|
|
|
|
|
|
Such amounts for CHS debt will be reflected in the results of
operations as a loss on extinguishment of debt upon completion
of the refinancing.
36
NOTES TO
UNAUDITED PRO FORMA
CONDENSED
FINANCIAL STATEMENTS (Continued)
(d) To record additional interest expense based upon the
assumed debt structure as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year
|
|
|
Six Months
|
|
|
Six Months
|
|
|
|
Ended
|
|
|
Ended
|
|
|
Ended
|
|
|
|
December 31,
|
|
|
June 30,
|
|
|
June 30,
|
|
|
|
2006
|
|
|
2006
|
|
|
2007
|
|
|
Senior Secured Term Loan Facility
|
|
$
|
453,698
|
|
|
$
|
219,979
|
|
|
$
|
235,107
|
|
The Notes
|
|
|
268,143
|
|
|
|
134,072
|
|
|
|
134,072
|
|
Capital leases and other debt
|
|
|
2,826
|
|
|
|
1,366
|
|
|
|
2,155
|
|
Deferred loan costs
|
|
|
22,950
|
|
|
|
11,475
|
|
|
|
11,475
|
|
Commitment fees
|
|
|
5,750
|
|
|
|
2,875
|
|
|
|
2,875
|
|
Amortization of note discount
|
|
|
1,935
|
|
|
|
946
|
|
|
|
1,035
|
|
Interest rate swaps
|
|
|
(15,342
|
)
|
|
|
(6,418
|
)
|
|
|
(8,686
|
)
|
Standby letters of credit
|
|
|
642
|
|
|
|
321
|
|
|
|
312
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total interest costs
|
|
|
740,602
|
|
|
|
364,616
|
|
|
|
378,345
|
|
Less: Capitalized interest
|
|
|
(8,190
|
)
|
|
|
(3,084
|
)
|
|
|
(8,860
|
)
|
Interest income
|
|
|
(21,811
|
)
|
|
|
(11,363
|
)
|
|
|
(6,443
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest expense, net
|
|
|
710,601
|
|
|
|
350,169
|
|
|
|
363,042
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Less: Interest expense, net, as
reported
|
|
|
|
|
|
|
|
|
|
|
|
|
CHS
|
|
|
(102,299
|
)
|
|
|
(45,657
|
)
|
|
|
(61,559
|
)
|
Triad
|
|
|
(95,300
|
)
|
|
|
(47,414
|
)
|
|
|
(48,225
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net interest expense adjustment
|
|
$
|
513,002
|
|
|
$
|
257,098
|
|
|
$
|
253,258
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For purposes of these unaudited pro forma condensed financial
statements, management has assumed a weighted-average interest
rate of 7.48% for the year ended December 31, 2006, 7.31%
for the six months ended June 30, 2006 and 7.61% for the
six months ended June 30, 2007 on its Senior Secured Term
Loan Facility, and the actual interest rate of
87/8%
on the notes. A fluctuation in interest rates of 0.125% on the
Senior Secured Term Loan Facility would result in an annual
fluctuation in interest expense of approximately
$7.6 million.
(e) To adjust depreciation expense related to the
write-up of
Triads property and equipment to fair market value.
Management believes the
write-up
will be primarily to land and buildings, of which it estimates
the buildings to have a weighted-average useful life remaining
of 20 years. A change in building value of
$10.0 million will affect depreciation expense by
approximately $0.5 million annually and a change in
equipment value of $10.0 million will affect depreciation
by approximately $1.3 million.
(f) Triads costs classified as reimbursable expenses,
which relate to salaries and benefits of its subsidiary, Quorum
Health Resources, LLC, or QHR, are reclassified to salaries and
benefits to conform with our presentation in the income
statement.
(g) Triads rent expense is reclassified from other
operating expense to rent to conform with our presentation in
the income statement.
(h) Triads (gain) loss on sale of assets is
reclassified to other operating expenses to conform with our
presentation in the income statement.
(i) To record amortization expense related to the
write-up of
identifiable intangible assets. Management believes such
intangible assets will principally relate to certificates of
need, licenses and permits, and will have a useful life of
approximately five years.
37
NOTES TO
UNAUDITED PRO FORMA
CONDENSED
FINANCIAL STATEMENTS (Continued)
(j) To record the elimination of salaries and benefits for
actual costs incurred related to (1) 25 Triad corporate
officers who were covered by change of control arrangements, and
whose employment did not continue beyond the date of the Merger
and whose positions are not being replaced, and (2) 19
other Triad corporate employees who terminated their employment
with Triad prior to the Merger and whose positions are not being
replaced. Management believes that the positions being
eliminated will have no impact on revenue-generating activities
subsequent to the Merger.
(k) To record the elimination of duplicate board of
directors fees and directors and officers insurance
expense less the incremental increase in the post-Merger
directors and officers insurance expense.
(l) To record the elimination of Triads Employee
Stock Ownership Plan, or ESOP, which terminated upon the
completion of the Merger and for which we do not have a similar
plan, nor the intent to create such a plan in its place.
(m) To record the income tax effects of the pro forma
statement of operations adjustments using a statutory tax rate
of 38.5%.
|
|
3.
|
Other
Historical Costs
|
Included in Triads other operating expenses for the
six months ended June 30, 2007 are $20.9 million
of legal, investment banking and other fees related to the
Merger. Such costs are not included in the pro forma
adjustments, however, the Companys management believes
that since these costs are transaction specific, the resulting
reduction to earnings is such that Triads earnings for the
six months ended June 30, 2007 are not indicative of
future operating results.
38
Terms of
the Exchange Offer; Period for Tendering Outstanding Old
Notes
We issued the Old Notes on July 25, 2007 and entered into a
registration rights agreement with the initial purchasers. The
registration rights agreement requires that we register the
Exchange Notes with the SEC and offer to exchange the registered
Exchange Notes for the outstanding Old Notes.
Upon the terms and subject to the conditions set forth in this
prospectus, we will accept any and all Old Notes that were
acquired pursuant to Rule 144A or Regulation S validly
tendered and not withdrawn prior to 5:00 p.m., New York
City time, on the expiration date of the exchange offer. We will
issue $1,000 principal amount of Exchange Notes in exchange for
each $1,000 principal amount of Old Notes accepted in the
exchange offer. Holders may tender some or all of their Old
Notes pursuant to the exchange offer. However, Old Notes may be
tendered only in integral multiples of $1,000.
The form and terms of the Exchange Notes are the same as the
form and terms of the outstanding Old Notes except that:
(1) the Exchange Notes being issued in the exchange offer
will be registered under the Securities Act and will not have
legends restricting their transfer;
(2) the Exchange Notes being issued in the exchange offer
will not contain the registration rights and liquidated damages
provisions contained in the outstanding Old Notes; and
(3) interest on the Exchange Notes will accrue from the
last interest date on which interest was paid on your Old Notes.
The Exchange Notes will evidence the same debt as the
outstanding securities and will be entitled to the benefits of
the indenture.
We intend to conduct the exchange offer in accordance with the
applicable requirements of the Securities Exchange Act of 1934,
as amended, referred to herein as the Exchange Act, and the
rules and regulations of the SEC.
We will be deemed to have accepted validly tendered Old Notes
when, as and if we have given oral or written notice of our
acceptance to the exchange agent. The exchange agent will act as
agent for the tendering holders for the purpose of receiving the
Exchange Notes from us.
If any tendered Old Notes are not accepted for exchange because
of an invalid tender or the occurrence of specified other events
set forth in this prospectus, the certificates for any
unaccepted Old Notes will be promptly returned, without expense,
to the tendering holder.
Holders who tender Old Notes in the exchange offer will not be
required to pay brokerage commissions or fees or transfer taxes
with respect to the exchange of Old Notes pursuant to the
exchange offer. We will pay all charges and expenses, other than
transfer taxes in certain circumstances, in connection with the
exchange offer. See Fees and Expenses and
Transfer Taxes below.
The exchange offer will remain open for at least 20 full
business days. The term expiration date will mean
5:00 p.m., New York City time,
on ,
2007, unless we, in our sole discretion, extend the exchange
offer, in which case the term expiration date will
mean the latest date and time to which the exchange offer is
extended.
To extend the exchange offer, prior to 9:00 a.m., New York
City time, on the next business day after the previously
scheduled expiration date, we will:
(1) notify the exchange agent of any extension by oral
notice (promptly confirmed in writing) or written notice,
(2) mail to the registered holders an announcement of any
extension, and issue a notice by press release or other public
announcement before such expiration date.
39
We reserve the right, in our sole discretion:
(1) if any of the conditions below under the heading
Conditions to the Exchange Offer shall have not been
satisfied,
(a) to delay accepting any Old Notes,
(b) to extend the exchange offer, or
(c) to terminate the exchange offer, and
(2) to amend the terms of the exchange offer in any manner,
provided however, that if we amend the exchange offer to make a
material change, including the waiver of a material condition,
we will extend the exchange offer, if necessary, to keep the
exchange offer open for at least five business days after such
amendment or waiver; provided further, that if we amend the
exchange offer to change the percentage of notes being exchanged
or the consideration being offered, we will extend the exchange
offer, if necessary, to keep the exchange offer open for at
least ten business days after such amendment or waiver.
Any delay in acceptance, extension, termination or amendment
will be followed as promptly as practicable by oral or written
notice to the registered holders.
Procedures
for Tendering Old Notes Through Brokers and Banks
Since the Old Notes are represented by global book-entry notes,
The Depositary Trust Company or DTC, as depositary, or its
nominee is treated as the registered holder of the Old Notes and
will be the only entity that can tender your Old Notes for
Exchange Notes. Therefore, to tender Old Notes subject to this
exchange offer and to obtain Exchange Notes, you must instruct
the institution where you keep your Old Notes to tender your Old
Notes on your behalf so that they are received on or prior to
the expiration of this exchange offer.
The BLUE-colored Letter of Transmittal shall be used
by you to give such instructions.
IF YOU WISH TO ACCEPT THIS EXCHANGE OFFER, PLEASE INSTRUCT
YOUR BROKER OR ACCOUNT REPRESENTATIVE IN TIME FOR YOUR OLD
NOTES TO BE TENDERED BEFORE THE 5:00 PM (NEW YORK CITY
TIME) DEADLINE
ON ,
2007.
To tender your Old Notes in the exchange offer you must
represent for our benefit that:
(1) You are acquiring the Exchange Notes for your
outstanding Old Notes in the ordinary course of business;
(2) You do not have an arrangement or understanding with
any person to participate in the distribution of Exchange Notes;
(3) You are not an affiliate as defined under
Rule 405 of the Securities Act;
(4) You will also have to acknowledge that if you are not a
broker-dealer, you are not engaged in and do not intend to
engage in a distribution of the Exchange Notes; and
(5) You will also have to acknowledge that if you are a
broker-dealer, and acquired the Old Notes as a result of market
making activities or other trading activities, you will deliver
a prospectus meeting the requirements of the Securities Act in
connection with any for sale of such Exchange Notes.
You must make such representations by executing the Blue colored
Letter of Transmittal and delivering it to the
institution through which you hold your Old Notes.
Such institution will have to acknowledge that such
representations were made by you.
You may tender some or all of your Old Notes in this exchange
offer. However, your Old Notes may be tendered only in integral
multiples of $1,000.
40
When you tender your outstanding Old Notes and we accept them,
the tender will be a binding agreement between you and us as
described in this prospectus.
The method of delivery of outstanding Old Notes and all other
required documents to the exchange agent is at your election and
risk.
We will decide all questions about the validity, form,
eligibility, acceptance and withdrawal of tendered Old Notes,
and our reasonable determination will be final and binding on
you. We reserve the absolute right to:
(1) reject any and all tenders of any particular Old Note
not properly tendered;
(2) refuse to accept any Old Note if, in our reasonable
judgment or the judgment of our counsel, the acceptance would be
unlawful; and
(3) waive any defects or irregularities or conditions of
the exchange offer as to any particular Old Notes before the
expiration of the offer.
Our interpretation of the terms and conditions of the exchange
offer will be final and binding on all parties. You must cure
any defects or irregularities in connection with tenders of Old
Notes as we will reasonably determine. Neither us, the exchange
agent nor any other person will incur any liability for failure
to notify you or any defect or irregularity with respect to your
tender of Old Notes. If we waive any terms or conditions
pursuant to (3) above with respect to a noteholder, we will
extend the same waiver to all noteholders with respect to that
term or condition being waived.
Procedures
for Brokers and Custodian Banks; DTC ATOP Account
In order to accept this exchange offer on behalf of a holder of
Old Notes you must submit or cause your DTC participant to
submit an Agents Message as described below.
The exchange agent, on our behalf will seek to establish an
Automated Tender Offer Program (ATOP) account with
respect to the outstanding Old Notes at DTC promptly after the
delivery of this prospectus. Any financial institution that is a
DTC participant, including your broker or bank, may make
book-entry tender of outstanding Old Notes by causing the
book-entry transfer of such Old Notes into our ATOP account in
accordance with DTCs procedures for such transfers.
Concurrently with the delivery of Old Notes, an Agents
Message in connection with such book-entry transfer must be
transmitted by DTC to, and received by, the exchange agent on or
prior to 5:00 pm, New York City Time on the expiration date. The
confirmation of a book entry transfer into the ATOP account as
described above is referred to herein as a Book-Entry
Confirmation.
The term Agents Message means a message
transmitted by the DTC participants to DTC, and thereafter
transmitted by DTC to the exchange agent, forming a part of the
Book-Entry Confirmation which states that DTC has received an
express acknowledgment from the participant in DTC described in
such Agents Message stating that such participant and
beneficial holder agree to be bound by the terms of this
exchange offer.
Each Agents Message must include the following information:
(1) Account number of the beneficial owner tendering such
Old Notes;
(2) Principal amount of Old Notes tendered by such
beneficial owner; and
(3) A confirmation that the beneficial holder of the Old
Notes tendered has made the representations for the benefit of
the Company set forth under Procedures for Tendering Old
Notes Held Through Brokers or Banks above.
BY SENDING AN AGENTS MESSAGE THE DTC PARTICIPANT IS
DEEMED TO HAVE CERTIFIED THAT THE BENEFICIAL HOLDER FOR WHOM
NOTES ARE BEING TENDERED HAS BEEN PROVIDED WITH A COPY OF THIS
PROSPECTUS.
41
The delivery of Old Notes through DTC, and any transmission of
an Agents Message through ATOP, is at the election and
risk of the person tendering Old Notes. We will ask the exchange
agent to instruct DTC to promptly return those Old Notes, if
any, that were tendered through ATOP but were not accepted by
us, to the DTC participant that tendered such Old Notes on
behalf of holders of the Old Notes.
Acceptance of Outstanding Old Notes for Exchange; Delivery of
Exchange Notes Issued in the Exchange Offer upon Expiration of
the Exchange Offer
We will accept validly tendered Old Notes when the conditions to
the exchange offer have been satisfied or we have waived them.
We will have accepted our validly tendered Old Notes when we
have given oral or written notice to the exchange agent. The
exchange agent will act as agent for the tendering holders for
the purpose of receiving the Exchange Notes from us. If we do
not accept any tendered Old Notes for exchange because of an
invalid tender or other valid reason, the exchange agent will
promptly return the certificates, without expense, to the
tendering holder after the exchange offer terminates or expires.
If a holder has tendered Old Notes by book-entry transfer, we
will promptly credit the Notes to an account maintained with The
Depositary Trust Company after the exchange offer
terminates or expires.
THE AGENTS MESSAGE MUST BE TRANSMITTED TO EXCHANGE AGENT
ON OR BEFORE 5:00 PM, NEW YORK CITY TIME, ON THE EXPIRATION
DATE.
Withdrawal
Rights
You may withdraw your tender of outstanding Notes at any time
before 5:00 p.m., New York City time, on the expiration
date.
For a withdrawal to be effective, you should contact your bank
or broker where your Old Notes are held and have them send an
ATOP notice of withdrawal so that it is received by the exchange
agent before 5:00 p.m., New York City time, on the
expiration date. Such notice of withdrawal must:
(1) specify the name of the person that tendered the Old
Notes to be withdrawn;
(2) identify the Old Notes to be withdrawn, including the
CUSIP number and principal amount at maturity of the Old Notes;
specify the name and number of an account at the DTC to which
your withdrawn Old Notes can be credited.
We will decide all questions as to the validity, form and
eligibility of the notices and our determination will be final
and binding on all parties. Any tendered Old Notes that you
withdraw will not be considered to have been validly tendered.
We will promptly return any outstanding Old Notes that have been
tendered but not exchanged, or credit them to the DTC account.
You may re-tender properly withdrawn Old Notes by following one
of the procedures described above before the expiration date.
Conditions
To The Exchange Offer
Notwithstanding any other provision herein, we are not required
to accept for exchange, or to issue Exchange Notes in exchange
for, any outstanding Old Notes. We may terminate or amend the
exchange offer, before the expiration of the exchange offer:
(1) if any federal law, statute, rule or regulation has
been adopted or enacted which, in our judgment, would reasonably
be expected to impair our ability to proceed with the exchange
offer;
(2) if any stop order is threatened or in effect with
respect to the registration statement which this prospectus is a
part of or the qualification of the indenture under the
Trust Indenture Act of 1939; or
(3) if there is a change in the current interpretation by
the staff of the SEC which permits holders who have made the
required representations to us to resell, offer for resale, or
otherwise transfer Exchange Notes issued in the exchange offer
without registration of the Exchange Notes and delivery of a
prospectus, as discussed above.
42
These conditions are for our sole benefit and we may assert them
at any time before the expiration of the exchange offer. Our
failure to exercise any of the foregoing rights will not be a
waiver of our rights.
Exchange
Agent
You should direct questions, requests for assistance, and
requests for additional copies of this prospectus and the
BLUE-colored Letter of Transmittal to the exchange
agent at:
U.S. BANK
NATIONAL ASSOCIATION
By
Registered or Certified Mail, Hand Delivery or Overnight
Courier:
U.S. Bank
National Association
Specialized Finance Unit
60 Livingston Avenue
St. Paul, MN 55107
Attention: Rachel Muehlbauer
|
|
|
By
Facsimile:
|
|
By
Telephone:
|
(651)
495-8158
|
|
(800) 934-6802
|
(For Eligible Institutions Only)
|
|
|
Delivery to an address other than set forth above will not
constitute a valid delivery.
Fees And
Expenses
We will not make any payment to brokers, dealers, or others
soliciting acceptances of the exchange offer except for
reimbursement of mailing expenses.
We will pay the estimated cash expenses connected with the
exchange offer.
Accounting
Treatment
The Exchange Notes will be recorded at the same carrying value
as the existing Old Notes, as reflected in our accounting
records on the date of exchange. Accordingly, we will recognize
no gain or loss for accounting purposes. The expenses of the
exchange offer will be expensed over the term of the Exchange
Notes.
Transfer
Taxes
If you tender outstanding Old Notes for exchange you will not be
obligated to pay any transfer taxes. However, if you instruct us
to register Exchange Notes in the name of, or request that your
Old Notes not tendered or not accepted in the exchange offer be
returned to, a person other than you, you will be responsible
for paying any transfer tax owed.
YOU MAY SUFFER ADVERSE CONSEQUENCES IF YOU FAIL TO EXCHANGE
OUTSTANDING OLD NOTES.
If you do not tender your outstanding Old Notes, you will not
have any further registration rights, except for the rights
described in the registration rights agreement and described
above, and your Old Notes will continue to be subject to
restrictions on transfer when we complete the exchange offer.
Accordingly, if you do not tender your Old Notes in the exchange
offer, your ability to sell your Old Notes could be adversely
affected. Once we have completed the exchange offer, holders who
have not tendered Notes will not continue to be entitled to any
increase in interest rate that the indenture provides for if we
do not complete the exchange offer.
43
Consequences
Of Failure to Exchange
The Old Notes that are not exchanged for Exchange Notes pursuant
to the exchange offer will remain restricted securities.
Accordingly, the Old Notes may be resold only:
(1) to us upon redemption thereof or otherwise;
(2) so long as the outstanding securities are eligible for
resale pursuant to Rule 144A, to a person inside the United
States who is a qualified institutional buyer within the meaning
of Rule 144A under the Securities Act in a transaction
meeting the requirements of Rule 144A, in accordance with
Rule 144 under the Securities Act, or pursuant to another
exemption from the registration requirements of the Securities
Act, which other exemption is based upon an opinion of counsel
reasonably acceptable to us;
(3) outside the United States to a foreign person in a
transaction meeting the requirements of Rule 904 under the
Securities Act; or
(4) pursuant to an effective registration statement under
the Securities Act, in each case in accordance with any
applicable securities laws of any state of the United States.
Resale of
the Exchange Notes
With respect to resales of Exchange Notes, based on
interpretations by the staff of the SEC set forth in no-action
letters issued to third parties, we believe that a holder or
other person who receives Exchange Notes (other than a person
that is our affiliate within the meaning of Rule 405 under
the Securities Act) in exchange for Old Notes in the ordinary
course of business and who is not participating, does not intend
to participate, and has no arrangement or understanding with any
person to participate, in the distribution of the Exchange
Notes, will be allowed to resell the Exchange Notes to the
public without further registration under the Securities Act and
without delivering to the purchasers of the Exchange Notes a
prospectus that satisfies the requirements of Section 10 of
the Securities Act. However, if any holder acquires Exchange
Notes in the exchange offer for the purpose of distributing or
participating in a distribution of the Exchange Notes, the
holder cannot rely on the position of the staff of the SEC
expressed in the no-action letters or any similar interpretive
letters, and must comply with the registration and prospectus
delivery requirements of the Securities Act in connection with
any resale transaction, unless an exemption from registration is
otherwise available. Further, each broker-dealer that receives
Exchange Notes for its own account in exchange for Old Notes,
where the Old Notes were acquired by the broker-dealer as a
result of market-making activities or other trading activities,
must acknowledge that it will deliver a prospectus in connection
with any resale of the Exchange Notes.
Shelf
Registration
The registration rights agreement also requires that we file a
shelf registration statement if:
(1) we cannot file a registration statement for the
exchange offer because the exchange offer is not permitted by
law or SEC policy;
(2) a law or SEC policy prohibits a holder from
participating in the exchange offer;
(3) a holder cannot resell the Exchange Notes it acquires
in the exchange offer without delivering a prospectus and this
prospectus is not appropriate or available for resales by the
holder; or
(4) a holder is a broker-dealer and holds Notes acquired
directly from us or one of our affiliates.
44
We will also register the Exchange Notes under the securities
laws of jurisdictions that holders may request before offering
or selling Notes in a public offering. We do not intend to
register Exchange Notes in any jurisdiction unless a holder
requests that we do so.
Old Notes may be subject to restrictions on transfer until:
(1) a person other than a broker-dealer has exchanged the
Old Notes in the exchange offer;
(2) a broker-dealer has exchanged the Old Notes in the
exchange offer and sells them to a purchaser that receives a
prospectus from the broker, dealer on or before the sale;
(3) the Old Notes are sold under an effective shelf
registration statement that we have filed; or
(4) the Old Notes are sold to the public under
Rule 144 of the Securities Act.
45
SELECTED
HISTORICAL FINANCIAL INFORMATION
COMMUNITY HEALTH SYSTEMS, INC.
The following table of our selected consolidated historical
financial data should be read in conjunction with
Managements Discussion and Analysis of Financial
Conditions and Results of Operations and the consolidated
financial statements and notes thereto incorporated by reference
in this prospectus. The consolidated statement of operations
data for each of the fiscal years ended December 31, 2004,
2005 and 2006, and the consolidated balance sheet data at
December 31, 2005 and 2006 have been derived from our
audited consolidated financial statements incorporated by
reference in this prospectus. The consolidated balance sheet and
statement of operations data as of and for the years ended
December 31, 2002 and 2003 were derived from our audited
consolidated financial statements, not included herein, giving
effect to adjustments for discontinued operations. The
consolidated statement of operations data for the six-month
periods ended June 30, 2006 and June 30, 2007 have
been derived from our unaudited interim condensed consolidated
financial statements incorporated by reference in this
prospectus. In the opinion of management, the unaudited interim
financial data includes all adjustments, consisting of only
normal non-recurring adjustments, considered necessary for a
fair presentation of this information. The results of operations
for interim periods are not necessarily indicative of the
results that may be expected for the entire year. The following
data should be read in conjunction with our consolidated
financial statements and related notes, Managements
Discussion and Analysis of Financial Condition and Results of
Operations and other financial information included or
incorporated by reference in this prospectus.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Six Months Ended
|
|
|
|
Year Ended December 31,
|
|
|
June 30,
|
|
|
|
2002
|
|
|
2003
|
|
|
2004
|
|
|
2005
|
|
|
2006
|
|
|
2006
|
|
|
2007
|
|
|
|
(Dollars in thousands)
|
|
|
Consolidated Statement of
Operations Data:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net operating revenues
|
|
$
|
2,039,250
|
|
|
$
|
2,676,520
|
|
|
$
|
3,203,507
|
|
|
$
|
3,738,320
|
|
|
$
|
4,365,576
|
|
|
$
|
2,087,616
|
|
|
$
|
2,453,125
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Salaries and benefits
|
|
|
820,765
|
|
|
|
1,070,283
|
|
|
|
1,279,136
|
|
|
|
1,486,407
|
|
|
|
1,741,223
|
|
|
|
827,815
|
|
|
|
981,421
|
|
Provision for doubtful accounts
|
|
|
177,761
|
|
|
|
255,808
|
|
|
|
324,643
|
|
|
|
377,596
|
|
|
|
547,781
|
|
|
|
223,295
|
|
|
|
284,360
|
|
Supplies
|
|
|
238,243
|
|
|
|
314,818
|
|
|
|
389,584
|
|
|
|
448,210
|
|
|
|
510,351
|
|
|
|
248,520
|
|
|
|
286,541
|
|
Rent
|
|
|
50,156
|
|
|
|
65,080
|
|
|
|
76,986
|
|
|
|
87,210
|
|
|
|
97,104
|
|
|
|
46,628
|
|
|
|
54,240
|
|
Other operating expenses
|
|
|
403,656
|
|
|
|
541,464
|
|
|
|
639,037
|
|
|
|
765,697
|
|
|
|
897,091
|
|
|
|
426,156
|
|
|
|
503,815
|
|
Minority interest in earnings
|
|
|
2,070
|
|
|
|
2,329
|
|
|
|
2,494
|
|
|
|
3,104
|
|
|
|
2,795
|
|
|
|
1,068
|
|
|
|
818
|
|
Depreciation and amortization
|
|
|
106,505
|
|
|
|
132,930
|
|
|
|
149,155
|
|
|
|
164,563
|
|
|
|
188,771
|
|
|
|
89,689
|
|
|
|
104,619
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total operating costs and expenses
|
|
|
1,799,156
|
|
|
|
2,382,712
|
|
|
|
2,861,035
|
|
|
|
3,332,787
|
|
|
|
3,985,116
|
|
|
|
1,863,171
|
|
|
|
2,215,814
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from operations
|
|
|
240,094
|
|
|
|
293,808
|
|
|
|
342,472
|
|
|
|
405,533
|
|
|
|
380,460
|
|
|
|
224,445
|
|
|
|
237,311
|
|
Interest expense, net
|
|
|
59,960
|
|
|
|
68,192
|
|
|
|
75,256
|
|
|
|
94,613
|
|
|
|
102,299
|
|
|
|
45,657
|
|
|
|
61,559
|
|
Loss from early extinguishment of
debt
|
|
|
8,646
|
|
|
|
|
|
|
|
788
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations
before income taxes
|
|
|
171,488
|
|
|
|
225,616
|
|
|
|
266,428
|
|
|
|
310,920
|
|
|
|
278,161
|
|
|
|
178,788
|
|
|
|
175,752
|
|
Provision for income taxes
|
|
|
70,433
|
|
|
|
90,197
|
|
|
|
104,071
|
|
|
|
120,782
|
|
|
|
106,682
|
|
|
|
69,165
|
|
|
|
67,665
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations
|
|
|
101,055
|
|
|
|
135,419
|
|
|
|
162,357
|
|
|
|
190,138
|
|
|
|
171,479
|
|
|
|
109,623
|
|
|
|
108,087
|
|
Loss on discontinued operations,
net of taxes
|
|
|
(1,071
|
)
|
|
|
(3,947
|
)
|
|
|
(10,924
|
)
|
|
|
(22,594
|
)
|
|
|
(3,216
|
)
|
|
|
(3,216
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
$
|
99,984
|
|
|
$
|
131,472
|
|
|
$
|
151,433
|
|
|
$
|
167,544
|
|
|
$
|
168,263
|
|
|
$
|
106,407
|
|
|
$
|
108,087
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance Sheet Data:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Working capital
|
|
$
|
329,296
|
|
|
$
|
298,016
|
|
|
$
|
453,090
|
|
|
$
|
476,806
|
|
|
$
|
446,101
|
|
|
$
|
405,857
|
|
|
$
|
521,289
|
|
Property and equipment, net
|
|
|
1,029,337
|
|
|
|
1,395,345
|
|
|
|
1,484,548
|
|
|
|
1,610,991
|
|
|
|
1,986,577
|
|
|
|
1,757,218
|
|
|
|
2,089,142
|
|
Cash and cash equivalents
|
|
|
132,844
|
|
|
|
16,331
|
|
|
|
82,498
|
|
|
|
104,108
|
|
|
|
40,566
|
|
|
|
24,157
|
|
|
|
21,357
|
|
Total assets
|
|
|
2,809,496
|
|
|
|
3,350,211
|
|
|
|
3,632,608
|
|
|
|
3,934,218
|
|
|
|
4,506,579
|
|
|
|
4,178,660
|
|
|
|
4,793,111
|
|
Total debt
|
|
|
1,192,458
|
|
|
|
1,474,658
|
|
|
|
1,831,735
|
|
|
|
1,667,624
|
|
|
|
1,941,177
|
|
|
|
1,677,604
|
|
|
|
1,999,997
|
|
Other long-term obligations
|
|
|
102,832
|
|
|
|
156,577
|
|
|
|
225,390
|
|
|
|
283,738
|
|
|
|
301,842
|
|
|
|
289,592
|
|
|
|
346,880
|
|
Stockholders equity
|
|
$
|
1,214,305
|
|
|
$
|
1,350,589
|
|
|
$
|
1,239,991
|
|
|
$
|
1,564,577
|
|
|
$
|
1,723,673
|
|
|
$
|
1,698,299
|
|
|
$
|
1,860,967
|
|
46
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Six Months Ended
|
|
|
|
Year Ended December 31,
|
|
|
June 30,
|
|
|
|
2004
|
|
|
2005
|
|
|
2006
|
|
|
2006
|
|
|
2007
|
|
|
|
(Dollars in thousands)
|
|
|
Consolidated Data:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of hospitals (at end of
period)
|
|
|
66
|
|
|
|
69
|
|
|
|
77
|
|
|
|
74
|
|
|
|
79
|
|
Licensed beds(1)
|
|
|
7,358
|
|
|
|
7,974
|
|
|
|
9,117
|
|
|
|
8,546
|
|
|
|
9,550
|
|
Beds in service(2)
|
|
|
5,960
|
|
|
|
6,476
|
|
|
|
7,341
|
|
|
|
6,871
|
|
|
|
7,777
|
|
Admissions(3)
|
|
|
267,390
|
|
|
|
291,633
|
|
|
|
326,235
|
|
|
|
157,214
|
|
|
|
175,763
|
|
Adjusted admissions(4)
|
|
|
493,776
|
|
|
|
538,445
|
|
|
|
605,511
|
|
|
|
290,305
|
|
|
|
326,960
|
|
Patient days(5)
|
|
|
1,091,889
|
|
|
|
1,204,001
|
|
|
|
1,334,728
|
|
|
|
654,822
|
|
|
|
717,654
|
|
Average length of stay (days)(6)
|
|
|
4.1
|
|
|
|
4.1
|
|
|
|
4.1
|
|
|
|
4.2
|
|
|
|
4.1
|
|
Occupancy rate (beds in service)(7)
|
|
|
51.2
|
%
|
|
|
52.9
|
%
|
|
|
53.0
|
%
|
|
|
54.5
|
%
|
|
|
52.8
|
%
|
Net operating revenues
|
|
$
|
3,203,507
|
|
|
$
|
3,738,320
|
|
|
$
|
4,365,576
|
|
|
|
2,087,616
|
|
|
|
2,453,125
|
|
Net inpatient revenues as a
percentage of total net operating revenues
|
|
|
50.5
|
%
|
|
|
50.9
|
%
|
|
|
50.0
|
%
|
|
|
50.3
|
%
|
|
|
49.2
|
%
|
Net outpatient revenues as a
percentage of total net operating revenues
|
|
|
48.1
|
%
|
|
|
47.8
|
%
|
|
|
48.7
|
%
|
|
|
48.4
|
%
|
|
|
49.6
|
%
|
Other Financial Data:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Capital expenditures
|
|
$
|
164,286
|
|
|
$
|
188,365
|
|
|
$
|
224,519
|
|
|
$
|
94,194
|
|
|
$
|
108,849
|
|
Liquidity Data:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash flows provided by
operating activities
|
|
$
|
325,750
|
|
|
$
|
411,049
|
|
|
$
|
350,255
|
|
|
$
|
207,046
|
|
|
$
|
215,988
|
|
Net cash flows used in investing
activities
|
|
$
|
(318,479
|
)
|
|
$
|
(327,272
|
)
|
|
$
|
(640,257
|
)
|
|
$
|
(295,767
|
)
|
|
$
|
(309,270
|
)
|
Net cash flows provided by (used
in) financing activities
|
|
$
|
58,896
|
|
|
$
|
(62,167
|
)
|
|
$
|
226,460
|
|
|
$
|
8,770
|
|
|
$
|
74,073
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended
|
|
|
Six Months Ended
|
|
|
|
December 31,
|
|
|
June 30,
|
|
|
|
2005
|
|
|
2006
|
|
|
2006
|
|
|
2007
|
|
|
|
(Dollars in thousands)
|
|
|
Same-Store Data:(8)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Admissions(3)
|
|
|
291,633
|
|
|
|
294,820
|
|
|
|
155,696
|
|
|
|
156,330
|
|
Adjusted admissions(4)
|
|
|
538,445
|
|
|
|
543,074
|
|
|
|
288,022
|
|
|
|
289,197
|
|
Patient days(5)
|
|
|
1,204,001
|
|
|
|
1,213,429
|
|
|
|
649,396
|
|
|
|
641,224
|
|
Average length of stay (days)(6)
|
|
|
4.1
|
|
|
|
4.1
|
|
|
|
4.2
|
|
|
|
4.1
|
|
Occupancy rate (beds in service)(7)
|
|
|
52.9
|
%
|
|
|
53.3
|
%
|
|
|
54.7
|
%
|
|
|
53.5
|
%
|
Net operating revenues
|
|
$
|
3,737,607
|
|
|
$
|
4,000,828
|
|
|
$
|
2,072,549
|
|
|
$
|
2,182,151
|
|
Income from operations
|
|
$
|
406,774
|
|
|
$
|
365,173
|
|
|
$
|
225,266
|
|
|
$
|
225,635
|
|
Depreciation and amortization
|
|
$
|
163,455
|
|
|
$
|
173,443
|
|
|
$
|
88,961
|
|
|
$
|
93,686
|
|
Minority interest in earnings
|
|
$
|
3,104
|
|
|
$
|
3,140
|
|
|
$
|
1,068
|
|
|
$
|
818
|
|
|
|
|
(1) |
|
Licensed beds are the number of beds for which the appropriate
state agency licenses a facility, regardless of whether the beds
are actually available for patient use. |
|
(2) |
|
Beds in service are the number of beds that are readily
available for patient use. |
47
|
|
|
(3) |
|
Admissions represent the number of patients admitted for
inpatient treatment. |
|
(4) |
|
Adjusted admissions is a general measure of combined inpatient
and outpatient volume. We computed adjusted admissions by
multiplying admissions by gross patient revenues and then
dividing that number by gross inpatient revenues. |
|
(5) |
|
Patient days represent the total number of days of care provided
to inpatients. |
|
(6) |
|
Average length of stay (days) represents the average number of
days inpatients stay in our hospitals. |
|
(7) |
|
We calculated percentages by dividing the average daily number
of inpatients by the weighted average of beds in service. |
|
(8) |
|
Includes acquired hospitals to the extent we operated them
during comparable periods in each year. |
48
Our
Company
We are the largest non-urban provider of general hospital
healthcare services in the United States in terms of number of
facilities and net operating revenues. As of July 25, 2007,
prior to the acquisition of Triad, we owned, leased or operated
79 hospitals, geographically diversified across 23 states,
with an aggregate of 9,550 licensed beds. We generate
revenues by providing a broad range of general hospital
healthcare services to patients in the communities in which we
are located. Services provided by our hospitals include
emergency room services, general surgery, critical care,
internal medicine, obstetrics and diagnostic services. As part
of providing these services, we also own physician practices,
imaging centers, home health agencies and ambulatory surgery
centers. For the six months ended June 30, 2007, our net
operating revenues were $2,453 million.
Historically, we have grown by acquiring hospitals and by
improving the operations of our facilities. We targeted
hospitals in growing, non-urban healthcare markets for
acquisition because of their favorable demographic and economic
trends and competitive conditions. Because non-urban service
areas have smaller populations, there are generally fewer
hospitals and other healthcare service providers in these
communities and a lower level of managed care presence in these
markets. We believe that smaller populations support less direct
competition for hospital-based services. Over the past several
years, we also have expanded our focus beyond these non-urban
markets, acquiring larger facilities in more urban markets.
Based on our experience and our observations about our industry,
we have recognized that more rapid growth opportunities exist
for a skillful and disciplined operator in selected larger
markets.
On July 25, 2007, we acquired Triad, a publicly-owned
hospital company. Triad provides a broad range of general
hospital healthcare services to patients in non-urban and
mid-size markets located primarily in the southern, midwestern
and western United States. As of July 25, 2007, Triad
owned, leased or operated 50 hospitals in 17 states,
with an aggregate of approximately 9,600 licensed beds. Upon
closing of the acquisition, we became the largest publicly-owned
provider of hospital services, operating 129 hospitals in
28 states with an aggregate of approximately 19,200
licensed beds. Pro forma for the Triad acquisition, our net
operating revenues for the year ended December 31, 2006 and
the six months ended June 30, 2007 would have been
$9,903 million and $5,429 million, respectively. In
connection with the Merger, the Company obtained
$7,215 million of senior secured financing under the New
Credit Facility and its wholly-owned subsidiary,
CHS/Community Health Systems, Inc. issued the Old Notes at the
Closing of the Merger. We also refer to the acquisition of Triad
as the Merger. See Unaudited Pro Forma Condensed Financial
Statements.
We believe the Triad acquisition will:
|
|
|
|
|
complement our non-urban market presence with mid-size markets
having greater population growth than non-urban markets and less
competition than major metropolitan markets;
|
|
|
|
increase the scale of our operations, enabling us to realize
corporate overhead efficiencies and purchasing savings;
|
|
|
|
increase our operating growth and profitability as we centralize
certain functions and standardize best practices across these
facilities; and
|
|
|
|
increase our presence in 12 states and expand into five new
states.
|
Our
Industry
The U.S. healthcare industry is large and growing. CMS
reported that in 2005, total U.S. healthcare expenditures
grew by 6.9% to $2.0 trillion. It also projected total
U.S. healthcare spending to grow by 6.8% in 2006 and by an
average of 6.9% per year through 2015. By these estimates,
healthcare expenditures will account for approximately $3.9
trillion, or 19.2% of the total U.S. gross domestic
product, by 2015.
Hospital services, the market in which we operate, is the
largest single category of healthcare at 31% of total healthcare
spending in 2005, or $611.6 billion, as reported by CMS.
CMS projects the hospital services
49
market to grow by an average of 7.0% per year through 2015. It
expects growth in hospital healthcare spending to continue due
to the aging of the U.S. population and consumer demand for
expanded medical services. As hospitals remain the primary
setting for healthcare delivery, CMS expects hospital services
to remain the largest category of healthcare spending.
We believe that we are well-positioned to benefit from the
expected growth in hospital spending as well as shifts in
demographics in the United States. According to the
U.S. Census Bureau, there are approximately
36.9 million Americans age 65 or older in the United
States, who comprise approximately 13% of the total
U.S. population. By the year 2030 the number of elderly is
expected to climb to 71.5 million, or 20% of the total
population. Due to the increasing life expectancy of Americans,
the number of people aged 85 years and older is also
expected to increase from 4.3 million to 9.6 million
by the year 2030. This increase in life expectancy will increase
demand for healthcare services and, as importantly, the demand
for innovative, more sophisticated means of delivering those
services. Hospitals, as the largest category of care in the
healthcare market, will be among the main beneficiaries of this
increase in demand. Based on data compiled for us, the
populations of the service areas where our current hospitals are
located grew 19.6% from 1990 to 2005 and are expected to grow
4.9% from 2005 to 2010. The number of people aged 55 or older in
these service areas grew 25.8% from 1990 to 2005, and is
expected to grow 12.7% from 2005 to 2010. We believe the aging
of the population will benefit both non-urban and mid-size
markets, particularly in the southern regions in which we
operate.
The acute care hospital sector is characterized by a stable
Medicare reimbursement and commercial pricing environment. In
the United States, general acute care hospitals are instrumental
to the delivery of quality healthcare and represent a critical
element of the overall healthcare infrastructure. Approximately
82% of these hospitals are owned and managed by not-for-profit
or government entities that, according to the AHA, tend to have
lower operating margins than investor-owned hospitals. We
believe that Medicare, which accounts for approximately 30% of
total hospital spending, will continue to provide appropriate
pricing increases that will enable hospitals to provide high
quality clinical care. For fiscal 2007, Medicare has budgeted a
total payment increase of $3,400 million for acute care
inpatient services, which we believe is consistent with recent
historical experience. CMS forecasts Medicare hospital spending
to nearly double over the next 10 years.
Commercial pricing has also been stable for hospital providers,
and we believe commercial payors typically offer rate increases
that exceed those offered by Medicare. With respect to
commercial reimbursement, based on our experience,
well-positioned hospital companies generally have been
successful at receiving mid- to high single-digit private pay
increases over the past few years, and we expect this trend to
continue.
Urban
vs. Non-Urban Hospitals
According to the United States Census Bureau, 21% of the United
States population lives in communities designated as non-urban.
In these non-urban communities, hospitals are typically the
primary source of healthcare. In many cases, a single hospital
is the only provider of general healthcare services in these
communities. According to the AHA, in 2006, there were
approximately 2,000 non-urban hospitals in the United States. We
believe that a majority of these hospitals are owned by
not-for-profit or governmental entities.
Factors Affecting Performance. Among the many
factors that can influence a hospitals financial and
operating performance are:
|
|
|
|
|
facility size and location;
|
|
|
|
facility ownership structure (i.e., tax-exempt or
investor owned);
|
|
|
|
a facilitys ability to participate in group purchasing
organizations; and
|
|
|
|
facility payor mix.
|
50
We believe that non-urban hospitals are generally able to obtain
higher operating margins than urban hospitals. Factors
contributing to a non-urban hospitals margin advantage
include fewer patients with complex medical problems, a lower
cost structure, limited competition and favorable Medicare
payment provisions. Patients needing the most complex care are
more often served by the larger
and/or more
specialized urban hospitals. A non-urban hospitals lower
cost structure results from its geographic location, as well as
the lower number of patients treated who need the most highly
advanced services. Additionally, because non-urban hospitals are
generally sole providers or one of a small group of providers in
their markets, there is limited competition. This generally
results in more favorable pricing with commercial payors.
Medicare has special payment provisions for sole community
hospitals. Under present law, hospitals that qualify for
this designation can receive higher reimbursement rates. As of
December 31, 2006, 19 of our hospitals were sole
community hospitals. In addition, we believe that
non-urban communities are generally characterized by a high
level of patient and physician loyalty that fosters cooperative
relationships among the local hospitals, physicians, employees
and patients.
The type of third party responsible for the payment of services
performed by healthcare service providers is also an important
factor which affects hospital operating margins. These payors
have increasingly exerted pressure on healthcare service
providers to reduce the cost of care. The most active payors in
this regard have been health maintenance organizations, or HMOs,
preferred provider organizations, or PPOs, and other managed
care organizations. The characteristics of non-urban markets
make them less attractive to these managed care organizations.
This is partly because the limited size of non-urban markets and
their diverse, non-national employer bases minimize the ability
of managed care organizations to achieve economies of scale. In
2006, approximately 23.9% of our net operating revenues were
paid by managed care organizations as compared to 23.7% in 2005
and 22.2% in 2004.
Our
Strengths
We believe the following strengths will allow us to continue to
improve our operations and profitability:
Leading local market provider. We are a
leading provider of acute care services in the markets we serve.
As of June 30, 2007, we are one of three or fewer providers
in approximately 98% of our markets, and we are the sole
provider in approximately 85% of our markets. We have focused on
non-urban markets with strong demographic growth and underserved
medical populations. In general, reimbursement is more favorable
in these markets than in markets with more direct competition
for hospital-based services. In some of our markets, we receive
higher reimbursement rates from Medicare for designated sole
community hospitals. Additionally, our leading market position
enables us to achieve a strong return on investments in facility
expansion and physician recruitment. As of June 30, 2007,
pro forma for the Triad acquisition, we are one of three or
fewer providers in approximately 86% of our markets and the sole
provider in approximately 65% of our markets.
Geographic diversity and operating scale. We
operated 79 hospitals in 23 states as of July 25,
2007, prior to the acquisition of Triad. With our acquisition of
Triad, we have expanded into five new states and operate 129
hospitals across 28 states. Pro forma for the Triad
acquisition, our 2006 revenue exposure to any one state is less
than 13% (as compared to less than 21% for us prior to the
acquisition). Our geographic diversity helps to mitigate risk
associated with fluctuating state regulations related to
Medicaid reimbursement and state-specific economic conditions.
Furthermore, we believe our current operations, together with
those we acquired from Triad, will enable us to realize the
benefits of economies of scale, purchasing power and increased
operating efficiencies.
Strong presence in attractive markets. The
underserved non-urban markets, on which we have historically
focused, provide an attractive environment for our operations.
With fewer hospitals and healthcare providers and generally a
lower level of managed care penetration, these markets allow us
to profitably provide much needed acute care services. We
believe the Triad acquisition expands our presence in non-urban
markets and complements our non-urban focus, as Triads
mid-size markets have greater population growth than non-urban
markets. Triads facilities also enjoy strong patient and
physician loyalty and have less direct competition than
hospitals in major metropolitan markets.
51
Emphasis on quality of care. We have developed
significant expertise in implementing a variety of programs to
ensure continuous improvement in the quality of care provided at
our hospitals. This is an evolving aspect of our business, as
payors and accrediting agencies expand their views of quality to
include measurement, reporting and continual improvement of the
timeliness, safety, effectiveness, efficiency and
patient-centeredness of clinical care. We understand that high
levels of clinical care are only achieved when
quality is a company-wide leadership focus that
embraces patient, physician and employee satisfaction and
continual, systematic improvements. Seeking the highest levels
of improvement typically yields the best results for patients,
reduces risk and improves our financial performance. We have
developed and implemented programs to support and monitor
quality of care improvement that include:
|
|
|
|
|
standardized data and benchmarks to assist and monitor hospital
quality improvement efforts;
|
|
|
|
recommended policies and procedures based on the best medical
and scientific evidence;
|
|
|
|
hospital-based training and coaching to achieve success with
respect to expectations of accrediting agencies;
|
|
|
|
training programs for hospital management and clinical staff
regarding regulatory and reporting requirements, as well as
skills in leadership, communications and service;
|
|
|
|
sharing of best practices for regulatory compliance and
performance improvement; and
|
|
|
|
evidence-based tools for improving patient, physician and staff
satisfaction.
|
Strong history of generating revenue growth and improving
profitability. Since 2001, we have grown from 57
to 79 hospitals and have increased revenue from
$1,657 million to $4,366 million, and income from
continuing operations from $44.7 million to
$171.5 million for the year ended December 31, 2006
(2001 numbers are not restated for insignificant discontinued
operations). We have improved profitability by recruiting
primary care physicians and specialists, expanding our service
offerings to include more complex care, optimizing our emergency
room strategy across our portfolio of hospitals and selectively
making capital investments in projects that generate a high
return on investment. Upon closing of the Triad acquisition, we
believe that a significant opportunity exists to continue to
improve profitability, as approximately 30% of the combined
companys facilities have been acquired within the past
four years.
Experienced management team with a proven track
record. We have a strong and committed management
team that has substantial industry knowledge and a proven track
record of operations success in the hospital industry. Our chief
executive officer and chief financial officer each have over
30 years of experience in the healthcare industry and have
worked together since 1973. Our management team has successfully
acquired and integrated 55 hospitals, and we believe this
experience positions us well to integrate and improve the
operations of the Triad facilities in addition to successfully
executing our business strategy.
Our
Strategy
We intend to continue to grow our business and improve our
financial performance by implementing our business strategy, the
key elements of which are to:
|
|
|
|
|
increase revenues at our facilities;
|
|
|
|
increase operating efficiencies to improve profitability;
|
|
|
|
complete the successful integration of Triad; and
|
|
|
|
deleverage our balance sheet.
|
Increase
Revenues at Our Facilities
Overview. We intend to increase revenues at
our facilities by providing a broader range of services in a
more attractive care setting. Our primary method of expanding
medical services is recruiting additional primary care
physicians and specialists. We intend to continue to expand the
breadth of services offered at our hospitals through targeted
capital expenditures to support the addition of more complex
services, including
52
orthopedics, cardiovascular services and urology. We also
provide the capital to invest in technology and the physical
plant at our facilities, particularly in our emergency rooms,
surgery/critical care departments and diagnostic services.
Physician Recruiting. The primary method of
adding or expanding medical services is the recruitment of new
physicians into the community. A core group of primary care
physicians is necessary as an initial contact point for all
local healthcare. The addition of specialists who offer
services, including general surgery, obstetrics, gynecology,
cardiovascular services, orthopedics and urology, completes the
full range of medical and surgical services required to meet a
communitys core healthcare needs. We analyze demographic
data and patient referral trends to identify the healthcare
needs of the communities in which each of our hospitals is
located. As a result of this analysis, we are able to determine
what we believe to be the optimal mix of primary care physicians
and specialists. We employ recruiters at the corporate level to
support the local hospital managers in their recruitment
efforts. We have increased the number of physicians affiliated
with us through our recruiting efforts, net of turnover, by
approximately 300 in 2006, 290 in 2005 and 270 in 2004. Over 60%
of the physicians commencing practice with us in 2006 were
specialists. Although in recent years we have begun employing
more physicians, most of our physicians are in private practice
in their communities and thus are not our employees. We have
been successful in recruiting physicians because of the practice
opportunities and income potential afforded physicians in our
markets, as well as lower managed care penetration as compared
to major metropolitan areas. We believe our analysis of
community demographics and patient referral trends, our approach
to determining the optimal mix of primary care physicians and
specialists, and our centralized physician recruiting program
can be successfully applied to Triads facilities.
Emergency Room Initiatives. Approximately
60% of our hospital admissions originate in the emergency room.
We systematically take steps to upgrade our emergency rooms and
increase patient flow in our emergency rooms as a means of
optimizing utilization rates for our hospitals. The impression
of our overall operations by our customers is substantially
influenced by our emergency rooms, since generally that is their
first experience with our hospitals. One component of upgrading
our emergency rooms is the implementation of specialized
computer software programs designed to assist physicians in
making diagnoses and determining treatments. The software also
benefits patients and hospital personnel by assisting in proper
documentation of patient records and tracking patient flow. It
enables our nurses to provide more consistent patient care and
provides clear instructions to patients at time of discharge to
help them better understand their treatments. The steps we take
to increase patient flow in our emergency rooms include
renovating and expanding our emergency room facilities,
improving service and reducing waiting times, as well as
publicizing our emergency room capabilities in the local
community. We have also implemented marketing campaigns that
emphasize the quality and convenience of our emergency rooms to
enhance community awareness. We believe the Triad acquisition
presents an opportunity for growth, as Triad has not pursued a
similar emergency room enhancement strategy.
Expansion of Services. In an effort to better
meet the healthcare needs of the communities we serve and to
capture a greater portion of the healthcare spending in our
markets, we have added a broad range of services to our
facilities. These services range from various types of
diagnostic equipment capabilities to additional and renovated
emergency rooms, surgical and critical care suites and specialty
services. We continue to believe that appropriate capital
investments in our facilities, combined with the development of
our service capabilities, will reduce the migration of patients
to competing providers while providing an attractive return on
investment. Over the last four years, Triad has invested
approximately $1,573 million (or approximately 9% of
revenues) into its facilities, and we believe we can leverage
these already well-capitalized facilities and increase operating
efficiencies and profitability.
53
Increase
Operating Efficiencies to Improve Profitability
Overview. We continually focus on improving
operating efficiency to increase our operating margins. We seek
to reduce costs and enhance efficiency through various methods
and across the broad spectrum of our operations, including:
|
|
|
|
|
standardizing and centralizing our methods of operation and
management;
|
|
|
|
improving quality of care and patient, physician and staff
satisfaction;
|
|
|
|
implementing management and healthcare industry best practices,
which drive efficiencies in areas as diverse and wide-ranging as
adjusting staffing levels to patient volume and acuity, and
adopting drug formularies;
|
|
|
|
utilizing our proven case and resource management program, which
guides our hospitals in the allocation and application of
resources, which assists in optimizing clinical care and, in
turn, containing expenses;
|
|
|
|
capitalizing on our participation in a wide range of group
purchasing arrangements by monitoring and ensuring compliance by
our hospitals with the terms of those purchasing
arrangements; and
|
|
|
|
utilizing standardized management information systems
appropriate for the size and complexity of a particular hospital.
|
In addition, each of our hospital management teams is supported
by our centralized operational, reimbursement, regulatory and
compliance expertise, as well as by our senior management team,
which has an average of over 25 years of experience in the
healthcare industry.
Standardization and Centralization. Our
standardization and centralization initiatives encompass nearly
every aspect of our business, from developing standard policies
and procedures with respect to patient accounting and physician
practice management to implementing standard processes to
initiate, evaluate and complete construction projects. Our
standardization and centralization initiatives are a key element
in improving our operating results.
|
|
|
|
|
Physician Support. We support our newly
recruited physicians to enhance their transition into our
communities. We have implemented physician practice management
seminars and training. We host these seminars bi-monthly.
|
|
|
|
Procurement and Materials Management. We have
standardized and centralized our operations with respect to
medical supplies, equipment and pharmaceuticals used in our
hospitals. We are in the second year of a five-year
participating agreement with automatic renewal terms of one year
with HealthTrust, a GPO. HealthTrust is the source for a
substantial portion of our medical supplies, equipment and
pharmaceuticals.
|
|
|
|
Billing and Collections. We have adopted
standard policies and procedures with respect to billing and
collections. We have also automated and standardized various
components of the collection cycle, including statement and
collection letters and the movement of accounts through the
collection cycle.
|
|
|
|
Internal Controls Over Financial Reporting. We
have centralized many of our significant internal controls over
financial reporting and standardized those other controls that
are performed at our hospital locations. We continuously monitor
compliance with and evaluate the effectiveness of our internal
controls over financial reporting.
|
|
|
|
Case and Resource Management. Our case and
resource management program guides our hospitals in the
allocation and application of resources, assists in optimizing
clinical care and, in turn, assists in containing expenses.
|
|
|
|
Facilities Management. We have standardized
interiors, lighting and furniture programs. We have also
implemented a standard process to initiate, evaluate and
complete construction projects. Our corporate staff monitors all
construction projects, and reviews and pays all construction
project invoices. Our
|
54
|
|
|
|
|
initiatives in this area have reduced our construction costs
while maintaining the same level of quality, and have shortened
the time it takes us to complete these projects.
|
|
|
|
|
|
Other Initiatives. We have also improved
margins by implementing standard programs with respect to
ancillary services in areas including emergency rooms, pharmacy,
laboratory, imaging, home health, skilled nursing, centralized
outpatient scheduling and health information management. We have
reduced costs associated with these services by improving
contract terms and standardizing information systems. We work to
identify and communicate best practices and monitor these
improvements throughout the Company.
|
Complete
Successful Integration of Triad
We have successfully acquired and integrated 55 hospitals since
1996, and our focus over the next two years will be to
successfully integrate the acquisition of Triad. We have an
established, experienced and dedicated team to manage the
integration of Triad. We believe that, in the first year
following the acquisition of Triad, we will realize
approximately $28 million of annual cost savings related to
cash expenses from the elimination of certain head count
reductions and the elimination of certain duplicate overhead
costs. We anticipate that we will realize additional savings
from improved pricing opportunities under our purchasing
contracts, the elimination of certain other duplicate corporate
overhead costs and the implementation of other cost saving
initiatives that management has identified. Additionally, we
intend to continue to pursue a disciplined approach in making
capital investments that generate a high return on investment,
and will apply this focus to our acquired hospitals. Over the
last four years, Triad has invested approximately
$1,573 million (or approximately 9% of revenues) into its
facilities. We believe we can leverage these already
well-capitalized facilities and increase operating efficiencies
and profitability.
Deleverage
Balance Sheet
Historically, we have generated relatively strong and stable
cash flow which has allowed us to fund our growth-related
investments while maintaining reasonable leverage levels. From
March 31, 2000 (prior to the June, 2000 initial public
offering of our common stock) to June 30, 2007, our debt as
a percentage of total capitalization decreased from 86.6% to
51.8%. We intend to continue our strategy of utilizing cash
flows from our combined operations to service debt and to fund
our future growth initiatives. We will also consider issuing
equity or equity-related securities or divesting selected
hospital facilities to deleverage our balance sheet.
Sources
of Revenue
We receive payment for healthcare services provided by our
hospitals from:
|
|
|
|
|
the federal Medicare program;
|
|
|
|
state Medicaid or similar programs;
|
|
|
|
healthcare insurance carriers, HMOs, PPOs and other managed care
programs; and
|
|
|
|
patients directly.
|
The following table presents the approximate percentages of net
operating revenue received from Medicare, Medicaid, managed
care, self-pay and other sources for the periods indicated. The
data for the years
55
presented are not strictly comparable due to the significant
effect that hospital acquisitions have had on these statistics.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2004
|
|
|
2005
|
|
|
2006
|
|
|
Net Operating Revenues by Payor
Source
|
|
|
|
|
|
|
|
|
|
|
|
|
Medicare
|
|
|
31.9
|
%
|
|
|
32.0
|
%
|
|
|
30.7
|
%
|
Medicaid
|
|
|
10.3
|
%
|
|
|
11.2
|
%
|
|
|
11.0
|
%
|
Managed Care
|
|
|
22.2
|
%
|
|
|
23.7
|
%
|
|
|
23.9
|
%
|
Self-pay
|
|
|
12.9
|
%
|
|
|
11.5
|
%
|
|
|
11.9
|
%
|
Other Third-Party Payors
|
|
|
22.7
|
%
|
|
|
21.6
|
%
|
|
|
22.5
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
100.0
|
%
|
|
|
100.0
|
%
|
|
|
100.0
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As shown above, we receive a substantial portion of our revenue
from the Medicare and Medicaid programs. Other Third-Party
Payors includes insurance companies for which we do not
have insurance provider contracts, workers compensation
carriers, and non-patient service revenue, such as rental income
and cafeteria sales.
Medicare is a federal program that provides medical insurance
benefits to persons age 65 and over, some disabled persons,
and persons with end-stage renal disease. Medicaid is a
federal-state funded program, administered by the states, which
provides medical benefits to individuals who are unable to
afford healthcare. All of our hospitals are certified as
providers of Medicare and Medicaid services. Amounts received
under the Medicare and Medicaid programs are generally
significantly less than a hospitals customary charges for
the services provided. Since a substantial portion of our
revenue comes from patients under Medicare and Medicaid
programs, our ability to operate our business successfully in
the future will depend in large measure on our ability to adapt
to changes in these programs.
In addition to government programs, we are paid by private
payors, which include insurance companies, HMOs, PPOs, other
managed care companies, employers, and by patients directly. The
Blue Cross HMO payors are included in the above-captioned
Managed Care line item. All other Blue Cross payors are included
in the above-captioned Other Third-Party Payors line
item. Patients are generally not responsible for any difference
between customary hospital charges and amounts paid for hospital
services by Medicare and Medicaid programs, insurance companies,
HMOs, PPOs, and other managed care companies, but are
responsible for services not covered by these programs or plans,
as well as for deductibles and co-insurance obligations of their
coverage. The amount of these deductibles and co-insurance
obligations has increased in recent years. Collection of amounts
due from individuals is typically more difficult than collection
of amounts due from government or business payors. To further
reduce their healthcare costs, an increasing number of insurance
companies, HMOs, PPOs and other managed care companies are
negotiating discounted fee structures or fixed amounts for
hospital services performed, rather than paying healthcare
providers the amounts billed. We negotiate discounts with
managed care companies, which are typically smaller than
discounts under governmental programs. If an increased number of
insurance companies, HMOs, PPOs, and other managed care
companies succeed in negotiating discounted fee structures or
fixed amounts, our results of operations may be negatively
affected. For more information on the payment programs on which
our revenues depend, see Our Business
Payment.
Hospital revenues depend upon inpatient occupancy levels, the
volume of outpatient procedures and the charges or negotiated
payment rates for hospital services provided. Charges and
payment rates for routine inpatient services vary significantly
depending on the type of service performed and the geographic
location of the hospital. In recent years, we have experienced a
significant increase in revenue received from outpatient
services. We attribute this increase to:
|
|
|
|
|
advances in technology, which have permitted us to provide more
services on an outpatient basis; and
|
|
|
|
pressure from Medicare or Medicaid programs, insurance companies
and managed care plans to reduce hospital stays and to reduce
costs by having services provided on an outpatient rather than
on an inpatient basis.
|
56
Government
Regulation
Overview. The healthcare industry is required
to comply with extensive government regulation at the federal,
state and local levels. Under these regulations, hospitals must
meet requirements to be certified as hospitals and qualified to
participate in government programs, including the Medicare and
Medicaid programs. These requirements relate to the adequacy of
medical care, equipment, personnel, operating policies and
procedures, maintenance of adequate records, hospital use,
rate-setting, compliance with building codes and environmental
protection laws. There are also extensive regulations governing
a hospitals participation in these government programs. If
we fail to comply with applicable laws and regulations, we can
be subject to criminal penalties and civil sanctions, our
hospitals can lose their licenses and we could lose our ability
to participate in these government programs. In addition,
government regulations may change. If that happens, we may have
to make changes in our facilities, equipment, personnel, and
services so that our hospitals remain certified as hospitals and
qualified to participate in these programs. We believe that our
hospitals are in substantial compliance with current federal,
state and local regulations and standards.
Hospitals are subject to periodic inspection by federal, state
and local authorities to determine their compliance with
applicable regulations and requirements necessary for licensing
and certification. All of our hospitals are licensed under
appropriate state laws and are qualified to participate in the
Medicare and Medicaid programs. In addition, most of our
hospitals are accredited by the Joint Commission on
Accreditation of Healthcare Organizations, or the Joint
Commission. This accreditation indicates that a hospital
satisfies the applicable health and administrative standards to
participate in the Medicare and Medicaid programs.
Recent Changes. In recent years, numerous
changes have been made in the oversight of healthcare providers
to provide an increased emphasis on the linkage between quality
of care criteria and payment levels. For example, hospital
Medicare payments are now impacted by the hospitals
accurate reporting of the basic elements of care provided to
patients with certain diagnoses. As another indication of this
trend and focus, the Joint Commission no longer gives numerical
scores at scheduled triennial surveys; it now scores hospitals
and other accredited providers on a pass-fail basis at
unannounced surveys. Because hospitals no longer are able to
prepare for a survey at a time certain, it is possible that
there will be an increase in negative survey findings, which
could lead to a loss of accreditation. Other provider types are
facing similar changes in payment and quality oversight.
Fraud and Abuse Laws. Participation in the
Medicare program is heavily regulated by federal statute and
regulation. If a hospital fails substantially to comply with the
requirements for participating in the Medicare program, the
hospitals participation in the Medicare program may be
terminated
and/or civil
or criminal penalties may be imposed. For example, a hospital
may lose its ability to participate in the Medicare program if
it does any of the following:
|
|
|
|
|
makes claims to Medicare for services not provided or
misrepresents actual services provided in order to obtain higher
payments;
|
|
|
|
pays money to induce the referral of patients where services are
reimbursable under a federal health program; or
|
|
|
|
pays money to limit or reduce the services provided to Medicare
beneficiaries.
|
HIPAA broadened the scope of the fraud and abuse
laws. Under HIPAA, any person or entity that
knowingly and willfully defrauds or attempts to defraud a
healthcare benefit program, including private healthcare plans,
may be subject to fines, imprisonment or both. Additionally, any
person or entity that knowingly and willfully falsifies or
conceals a material fact or makes any material false or
fraudulent statements in connection with the delivery or payment
of healthcare services by a healthcare benefit plan is subject
to a fine, imprisonment or both.
Another law regulating the healthcare industry is a section of
the Social Security Act, known as the anti-kickback
statute. This law prohibits some business practices and
relationships under Medicare, Medicaid and other federal
healthcare programs. These practices include the payment,
receipt, offer or solicitation of
57
remuneration of any kind in exchange for items or services that
are reimbursed under most federal or state healthcare programs.
Violations of the anti-kickback statute may be punished by
criminal and civil fines, exclusion from federal healthcare
programs, and damages up to three times the total dollar amount
involved.
The Office of Inspector General of the Department of Health and
Human Services, or OIG, is responsible for identifying and
investigating fraud and abuse activities in federal healthcare
programs. As part of its duties, the OIG provides guidance to
healthcare providers by identifying types of activities that
could violate the anti-kickback statute. The OIG also publishes
regulations outlining activities and business relationships that
would be deemed not to violate the anti-kickback statute. These
regulations are known as safe harbor regulations.
However, the failure of a particular activity to comply with the
safe harbor regulations does not necessarily mean that the
activity violates the anti-kickback statute.
The OIG has identified the following incentive arrangements as
potential violations of the anti-kickback statute:
|
|
|
|
|
payment of any incentive by the hospital when a physician refers
a patient to the hospital;
|
|
|
|
use of free or significantly discounted office space or
equipment for physicians in facilities usually located close to
the hospital;
|
|
|
|
provision of free or significantly discounted billing, nursing
or other staff services;
|
|
|
|
free training for a physicians office staff, including
management and laboratory techniques (but excluding compliance
training);
|
|
|
|
guarantees which provide that if the physicians income
fails to reach a predetermined level, the hospital will pay any
portion of the remainder;
|
|
|
|
low-interest or interest-free loans, or loans which may be
forgiven if a physician refers patients to the hospital;
|
|
|
|
payment of the costs of a physicians travel and expenses
for conferences;
|
|
|
|
payment of services which require few, if any, substantive
duties by the physician, or payment for services in excess of
the fair market value of the services rendered; or
|
|
|
|
purchasing goods or services from physicians at prices in excess
of their fair market value.
|
We have a variety of financial relationships with physicians who
refer patients to our hospitals. Physicians own interests in a
number of our facilities. Physicians may also own our stock. We
also have contracts with physicians providing for a variety of
financial arrangements, including employment contracts, leases,
management agreements and professional service agreements. We
provide financial incentives to recruit physicians to relocate
to communities served by our hospitals. These incentives include
relocation, reimbursement for certain direct expenses, income
guarantees and, in some cases, loans. Although we believe that
we have structured our arrangements with physicians in light of
the safe harbor rules, we cannot assure you that
regulatory authorities will not determine otherwise. If that
happens, we could be subject to criminal and civil penalties
and/or
exclusion from participating in Medicare, Medicaid or other
government healthcare programs.
The Social Security Act also includes a provision commonly known
as the Stark law. This law prohibits physicians from
referring Medicare patients to healthcare entities in which they
or any of their immediate family members have ownership
interests or other financial arrangements. These types of
referrals are commonly known as self-referrals.
Sanctions for violating the Stark law include denial of payment,
civil money penalties, assessments equal to twice the dollar
value of each service and exclusion from government payor
programs. There are ownership and compensation arrangement
exceptions to the self-referral prohibition. One exception
allows a physician to make a referral to a hospital if the
physician owns an interest in the entire hospital, as opposed to
an ownership interest in a department of the hospital. Another
exception allows a physician to refer patients to a healthcare
entity in which the physician has an ownership interest if the
entity is located in a rural area, as defined in the statute.
There are also exceptions for many of the
58
customary financial arrangements between physicians and
providers, including employment contracts, leases and
recruitment agreements. In January 2002 and March 2004, the
federal government issued regulations that interpret some of the
provisions included in the Stark law. We strive to comply with
the Stark law and regulations; however, the government may
interpret the law and regulations differently. If we are found
to have violated the Stark law or regulations, we could be
subject to significant sanctions, including damages, penalties
and exclusion from federal healthcare programs.
Many states in which we operate also have adopted, or are
considering adopting, similar laws relating to financial
relationships with physicians. Some of these state laws apply
even if the payment for care does not come from the government.
These statutes typically provide criminal and civil penalties as
well as loss of licensure. While there is little precedent for
the interpretation or enforcement of these state laws, we have
attempted to structure our financial relationships with
physicians and others in light of these laws. However, if we are
found to have violated these state laws, it could result in the
imposition of criminal and civil penalties as well as possible
licensure revocation.
False Claims Act. Another trend in healthcare
litigation is the increased use of the False Claims Act, or FCA.
This law makes providers liable for, among other things, the
knowing submission of a false claim for reimbursement by the
federal government. The FCA has been used not only by the
U.S. government, but also by individuals who bring an
action on behalf of the government under the laws
qui tam or whistleblower
provisions and share in any recovery. When a private party
brings a qui tam action under the FCA, it files the
complaint with the court under seal, and the defendant will
generally not be aware of the lawsuit until the government makes
a determination whether it will intervene and take a lead in the
litigation.
Civil liability under the FCA can be up to three times the
actual damages sustained by the government plus civil penalties
of up to $11,000 for each separate false claim submitted to the
government. There are many potential bases for liability under
the FCA. Although liability under the FCA arises when an entity
knowingly submits a false claim for reimbursement, the FCA
defines the term knowingly to include reckless
disregard of the truth or falsity of the claim being submitted.
A number of states in which we operate have enacted or are
considering enacting state false claims legislation. These state
false claims laws are generally modeled on the federal FCA, with
similar damages, penalties and qui tam enforcement
provisions. An increasing number of healthcare false claims
cases seek recoveries under both federal and state law.
Provisions in the Deficit Reduction Act of 2005, or the DRA,
that went into effect on January 1, 2007 give states
significant financial incentives to enact false claims laws
modeled on the federal FCA. Additionally, the DRA requires every
entity that receives annual payments of at least
$5.0 million from a state Medicaid plan to establish
written policies for its employees that provide detailed
information about federal and state false claims statutes and
the whistleblower protections that exist under those laws. Both
provisions of the DRA are expected to result in increased false
claims litigation against healthcare providers. We have complied
with the written policy requirements.
Emergency Medical Treatment and Active Labor
Act. The Emergency Medical Treatment and Active
Labor Act imposes requirements as to the care that must be
provided to anyone who comes to facilities providing emergency
medical services seeking care before they may be transferred to
another facility or otherwise denied care. Sanctions for failing
to fulfill these requirements include exclusion from
participation in the Medicare and Medicaid programs and civil
money penalties. In addition, the law creates private civil
remedies which enable an individual who suffers personal harm as
a direct result of a violation of the law to sue the offending
hospital for damages and equitable relief. A medical facility
that suffers a financial loss as a direct result of another
participating hospitals violation of the law also has a
similar right. Although we seek to comply with the law, we can
give no assurance that government officials responsible for
enforcing the law or others will not assert that we are in
violation of these laws.
Privacy and Security Requirements of
HIPAA. The Administrative Simplification
Provisions of HIPAA require the use of uniform electronic data
transmission standards for healthcare claims and payment
59
transactions submitted or received electronically. These
provisions are intended to encourage electronic commerce in the
healthcare industry. We believe we are in compliance with these
regulations.
The Administrative Simplification Provisions also require CMS to
adopt standards to protect the security and privacy of
health-related information. These privacy regulations became
effective April 14, 2001, but compliance with these
regulations was not required until April 2003. The privacy
regulations extensively regulate the use and disclosure of
individually identifiable health-related information. If we
violate these regulations, we could be subject to monetary fines
and penalties, criminal sanctions and civil causes of action. We
have implemented and operate continuing employee education
programs to reinforce operational compliance with policy and
procedures which adhere to privacy regulations. Regulations
relating to the security of electronic protected health
information went into effect on April 21, 2003, and
compliance was required as of April 21, 2005. The HIPAA
security standards and privacy regulations serve similar
purposes and overlap to a certain extent, but the security
regulations relate more specifically to protecting the
integrity, confidentiality and availability of electronic
protected health information while it is in our custody or being
transmitted to others. We believe we have established proper
controls to safeguard access to protected health information.
Corporate Practice of Medicine;
Fee-Splitting. Some states have laws that
prohibit unlicensed persons or business entities, including
corporations, from employing physicians. Some states also have
adopted laws that prohibit direct or indirect payments or
fee-splitting arrangements between physicians and unlicensed
persons or business entities. Possible sanctions for violations
of these restrictions include loss of a physicians
license, civil and criminal penalties and rescission of business
arrangements. These laws vary from state to state, are often
vague and have seldom been interpreted by the courts or
regulatory agencies. We structure our arrangements with
healthcare providers to comply with the relevant state law.
However, we cannot assure you that government officials
responsible for enforcing these laws will not assert that we, or
transactions in which we are involved, are in violation of these
laws. These laws may also be interpreted by the courts in a
manner inconsistent with our interpretations.
Certificates of Need. The construction of new
facilities, the acquisition of existing facilities and the
addition of new services at our facilities may be subject to
state laws that require prior approval by state regulatory
agencies. These certificate of need laws generally require that
a state agency determine the public need and give approval prior
to the construction or acquisition of facilities or the addition
of new services. We operate 44 hospitals in 12 states that
have adopted certificate of need laws for acute care facilities.
If we fail to obtain necessary state approval, we will not be
able to expand our facilities, complete acquisitions or add new
services in these states. Violation of these state laws may
result in the imposition of civil sanctions or the revocation of
a hospitals licenses.
Conversion Legislation. Many states, including
some where we have hospitals and others where we may in the
future acquire hospitals, have adopted legislation regarding the
sale or other disposition of hospitals operated by
not-for-profit entities. In other states that do not have
specific legislation, the attorneys general have demonstrated an
interest in these transactions under their general obligations
to protect charitable assets from waste. These legislative and
administrative efforts primarily focus on the appropriate
valuation of the assets divested and the use of the proceeds of
the sale by the not-for-profit seller. While these reviews and,
in some instances, approval processes can add additional time to
the closing of a hospital acquisition, we have not had any
significant difficulties or delays in completing the process.
There can be no assurance, however, that future actions on the
state level will not seriously delay or even prevent our ability
to acquire hospitals. If these activities are widespread, they
could limit our ability to acquire additional hospitals.
Healthcare Reform. The healthcare industry
continues to attract much legislative interest and public
attention. In recent years, an increasing number of legislative
proposals have been introduced or proposed in Congress and in
some state legislatures that would effect major changes in the
healthcare system. Proposals that have been considered include
cost controls on hospitals, insurance market reforms to increase
the availability of group health insurance to small businesses,
and mandatory health insurance coverage for employees. The costs
of implementing some of these proposals could be financed, in
part, by reductions in payments to healthcare providers under
Medicare, Medicaid and other government programs. We cannot
60
predict the course of future healthcare legislation or other
changes in the administration or interpretation of governmental
healthcare programs and the effect that any legislation,
interpretation, or change may have on us.
Payment
Medicare. Under the Medicare program, we are
paid for inpatient and outpatient services performed by our
hospitals.
Payments for inpatient acute services are generally made
pursuant to a prospective payment system, commonly known as
PPS. Under PPS, our hospitals are paid a
predetermined amount for each hospital discharge based on the
patients diagnosis. Specifically, each discharge is
assigned to a DRG based upon the patients condition and
treatment during the relevant inpatient stay. For the federal
fiscal year 2007, each DRG is assigned a payment rate using 67%
of the national average charge per case and 33% of the national
average cost per case. For the federal fiscal year 2008, each
DRG is assigned a payment rate using 67% of the national average
cost per case and 33% of the national average charge per case.
For the federal fiscal year 2009, each DRG is assigned a payment
rate using 100% of the national average cost per case. DRG
payments are based on national averages and not on charges or
costs specific to a hospital. However, DRG payments are adjusted
by a predetermined geographic adjustment factor assigned to the
geographic area in which the hospital is located. While a
hospital generally does not receive payment in addition to a DRG
payment, hospitals may qualify for an outlier
payment when the relevant patients treatment costs are
extraordinarily high and exceed a specified regulatory threshold.
The DRG rates are adjusted by an update factor on October 1 of
each year, the beginning of the federal fiscal year
(i.e., the federal fiscal year beginning October 1,
2006 is referred to as the 2007 federal fiscal year). The index
used to adjust the DRG rates, known as the market basket
index, gives consideration to the inflation experienced by
hospitals in purchasing goods and services. Under the Medicare
Prescription Drug, Improvement, and Modernization Act of 2003,
DRG payment rates were increased by the full market basket
index, for the federal fiscal years 2004, 2005, 2006 and
2007 or 3.4%, 3.3%, 3.7% and 3.4%, respectively. The Deficit
Reduction Act of 2005 imposes a 2% reduction to the market
basket index beginning in the federal fiscal year 2007 if
patient quality data is not submitted. We intend to comply with
this data submission requirement. Future legislation may
decrease the rate of increase for DRG payments, but we are not
able to predict the amount of any reduction or the effect that
any reduction will have on us.
In addition, hospitals may qualify for Medicare disproportionate
share payments when their percentage of low income patients
exceeds specified regulatory thresholds. A majority of our
hospitals qualify to receive Medicare disproportionate share
payments. For the majority of our hospitals that qualify to
receive Medicare disproportionate share payments, these payments
were increased by the Medicare Prescription Drug, Improvement,
and Modernization Act of 2003 effective April 1, 2004.
These Medicare disproportionate share payments as a percentage
of net operating revenues were 2.1% for each of the three years
ended December 31, 2006, 2005 and 2004, respectively.
Beginning August 1, 2000, we began receiving Medicare
reimbursement for outpatient services through a PPS. Under the
Balanced Budget Refinement Act of 1999, non-urban hospitals with
100 beds or fewer were held harmless through December 31,
2004 under this Medicare outpatient PPS. The Medicare
Prescription Drug, Improvement, and Modernization Act of 2003
extended the hold harmless provision for non-urban hospitals
with 100 beds or fewer and for non-urban sole community
hospitals with more than 100 beds through December 31,
2005. The Deficit Reduction Act of 2005 extended the hold
harmless provision for non-urban hospitals with 100 beds or
fewer that are not sole community hospitals through
December 31, 2008; however the Act reduces the amount these
hospitals would receive in hold harmless payment by 5% in 2006,
10% in 2007 and 15% in 2008. Of our 77 hospitals at
December 31, 2006, 31 qualified for this relief. The
outpatient conversion factor rate was increased by 3.4%
effective January 1, 2004; however, adjustments to other
variables within the outpatient PPS resulted in an approximate
4.3% to 4.7% net increase in outpatient PPS payments. The
outpatient conversion factor was increased 3.3% effective
January 1, 2005; however, coupled with adjustments to other
variables within the outpatient PPS resulted in an approximate
4.8% to
61
5.2% net increase in outpatient PPS payments. The outpatient
conversion factor was increased 3.7% effective January 1,
2006; however, coupled with adjustments to other variables with
the outpatient PPS, an approximate 2.2% to 2.6% net increase in
outpatient payments occurred. The outpatient conversion factor
was increased 3.4% effective January 1, 2007; however,
coupled with adjustments to other variables with the outpatient
PPS, an approximate 2.5% to 2.9% net increase in outpatient
payments is expected to occur.
Skilled nursing facilities and swing bed facilities were
historically paid by Medicare on the basis of actual costs,
subject to limitations. The Balanced Budget Act of 1997
established a PPS for Medicare skilled nursing facilities and
mandated that swing bed facilities must be incorporated into the
skilled nursing facility PPS. For federal fiscal year 2004,
skilled nursing facility PPS payment rates are increased by the
full market basket of 3.0% coupled with a 3.26% increase to
reflect the difference between the market basket forecast and
the actual market basket increase from the start of the skilled
nursing facility PPS in July 1998. For federal fiscal year 2005,
skilled nursing facility PPS payment rates were increased by the
full market basket of 2.8%. For federal fiscal year 2006,
skilled nursing facility PPS payment rates were increased 3.1%;
however, coupled with adjustments to other variables within the
skilled nursing facility PPS, an approximate 3.9% to 4.3% net
increase in skilled nursing facility PPS payments occurred. For
federal fiscal year 2007, skilled nursing facility PPS rates
were increased by the full SNF market basket index of 3.1%.
The Department of Health and Human Services established a PPS
for home health services effective October 1, 2000. The
home health agency PPS per episodic payment rate increased by
3.3% on October 11, 2003. The Medicare Prescription Drug,
Improvement, and Modernization Act of 2003 implemented an 0.8%
reduction to the market basket increase to the home health
agency PPS per episodic payment rate effective April 1,
2004 and for the federal fiscal years 2005 and 2006, and
increased Medicare payments by 5.0% to home health services
provided in rural areas from April 1, 2004 through
March 31, 2005. The Deficit Reduction Act of 2005 extended
the 5.0% increase to home health services provided in rural
areas for an additional year effective January 1, 2006 and
froze home health agency payments for 2006 at 2005 levels. The
home health agency PPS per episodic payment rate increased by
2.3% on January 1, 2005, 0% on January 1, 2006, and
3.3% on January 1, 2007.
Medicaid. Most state Medicaid payments are
made under a PPS or under programs which negotiate payment
levels with individual hospitals. Medicaid is currently funded
jointly by state and federal government. The federal government
and many states are currently considering significantly reducing
Medicaid funding, while at the same time expanding Medicaid
benefits. We can provide no assurance that reductions to
Medicaid funding will not have a material adverse effect on our
results of operations.
Annual Cost Reports. Hospitals participating
in the Medicare and some Medicaid programs, whether paid on a
reasonable cost basis or under a PPS, are required to meet
specified financial reporting requirements. Federal and, where
applicable, state regulations require submission of annual cost
reports identifying medical costs and expenses associated with
the services provided by each hospital to Medicare beneficiaries
and Medicaid recipients.
Annual cost reports required under the Medicare and some
Medicaid programs are subject to routine governmental audits.
These audits may result in adjustments to the amounts ultimately
determined to be due to us under these reimbursement programs.
Finalization of these audits often takes several years.
Providers can appeal any final determination made in connection
with an audit. DRG outlier payments have been and continue to be
the subject of CMS audit and adjustment. The OIG is also
actively engaged in audits and investigations into alleged
abuses of the DRG outlier payment system.
Commercial Insurance. Our hospitals provide
services to individuals covered by private healthcare insurance.
Private insurance carriers pay our hospitals or in some cases
reimburse their policyholders based upon the hospitals
established charges and the coverage provided in the insurance
policy. Commercial insurers are trying to limit the costs of
hospital services by negotiating discounts, including PPS, which
would reduce payments by commercial insurers to our hospitals.
Reductions in payments for services provided by our hospitals to
individuals covered by commercial insurers could adversely
affect us.
62
Supply
Contracts
In March 2005, we began purchasing items, primarily medical
supplies, medical equipment and pharmaceuticals, under an
agreement with HealthTrust, a GPO in which we are a minority
partner. By participating in this organization we are able to
procure items at competitively priced rates for our hospitals.
There can be no assurance that our arrangement with HealthTrust
will provide the discounts we expect to achieve. Prior to March
2005, we had an agreement with and purchased supplies using
Broadlane Inc., another GPO.
Competition
The hospital industry is highly competitive, including
competition with other hospitals and healthcare providers for
patients. The competition among hospitals and other healthcare
providers for patients has intensified in recent years. Our
hospitals are located in non-urban and mid-size service areas.
In approximately 85% of our markets, we are the sole provider of
general healthcare services. After the Merger, this percentage
decreased to 65%. In many of our other markets, the primary
competitor is a not-for-profit hospital. These not-for-profit
hospitals generally differ in each jurisdiction. In addition,
our hospitals face competition from hospitals outside of their
primary service area, including hospitals in urban areas that
provide more complex services. These facilities generally are
located some distance from our facilities. Patients in our
primary service areas may travel to these other hospitals for a
variety of reasons. These reasons include physician referrals or
the need for services we do not offer. Patients who seek
services from these other hospitals may subsequently shift their
preferences to those hospitals for the services we provide.
Some of our hospitals operate in primary service areas where
they compete with one or more other hospitals. Some of these
competing hospitals use equipment and services more specialized
than those available at our hospitals. In addition, some
competing hospitals are owned by tax-supported governmental
agencies or not-for-profit entities supported by endowments and
charitable contributions. These hospitals can make capital
expenditures without paying sales, property and income taxes. We
also face competition from other specialized care providers,
including outpatient surgery, orthopedic, oncology and
diagnostic centers.
The number and quality of the physicians on a hospitals
staff is an important factor in a hospitals competitive
advantage. Physicians decide whether a patient is admitted to
the hospital and the procedures to be performed. Admitting
physicians may be on the medical staffs of other hospitals in
addition to those of our hospitals. We attempt to attract our
physicians patients to our hospitals by offering quality
services and facilities, convenient locations and
state-of-the-art equipment.
Compliance
Program
We take an operations team approach to compliance and utilize
corporate experts for program design efforts and facility
leaders for employee-level implementation. Compliance is another
area where our utilization of standardization and centralization
techniques and initiatives yield efficiencies and consistency
throughout our facilities. We recognize that our compliance with
applicable laws and regulations depends on individual employee
actions as well as company operations. Our approach focuses on
integrating compliance responsibilities with operational
functions. This approach is intended to reinforce our
company-wide commitment to operate strictly in accordance with
the laws and regulations that govern our business.
Our company-wide compliance program has been in place since
1997. Currently, the programs elements include leadership,
management and oversight at the highest levels, a Code of
Conduct, risk area specific policies and procedures, employee
education and training, an internal system for reporting
concerns, auditing and monitoring programs, and a means for
enforcing the programs policies.
Since its initial adoption, the compliance program continues to
be expanded and developed to meet the industrys
expectations and our needs. Specific written policies,
procedures, training and educational materials and programs, as
well as auditing and monitoring activities, have been prepared
and implemented to address the functional and operational
aspects of our business. Included within these functional areas
are materials and activities for business
sub-units,
including laboratory, radiology, pharmacy, emergency, surgery,
observation,
63
home health, skilled nursing and clinics. Specific areas
identified through regulatory interpretation and enforcement
activities have also been addressed in our program. Claims
preparation and submission, including coding, billing and cost
reports, comprise the bulk of these areas. Financial
arrangements with physicians and other referral sources,
including compliance with anti-kickback and Stark laws,
emergency department treatment and transfer requirements, and
other patient disposition issues are also the focus of policy
and training, standardized documentation requirements, and
review and audit. Another focus of the program is the
interpretation and implementation of HIPAA standards for privacy
and security.
We have a Code of Conduct which applies to all directors,
officers, employees and consultants, and a confidential
disclosure program to enhance the statement of ethical
responsibility expected of our employees and business associates
who work in the accounting, financial reporting and asset
management areas of our Company. Our Code of Conduct is posted
on our website, www.chs.net.
Employees
At June 30, 2007, we employed approximately
26,000 full-time employees and 12,000 part-time
employees. Of these employees, approximately 2,000 are union
members. We currently believe that our labor relations are good.
Professional
Liability
As part of our business of owning and operating hospitals, we
are subject to legal actions alleging liability on our part. To
cover claims arising out of the operations of hospitals, we
maintain professional malpractice liability insurance and
general liability insurance on a claims made basis in excess of
those amounts for which we are self-insured, in amounts we
believe to be sufficient for our operations. We also maintain
umbrella liability coverage for claims which, due to their
nature or amount, are not covered by our other insurance
policies. However, our insurance coverage does not cover all
claims against us or may not continue to be available at a
reasonable cost for us to maintain adequate levels of insurance.
For a further discussion of our insurance coverage, see our
discussion of professional liability insurance claims in
Managements Discussion and Analysis of Financial
Condition and Results of Operations Professional
Liability Insurance Claims.
Environmental
Matters
We are subject to various federal, state, and local laws and
regulations governing the use, discharge and disposal of
hazardous materials, including petroleum products and medical
and/or
low-level radioactive wastes. Compliance with these laws and
regulations has not had, and is not in the future expected to
have, a material adverse effect on our business, competitive
position, or results of operations.
Environmental laws also can impose liability for the
investigation and cleanup of environmental contamination on any
current or former owners or tenants of property, or on those
parties who sent wastes off-site for disposal. Although we are
not currently aware of any such material obligations at any of
our current or former properties or at third-party disposal
sites, we may be required to conduct or participate in remedial
activities in the future and may be subject to claims for
personal injury or property or natural resources damages in the
future as a result of such matters. The costs associated with
such matters can be significant. We have insurance coverage for
certain damages to personal property or personal injury arising
out of contamination associated with some of our underground and
above-ground storage tanks. This policy also pays for
environmental clean up resulting from storage tank leaks. Our
policy coverage is $2.0 million per occurrence with a
$25,000 deductible and a $5.0 million annual aggregate.
Legal
Proceedings
From time to time, we receive various inquiries or subpoenas
from state regulators, fiscal intermediaries, CMS and the
Department of Justice regarding various Medicare and Medicaid
issues. In addition, we are subject to other claims and lawsuits
arising in the ordinary course of our business. We are not aware
of any pending or threatened litigation that is not covered by
insurance policies or reserved for in our financial
64
statements or which we believe would have a material adverse
impact on us. It is also possible that claims may be filed
against us that are under seal, which we may or may
not be aware of or of which we may or may not be able to
publicly disclose. With respect to any such items, we may not be
able to assess the potential impact until the matter is unsealed
and a full inquiry can be made.
In May 1999, we were served with a complaint in U.S. ex
rel. Bledsoe v. Community Health Systems, Inc.,
subsequently moved to the Middle District of Tennessee, Case
No. 2-00-0083.
This qui tam action sought treble damages and penalties
under the False Claims Act against us. The Department of Justice
did not intervene in this action. The allegations in the amended
complaint were extremely general, but involved Medicare billing
at our White County Community Hospital in Sparta, Tennessee. By
order entered on September 19, 2001, the U.S. District
Court granted our motion for judgment on the pleadings and
dismissed the case, with prejudice.
The qui tam whistleblower (also referred to as a
relator) appealed the district courts ruling
to the U.S. Court of Appeals for the Sixth Circuit. On
September 10, 2003, the Sixth Circuit Court of Appeals
rendered its decision in this case, affirming in part and
reversing in part the District Courts decision to dismiss
the case with prejudice. The court affirmed the lower
courts dismissal of certain of plaintiffs claims on
the grounds that his allegations had been previously publicly
disclosed. In addition, the appeals court agreed that, as to all
other allegations, the relator had failed to include enough
information to meet the special pleading requirements for fraud
under the False Claims Act and the Federal Rules of Civil
Procedure. However, the case was returned to the district court
to allow the relator another opportunity to amend his complaint
in an attempt to plead his fraud allegations with particularity.
In May 2004, the relator in U.S. ex rel. Bledsoe
filed an amended complaint alleging fraud involving Medicare
billing at White County Community Hospital. We then filed a
renewed motion to dismiss the amended complaint. On
January 6, 2005, the District Court dismissed with
prejudice the bulk of the relators allegations. The only
remaining allegations involve a handful of
1997-98
charges at White County. After further motion practice between
the relator and the United States Government regarding the
relators right to participate in a previous settlement
with the Company, the District Court again dismissed all claims
in the case on December 13, 2005. On January 9, 2006,
the relator filed a notice of appeal to the U.S. Court of
Appeals for the Sixth Circuit and on September 6, 2007, the
Court of Appeals issued its 25 page opinion affirming in part,
reversing in part, and remanding the case to the District Court
for further proceedings. We are in the process of evaluating our
next steps with respect to this case.
In August 2004, we were served with a complaint in Arleana
Lawrence and Robert Hollins v. Lakeview Community Hospital
and Community Health Systems, Inc. (now styled Arleana Lawrence
and Lisa Nichols v. Eufaula Community Hospital, Community
Health Systems, Inc., South Baldwin Regional Medical Center and
Community Health Systems Professional Services Corporation)
in the Circuit Court of Barbour County, Alabama (Eufaula
Division). This alleged class action was brought by the
plaintiffs on behalf of themselves and as the representatives of
similarly situated uninsured individuals who were treated at our
Lakeview Hospital or any of our other Alabama hospitals. The
plaintiffs allege that uninsured patients who do not qualify for
Medicaid, Medicare or charity care are charged unreasonably high
rates for services and materials and that we use unconscionable
methods to collect bills. The plaintiffs seek restitution of
overpayment, compensatory and other allowable damages and
injunctive relief. In October 2005, the complaint was amended to
eliminate one of the named plaintiffs and to add our management
company subsidiary as a defendant. In November 2005, the
complaint was again amended to add another plaintiff, Lisa
Nichols, and another defendant, our hospital in Foley, Alabama,
South Baldwin Regional Medical Center. Discovery has been
concluded on the class determination issues. A class
certification hearing was held on June 13, 2007 and we
await the ruling of the court. We are vigorously defending this
case.
On March 3, 2005, we were served with a complaint in
Sheri Rix v. Heartland Regional Medical Center and
Health Care Systems, Inc. in the Circuit Court of Williamson
County, Illinois. This alleged class action was brought by the
plaintiff on behalf of herself and as the representative of
similarly situated uninsured individuals who were treated at our
Heartland Regional Medical Center. The plaintiff alleges that
uninsured patients who do not qualify for Medicaid, Medicare or
charity care are charged unreasonably high rates for
65
services and materials and that we use unconscionable methods to
collect bills. The plaintiff seeks recovery for breach of
contract and the covenant of good faith and fair dealing,
violation of the Illinois Consumer Fraud and Deceptive Practices
Act, restitution of overpayment, and for unjust enrichment. The
plaintiff class seeks compensatory and other damages and
equitable relief. The Circuit Court Judge recently granted our
motion to dismiss this case, but allowed the plaintiff to
re-plead her case. The plaintiff elected to appeal the Circuit
Courts decision in lieu of amending her case. The parties
are briefing their positions. We are vigorously defending this
case.
On April 8, 2005, we were served with a first amended
complaint, styled Chronister, et al. v. Granite City
Illinois Hospital Company, LLC d/b/a Gateway Regional Medical
Center, in the Circuit Court of Madison County, Illinois.
The complaint seeks class action status on behalf of the
uninsured patients treated at Gateway Regional Medical Center
and alleges statutory, common law, and consumer fraud in the
manner in which the hospital bills and collects for the services
rendered to uninsured patients. The plaintiff seeks compensatory
and punitive damages and declaratory and injunctive relief. Our
motion to dismiss has been granted in part and denied in part
and discovery has commenced. Gateway Regional Medical
Center v. Holman is a companion case to the
Chronister action, seeking counterclaim recovery on a
collections case. Holman has been stayed pending the
outcome of the Chronister action. We are vigorously
defending these cases.
On February 10, 2006, we received a letter from the Civil
Division of the Department of Justice requesting documents in an
investigation they are conducting involving the Company. The
inquiry relates to the way in which different state Medicaid
programs apply to the federal government for matching or
supplemental funds that are ultimately used to pay for a small
portion of the services provided to Medicaid and indigent
patients. These programs are referred to by different names,
including intergovernmental payments, upper
payment limit programs, and Medicaid
disproportionate share hospital payments. The
February 10th letter focused on our hospitals in three
states: Arkansas, New Mexico and South Carolina. On
August 31, 2006, we received a
follow-up
letter from the Department of Justice requesting additional
documents relating to the programs in New Mexico and the
payments to the Companys three hospitals there. For
hospitals in New Mexico, the payments for this program
approximate 0.3% of annual net operating revenue for 2006. We
have provided the Department of Justice with the requested
documents and continue to cooperate with the governments
inquiry. We are unable at this time to evaluate the existence or
extent of any potential financial exposure.
In August 2006, our facility in Petersburg, Virginia (Southside
Regional Medical Center) was notified of the pendency of a
federal False Claims Act case styled U.S. ex rel.
Vuyyuru v. Jadhav et al. filed in the Eastern District
of Virginia. In addition to naming the hospital, Community
Health Systems Professional Services Corporation, our management
subsidiary, has also been named. The suit alleges that
Dr. Jadhav, Southside Regional Medical Center, and other
healthcare providers performed medically unnecessary procedures
and billed federal healthcare programs and also alleges that the
defendants defamed Dr. Vuyyuru in the process of
terminating his medical staff privileges. Almost all of the
allegations pre-date our acquisition of this facility and the
sellers
successor-in-interest
has agreed to indemnify the Company and its affiliates. We
believe that the allegations in this case are without merit and
are vigorously defending the case. A motion to dismiss the case
has been granted and the relator has appealed the ruling to the
U.S. Court of Appeals for the Fourth Circuit.
Triad
Hospitals, Inc. Litigation
Triad is the subject of litigation entitled In re: Triad
Hospitals, Inc. Shareholders Litigation, pending in the
296th District Court of Collin County, Texas. The
consolidated amended petition alleges, among other things, that
(i) the $54 per share in cash purchase price to be paid to
the stockholders in connection with the Triad merger with the
Company is inadequate; (ii) the go shop auction
process that led to the higher offer from the Company was
flawed; (iii) the directors violated their fiduciary duties
to shareholders by administering a sale process that failed to
maximize shareholder value; (iv) the terms of the merger
agreement with CHS, which included a so-called
non-solicitation clause and a $130 million
termination fee, would artificially deter higher bids for the
Company; (v) the directors breached their fiduciary duties
by approving, in mid December 2006, amended Change in Control
Severance Agreements with several Triad executives; and
66
(vi) the Company failed to disclose certain purportedly
material information relating to the valuation of the Company
and the process leading to the approval of the merger. The
consolidated amended petition seeks declaratory rulings
regarding the breaches of fiduciary duties, sought to enjoin the
closing of the merger transaction, and an award plaintiffs
attorneys fees and costs. The Company believes that this
consolidated lawsuit is without merit. Shortly after filing
their amended petition and initiating discovery, the plaintiffs
abandoned their efforts to seek pre-merger relief. On
September 19, 2007, the plaintiffs advised us that they
were seeking to nonsuit the case, which will dispose of the case.
Triad, and its subsidiary, Quorum Health Resources, Inc. are
defendants in a qui tam case styled U.S. ex rel.
Whitten vs. Quorum Health Resources, Inc. et al., which is
pending in the Southern District of Georgia, Brunswick Division.
Whitten, a long-term employee of a two hospital system in
Brunswick and Camden, Georgia sued both his employer and Quorum
Health Resources, Inc. and its predecessors, which had managed
the facility from 1989 through September 2000; upon his
termination of employment, Whitten signed a release and was paid
$124,000. Whittens original qui tam complaint was
filed under seal in November 2002 and the case was unsealed in
2004. Whitten alleges various charging and billing infractions,
including charging for routine equipment supplies and services
not separately billable, billing for observation services that
were not medically necessary or for which there was no physician
order, billing labor and delivery patients for durable medical
equipment that was not separately billable, inappropriate
preparation of patients histories and physicals, billing
for cardiac rehabilitation services without physician
supervision, performing outpatient dialysis without Medicare
certification, and performing mental health services without the
proper staff assignments. In October 2005, the district court
granted Quorums motion for summary judgment on the grounds
that his claims were precluded under his severance agreement
with the hospital, without reaching two other arguments made by
Quorum, which included that a prior settlement agreement between
the hospital and the federal government precluded the claims
brought by Whitten as well as the doctrine of prior public
disclosure. On appeal to the
11th Circuit
Court of Appeals, the court reversed the findings of the
district court regarding the severance agreement, but remanded
the case to the district court for findings on Quorums
other two arguments. Limited discovery has been conducted and
renewed motions to resolve the case in Quorums favor and
to stay further discovery have recently been filed. The Company
continues to believe that the relators claims are without
merit and will continue to vigorously defend this case.
In a case styled U.S. ex rel. Bartlett vs. Quorum Health
Resources, Inc., et al., pending in the Western District of
Pennsylvania, Johnstown Division, the relator alleges in his
second amended complaint, filed in January 2006 (the first
amended complaint having been dismissed), alleges that Quorum
conspired with the hospital to pay a illegal remuneration in
violation of the anti-kickback statute and the Stark laws, thus
causing false claims to be filed. A renewed motion to dismiss
that was filed in March 2006 asserting that the second amended
complaint did not cure the defects contained in the first
amended complaint. In September 2006, the hospital and one of
the other hospital affiliate defendants filed for protection
under Chapter 11 of the federal bankruptcy code, which
imposes an automatic stay on proceedings in the case. The
Company believes that this case is without merit and should the
stay be lifted, will continue to vigorously defend it.
Quorum is a defendant in a qui tam case styled
U.S. ex rel. Mosby vs. Quorum Health Resources, Inc., et
al, pending in the Western District of Mississippi, Western
Division. Mosby was a long time medical records employee at a
Quorum managed facility. She alleges wrongful termination for
being a whistleblower and because of her race. Mosbys
first amended complaint was filed in May 2003 and contains
allegations of false claims related to non-allowable costs and
cost reports. In October 2003, Quorum filed a motion to dismiss,
asserting that Mosbys substantive allegations were lifted
from the 1997 Alderson case filed in Tampa against Quorum, which
was resolved in a settlement with the government in 2001;
without any predicate false claims cases, the Company believes
that Mosbys retaliatory discharge allegations are
unsupported. We await the courts ruling on this motion.
67
Prior to our acquisition of Triad, Triad was one of the largest
publicly owned hospital companies in the United States. Triad
provides a broad range of general hospital healthcare services
to patients in non-urban and mid-sized markets located primarily
in the southern, midwestern and western United States. As of
July 25, 2007, prior to the acquisition, Triad owned,
leased or operated 50 hospitals in 17 states with an
aggregate of approximately 9,600 beds. Triad also operates one
general acute care hospital located in Dublin, Ireland. Included
among Triads U.S. hospital facilities is one hospital
operated through a 50/50 joint venture that is not consolidated
for financial reporting purposes and one hospital that is under
construction. Triad is also a minority investor in three joint
ventures that own seven general acute care hospitals in Georgia
and Nevada. Through Triads wholly-owned subsidiary, QHR,
Triad also provides management and consulting services to
independent general acute care hospitals located throughout the
United States.
Triads general acute care hospitals typically provide a
full range of services commonly available in hospitals, such as
internal medicine, general surgery, cardiology, oncology,
neurosurgery, orthopedics, obstetrics, diagnostic and emergency
services. These hospitals also generally provide outpatient and
ancillary healthcare services such as outpatient surgery,
laboratory, radiology, respiratory therapy, cardiology and
physical therapy. Outpatient services also are provided by
ambulatory surgery centers that Triad operates. In addition,
some of Triads general acute care hospitals have a limited
number of licensed psychiatric beds and provide psychiatric
skilled nursing services.
Triads
Formation
Triads healthcare service business previously comprised
the Pacific Group business of HCA, Inc., or HCA. On May 11,
1999, HCA divested its Pacific Group business to Triad through a
spin-off to its stockholders. The spin-off was accomplished by a
pro rata distribution of all outstanding shares of Triads
common stock to the stockholders of HCA. Triad was incorporated
under the laws of the State of Delaware in 1999. Information
about certain indemnification and other arrangements entered
into by HCA and Triad in connection with the distribution is
included in the consolidated financial statements.
On April 27, 2001, Triad completed its merger with Quorum
Health Group, Inc., or Quorum, for approximately
$2,400 million in cash, stock and assumption of debt.
Pursuant to the terms of the Quorum merger agreement, each
former Quorum shareholder was entitled to receive $3.50 in cash
and 0.4107 shares of Triads common stock for each
outstanding share of Quorum stock, plus cash in lieu of
fractional shares of Triads common stock.
Triads
Markets
Triad provides a broad range of general hospital healthcare
services to patients in non-urban and mid-size markets located
primarily in the southern, midwestern and western United States.
As of July 25, 2007, Triad owned, leased or operated 50
hospitals in 17 states. In approximately 70% of its
markets, Triad is one of three or fewer providers and in
approximately 38% of its markets, Triad is the sole provider.
Through QHR, Triads separate contract management services
and consulting subsidiary, Triad also provides consulting,
education, intensive resource and management services to
independent hospitals and hospital systems located primarily in
non-urban areas throughout the United States.
68
Triads
Selected Financial Data
The following selected consolidated financial data of Triad as
of and for the years ended December 31, 2004, 2005 and 2006
should be read in conjunction with and is qualified by reference
to Managements Discussion and Analysis of Financial
Condition and Results of Operations contained in
Triads Annual Reports on Form 10-K for the years
ended December 31, 2004, 2005 and 2006, which are
incorporated by reference in this prospectus, and Triads
audited consolidated financial statements and related notes to
the consolidated financial statements for the years ended
December 31, 2004, 2005 and 2006, which are incorporated by
reference in this prospectus. The consolidated statement of
operations data for the six month periods ended June 30,
2006 and June 30, 2007 have been derived from Triads
unaudited interim condensed consolidated financial statements
incorporated by reference in this prospectus. The consolidated
balance sheet and statement of operations data as of and for the
years ended December 31, 2002 and 2003 were derived from
Triads audited consolidated financial statements, not
included herein.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Six Months Ended
|
|
|
|
Year Ended December 31,
|
|
|
June 30,
|
|
|
|
2002
|
|
|
2003
|
|
|
2004
|
|
|
2005
|
|
|
2006
|
|
|
2006
|
|
|
2007
|
|
|
|
(Dollars in millions)
|
|
|
Income Statement Data:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenues
|
|
$
|
3,145.3
|
|
|
$
|
3,550.6
|
|
|
$
|
4,218.0
|
|
|
$
|
4,747.3
|
|
|
$
|
5,537.9
|
|
|
$
|
2,747.3
|
|
|
$
|
2,975.9
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Salaries and benefits
|
|
|
1,319.2
|
|
|
|
1,446.0
|
|
|
|
1,695.4
|
|
|
|
1,940.2
|
|
|
|
2,233.1
|
|
|
|
1,111.4
|
|
|
|
1,230.6
|
|
Reimbursable expenses
|
|
|
54.7
|
|
|
|
51.6
|
|
|
|
51.1
|
|
|
|
51.1
|
|
|
|
49.7
|
|
|
|
26.0
|
|
|
|
24.6
|
|
Supplies
|
|
|
491.9
|
|
|
|
556.4
|
|
|
|
692.4
|
|
|
|
801.3
|
|
|
|
957.9
|
|
|
|
471.7
|
|
|
|
505.7
|
|
Other operating expenses
|
|
|
567.1
|
|
|
|
663.2
|
|
|
|
781.2
|
|
|
|
874.0
|
|
|
|
1,069.8
|
|
|
|
525.4
|
|
|
|
610.3
|
|
Provision for doubtful accounts
|
|
|
237.8
|
|
|
|
360.6
|
|
|
|
427.2
|
|
|
|
403.3
|
|
|
|
576.9
|
|
|
|
248.9
|
|
|
|
303.5
|
|
Depreciation
|
|
|
140.0
|
|
|
|
153.0
|
|
|
|
172.3
|
|
|
|
199.6
|
|
|
|
223.2
|
|
|
|
108.8
|
|
|
|
119.4
|
|
Amortization
|
|
|
6.0
|
|
|
|
5.8
|
|
|
|
6.3
|
|
|
|
6.3
|
|
|
|
6.6
|
|
|
|
3.6
|
|
|
|
3.9
|
|
Interest expense
|
|
|
135.6
|
|
|
|
133.7
|
|
|
|
113.7
|
|
|
|
110.6
|
|
|
|
115.3
|
|
|
|
57.6
|
|
|
|
53.9
|
|
Interest income
|
|
|
(1.7
|
)
|
|
|
(2.7
|
)
|
|
|
(2.6
|
)
|
|
|
(9.0
|
)
|
|
|
(20.0
|
)
|
|
|
(10.2
|
)
|
|
|
(5.7
|
)
|
Refinancing transaction costs
|
|
|
|
|
|
|
39.9
|
|
|
|
76.0
|
|
|
|
8.4
|
|
|
|
|
|
|
|
|
|
|
|
|
|
ESOP expense
|
|
|
10.8
|
|
|
|
8.5
|
|
|
|
10.3
|
|
|
|
14.1
|
|
|
|
12.5
|
|
|
|
6.1
|
|
|
|
7.5
|
|
Litigation settlement
|
|
|
(10.4
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Gain) Loss on sales of assets
|
|
|
(4.5
|
)
|
|
|
(1.4
|
)
|
|
|
|
|
|
|
(0.4
|
)
|
|
|
(6.0
|
)
|
|
|
(0.6
|
)
|
|
|
0.4
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total operating costs and expenses
|
|
|
2,946.5
|
|
|
|
3,414.6
|
|
|
|
4,023.3
|
|
|
|
4,399.5
|
|
|
|
5,219.0
|
|
|
|
2,548.7
|
|
|
|
2,854.1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations
before minority interests, equity in earnings and income tax
provision
|
|
|
198.8
|
|
|
|
136.0
|
|
|
|
194.7
|
|
|
|
347.8
|
|
|
|
318.9
|
|
|
|
198.6
|
|
|
|
121.8
|
|
Minority interests in earnings of
consolidated entities
|
|
|
(6.0
|
)
|
|
|
(0.3
|
)
|
|
|
(1.4
|
)
|
|
|
(11.5
|
)
|
|
|
(22.0
|
)
|
|
|
(10.0
|
)
|
|
|
(12.8
|
)
|
Equity in earnings of affiliates
|
|
|
21.7
|
|
|
|
25.4
|
|
|
|
20.5
|
|
|
|
35.0
|
|
|
|
43.5
|
|
|
|
19.8
|
|
|
|
23.6
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations
before income tax provision
|
|
|
214.5
|
|
|
|
161.1
|
|
|
|
213.8
|
|
|
|
371.3
|
|
|
|
340.4
|
|
|
|
208.4
|
|
|
|
132.6
|
|
Income tax provision
|
|
|
(86.0
|
)
|
|
|
(64.1
|
)
|
|
|
(81.8
|
)
|
|
|
(141.9
|
)
|
|
|
(132.5
|
)
|
|
|
(80.5
|
)
|
|
|
(60.7
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations
|
|
|
128.5
|
|
|
|
97.0
|
|
|
|
132.0
|
|
|
|
229.4
|
|
|
|
207.9
|
|
|
|
127.9
|
|
|
|
71.9
|
|
Income (loss) from discontinued
operations, net of tax
|
|
|
13.0
|
|
|
|
(1.8
|
)
|
|
|
59.0
|
|
|
|
(3.4
|
)
|
|
|
14.4
|
|
|
|
15.3
|
|
|
|
(0.4
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income(a)
|
|
$
|
141.5
|
|
|
$
|
95.2
|
|
|
$
|
191.0
|
|
|
$
|
226.0
|
|
|
$
|
222.3
|
|
|
$
|
143.2
|
|
|
$
|
71.5
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance Sheet Data:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Working capital
|
|
$
|
618.6
|
|
|
$
|
593.3
|
|
|
$
|
593.6
|
|
|
$
|
958.6
|
|
|
$
|
892.9
|
|
|
$
|
940.5
|
|
|
$
|
727.5
|
|
Property and equipment, net
|
|
|
1,767.1
|
|
|
|
2,023.0
|
|
|
|
2,264.0
|
|
|
|
2,584.2
|
|
|
|
2,940.2
|
|
|
|
2,769.6
|
|
|
|
3,169.0
|
|
Cash and cash equivalents
|
|
|
67.4
|
|
|
|
14.2
|
|
|
|
56.6
|
|
|
|
310.2
|
|
|
|
208.6
|
|
|
|
276.0
|
|
|
|
63.2
|
|
Total assets
|
|
|
4,381.6
|
|
|
|
4,735.4
|
|
|
|
4,981.4
|
|
|
|
5,736.9
|
|
|
|
6,233.8
|
|
|
|
5,997.5
|
|
|
|
6,379.2
|
|
Total debt
|
|
|
1,689.1
|
|
|
|
1,758.0
|
|
|
|
1,667.0
|
|
|
|
1,703.5
|
|
|
|
1,705.4
|
|
|
|
1,707.5
|
|
|
|
1,697.5
|
|
Other long-term obligations
|
|
|
314.7
|
|
|
|
419.2
|
|
|
|
501.0
|
|
|
|
598.1
|
|
|
|
721.8
|
|
|
|
645.5
|
|
|
|
713.1
|
|
Total stockholders equity
|
|
$
|
1,954.5
|
|
|
$
|
2,076.3
|
|
|
$
|
2,343.3
|
|
|
$
|
2,927.7
|
|
|
$
|
3,226.4
|
|
|
$
|
3,115.9
|
|
|
$
|
3,336.3
|
|
|
|
|
(a) |
|
Includes charges related to impairment of long-lived assets of
discontinued operations of $7.5 million ($4.7 million
after tax benefit) and $18.5 million ($12.4 million
after tax benefit) for the years ended December 31, 2005
and 2003, respectively. |
69
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Six Months Ended
|
|
|
|
Year Ended December 31,
|
|
|
June 30,
|
|
|
|
2004
|
|
|
2005
|
|
|
2006
|
|
|
2006
|
|
|
2007
|
|
|
|
(Dollars in millions)
|
|
|
Consolidated Data:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of hospitals (at end of
period)(a)
|
|
|
45
|
|
|
|
48
|
|
|
|
52
|
|
|
|
50
|
|
|
|
50
|
|
Licensed beds(b)
|
|
|
7,475
|
|
|
|
8,674
|
|
|
|
9,614
|
|
|
|
9,250
|
|
|
|
9,618
|
|
Beds in service(c)
|
|
|
6,766
|
|
|
|
7,773
|
|
|
|
8,314
|
|
|
|
8,183
|
|
|
|
8,356
|
|
Admissions(d)
|
|
|
296,542
|
|
|
|
316,963
|
|
|
|
349,491
|
|
|
|
174,344
|
|
|
|
179,717
|
|
Adjusted admissions(e)
|
|
|
506,334
|
|
|
|
538,635
|
|
|
|
596,061
|
|
|
|
295,935
|
|
|
|
310,098
|
|
Patient days(f)
|
|
|
1,380,089
|
|
|
|
1,484,104
|
|
|
|
1,643,495
|
|
|
|
826,582
|
|
|
|
843,709
|
|
Average length of stay (days)(g)
|
|
|
4.7
|
|
|
|
4.7
|
|
|
|
4.7
|
|
|
|
4.7.
|
|
|
|
4.7
|
|
Occupancy rate (beds in service)(h)
|
|
|
56.3
|
%
|
|
|
52.0
|
%
|
|
|
54.0
|
%
|
|
|
55.8
|
%
|
|
|
55.8
|
%
|
Revenues
|
|
$
|
4,218.0
|
|
|
$
|
4,747.3
|
|
|
$
|
5,537.9
|
|
|
$
|
2,747.3
|
|
|
$
|
2,975.9
|
|
Net inpatient revenues as a
percentage of total revenues
|
|
|
52.7
|
%
|
|
|
54.6
|
%
|
|
|
54.5
|
%
|
|
|
54.6
|
%
|
|
|
53.1
|
%
|
Net outpatient revenues as a
percentage of total revenues
|
|
|
47.3
|
%
|
|
|
45.4
|
%
|
|
|
45.5
|
%
|
|
|
45.4
|
%
|
|
|
46.9
|
%
|
Other Financial Data:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Capital expenditures
|
|
$
|
436.0
|
|
|
$
|
393.7
|
|
|
$
|
461.8
|
|
|
$
|
233.4
|
|
|
$
|
350.1
|
|
Liquidity Data:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash flows provided by
operating activities
|
|
$
|
358.1
|
|
|
$
|
419.6
|
|
|
$
|
303.4
|
|
|
$
|
132.9
|
|
|
$
|
215.8
|
|
Net cash flows used in investing
activities
|
|
$
|
(209.9
|
)
|
|
$
|
(584.5
|
)
|
|
$
|
(467.9
|
)
|
|
$
|
(189.7
|
)
|
|
$
|
(375.0
|
)
|
Net cash flows provided by (used
in) financing activities
|
|
$
|
(105.8
|
)
|
|
$
|
418.5
|
|
|
$
|
62.9
|
|
|
$
|
22.6
|
|
|
$
|
13.8
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Six Months Ended
|
|
|
|
Year Ended December 31,
|
|
|
June 30,
|
|
|
|
2005
|
|
|
2006
|
|
|
2006
|
|
|
2007
|
|
|
|
(Dollars in millions)
|
|
|
Same-Store Data(i)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Admissions(d)
|
|
|
303,783
|
|
|
|
309,251
|
|
|
|
168,749
|
|
|
|
171,112
|
|
Adjusted admissions(e)
|
|
|
517,695
|
|
|
|
530,541
|
|
|
|
285,523
|
|
|
|
292,337
|
|
Patient days(f)
|
|
|
1,412,379
|
|
|
|
1,436,712
|
|
|
|
801,992
|
|
|
|
808,088
|
|
Average length of stay (days)(g)
|
|
|
4.7
|
|
|
|
4.7
|
|
|
|
4.8
|
|
|
|
4.7
|
|
Occupancy rate (beds in service)(h)
|
|
|
54.9
|
%
|
|
|
55.2
|
%
|
|
|
56.4
|
%
|
|
|
56.5
|
%
|
Net operating revenues
|
|
$
|
4,575,600
|
|
|
$
|
4,996,500
|
|
|
$
|
2,680,300
|
|
|
$
|
2,824,000
|
|
Income from operations
|
|
$
|
475,000
|
|
|
$
|
436,000
|
|
|
$
|
257,100
|
|
|
$
|
189,800
|
|
Depreciation and amortization
|
|
$
|
200,600
|
|
|
$
|
209,900
|
|
|
$
|
108,300
|
|
|
$
|
115,500
|
|
Minority interest in earnings
|
|
$
|
10,400
|
|
|
$
|
16,300
|
|
|
$
|
10,200
|
|
|
$
|
12,800
|
|
|
|
|
(a) |
|
Number of hospitals excludes facilities designated as
discontinued operations and facilities under construction. This
table does not include any operating statistics for facilities
designated as discontinued operations and non-consolidating
joint ventures. |
|
(b) |
|
Licensed beds are those beds for which a facility has been
granted approval to operate from the applicable state licensing
agency. |
70
|
|
|
(c) |
|
Beds in service are the number of beds that are readily
available for patient use. |
|
(d) |
|
Admissions represent the total number of patients admitted (in
the facility for a period in excess of 23 hours) to our
hospitals and are used by management and certain investors as a
general measure of inpatient volume. |
|
(e) |
|
Adjusted admissions are used by management and certain investors
as a general measure of combined inpatient and outpatient
volume. Adjusted admissions are computed by multiplying
admissions (inpatient volume) by the sum of gross inpatient
revenue and gross outpatient revenue and then dividing the
resulting amount by gross inpatient revenue. The adjusted
admissions computation adjusts outpatient revenue to
the volume measure (admissions) used to measure inpatient volume
resulting in a general measure of combined inpatient and
outpatient volume. |
|
(f) |
|
Patient days represent the total number of days of care provided
to inpatients. |
|
(g) |
|
Average length of stay represents the average number of days
admitted patients stay in our hospitals. |
|
(h) |
|
Occupancy rate represents the percentage of hospital available
beds occupied by patients. Both average daily census and
occupancy rate provide measures of the utilization of inpatient
rooms. |
|
(i) |
|
Includes acquired hospitals to the extent Triad operated them
during comparable periods in both years. |
The following tables summarize, for the periods indicated,
selected operating data.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Six Months
|
|
|
|
Year Ended December 31,
|
|
|
Ended June 30,
|
|
|
|
2004
|
|
|
2005
|
|
|
2006
|
|
|
2006
|
|
|
2007
|
|
|
|
(Expressed as a percentage of revenues)
|
|
|
Consolidated(a):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenues
|
|
|
100.0
|
%
|
|
|
100.0
|
%
|
|
|
100.0
|
%
|
|
|
100.0
|
%
|
|
|
100.0
|
%
|
Operating expenses(b)
|
|
|
(88.0
|
)
|
|
|
(85.5
|
)
|
|
|
(87.6
|
)
|
|
|
(86.2
|
)
|
|
|
(89.4
|
)
|
Depreciation and amortization
|
|
|
(4.3
|
)
|
|
|
(4.3
|
)
|
|
|
(4.2
|
)
|
|
|
(4.1
|
)
|
|
|
(4.1
|
)
|
Minority interest in earnings
|
|
|
(0.0
|
)
|
|
|
(0.2
|
)
|
|
|
(0.4
|
)
|
|
|
(0.4
|
)
|
|
|
(0.4
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from operations
|
|
|
7.7
|
|
|
|
10.0
|
|
|
|
7.8
|
|
|
|
9.3
|
|
|
|
6.1
|
|
Interest expense, net
|
|
|
(2.6
|
)
|
|
|
(2.2
|
)
|
|
|
(1.7
|
)
|
|
|
(1.7
|
)
|
|
|
(1.6
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations
before income taxes
|
|
|
5.1
|
|
|
|
7.8
|
|
|
|
6.1
|
|
|
|
7.6
|
|
|
|
4.5
|
|
Provision for income taxes
|
|
|
(2.0
|
)
|
|
|
(3.0
|
)
|
|
|
(2.4
|
)
|
|
|
(2.9
|
)
|
|
|
(2.1
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations
|
|
|
3.1
|
|
|
|
4.8
|
|
|
|
3.7
|
|
|
|
4.7
|
|
|
|
2.4
|
|
Income (Loss) on discontinued
operations
|
|
|
1.4
|
|
|
|
(0.0
|
)
|
|
|
0.3
|
|
|
|
0.5
|
|
|
|
0.0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
|
4.5
|
|
|
|
4.8
|
|
|
|
4.0
|
|
|
|
5.2
|
|
|
|
2.4
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
71
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended
|
|
|
Six Months
|
|
|
|
December 31,
|
|
|
Ended June 30,
|
|
|
|
2005
|
|
|
2006
|
|
|
2007
|
|
|
|
(Expressed in percentages)
|
|
|
Percentage increase from prior
year(s):
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenues
|
|
|
12.5
|
|
|
|
16.6
|
|
|
|
8.3
|
|
Admissions
|
|
|
6.9
|
|
|
|
10.3
|
|
|
|
3.1
|
|
Adjusted admissions(c)
|
|
|
6.4
|
|
|
|
10.7
|
|
|
|
4.8
|
|
Average length of stay
|
|
|
|
|
|
|
|
|
|
|
(1.0
|
)
|
Same-store percentage increase
from prior year(d):
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenues
|
|
|
6.5
|
|
|
|
9.2
|
|
|
|
5.4
|
|
Admissions
|
|
|
0.7
|
|
|
|
1.8
|
|
|
|
1.4
|
|
Adjusted admissions(c):
|
|
|
0.2
|
|
|
|
2.5
|
|
|
|
2.4
|
|
|
|
|
(a) |
|
Pursuant to Statement of Financial Accounting Standards, or
SFAS No. 144, Accounting for the Impairment or
Disposal of Long-Lived Assets, Triad has restated its
prior period financial statements and statistical results to
reflect the reclassification of discontinued operations. |
|
(b) |
|
Operating expenses include salaries and benefits, reimbursable
expenses, supplies, other operating expenses, provision for
doubtful accounts, refinancing transaction costs, ESOP expense,
litigation settlement, gain on sales of assets, and equity in
earning of affiliates. |
|
(c) |
|
Adjusted admissions are used by management and certain investors
as a general measure of combined inpatient and outpatient
volume. Adjusted admissions are computed by multiplying
admissions (inpatient volume) by the sum of gross inpatient
revenue and gross outpatient revenue and then dividing the
resulting amount by gross inpatient revenue. The adjusted
admissions computation adjusts outpatient revenue to
the volume measure (admissions) used to measure inpatient volume
resulting in a general measure of combined inpatient and
outpatient volume. |
|
(d) |
|
Includes acquired hospitals to the extent Triad operated them
during comparable periods in both years. |
72
The following sets forth information regarding our executive
officers (ages as of June 30, 2007). Each of our executive
officers holds an identical position with CHS/Community Health
Systems, Inc. and Community Health Systems Professional Services
Corporation, two of our wholly owned subsidiaries:
|
|
|
|
|
|
|
Name
|
|
Age
|
|
Position
|
|
Wayne T. Smith
|
|
|
61
|
|
|
Chairman of the Board, President
and Chief Executive Officer and Director (Class III)
|
W. Larry Cash
|
|
|
58
|
|
|
Executive Vice President, Chief
Financial Officer and Director (Class I)
|
David L. Miller
|
|
|
58
|
|
|
Division President
Operations
|
Gary D. Newsome
|
|
|
49
|
|
|
Division President
Operations
|
Michael T. Portacci
|
|
|
49
|
|
|
Division President
Operations
|
William S. Hussey
|
|
|
58
|
|
|
Division President
Operations
|
Thomas D. Miller
|
|
|
49
|
|
|
Division President
Operations
|
Rachel A. Seifert
|
|
|
48
|
|
|
Senior Vice President, Secretary
and General Counsel
|
T. Mark Buford
|
|
|
54
|
|
|
Vice President and Corporate
Controller
|
Harvey Klein, M.D.
|
|
|
70
|
|
|
Director (Class I)
|
H. Mitchell Watson, Jr.
|
|
|
70
|
|
|
Director (Class I)
|
Dale F. Frey
|
|
|
74
|
|
|
Director (Class II)
|
John A. Fry
|
|
|
47
|
|
|
Director (Class II)
|
John A. Clerico
|
|
|
66
|
|
|
Director (Class III)
|
Julia B. North
|
|
|
60
|
|
|
Director (Class III)
|
Wayne T. Smith serves as Chairman, President and Chief
Executive Officer. Mr. Smith joined us in January 1997 as
President. In April 1997, we also named him our Chief Executive
Officer and a member of the Board of Directors. In February
2001, he was elected Chairman of our Board of Directors. Prior
to joining us, Mr. Smith spent 23 years at Humana,
Inc., most recently as President and Chief Operating Officer,
and as a director, from 1993 to mid-1996. He is currently a
member of the Board of Directors of (i) Citadel
Broadcasting Corporation, and serves on its audit committee, and
(ii) Praxair, Inc., and serves on its compensation and
governance and nominating committees. Mr. Smith is a member
of the board of directors and a past chairman of the Federation
of American Hospitals.
W. Larry Cash serves as Executive Vice President and
Chief Financial Officer. Prior to joining Community Health
Systems, he served as Vice President and Group Chief Financial
Officer of Columbia/HCA Healthcare Corporation from September
1996 to August 1997. Prior to Columbia/HCA, Mr. Cash spent
23 years at Humana, Inc., most recently as Senior Vice
President of Finance and Operations from 1993 to 1996. He is
also a director of Cross Country Healthcare, Inc. and serves on
its audit (chair) and compensation committees.
David L. Miller serves as Division President
Operations. Mr. D. Miller joined us in November 1997 as a
Group Vice President, and presently manages hospitals in
Alabama, Florida, Louisiana, North Carolina, South Carolina,
Virginia and West Virginia. Prior to joining us, he served as a
Divisional Vice President for Health Management Associates,
Inc. from January 1996 to October 1997. From July 1994 to
December 1995, Mr. D. Miller was the Chief Executive
Officer of a facility owned by Health Management Associates, Inc.
Gary D. Newsome serves as Division President
Operations. Mr. Newsome joined us in February 1998 as Group
Vice President, and presently manages hospitals in Illinois,
Kentucky, New Jersey and Pennsylvania. Prior to joining us, he
was a Divisional Vice President of Health Management Associates,
Inc. From January 1995 to January 1996, Mr. Newsome served
as Assistant Vice President/Operations and Group Operations Vice
President responsible for certain facilities operated by Health
Management Associates, Inc.
73
Michael T. Portacci serves as Division
President Operations. Mr. Portacci joined us in
1987 as a hospital administrator and became a Group Director in
1991. In 1994, he became Group Vice President, and presently
manages hospitals in Arizona, California, Missouri, New Mexico,
Texas, Utah and Wyoming.
William S. Hussey serves as Division
President Operations. Mr. Hussey joined us in
June 2001 as a Group Assistant Vice President. In January 2003,
he was promoted to Group Vice President to manage our
acquisition of seven hospitals in West Tennessee, and in January
2004, he was promoted to Group Senior Vice President and assumed
responsibility for additional hospitals. Mr. Hussey
presently manages hospitals in Arkansas, Georgia, Kentucky and
Tennessee. Prior to joining us, he served as President and CEO
for a hospital facility in Ft. Myers, Florida (1998 to
2001). From 1992 to 1997, Mr. Hussey served as
President Tampa Bay Division, for Columbia/HCA
Healthcare Corporation.
Thomas D. Miller serves as Division President
Operations. Mr. T. Miller joined the Company at the
time of the Triad Merger and is assigned oversight
responsibility for the Companys facilities in Indiana,
Kentucky, and Ohio. From 1998 until his promotion to his current
position, Mr. T. Miller served as the president and chief
executive officer of Lutheran Health Network in northeast
Indiana, a system that includes five hospital facilities. For
the ten years prior to 1998, he was with Hospital Corporation of
America, in various, increasingly responsible positions of
hospital and market leadership.
Rachel A. Seifert serves as Senior Vice President,
Secretary and General Counsel. She joined us in January 1998 as
Vice President, Secretary and General Counsel. From 1992 to
1997, she was Associate General Counsel of Columbia/HCA
Healthcare Corporation and became Vice President
Legal Operations in 1994. Prior to joining Columbia/HCA in 1992,
she was in private practice in Dallas, Texas.
T. Mark Buford, C.P.A., serves as Vice President and
Corporate Controller. Mr. Buford has served as our
Corporate Controller since 1986 and as Vice President since 1988.
Harvey Klein, M.D., has served as Attending
Physician at the New York Hospital since 1992. Dr. Klein
serves as the William S. Paley Professor of Clinical Medicine at
Cornell University Medical College, a position he has held since
1992. He also has been a Member of the Board of Overseers of
Weill Medical College of Cornell University since 1997.
Dr. Klein is a member of the American Board of Internal
Medicine and American Board of Internal Medicine,
Gastroenterology.
H. Mitchell Watson, Jr., currently retired. From
1982 to 1989, Mr. Watson was a Vice President of IBM,
serving from 1982 to 1986 as President, Systems Product
Division, and from 1986 to 1989 as Vice President, Marketing.
From 1989 to 1992, Mr. Watson was President and Chief
Executive Officer of ROLM Company. Mr. Watson is a member
of the Board of Directors of Praxair, Inc., and serves on its
audit and compensation committee. Mr. Watson is
chairman emeritus of Helen Keller International and
the Chairman of the Brevard Music Center.
Dale F. Frey, was elected as our Lead Director in
February 2004. Mr. Frey is currently retired. From 1984
until 1997, Mr. Frey was the Chairman of the Board and
President of General Electric Investment Corp. From 1980 to
1997, he was also Vice President of General Electric Company.
Mr. Frey is also a director of Ambassadors Group, Inc., and
K&F Industries Holdings, Inc.
John A. Fry, presently serves as President of
Franklin & Marshall College. From 1995 to 2002, he was
Executive Vice President of the University of Pennsylvania and
served as the Chief Operating Officer of the University and as a
member of the executive committee of the University of
Pennsylvania Health System. Mr. Fry is a member of
(i) the Board of Directors of Allied Security Holdings,
LLC, and (ii) the Board of Trustees of Delaware
Investments, with oversight responsibility for all of the
portfolios in that mutual fund family.
John A. Clerico, has served as chairman and as a
registered financial advisor of ChartMark Investments, Inc.
since 2000. From 1992 to 2000, he served as an Executive Vice
President and the Chief Financial Officer and a Director of
Praxair, Inc. From 1983 until its spin-off of Praxair, Inc. in
1992, he served as an executive officer in various financial and
accounting areas of Union Carbide Corporation. Mr. Clerico
currently serves
74
on the Board of Directors of (i) Educational Development
Corporation, and on its audit and executive committees, and
(ii) Global Industries, Ltd., and on its audit and finance
(chair) committees.
Julia B. North, was appointed to our Board of Directors
in December 2004. She is presently retired. Over the course of
her career, Ms. North has served in many senior executive
positions, including as President of Consumer Services for
BellSouth Telecommunications from 1994 to 1997. After leaving
BellSouth Telecommunications in 1997, she served as the
President and CEO of VSI Enterprises, Inc. She currently serves
on the Board of Directors of (i) Acuity Brands, Inc., and
on its compensation and governance and nominating committees,
and (ii) Simtrol Inc., and on its audit committee.
The executive officers named above were appointed by the Board
of Directors to serve in such capacities until their respective
successors have been duly appointed and qualified, or until
their earlier death, resignation or removal from office.
75
SECURITY
OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT
Holdings owns 100% of the Issuers capital stock. The
following table sets forth certain information with respect to
the beneficial ownership of Holdings common stock at
September 17, 2007, by: (1) each person or entity who
owns of record or beneficially 5% or more of any class of
Holdings voting securities; (2) each of our named
executive officers and directors; and (3) all of our
directors and named executive officers as a group. Except as
noted below, the address for each of the directors and named
executive officers is
c/o CHS/Community
Health Systems, Inc., 4000 Meridian Boulevard, Franklin,
Tennessee 37067.
|
|
|
|
|
|
|
|
|
|
|
Shares of Common Stock Beneficially Owned(1)
|
|
|
|
Number of
|
|
|
Percentage
|
|
Name
|
|
Shares
|
|
|
of Class
|
|
|
5% Shareholders:
|
|
|
|
|
|
|
|
|
FMR Corp.
|
|
|
9,222,049
|
(2)
|
|
|
9.6
|
%
|
TPG-Axon Management
|
|
|
6,234,000
|
(3)
|
|
|
6.5
|
%
|
T. Rowe Price Associates,
Inc.
|
|
|
4,962,422
|
(4)
|
|
|
5.1
|
%
|
Directors:
|
|
|
|
|
|
|
|
|
John A. Clerico
|
|
|
57,000
|
(5)
|
|
|
*
|
|
Dale F. Frey
|
|
|
44,837
|
(6)
|
|
|
*
|
|
John A. Fry
|
|
|
32,000
|
(7)
|
|
|
*
|
|
Harvey Klein
|
|
|
42,000
|
(8)
|
|
|
*
|
|
Julia B. North
|
|
|
28,000
|
(9)
|
|
|
*
|
|
H. Mitchell Watson, Jr.
|
|
|
34,000
|
(10)
|
|
|
*
|
|
Wayne T. Smith
|
|
|
2,092,541
|
(11)
|
|
|
2.1
|
%
|
W. Larry Cash
|
|
|
893,355
|
(12)
|
|
|
0.9
|
%
|
Other Named Executive Officers:
|
|
|
|
|
|
|
|
|
David L. Miller
|
|
|
410,373
|
(13)
|
|
|
*
|
|
Gary D. Newsome
|
|
|
348,845
|
(14)
|
|
|
*
|
|
Michael T. Portacci
|
|
|
372,535
|
(15)
|
|
|
*
|
|
All Directors and Executive
Officers as Group (15 persons)
|
|
|
4,998,669
|
(16)
|
|
|
5.0
|
%
|
|
|
|
* |
|
Represents less than 1%. |
|
(1) |
|
For purposes of this table, a person or group of persons is
deemed to have beneficial ownership of any shares of
common stock when such person or persons has the right to
acquire them within 60 days after September 17, 2007.
For purposes of computing the percentage of outstanding shares
of common stock held by each person or group of persons named
above, any shares which such person or persons have the right to
acquire within 60 days after September 17, 2007 is
deemed to be outstanding but is not deemed to be outstanding for
the purpose of computing the percentage ownership of any other
person. |
|
(2) |
|
Shares beneficially owned are based on a Schedule 13G filed
on February 14, 2007, by FMR Corp. The address of FMR Corp.
is 82 Devonshire St., Boston, MA 02109. |
|
(3) |
|
Shares beneficially owned are based on a Schedule 13G filed
on June 21, 2007, by TPG-Axon Management. The address of
TPG-Axon Management is 888 Seventh Avenue 38th Floor, New York,
NY 10019. These securities are owned by GPLLC, PartnersGP,
TPG-Axon Domestic, TPG-Axon Offshore, Dinakar Singh and Singh
LLC. For purposes of reporting requirements of the Exchange Act,
TPG-Axon Management, as investment manager to TPG-Axon Domestic
and TPG-Axon Offshore, has the power to direct the disposition
and voting of the shares held by TPG-Axon Domestic and TPGAxon
Offshore. PartnersGP is the general partner of TPG-Axon
Domestic. GPLLC is the general partner of PartnersGP and
TPG-Axon Management. Singh LLC is a Managing Member of GPLLC.
Mr. Singh, an individual, is the Managing Member of Singh
LLC and in such capacity may be deemed to control Singh LLC,
GPLLC and TPG-Axon Management, and therefore may be deemed the
beneficial owner of the |
76
|
|
|
|
|
securities held by TPG-Axon Domestic and TPG-Axon Offshore.
Mr. Singh and Eric Mandelblatt are Co-Chief Executive
Officers of TPG-Axon Management. |
|
|
|
(4) |
|
Shares beneficially owned are based upon a Schedule 13G
filed on February 13, 2007, by T. Rowe Price Associates,
Inc. The address of T. Rowe Price Associates, Inc., is 100 East
Pratt St., Baltimore, MD 21202. These securities are owned
by various individual and institutional investors, which T. Rowe
Price Associates, Inc. (Price Associates) serves as
investment advisor with power to direct investments
and/or sole
power to vote the securities. For purposes of the reporting
requirements of the Exchange Act, Price Associates is deemed to
be a beneficial owner of such securities; however, Price
Associates expressly disclaims that it is, in fact, the
beneficial owner of such securities. |
|
(5) |
|
Includes 20,000 shares subject to options which are
currently exercisable or exercisable within 60 days of
September 17, 2007. |
|
(6) |
|
Includes 15,000 shares subject to options which are
currently exercisable or exercisable within 60 days of
September 17, 2007. |
|
(7) |
|
Includes 15,000 shares subject to options which are
currently exercisable or exercisable within 60 days of
September 17, 2007. |
|
(8) |
|
Includes 25,000 shares subject to options which are
currently exercisable or exercisable within 60 days of
September 17, 2007. |
|
(9) |
|
Includes 10,000 shares subject to options which are
currently exercisable or exercisable within 60 days of
September 17, 2007. |
|
(10) |
|
Includes 15,000 shares subject to options which are
currently exercisable or exercisable within 60 days of
September 17, 2007. |
|
(11) |
|
Includes 1,099,999 shares subject to options which are
currently exercisable or exercisable within 60 days of
September 17, 2007. |
|
(12) |
|
Includes 559,999 shares subject to options which are
currently exercisable or exercisable within 60 days of
September 17, 2007. |
|
(13) |
|
Includes 226,666 shares subject to options which are
currently exercisable or exercisable within 60 days of
September 17, 2007. |
|
(14) |
|
Includes 226,666 shares subject to options which are
currently exercisable or exercisable within 60 days of
September 17, 2007. |
|
(15) |
|
Includes 226,666 shares subject to options which are
currently exercisable or exercisable within 60 days of
September 17, 2007. |
|
(16) |
|
Includes 2,826,662 shares subject to options which are
currently exercisable or exercisable within 60 days of
September 17, 2007. |
77
CERTAIN
RELATIONSHIPS AND RELATED TRANSACTIONS
We employ Brad Cash, son of W. Larry Cash. In 2006, Brad Cash
received compensation of $219,822, including relocation expense
of $29,941, while sequentially serving as a Chief Financial
Officer of two of our hospitals.
In 2005, CHS established Community Health Systems Foundation, a
tax-exempt charitable foundation. One of the purposes of the
Foundation is to match charitable contributions made by the
Companys directors and officers up to an aggregate maximum
per year of $25,000 per individual. In 2006, the Company
contributed $1.5 million to this foundation.
We believe each of the transactions or financial relationships
were on terms as favorable as could have been obtained from
unrelated third parties.
We had no loans outstanding during 2006 from us to any of our
directors, nominees for director, executive officers, or any
beneficial owners of 10% or more of our equity securities, or
any family member of any of the foregoing.
We apply the following policy and procedure with respect to
related person transactions. All such transactions are first
referred to the General Counsel to determine if they are
exempted or included under our written policy. If they are
included, the transaction must be reviewed by the Audit and
Compliance Committee to consider and determine whether the
benefits of the relationship outweigh the potential conflicts
inherent in such relationships and whether the transaction is
otherwise in compliance with our Code of Conduct and other
policies, including for example, the independence standards of
the Governance Principles of the Board of Directors. Related
person transactions are reviewed not less frequently than
annually if they are to continue beyond the year in which the
transaction is initiated. Related person transaction
means those financial relationships involving us and any of our
subsidiaries, on the one hand, and any person who is a director
(or nominee) or an executive officer, any immediate family
member of any of the foregoing persons, any person who is a
direct or beneficial owner of 5% or more of our common stock
(our only class of voting securities), or is employed by or in a
principal position with such an owner, on the other hand.
Exempted from related person transactions are those transactions
in which the consideration in the transaction during a fiscal
year is expected to be less than $120,000 (aggregating any
transactions conducted as a series of transactions).
78
DESCRIPTION
OF CERTAIN INDEBTEDNESS
New
Credit Facility
In connection with the acquisition of Triad, we entered into the
New Credit Facility with a syndicate of financial institutions
led by Credit Suisse, as administrative agent and collateral
agent. The New Credit Facility provides for financing consisting
of a $6,065 million funded term loan facility with a
maturity of seven years, a $400 million delayed draw term
loan facility with a maturity of seven years and a
$750 million revolving credit facility with a maturity of
six years. The revolving credit facility also includes a
subfacility for letters of credit and a swingline subfacility.
In addition, we are entitled, subject to obtaining lender
commitments and meeting certain other conditions, to incur up to
an additional $600 million term loans under the New Credit
Facility.
The credit agreement requires us to make quarterly amortization
payments of each term loan facility in quarterly amounts equal
to 0.25% of the outstanding amount of the term loans, if any,
with the outstanding principal balance payable on the
anniversary of the credit agreement in 2014.
The term loan facility must be prepaid in an amount equal to
(1) 100% of the net cash proceeds of certain asset sales
and dispositions by Holdings and its subsidiaries, subject to
certain exceptions and reinvestment rights, (2) 100% of the
net cash proceeds of issuances of certain debt obligations by
Holdings and its subsidiaries, subject to certain exceptions,
and (3) 50%, subject to reduction to a lower percentage
based on our leverage ratio, of excess cash flow for any year,
commencing in 2008, subject to certain exceptions.
Voluntary prepayments and commitment reductions are permitted in
whole or in part, without premium or penalty, subject to minimum
prepayment or reduction requirements.
All of our obligations under the New Credit Facility are
unconditionally guaranteed by Holdings and certain existing and
subsequently acquired or organized domestic subsidiaries. All
obligations under the New Credit Facility and the related
guarantees are secured by a perfected first priority lien or
security interest in substantially all of our assets and each
subsidiary guarantors assets, including equity interests
held by us or any subsidiary guarantor, excluding, among others,
the equity interests of non-significant subsidiaries,
syndication subsidiaries, securitization subsidiaries and joint
venture subsidiaries.
The loans under the New Credit Facility bear interest on the
outstanding unpaid principal amount at a rate equal to an
applicable percentage plus, at our option, either (a) an
alternative base rate determined by reference to the greater of
(1) the prime rate announced by Credit Suisse and
(2) the federal funds rate plus one-half of 1.0%, or
(b) a reserve adjusted Eurodollar rate. The applicable
percentage for term loans is 1.25% for alternative base rate
loans and 2.25% for Eurodollar rate loans, and the applicable
percentage for revolving loans will be up to 1.25% for
alternative base rate revolving loans and up to 2.25% for
Eurodollar revolving loans, in each case based on our leverage
ratio. Loans under the swingline subfacility bear interest at
the rate applicable to alternative base rate loans under the
revolving credit facility.
We have agreed to pay letter of credit fees equal to the
applicable percentage then in effect with respect to Eurodollar
rate loans under the revolving credit facility times the maximum
aggregate amount available to be drawn under all letters of
credit issued under the subfacility for letters of credit. The
issuer of any letter of credit issued under the subfacility for
letters of credit will also receive a customary fronting fee and
other customary processing charges. We are also obligated to pay
commitment fees, depending on our total leverage ratio, of up to
0.50% per annum, on the unused portion of the revolving credit
facility. For purposes of this calculation, swingline loans are
not treated as usage of the revolving credit facility. We will
also pay an annual administrative agent fee.
The credit agreement documentation contains customary
representations and warranties, subject to limitations and
exceptions, and customary covenants restricting our and our
subsidiaries ability to, among other things and subject to
various exceptions, (1) declare dividends, make
distributions or redeem or repurchase capital stock,
(2) prepay, redeem or repurchase other debt, (3) incur
liens or grant negative pledges, (4) make loans and
investments and enter into acquisitions and joint ventures,
(5) incur additional
79
indebtedness, (6) make capital expenditures,
(7) engage in mergers, acquisitions and asset sales,
(8) conduct transactions with affiliates, (9) alter
the nature of our businesses, or (10) change our fiscal
year. We and our subsidiaries are also required to comply with
specified financial covenants (consisting of a leverage ratio
and an interest coverage ratio) and various affirmative
covenants.
Events of default under the credit agreement include, but are
not be limited to, (1) our failure to pay principal,
interest, fees or other amounts under the credit agreement when
due (taking into account any applicable grace period),
(2) any representation or warranty proving to have been
materially incorrect when made, (3) covenant defaults
subject, with respect to certain covenants, to a grace period,
(4) bankruptcy events, (5) a cross default to certain
other debt, (6) certain undischarged judgments (not paid
within an applicable grace period), (7) a change of
control, (8) certain ERISA-related defaults, and
(9) the invalidity or impairment of specified security
interests.
80
DESCRIPTION
OF THE EXCHANGE NOTES
CHS/Community Health Systems, Inc. will issue
$3,021 million aggregate principal amount of
87/8%
Exchange Notes due 2015 (the Notes) under an
Indenture (the Indenture) among itself, the
Guarantors and U.S. Bank National Association, as Trustee.
Except as set forth herein, the terms of the Notes will be
substantially identical and include those stated in the
Indenture and those made part of the Indenture by reference to
the Trust Indenture Act.
Certain terms used in this description are defined under the
subheading Certain Definitions. In
this description the word Company, we
and our refers only to CHS/Community Health Systems,
Inc. and not to any of its Subsidiaries.
The following description is only a summary of the material
provisions of the Indenture and the Registration Rights
Agreement. We urge you to read the Indenture and the
Registration Rights Agreement because they, not this
description, define your rights as holders of these Notes.
Brief
Description of the Notes
These Notes:
|
|
|
|
|
are unsecured senior obligations of the Company;
|
|
|
|
are senior in right of payment to any future Subordinated
Obligations of the Company; and
|
|
|
|
are guaranteed by each Guarantor on an unsecured senior basis.
|
Principal,
Maturity and Interest
The Company will issue the Notes initially with a maximum
aggregate principal amount of $3,021 million. The Company
will issue the Notes in minimum denominations of $2,000 and any
greater integral multiple of $1,000. The Notes will mature on
July 15, 2015. Subject to our compliance with the covenant
described under the subheading Certain
Covenants Limitation on Indebtedness, we are
permitted to issue more Notes from time to time. The Notes
offered by the Company and any additional notes subsequently
issued under the Indenture will be treated as a single class for
all purposes under the Indenture, including waivers, amendments,
redemptions and offers to purchase. Unless the context otherwise
requires, for all purposes of the Indenture and this
Description of the Notes, references to
Notes include any additional Notes actually issued.
Interest on the Notes will accrue at the rate of
87/8%
per annum and will be payable semiannually in arrears on January
15 and July 15, commencing on January 15, 2008. We
will make each interest payment to the Holders of record of the
Notes on the immediately preceding January 1 and July 1. We
will pay interest on overdue principal at 1% per annum in excess
of the above rate and will pay interest on overdue installments
of interest at such higher rate to the extent lawful.
Interest on the Notes will accrue from the date of original
issuance. Interest will be computed on the basis of a
360-day year
comprised of twelve
30-day
months.
Additional interest may accrue on the Notes in certain
circumstances pursuant to the Registration Rights Agreement.
Optional
Redemption
Except as set forth below, we will not be entitled to redeem the
Notes at our option prior to July 15, 2011.
On and after July 15, 2011, we will be entitled at our
option to redeem all or a portion of the 2015 Notes upon not
less than 30 nor more than 60 days notice, at the
redemption prices (expressed in percentages of principal amount
on the redemption date), plus accrued interest to the redemption
date (subject to the right of
81
Holders of record on the relevant record date to receive
interest due on the relevant interest payment date), if redeemed
during the
12-month
period commencing on July 15 of the years set forth below:
|
|
|
|
|
|
|
Redemption
|
|
Period
|
|
Price
|
|
|
2011
|
|
|
104.438
|
%
|
2012
|
|
|
102.219
|
%
|
2013 and thereafter
|
|
|
100.000
|
%
|
In addition, any time prior to July 15, 2010, we will be
entitled at our option on one or more occasions to redeem the
Notes (which includes additional Notes, if any) in an aggregate
principal amount not to exceed 35% of the aggregate principal
amount of the Notes (which includes additional Notes, if any)
originally issued at a redemption price (expressed as a
percentage of principal amount) of 108.875%, plus accrued and
unpaid interest to the redemption date, with the Net Cash
Proceeds from one or more Public Equity Offerings (provided that
if the Public Equity Offering is an offering by Parent, a
portion of the Net Cash Proceeds thereof equal to the amount
required to redeem any such Notes is contributed to the equity
capital of the Company); provided, however, that
(1) at least 65% of such aggregate principal amount of
Notes originally issued remains outstanding immediately after
the occurrence of each such redemption (other than the Notes
held, directly or indirectly, by the Company or its
Subsidiaries); and
(2) each such redemption occurs within 90 days after
the date of the related Public Equity Offering.
We are entitled at our option to redeem the Notes, in whole or
in part, at any time prior to July 15, 2011, upon not less
than 30 or more than 60 days notice, at a redemption price
equal to 100% of the principal amount of the Notes redeemed plus
the Applicable Premium as of, and accrued and unpaid interest,
if any, to, the applicable redemption date.
Selection
and Notice of Redemption
If we are redeeming less than all the Notes at any time, the
Trustee will select Notes on a pro rata basis to the extent
practicable.
We will redeem Notes of $2,000 or less in whole and not in part.
We will cause notices of redemption to be mailed by first-class
mail at least 30 but not more than 60 days before the
redemption date to each Holder of Notes to be redeemed at its
registered address.
If any Note is to be redeemed in part only, the notice of
redemption that relates to that Note will state the portion of
the principal amount thereof to be redeemed. We will issue a new
Note in a principal amount equal to the unredeemed portion of
the original Note in the name of the holder upon cancelation of
the original Note. Notes called for redemption become due on the
date fixed for redemption. On and after the redemption date,
interest ceases to accrue on Notes or portions of them called
for redemption.
Mandatory
Redemption; Offers to Purchase; Open Market Purchases
We are not required to make any mandatory redemption or sinking
fund payments with respect to the Notes. However, under certain
circumstances, we may be required to offer to purchase Notes as
described under the captions Change of
Control and Certain Covenants Limitation
on Sales of Assets and Subsidiary Stock. We may at any
time and from time to time purchase Notes in the open market or
otherwise.
Guaranties
Parent and the Subsidiary Guarantors will jointly and severally
guarantee, on a senior unsecured basis, our obligations under
these Notes. The obligations of each Subsidiary Guarantor under
its Subsidiary Guaranty will be limited as necessary to prevent
that Subsidiary Guaranty from constituting a fraudulent
conveyance under applicable law. See Risk
Factors Risks Related to the Notes.
82
Each Subsidiary Guarantor that makes a payment under its
Subsidiary Guaranty will be entitled upon payment in full of all
guarantied obligations under the Indenture to a contribution
from each other Subsidiary Guarantor in an amount equal to such
other Subsidiary Guarantors pro rata portion of such
payment based on the respective net assets of all the Subsidiary
Guarantors at the time of such payment determined in accordance
with GAAP.
If a Subsidiary Guaranty were rendered voidable, it could be
subordinated by a court to all other indebtedness (including
guarantees and other contingent liabilities) of the applicable
Subsidiary Guarantor, and, depending on the amount of such
indebtedness, a Subsidiary Guarantors liability on its
Subsidiary Guaranty could be reduced to zero. See Risk
Factors Risks Related to the Notes.
Pursuant to the Indenture, (A) a Subsidiary Guarantor may
consolidate with, merge with or into, or transfer all or
substantially all its assets to any other Person to the extent
described below under Certain
Covenants Merger and Consolidation and
(B) the Capital Stock of a Subsidiary Guarantor may be sold
or otherwise disposed of to another Person to the extent
described below under Certain
Covenants Limitation on Sales of Assets and
Subsidiary Stock; provided, however, that in the case of
the consolidation, merger or transfer of all or substantially
all the assets of such Subsidiary Guarantor, if such other
Person is not Parent, the Company or a Guarantor, such
Subsidiary Guarantors obligations under its Subsidiary
Guaranty must be expressly assumed by such other Person, except
that such assumption will not be required in the case of:
(1) the sale or other disposition (including by way of
consolidation or merger) of a Subsidiary Guarantor, including
the sale or disposition of Capital Stock of a Subsidiary
Guarantor following which such Subsidiary Guarantor is no longer
a Subsidiary; or
(2) the sale or disposition of all or substantially all the
assets of a Subsidiary Guarantor;
in each case other than to the Company or a Restricted
Subsidiary of the Company and as permitted by the Indenture and
if in connection therewith the Company provides an
Officers Certificate to the Trustee to the effect that the
Company will comply with its obligations under the covenant
described under Limitation on Sales of Assets and
Subsidiary Stock in respect of such disposition. Upon any
sale or disposition described in clause (1) or
(2) above, the obligor on the related Subsidiary Guaranty
will be released from its obligations thereunder.
The Subsidiary Guaranty of a Subsidiary Guarantor also will be
released:
(1) upon the designation of such Subsidiary Guarantor as an
Unrestricted Subsidiary or at any time as such Subsidiary
Guarantor is no longer a Restricted Subsidiary;
(2) at such time as such Subsidiary Guarantor does not have
any Indebtedness outstanding that would have required such
Subsidiary Guarantor to enter into a Guaranty Agreement pursuant
to the covenant described under Certain
Covenants Future Subsidiary Guarantors; or
(3) if we exercise our legal defeasance option or our
covenant defeasance option as described under
Defeasance or if our obligations under
the Indenture are discharged in accordance with the terms of the
Indenture.
The Parent Guaranty of the Parent Guarantor will be released if
we exercise our legal defeasance option or our covenant
defeasance option as described under
Defeasance or if our obligations under
the Indenture are discharged in accordance with the terms of the
Indenture.
Ranking
Senior
Indebtedness versus Notes
The indebtedness evidenced by these Notes and the Guaranties
will be unsecured and will rank pari passu in right of payment
to the Senior Indebtedness of the Company and the Guarantors, as
the case may be. The Notes will be guaranteed by the Guarantors.
83
As of June 30, 2007, after giving pro forma effect to the
Transactions:
(1) the Companys Senior Indebtedness would have been
approximately $9,154 million, including $6,133 million
of secured indebtedness; and
(2) the total liabilities, including trade payables of the
Guarantors would have been approximately $10,186 million,
including $6,133 million of secured indebtedness. Virtually
all of the Senior Indebtedness of the Guarantors consists of
their respective guaranties of Senior Indebtedness of the
Company under the Credit Agreement and with respect to the Notes.
The Notes are unsecured obligations of the Company. Secured debt
and other secured obligations of the Company (including
obligations with respect to the Credit Agreement) will be
effectively senior to the Notes to the extent of the value of
the assets securing such debt or other obligations.
Liabilities
of Subsidiaries versus Notes
(1) All of our operations is conducted through our
Subsidiaries. Some of our Subsidiaries are not Guaranteeing the
Notes, and, as described above under
Guaranties, Subsidiary Guaranties may be
released under certain circumstances. In addition, our future
Subsidiaries may not be required to guarantee the Notes. Claims
of creditors of such non-guarantor Subsidiaries, including trade
creditors and creditors holding indebtedness or Guarantees
issued by such non-guarantor Subsidiaries, and claims of
preferred stockholders of such non-guarantor Subsidiaries,
generally will have priority with respect to the assets and
earnings of such non-guarantor Subsidiaries over the claims of
our creditors, including holders of the Notes. Accordingly, the
Notes will be effectively subordinated to creditors (including
trade creditors) and preferred stockholders, if any, of such
non-guarantor Subsidiaries.
(2) As of June 30, 2007, the total liabilities of our
Subsidiaries (other than the Subsidiary Guarantors) were
approximately $1,397 million, including trade payables.
Although the Indenture limits the incurrence of Indebtedness and
preferred stock by certain of our Subsidiaries, such limitation
is subject to a number of significant qualifications. Moreover,
the Indenture does not impose any limitation on the incurrence
by such Subsidiaries of liabilities that are not considered
Indebtedness under the Indenture. See Certain
Covenants Limitation on Indebtedness.
Depository
Procedures
The following description of the operations and procedures of
DTC is provided solely as a matter of convenience. These
operations and procedures are solely within the control of the
respective settlement systems and are subject to changes by
them. We take no responsibility for these operations and
procedures and urge investors to contact the system or their
participants directly to discuss these matters.
DTC has advised us that DTC is a limited-purpose trust company
organized under the laws of the State of New York, a
banking organization within the meaning of the New
York Banking Law, a member of the Federal Reserve System, a
clearing corporation within the meaning of the
Uniform Commercial Code and a clearing agency
registered pursuant to the provisions of Section 17A of the
Exchange Act. DTC was created to hold securities for its
participating organizations (collectively, the
Participants) and to facilitate the clearance and
settlement of transactions in those securities between
Participants through electronic book-entry changes in accounts
of its Participants. The Participants include securities brokers
and dealers (including the initial purchasers), banks, trust
companies, clearing corporations and certain other
organizations. Access to DTCs system is also available to
other entities such as banks, brokers, dealers and trust
companies that clear through or maintain a custodial
relationship with a Participant, either directly or indirectly
(collectively, the Indirect Participants). Persons
who are not Participants may beneficially own securities held by
or on behalf of DTC only through the Participants or the
Indirect Participants. The ownership interests in, and transfers
of ownership interests in, each security held by or on behalf of
DTC are recorded on the records of the Participants and Indirect
Participants.
84
DTC has also advised us that, pursuant to procedures established
by it:
(1) upon deposit of the Global Notes, DTC will credit the
accounts of Participants designated by the Initial Purchasers
with portions of the principal amount of the Global
Notes; and
(2) ownership of these interests in the Global Notes will
be shown on, and the transfer of ownership of these interests
will be effected only through, records maintained by DTC (with
respect to the Participants) or by the Participants and the
Indirect Participants (with respect to other owners of
beneficial interests in the Global Notes).
Investors in the Global Notes who are Participants in DTCs
system may hold their interests therein directly through DTC.
Investors in the Global Notes who are not Participants may hold
their interests therein indirectly through organizations which
are Participants in such system. All interests in a Global Note
may be subject to the procedures and requirements of DTC. The
laws of some states require that certain Persons take physical
delivery in definitive form of securities that they own.
Consequently, the ability to transfer beneficial interests in a
Global Note to such Persons will be limited to that extent.
Because DTC can act only on behalf of Participants, which in
turn act on behalf of Indirect Participants, the ability of a
Person having beneficial interests in a Global Note to pledge
such interests to Persons that do not participate in the DTC
system, or otherwise take actions in respect of such interests,
may be affected by the lack of a physical certificate evidencing
such interests.
Except as described below, owners of an interest in the
Global Notes will not have Notes registered in their names, will
not receive physical delivery of Notes in certificated form and
will not be considered the registered owners or
Holders thereof under the Indenture for any
purpose.
Payments in respect of the principal of, and interest and
premium and additional interest, if any, on a Global Note
registered in the name of DTC or its nominee will be payable to
DTC in its capacity as the registered Holder under the
Indenture. Under the terms of the Indenture, the Company and the
Trustee will treat the Persons in whose names the Notes,
including the Global Notes, are registered as the owners of the
Notes for the purpose of receiving payments and for all other
purposes. Consequently, neither the Company, the Trustee nor any
agent of the Company or the Trustee has or will have any
responsibility or liability for:
(1) any aspect of DTCs records or any
Participants or Indirect Participants records
relating to or payments made on account of beneficial ownership
interests in the Global Notes or for maintaining, supervising or
reviewing any of DTCs records or any Participants or
Indirect Participants records relating to the beneficial
ownership interests in the Global Notes; or
(2) any other matter relating to the actions and practices
of DTC or any of its Participants or Indirect Participants.
DTC has advised us that its current practice, upon receipt of
any payment in respect of securities such as the Notes
(including principal and interest), is to credit the accounts of
the relevant Participants with the payment on the payment date
unless DTC has reason to believe it will not receive payment on
such payment date. Each relevant Participant is credited with an
amount proportionate to its beneficial ownership of an interest
in the principal amount of the relevant security as shown on the
records of DTC. Payments by the Participants and the Indirect
Participants to the beneficial owners of Notes will be governed
by standing instructions and customary practices and will be the
responsibility of the Participants or the Indirect Participants
and will not be the responsibility of DTC, the Trustee or the
Company. Neither the Company nor the Trustee will be liable for
any delay by DTC or any of its Participants in identifying the
beneficial owners of the Notes, and the Company and the Trustee
may conclusively rely on and will be protected in relying on
instructions from DTC or its nominee for all purposes.
Subject to the transfer restrictions set forth under
Transfer Restrictions, transfers between
Participants in DTC will be effected in accordance with
DTCs procedures, and will be settled in
same-day
funds.
DTC has advised the Company that it will take any action
permitted to be taken by a Holder of Notes only at the direction
of one or more Participants to whose account DTC has credited
the interests in the Global Notes and only in respect of such
portion of the aggregate principal amount of the Notes as to
which
85
such Participant or Participants has or have given such
direction. However, if there is an Event of Default under the
Notes, DTC reserves the right to exchange the Global Notes for
legended Notes in certificated form, and to distribute such
Notes to its Participants.
Although DTC has agreed to the foregoing procedures in order to
facilitate transfers of interests in the Global Notes among
participants, it is under no obligation to perform such
procedures, and such procedures may be discontinued or changed
at any time. Neither the Company nor the Trustee nor any of
their respective agents will have any responsibility for the
performance by DTC or its participants or indirect participants
of their respective obligations under the rules and procedures
governing their operations.
Exchange
of Global Notes for Certificated Notes
A Global Note is exchangeable for Certificated Notes if:
(1) DTC (a) notifies the Company that it is unwilling
or unable to continue as depositary for the Global Notes or
(b) has ceased to be a clearing agency registered under the
Exchange Act and, in each case, a successor depositary is not
appointed;
(2) the Company, at its option, notifies the Trustee in
writing that it elects to cause the issuance of the Certificated
Notes; or
(3) there has occurred and is continuing a Default with
respect to the Notes.
In addition, beneficial interests in a Global Note may be
exchanged for Certificated Notes upon prior written notice given
to the Trustee by or on behalf of DTC in accordance with the
Indenture. In all cases, Certificated Notes delivered in
exchange for any Global Note or beneficial interests in Global
Notes will be registered in the names, and issued in any
approved denominations, requested by or on behalf of the
depositary (in accordance with its customary procedures) and
will bear the applicable restrictive legend referred to in
Transfer Restrictions, unless that legend is not
required by applicable law.
Exchange
of Certificated Notes for Global Notes
Certificated Notes may not be exchanged for beneficial interests
in any Global Note unless the transferor first delivers to the
Trustee a written certificate (in the form provided in the
Indenture) to the effect that such transfer will comply with the
appropriate transfer restrictions applicable to such Notes. See
Transfer Restrictions.
Exchanges
Among Global Notes
Beneficial interests in the Temporary Regulation S Global
Note may be exchanged for beneficial interests in the Permanent
Regulation S Global Note or the Rule 144A Global Note
or the IAI Global Note only after the expiration of the
Distribution Compliance Period and then only upon certification
in form reasonably satisfactory to the Trustee that, among other
things, (i) beneficial ownership interests in such
Temporary Regulation S Note are owned by or being
transferred to either
non-U.S. persons
or U.S. persons who purchased such interests in a
transaction that did not require registration under the
Securities Act and (ii) in the case of an exchange for an
interest in an IAI Global Note, the interest in the Temporary
Regulation S Global Note is being transferred to an
accredited investor under the Securities Act that is
an institutional accredited investor acquiring the
securities for its own account or for the account of an
institutional accredited investor.
Beneficial interest in a Rule 144A Global Note or an IAI
Global Note may be transferred to a Person who takes delivery in
the form of an interest in the Regulation S Global Note,
whether before or after the expiration of the Distribution
Compliance Period, only if the transferor first delivers to the
Trustee a written certificate (in the form provided in the
Indenture) to the effect that such transfer is being made in
accordance with Rule 903 or 904 of Regulation S or
Rule 144.
Beneficial interest in the Rule 144A Global Note may be
exchanged for a beneficial interest in the IAI Global Note only
upon certification in a form reasonably satisfactory to the
Trustee that, among other things,
86
(i) the beneficial interest in such Rule 144A Global
Note is being transferred to an accredited investor
under the Securities Act that is an institutional
accredited investor acquiring the securities for its
own account or for the account of an institutional
accredited investor and (ii) such transfer is
being made in accordance with all applicable securities laws of
the States of the United States and other jurisdictions.
Beneficial interest in the IAI Global Note may be exchanged for
a beneficial interest in the Rule 144A Global Note only
upon certification in a form reasonably satisfactory to the
Trustee that, among other things, such interest is being
transferred in a transaction in accordance with Rule 144A.
Transfers involving exchanges of beneficial interests between
the Regulation S Global Notes, the IAI Global Notes and the
Rule 144A Global Notes will be effected in DTC by means of
an instruction originated by the Trustee through the DTC
Deposit/Withdraw at Custodian system. Accordingly, in connection
with any such transfer, appropriate adjustments will be made to
reflect the changes in the principal amounts of the
Regulation S Global Note, the IAI Global Note and the
Rule 144A Global Note, as applicable. Any beneficial
interest in one of the Global Notes that is transferred to a
Person who takes delivery in the form of an interest in the
other Global Note will, upon transfer, cease to be an interest
in such Global Note and will become an interest in the other
Global Note and, accordingly, will thereafter be subject to all
transfer restrictions and other procedures applicable to
beneficial interest in such other Global Note for so long as it
remains such an interest.
Same
Day Settlement and Payment
The Company will make payments in respect of the Notes
represented by the Global Notes (including principal, premium,
if any, interest and additional interest, if any) by wire
transfer of immediately available funds to the accounts
specified by the Global Note Holder. The Company will make all
payments of principal, interest and premium and additional
interest, if any, with respect to Certificated Notes by wire
transfer of immediately available funds to the accounts
specified by the Holders of the Certificated Notes or, if no
such account is specified, by mailing a check to each such
Holders registered address. The Notes represented by the
Global Notes are expected to be eligible to trade in the
PORTALsm
market and to trade in DTCs
Same-Day
Funds Settlement System, and any permitted secondary market
trading activity in such notes will, therefore, be required by
DTC to be settled in immediately available funds. The Company
expects that secondary trading in any Certificated Notes will
also be settled in immediately available funds.
Change of
Control
Upon the occurrence of any of the following events (each a
Change of Control), each Holder shall have the right
to require that the Company repurchase such Holders Notes
at a purchase price in cash equal to 101% of the principal
amount thereof on the date of purchase plus accrued and unpaid
interest, if any, to the date of purchase (subject to the right
of holders of record on the relevant record date to receive
interest due on the relevant interest payment date):
(1) the Company becomes aware of (by way of a report or any
other filing pursuant to Section 13(d) of the Exchange Act,
proxy, vote, written notice or otherwise) the acquisition by any
person (as such term is used in Sections 13(d)
and 14(d) of the Exchange Act) of beneficial
ownership (as defined in
Rules 13d-3
and 13d-5
under the Exchange Act, except that for purposes of this
clause (1) such person shall be deemed to have
beneficial ownership of all shares that any such
person has the right to acquire, whether such right is
exercisable immediately or only after the passage of time),
directly or indirectly, of more than 40% of the total voting
power of the Voting Stock of the Company or Parent;
(2) individuals who on the Issue Date constituted the Board
of Directors or the Parent Board (together with any new
directors whose election by such Board of Directors or the
Parent Board or whose nomination for election by the
shareholders of the Company or Parent, as the case may be, was
approved by a vote of a majority of the directors of the Company
or Parent, as the case may be, then still in office who were
either directors on the Issue Date or whose election or
nomination for election was previously so approved) cease for
any reason to constitute a majority of the Board of Directors or
the Parent Board then in office; and
87
(3) the merger or consolidation of Parent or the Company
with or into another Person or the merger of another Person with
or into Parent or the Company, or the sale of all or
substantially all the assets of Parent or the Company
(determined on a consolidated basis) to another Person other
than a transaction following which (i) in the case of a
merger or consolidation transaction, holders of securities that
represented 100% of the Voting Stock of Parent or the Company
immediately prior to such transaction (or other securities into
which such securities are converted as part of such merger or
consolidation transaction) own directly or indirectly at least a
majority of the voting power of the Voting Stock of the
surviving Person in such merger or consolidation transaction
immediately after such transaction and (ii) in the case of
a sale of assets transaction, each transferee becomes an obligor
in respect of the Notes.
Within 30 days following any Change of Control, we will
mail a notice to each Holder with a copy to the Trustee (the
Change of Control Offer) stating:
(1) that a Change of Control has occurred and that such
Holder has the right to require us to purchase such
Holders Notes at a purchase price in cash equal to 101% of
the principal amount thereof on the date of purchase, plus
accrued and unpaid interest, if any, to the date of purchase
(subject to the right of Holders of record on the relevant
record date to receive interest on the relevant interest payment
date);
(2) the circumstances and relevant facts regarding such
Change of Control (including information with respect to pro
forma historical income, cash flow and capitalization, in each
case after giving effect to such Change of Control);
(3) the purchase date (which shall be no earlier than
30 days nor later than 60 days from the date such
notice is mailed); and
(4) the instructions, as determined by us, consistent with
the covenant described hereunder, that a Holder must follow in
order to have its Notes purchased.
We will not be required to make a Change of Control Offer
following a Change of Control if a third party makes the Change
of Control Offer in the manner, at the times and otherwise in
compliance with the requirements set forth in the Indenture
applicable to a Change of Control Offer made by us and purchases
all Notes validly tendered and not withdrawn under such Change
of Control Offer.
We will comply, to the extent applicable, with the requirements
of Section 14(e) of the Exchange Act and any other
securities laws or regulations in connection with the repurchase
of Notes as a result of a Change of Control. To the extent that
the provisions of any securities laws or regulations conflict
with the provisions of the covenant described hereunder, we will
comply with the applicable securities laws and regulations and
shall not be deemed to have breached our obligations under the
covenant described hereunder by virtue of our compliance with
such securities laws or regulations.
The Change of Control purchase feature of the Notes may in
certain circumstances make more difficult or discourage a sale
or takeover of Parent and the Company and, thus, the removal of
incumbent management. The Change of Control purchase feature is
a result of negotiations between the Company and the Initial
Purchasers. Neither Parent nor the Company has the present
intention to engage in a transaction involving a Change of
Control, although it is possible that we or they could decide to
do so in the future. Subject to the limitations discussed below,
we or Parent could, in the future, enter into certain
transactions, including acquisitions, refinancings or other
recapitalizations, that would not constitute a Change of Control
under the Indenture, but that could increase the amount of
indebtedness outstanding at such time or otherwise affect our
capital structure or credit ratings. Restrictions on our ability
to Incur additional Indebtedness are contained in the covenants
described under Certain Covenants
Limitation on Indebtedness, Limitation
on Liens and Limitation on
Sale/Leaseback Transactions. Such restrictions can only be
waived with the consent of the holders of a majority in
principal amount of the Notes then outstanding. Except for the
limitations contained in such covenants, however, the Indenture
will not contain any covenants or provisions that may afford
holders of the Notes protection in the event of a highly
leveraged transaction.
88
The Credit Agreement will prohibit us from purchasing any Notes
and will also provide that the occurrence of certain change of
control events with respect to the Company would constitute a
default thereunder. In the event a Change of Control occurs at a
time when we are prohibited from purchasing Notes, we may seek
the consent of our lenders to the purchase of Notes or may
attempt to refinance the borrowings that contain such
prohibition. If we do not obtain such a consent or repay such
borrowings, we will remain prohibited from purchasing Notes. In
such case, our failure to offer to purchase Notes would
constitute a Default under the Indenture, which would, in turn,
constitute a default under the Credit Agreement.
Future indebtedness that we may incur may contain prohibitions
on the occurrence of certain events that would constitute a
Change of Control or require the repurchase of such indebtedness
upon a Change of Control. Moreover, the exercise by the holders
of their right to require us to repurchase their Notes could
cause a default under such indebtedness, even if the Change of
Control itself does not, due to the financial effect of such
repurchase on us. Finally, our ability to pay cash to the
holders of Notes following the occurrence of a Change of Control
may be limited by our then existing financial resources. We
cannot assure you that we will have sufficient funds available
when necessary to make any required repurchases.
The definition of Change of Control includes a
disposition of all or substantially all of the assets of Parent
or the Company to any Person. Although there is a limited body
of case law interpreting the phrase substantially
all, there is no precise established definition of the
phrase under applicable law. Accordingly, in certain
circumstances there may be a degree of uncertainty as to whether
a particular transaction would involve a disposition of
all or substantially all of the assets of Parent or
the Company. As a result, it may be unclear as to whether a
Change of Control has occurred and whether a holder of Notes may
require the Company to make an offer to repurchase the Notes as
described above.
The provisions under the Indenture relative to our obligation to
make an offer to repurchase the Notes as a result of a Change of
Control may be waived or modified with the written consent of
the holders of a majority in principal amount of the Notes.
Certain
Covenants
The Indenture contains covenants including, among others, the
following:
Limitation
on Indebtedness
(a) The Company will not, and will not permit any
Restricted Subsidiary to, Incur, directly or indirectly, any
Indebtedness; provided, however, that the Company and the
Subsidiary Guarantors will be entitled to Incur Indebtedness if,
on the date of such Incurrence and after giving effect thereto
on a pro forma basis, the Consolidated Coverage Ratio exceeds
2.0 to 1.0.
(b) Notwithstanding the foregoing paragraph (a), the
Company and the Restricted Subsidiaries will be entitled to
Incur any or all of the following Indebtedness:
(1) Indebtedness of the Company and the Subsidiary
Guarantors pursuant to Credit Facilities; provided, however,
that, immediately after giving effect to any such Incurrence,
the aggregate principal amount of all Indebtedness Incurred
under this clause (1) and clause (13) below and then
outstanding does not exceed $7,815 million less the sum of
all principal payments with respect to such Indebtedness
pursuant to paragraph (a)(3)(A) of the covenant described under
Limitation on Sales of Assets and Subsidiary
Stock;
(2) Indebtedness owed to and held by the Company or a
Restricted Subsidiary; provided, however, that (A) any
subsequent issuance or transfer of any Capital Stock which
results in any such Restricted Subsidiary ceasing to be a
Restricted Subsidiary or any subsequent transfer of such
Indebtedness (other than to the Company or a Restricted
Subsidiary) shall be deemed, in each case, to constitute the
Incurrence of such Indebtedness by the obligor thereon and
(B) if the Company is the obligor on such Indebtedness and
such Indebtedness is held by a Restricted Subsidiary that is not
a Subsidiary Guarantor, such Indebtedness is expressly
subordinated to the prior payment in full in cash of all
obligations with respect to the Notes and (C) if a
Subsidiary Guarantor is the obligor on such Indebtedness and
such
89
Indebtedness is held by a Restricted Subsidiary that is not a
Subsidiary Guarantor, such Indebtedness is expressly
subordinated to the prior payment in full in cash of all
obligations of such Subsidiary Guarantor with respect to its
Subsidiary Guaranty;
(3) the Notes and the Exchange Notes (other than any
Additional Notes);
(4) Indebtedness outstanding on the Issue Date (other than
Indebtedness described in clause (1), (2) or (3) of
this covenant);
(5) Indebtedness of a Restricted Subsidiary Incurred and
outstanding on or prior to the date on which such Subsidiary was
acquired by the Company (other than Indebtedness Incurred in
connection with, or to provide all or any portion of the funds
or credit support utilized to consummate, the transaction or
series of related transactions pursuant to which such Subsidiary
became a Subsidiary or was acquired by the Company); provided,
however, that on the date of such acquisition and after giving
pro forma effect thereto, the Company would have been entitled
to Incur at least $1.00 of additional Indebtedness pursuant to
paragraph (a) of this covenant or the Consolidated Coverage
Ratio would be higher after giving pro forma effect to such
acquisition;
(6) Refinancing Indebtedness in respect of Indebtedness
Incurred pursuant to paragraph (a) or pursuant to clause
(3), (4) or (5) or this clause (6); provided, however,
that to the extent such Refinancing Indebtedness directly or
indirectly Refinances Indebtedness of a Subsidiary Incurred
pursuant to clause (5), such Refinancing Indebtedness shall be
Incurred only by such Subsidiary;
(7) Hedging Obligations;
(8) obligations in respect of performance, bid, appeal and
surety bonds and completion guarantees provided by the Company
or any Restricted Subsidiary in the ordinary course of business;
(9) Indebtedness arising from the honoring by a bank or
other financial institution of a check, draft or similar
instrument drawn against insufficient funds in the ordinary
course of business; provided, however, that such Indebtedness is
extinguished within five Business Days of its Incurrence;
(10) Indebtedness consisting of the Guaranty of a
Subsidiary Guarantor of Indebtedness Incurred pursuant to this
covenant (other than Indebtedness Incurred pursuant to
clauses (5) and (14) of this paragraph or Refinancing
Indebtedness Incurred pursuant to clause (6) of this
paragraph to the extent such Refinancing Indebtedness Refinances
Indebtedness Incurred pursuant to such clause (5)); provided,
however, that if the Indebtedness being guaranteed is
subordinated to or pari passu with the Notes, then the Guarantee
thereof shall be subordinated or pari passu, as applicable, to
the same extent as the Indebtedness being Guaranteed;
(11) Purchase Money Indebtedness and any Refinancing
Indebtedness Incurred to Refinance such Indebtedness, in an
aggregate principal amount which, when added together with the
amount of Indebtedness Incurred pursuant to this
clause (11) and then outstanding, does not exceed 4.0% of
Total Assets;
(12) Physician Support Obligations incurred by the Company
or any Restricted Subsidiary;
(13) Indebtedness Incurred by a Receivables Subsidiary
pursuant to a Qualified Receivables Transaction; provided,
however, that, at the time of such Incurrence, the Company would
have been entitled to Incur an equal amount of Indebtedness
pursuant to clause (1) above;
(14) Non-Recourse Indebtedness of Restricted Subsidiaries
in an aggregate principal amount which, when taken together with
all other Non-Recourse Indebtedness of Restricted Subsidiaries
Incurred pursuant to this clause (14) and then outstanding
does not exceed 5% of Consolidated Tangible Assets;
(15) the Incurrence by the Company or any Guarantor of
Indebtedness to the extent that the net proceeds thereof are
promptly deposited to fully defease or fully satisfy and
discharge the notes; and
90
(16) Indebtedness of the Company or the Subsidiary
Guarantors in an aggregate principal amount which, when taken
together with all other Indebtedness of the Company and its
Subsidiary Guarantors Incurred pursuant to this clause (16)
and then outstanding does not exceed $600 million.
(c) For purposes of determining compliance with this
covenant:
(1) any Indebtedness remaining outstanding under the Credit
Agreement after the application of the net proceeds from the
sale of the Notes will be treated as Incurred on the Issue Date
under clause (1) of paragraph (b) above;
(2) in the event that an item of Indebtedness (or any
portion thereof) meets the criteria of more than one of the
types of Indebtedness described above, the Company, in its sole
discretion, will classify such item of Indebtedness (or any
portion thereof) at the time of Incurrence and will only be
required to include the amount and type of such Indebtedness in
one of the above clauses or paragraph (a) above;
(3) the Company will be entitled to divide and classify an
item of Indebtedness in more than one of the types of
Indebtedness described above; and
(4) in the case of any Indebtedness initially Incurred
pursuant to clause (b)(11), (b)(14) or (b)(16) above, the
Company will be entitled, in its sole discretion, to later
reclassify all or any portion of such Indebtedness as having
been Incurred under any other clause above or paragraph
(a) as long as, at the time of such reclassification, such
Indebtedness (or portion thereof) would be permitted to be
Incurred pursuant to such other clause or paragraph.
(d) For purposes of determining compliance with any
U.S. dollar restriction on the Incurrence of Indebtedness
where the Indebtedness Incurred is denominated in a different
currency, the amount of such Indebtedness will be the
U.S. Dollar Equivalent, determined on the date of the
Incurrence of such Indebtedness; provided, however, that if any
such Indebtedness denominated in a different currency is subject
to a Currency Agreement with respect to U.S. dollars,
covering all principal, premium, if any, and interest payable on
such Indebtedness, the amount of such Indebtedness expressed in
U.S. dollars will be as provided in such Currency
Agreement. The principal amount of any Refinancing Indebtedness
Incurred in the same currency as the Indebtedness being
Refinanced will be the U.S. Dollar Equivalent of the
Indebtedness Refinanced, except to the extent that (1) such
U.S. Dollar Equivalent was determined based on a Currency
Agreement, in which case the Refinancing Indebtedness will be
determined in accordance with the preceding sentence, and
(2) the principal amount of the Refinancing Indebtedness
exceeds the principal amount of the Indebtedness being
Refinanced, in which case the U.S. Dollar Equivalent of
such excess will be determined on the date such Refinancing
Indebtedness is Incurred.
Limitation
on Restricted Payments
(a) The Company will not, and will not permit any
Restricted Subsidiary, directly or indirectly, to make a
Restricted Payment if at the time the Company or such Restricted
Subsidiary makes such Restricted Payment:
(1) a Default shall have occurred and be continuing (or
would result therefrom);
(2) the Company is not entitled to Incur an additional
$1.00 of Indebtedness pursuant to paragraph (a) of the
covenant described under Limitation on
Indebtedness; or
(3) the aggregate amount of such Restricted Payment and all
other Restricted Payments since the Issue Date would exceed the
sum of (without duplication):
(A) 50% of the Consolidated Net Income accrued during the
period (treated as one accounting period) from the beginning of
the fiscal quarter during which the Issue Date occurs to the end
of the most recent fiscal quarter for which internal financial
statements are available at the time of such Restricted Payment
(or, in case such Consolidated Net Income shall be a deficit,
minus 100% of such deficit); plus
(B) 100% of the aggregate Net Cash Proceeds and the fair
market value, as determined in good faith by the Board of
Directors of the Company, of other property received by the
Company from
91
the issuance or sale of its Capital Stock (other than
Disqualified Stock) subsequent to the Issue Date (other than an
issuance or sale to a Subsidiary of the Company and other than
an issuance or sale to an employee stock ownership plan or to a
trust established by the Company or any of its Subsidiaries for
the benefit of their employees) and 100% of any cash capital
contribution and the fair market value, as determined in good
faith by the Board of Directors of the Company, of other
property received by the Company from its shareholders
subsequent to the Issue Date; plus
(C) 100% of the aggregate Net Cash Proceeds and the fair
market value, as determined in good faith by the Board of
Directors of the Company, of other property received by the
Company from the Incurrence of Indebtedness to the extent such
Indebtedness is converted or exchanged for Capital Stock (other
than Disqualified Stock) subsequent to the Issue Date (other
than an Incurrence to a Subsidiary of the Company and other than
an Incurrence to an employee stock ownership plan or to a trust
established by the Company or any of its Subsidiaries for the
benefit of their employees)(less the amount of any cash
distributed by the Company upon such conversion or exchange);
plus
(D) an amount equal to the sum of (x) the aggregate
amount received by the Company or its Restricted Subsidiaries
after the Issue Date resulting from repurchases, repayments or
redemptions of Investments (other than Permitted Investments)
made by the Company or any Restricted Subsidiary in any Person,
proceeds realized on the sale of such Investment and proceeds
representing the return of capital (excluding dividends and
distributions), in each case received by the Company or any
Restricted Subsidiary, and (y) to the extent such Person is
an Unrestricted Subsidiary, the portion (proportionate to the
Companys equity interest in such Subsidiary) of the fair
market value of the net assets of such Unrestricted Subsidiary
at the time such Unrestricted Subsidiary is designated a
Restricted Subsidiary.
(b) The preceding provisions will not prohibit:
(1) any Restricted Payment made out of the Net Cash
Proceeds of the substantially concurrent sale of, or made by
exchange for, Capital Stock of the Company (other than
Disqualified Stock and other than Capital Stock issued or sold
to a Subsidiary of the Company or an employee stock ownership
plan or to a trust established by the Company or any of its
Subsidiaries for the benefit of their employees) or a
substantially concurrent cash capital contribution received by
the Company from its shareholders; provided, however, that
(A) such Restricted Payment shall be excluded in the
calculation of the amount of Restricted Payments and
(B) the Net Cash Proceeds from such sale or such cash
capital contribution (to the extent so used for such Restricted
Payment) shall be excluded from the calculation of amounts under
clause (3)(B) of paragraph (a) above;
(2) any purchase, repurchase, redemption, defeasance or
other acquisition or retirement for value of Subordinated
Obligations of the Company or a Subsidiary Guarantor made by
exchange for, or out of the proceeds of the substantially
concurrent Incurrence of, Subordinated Obligations of such
Person which is permitted to be Incurred pursuant to the
covenant described under Limitation on
Indebtedness; provided, however, that such purchase,
repurchase, redemption, defeasance or other acquisition or
retirement for value shall be excluded in the calculation of the
amount of Restricted Payments;
(3) dividends paid within 60 days after the date of
declaration thereof if at such date of declaration such dividend
would have complied with this covenant or the redemption,
repurchase or retirement of Subordinated Obligations, if at the
date of any irrevocable redemption notice such payment would
have complied with this covenant; provided, however, that the
payment of such dividend or payment of Subordinated Obligations
shall be included in the calculation of the amount of Restricted
Payments;
(4) so long as no Default has occurred and is continuing,
the purchase, redemption or other acquisition of shares of
Capital Stock of Parent, the Company or any of its Subsidiaries
from consultants, former consultants, employees, former
employees, directors or former directors of Parent, the Company
or any of its Subsidiaries (or permitted transferees of such
employees, former employees, directors or former directors),
pursuant to the terms of the agreements (including employment
agreements) or plans (or amendments thereto) approved by the
Board of Directors under which such individuals purchase or
92
sell or are granted the option to purchase or sell, shares of
such Capital Stock; provided, however, that the aggregate amount
of such Restricted Payments (excluding amounts representing
cancelation of Indebtedness) shall not exceed $30 million
in any calendar year (with unused amounts in any calendar year
being carried over to succeeding calendar years); provided
further, however, that such amount in any calendar year may be
increased by an amount not to exceed (A) the cash proceeds
from the sale of Capital Stock of the Company and, to the extent
contributed to the Company, Capital Stock of Parent, in each
case to employees, directors or consultants of Parent, the
Company or any of its Restricted Subsidiaries, that occurs after
the Issue Date plus (B) the cash proceeds of key man life
insurance policies received by the Company or its Restricted
Subsidiaries, or by Parent to the extent contributed to the
Company, after the Issue Date (provided that the Company shall
be entitled to elect to apply all or any portion of the
aggregate increase contemplated by clauses (A) and
(B) above in any calendar year) less (C) the amount of
any Restricted Payments previously made pursuant to
clauses (A) and (B) of this clause (4); provided
further, however, that such Restricted Payments shall be
excluded in the calculation of the amount of Restricted Payments;
(5) the declaration and payments of dividends on
Disqualified Stock issued pursuant to the covenant described
under Limitation on Indebtedness;
provided, however, that, at the time of payment of such
dividend, no Default shall have occurred and be continuing (or
result therefrom); provided further, however, that such
dividends shall be excluded in the calculation of the amount of
Restricted Payments;
(6) repurchases of Capital Stock deemed to occur upon
exercise of stock options or warrants if such Capital Stock
represents a portion of the exercise price of such options or
warrants; provided, however, that such Restricted Payments shall
be excluded in the calculation of the amount of Restricted
Payments;
(7) cash payments in lieu of the issuance of fractional
shares in connection with the exercise of warrants, options or
other securities convertible into or exchangeable for Capital
Stock of the Company; provided, however, that any such cash
payment shall not be for the purpose of evading the limitation
of the covenant described under this subheading (as determined
in good faith by the Board of Directors); provided further,
however, that such payments shall be excluded in the calculation
of the amount of Restricted Payments;
(8) in the event of a Change of Control or Asset
Disposition, the payment, purchase, redemption, defeasance or
other acquisition or retirement of Subordinated Obligations or
Disqualified Stock of Parent, the Company or any Restricted
Subsidiary; provided, however, that prior to such payment,
purchase, redemption, defeasance or other acquisition or
retirement, the Company (or a third party to the extent
permitted by the Indenture) has made a Change of Control Offer
with respect to the Notes as a result of such Change of Control
or an offer to purchase Notes with the Net Cash Proceeds of an
Asset Disposition and has repurchased all Notes validly tendered
and not withdrawn in connection with such offer; provided
further, however, that such payments, purchases, redemptions,
defeasances or other acquisitions or retirements shall be
excluded in the calculation of the amount of Restricted Payments;
(9) payments of intercompany subordinated Indebtedness, the
Incurrence of which was permitted under clause (2) of
paragraph (b) of the covenant described under
Limitation on Indebtedness; provided,
however, that no Default has occurred and is continuing or would
otherwise result therefrom; provided further, however, that such
payments shall be excluded in the calculation of the amount of
Restricted Payments;
(10) Restricted Payments made by or in connection with the
sale, disposition, transfer, dividend, distribution,
contribution or other disposition of assets, other than cash or
Temporary Cash Investments, in an amount which, when taken
together with all Restricted Payments previously made pursuant
to this clause (10), does not exceed 5% of Consolidated Tangible
Assets; provided, however, that (A) at the time of each
such Restricted Payment, no Default shall have occurred and be
continuing (or result therefrom), (B) at the time of and
after giving effect to each such Restricted Payment, the Company
is entitled to Incur an additional $1.00 of Indebtedness
pursuant to paragraph (a) of the covenant described under
Limitation on Indebtedness and
(C) the amount of Restricted Payments made pursuant to this
clause (10) shall be excluded in the calculation of the
amount of Restricted Payments;
93
(11) the declaration and payment of dividends to, or the
making of loans to the Parent in amounts required for such
Person to pay, without duplication: (A) franchise taxes and
other fees, taxes and expenses required to maintain its
corporate existence; (B) income taxes to the extent such
income taxes are attributable to the income of the Company and
its Restricted Subsidiaries and, to the extent of the amount
actually received from the Unrestricted Subsidiaries, in amounts
required to pay such taxes to the extent attributable to the
income of the Unrestricted Subsidiaries; (C) customary
salary, bonus, severance, indemnification obligations and other
benefits payable to officers and employees of Parent;
(D) general corporate overhead and operating expenses for
Parent; and (E) reasonable fees and expenses incurred in
connection with any unsuccessful debt or equity offering or
other financing transaction by Parent; provided, however, that
such payments shall be excluded in the calculation of the amount
of Restricted Payments;
(12) distributions of Investments in Unrestricted
Subsidiaries; provided, however, that such distributions shall
be excluded in the calculation of the amount of Restricted
Payments;
(13) payments in connection with a Qualified Receivables
Transaction; provided, however, that such payments shall be
excluded in the calculation of the amount of Restricted
Payments; or
(14) Restricted Payments in an amount which, when taken
together with all Restricted Payments previously made pursuant
to this clause (14) does not exceed $300 million;
provided, however, that (A) at the time of each such
Restricted Payment, no Default shall have occurred and be
continuing (or result therefrom) and (B) the amount of
Restricted Payments made pursuant to this clause (14) shall
be excluded in the calculation of the amount of Restricted
Payments.
Limitation
on Restrictions on Distributions from Restricted
Subsidiaries
The Company will not, and will not permit any Restricted
Subsidiary to, create or otherwise cause or permit to exist or
become effective any consensual encumbrance or restriction on
the ability of any Restricted Subsidiary to (a) pay
dividends or make any other distributions on its Capital Stock
to the Company or a Restricted Subsidiary or pay any
Indebtedness owed to the Company, (b) make any loans or
advances to the Company or (c) transfer any of its property
or assets to the Company, except:
(1) with respect to clauses (a), (b) and (c),
(A) any encumbrance or restriction pursuant to an agreement
in effect at or entered into on the Issue Date, including the
Credit Agreement in effect on the Issue Date;
(B) any encumbrance or restriction with respect to a
Restricted Subsidiary pursuant to an agreement relating to any
Indebtedness Incurred by such Restricted Subsidiary on or prior
to the date on which such Restricted Subsidiary was acquired by
the Company (other than Indebtedness Incurred as consideration
in, or to provide all or any portion of the funds or credit
support utilized to consummate, the transaction or series of
related transactions pursuant to which such Restricted
Subsidiary became a Restricted Subsidiary or was acquired by the
Company) and outstanding on such date;
(C) any encumbrance or restriction pursuant to an agreement
effecting a Refinancing of Indebtedness Incurred pursuant to an
agreement referred to in clause (A) or (B) of
clause (1) of this covenant or this clause (C) or
contained in any amendment to an agreement referred to in
clause (A) or (B) of clause (1) of this covenant
or this clause (C); provided, however, that the encumbrances and
restrictions with respect to such Restricted Subsidiary
contained in any such refinancing agreement or amendment are no
less favorable to the Noteholders than encumbrances and
restrictions with respect to such Restricted Subsidiary
contained in such predecessor agreements;
(D) any encumbrance or restriction included in contracts
for the sale of assets, including any encumbrance or restriction
with respect to a Restricted Subsidiary imposed pursuant to an
agreement entered into for the sale or disposition of all or
substantially all the Capital Stock or assets of such Restricted
Subsidiary pending the closing of such sale or disposition;
94
(E) any encumbrance or restriction pursuant to the terms of
any agreement entered into by a Receivables Subsidiary in
connection with a Qualified Receivables Transaction; provided,
however, that such encumbrance or restriction applies only to
such Receivables Subsidiary;
(F) any encumbrance or restriction on cash or other
deposits or net worth imposed by customers under contracts
entered into in the ordinary course of business;
(G) any encumbrance or restriction pursuant to the terms of
any agreement or instrument relating to any Indebtedness of a
Restricted Subsidiary permitted to be Incurred subsequent to the
Issue Date pursuant to the covenant described under
Limitation on Indebtedness (i) if
such encumbrance and restriction contained in any such agreement
or instrument taken as a whole are not materially less favorable
to the holders of Notes than the encumbrances and restrictions
contained in the Credit Agreement on the Issue Date (as
determined in good faith by the Company) or (ii) if the
encumbrances and restrictions are not materially more
disadvantageous to the holders of Notes than is customary in
comparable financings (as determined in good faith by the
Company) and either (x) the Company determines that such
encumbrance or restriction will not adversely affect the
Companys ability to make principal and interest payments
on the Notes as and when they come due or (y) such
encumbrances and restrictions apply only during the continuance
of a default in respect of a payment or financial maintenance
covenant relating to such Indebtedness;
(H) any encumbrance or restriction pursuant to the terms of
any agreement or instrument relating to any Indebtedness of
Subsidiary Guarantors or Foreign Subsidiaries to the extent such
Indebtedness is permitted to be Incurred pursuant to an
agreement entered into subsequent to the Issue Date pursuant to
the covenant described under Limitation on
Indebtedness;
(I) any encumbrance or restriction pursuant to customary
provisions in joint venture agreements and other similar
agreements entered into in the ordinary course of
business; and
(J) applicable law or any applicable rule, regulation or
order; and
(2) with respect to clause (c) only,
(A) any encumbrance or restriction consisting of customary
nonassignment provisions in leases governing leasehold interests
to the extent such provisions restrict the transfer of the lease
or the property leased thereunder; and
(B) any encumbrance or restriction contained in security
agreements or mortgages securing Indebtedness of a Restricted
Subsidiary to the extent such encumbrance or restriction
restricts the transfer of the property subject to such security
agreements or mortgages.
Limitation
on Sales of Assets and Subsidiary Stock
(a) The Company will not, and will not permit any
Restricted Subsidiary to, directly or indirectly, consummate any
Asset Disposition unless:
(1) the Company or such Restricted Subsidiary receives
consideration at the time of such Asset Disposition at least
equal to the fair market value (including as to the value of all
non-cash consideration), as determined in good faith by the
Company, of the shares and assets subject to such Asset
Disposition;
(2) at least 75% of the consideration thereof received by
the Company or such Restricted Subsidiary is in the form of cash
or cash equivalents; and
(3) an amount equal to 100% of the Net Available Cash from
such Asset Disposition is applied by the Company (or such
Restricted Subsidiary, as the case may be)
(A) first, to the extent the Company elects (or is required
by the terms of any Indebtedness), to prepay, repay, redeem or
purchase Senior Indebtedness of the Company or of a Subsidiary
Guarantor or Indebtedness (other than any Disqualified Stock) of
a Restricted Subsidiary (in each case other
95
than Indebtedness owed to the Company or a Subsidiary of the
Company) within one year from the later of the date of such
Asset Disposition or the receipt of such Net Available Cash;
(B) second, to the extent of the balance of such Net
Available Cash after application in accordance with clause (A),
to the extent the Company elects, to acquire Additional Assets
within one year from the later of the date of such Asset
Disposition or the receipt of such Net Available Cash; and
(C) third, to the extent of the balance of such Net
Available Cash after application in accordance with
clauses (A) and (B), to make an offer to the Holders of the
Notes (and to holders of other Senior Indebtedness of the
Company or of a Subsidiary Guarantor designated by the Company)
to purchase Notes (and such other Senior Indebtedness of the
Company) pursuant to and subject to the conditions contained in
the Indenture;
provided, however, that in connection with any prepayment,
repayment or purchase of Indebtedness pursuant to
clause (A) or (C) above, the Company or such
Restricted Subsidiary shall permanently retire such Indebtedness
and shall cause the related loan commitment (if any) to be
permanently reduced in an amount equal to the principal amount
so prepaid, repaid or purchased, although such requirement to
retire Indebtedness and reduce loan commitments shall not be
deemed to prohibit the Company and the Restricted Subsidiaries
from thereafter Incurring Indebtedness otherwise permitted by
the covenant described under Limitation on
Indebtedness; provided, however, that, in the case of
clause (B) above, a binding commitment shall be treated as
a permitted application of the Net Available Cash from the date
of such commitment so long as the Company or such Restricted
Subsidiary enters into such commitment with the good faith
expectation that such Net Proceeds will be applied to satisfy
such commitment within 180 days of such commitment (an
Acceptable Commitment); provided further that if any
Acceptable Commitment is later canceled or terminated for any
reason before such Net Available Cash is applied, then such Net
Available Cash shall be applied pursuant to clause (C)
above.
Notwithstanding the foregoing provisions of this covenant, the
Company and the Restricted Subsidiaries will not be required to
apply any Net Available Cash in accordance with this covenant
except to the extent that the aggregate Net Available Cash from
all Asset Dispositions which is not applied in accordance with
this covenant exceeds $100 million. Pending application of
Net Available Cash pursuant to this covenant, such Net Available
Cash may be invested in Temporary Cash Investments or applied to
temporarily reduce revolving credit indebtedness or in any other
manner permitted by the Indenture.
For the purposes of this covenant, the following are deemed to
be cash or cash equivalents:
(1) the assumption or discharge of Indebtedness or other
liabilities of the Company (other than obligations in respect of
Disqualified Stock of the Company) or any Restricted Subsidiary
(other than obligations in respect of Disqualified Stock or
Preferred Stock of a Subsidiary Guarantor) and the release of
the Company or such Restricted Subsidiary from all liability on
such Indebtedness or other liability in connection with such
Asset Disposition;
(2) securities or other obligations received by the Company
or any Restricted Subsidiary from the transferee that are
converted by the Company or such Restricted Subsidiary into cash
within 180 days of the Asset Disposition, to the extent of
the cash received in that conversion;
(3) Additional Assets; and
(4) any Designated Noncash Consideration received by the
Company or any Restricted Subsidiary in such Asset Disposition
having an aggregate fair market value (as determined in good
faith by the Board of Directors), taken together with all other
Designated Noncash Consideration received pursuant to this
clause) that is at that time outstanding, not to exceed the
greater of (x) $250 million and (y) an amount
equal to 3% of Total Assets on the date on which such Designated
Noncash Consideration is received (with the fair market value of
each item of Designated Noncash Consideration being measured at
the time received without giving effect to subsequent changes in
value).
96
(b) In the event of an Asset Disposition that requires the
purchase of Notes (and other Senior Indebtedness of the Company
or of a Subsidiary Guarantor) pursuant to clause (a)(3)(C)
above, the Company will purchase Notes tendered pursuant to an
offer by the Company for the Notes (and such other Senior
Indebtedness of the Company or of a Subsidiary Guarantor) at a
purchase price of 100% of their principal amount (or, in the
event such other Senior Indebtedness was issued with significant
original issue discount, 100% of the accreted value thereof),
without premium, plus accrued but unpaid interest (or, in
respect of such other Senior Indebtedness, such other price, not
to exceed 100%, as may be provided for by the terms of such
other Senior Indebtedness) in accordance with the procedures
(including prorating in the event of oversubscription) set forth
in the Indenture. If the aggregate purchase price of the
securities tendered exceeds the Net Available Cash allotted to
their purchase, the Company will select the securities to be
purchased on a pro rata basis but in round denominations, which
in the case of the Notes will be denominations of $2,000
principal amount or any greater integral multiple of $1,000. The
Company shall not be required to make such an offer to purchase
Notes (and other Senior Indebtedness of the Company or of a
Subsidiary Guarantor) pursuant to this covenant if the Net
Available Cash available therefor is less than $50 million
(which lesser amount shall be carried forward for purposes of
determining whether such an offer is required with respect to
the Net Available Cash from any subsequent Asset Disposition).
Upon completion of such an offer to purchase, Net Available Cash
will be deemed to be reduced by the aggregate amount of such
offer.
(c) The Company will comply, to the extent applicable, with the
requirements of Section 14(e) of the Exchange Act and any
other securities laws or regulations in connection with the
repurchase of Notes pursuant to this covenant. To the extent
that the provisions of any securities laws or regulations
conflict with provisions of this covenant, the Company will
comply with the applicable securities laws and regulations and
will not be deemed to have breached its obligations under this
covenant by virtue of its compliance with such securities laws
or regulations.
Limitation
on Affiliate Transactions
(a) The Company will not, and will not permit any
Restricted Subsidiary to, enter into or permit to exist any
transaction (including the purchase, sale, lease or exchange of
any property, employee compensation arrangements or the
rendering of any service) with, or for the benefit of, any
Affiliate of the Company (an Affiliate Transaction)
involving aggregate consideration in excess of $5.0 million
unless:
(1) the terms of the Affiliate Transaction are no less
favorable to the Company or such Restricted Subsidiary than
those that could be obtained at the time of the Affiliate
Transaction in arms-length dealings with a Person who is
not an Affiliate;
(2) if such Affiliate Transaction involves an amount in
excess of $25 million, the terms of the Affiliate
Transaction are set forth in writing and a majority of the
directors of the Company disinterested with respect to such
Affiliate Transaction, if any, have determined in good faith
that the criteria set forth in clause (1) are satisfied and
have approved the relevant Affiliate Transaction as evidenced by
a resolution of the Board of Directors; and
(3) if such Affiliate Transaction involves an amount in
excess of $75 million, the Board of Directors shall also
have received a written opinion from an Independent Qualified
Party to the effect that such Affiliate Transaction is fair,
from a financial standpoint, to the Company and its Restricted
Subsidiaries or is not less favorable to the Company and its
Restricted Subsidiaries than could reasonably be expected to be
obtained at the time in an arms-length transaction with a
Person who was not an Affiliate.
(b) The provisions of the preceding paragraph (a) will
not prohibit:
(1) any Permitted Investment (other than a Permitted
Investment described in clauses (1), (2) or (15) of
the definition thereof) or Restricted Payment (but, in the case
of a Restricted Payment, only to the extent (i) included in
the calculation of the amount of Restricted Payments made
pursuant to paragraph (a)(3) of, or (ii) made pursuant to
clauses (4) through (14) of paragraph (b) of, the
covenant described under Limitation on Restricted
Payments);
97
(2) any issuance of securities, or other payments, awards
or grants in cash, securities or otherwise pursuant to, or the
funding of, employment arrangements, stock options and stock
ownership plans, or indemnities provided on behalf of employees
or directors approved by the Board of Directors or senior
management of the Company;
(3) loans or advances to employees in the ordinary course
of business consistent with past practices of the Company or its
Restricted Subsidiaries, but in any event not to exceed
$25 million in the aggregate outstanding at any one time;
(4) the payment of reasonable fees to directors of the
Company and its Restricted Subsidiaries who are not employees of
the Company or its Restricted Subsidiaries;
(5) any transaction with the Company, a Restricted
Subsidiary or joint venture or similar entity which would
constitute an Affiliate Transaction solely because the Company
or a Restricted Subsidiary owns an equity interest in or
otherwise controls such Restricted Subsidiary, joint venture or
similar entity;
(6) the issuance or sale of any Capital Stock (other than
Disqualified Stock) of the Company;
(7) transactions with customers, clients, suppliers, or
purchasers or sellers of goods or services, in each case in the
ordinary course of business and otherwise in compliance with the
terms of the Indenture that are fair to the Company or its
Restricted Subsidiaries, in the reasonable determination of the
Board of Directors or the senior management of the Company, or
are no less favorable to the Company and its Restricted
Subsidiaries than could reasonably be expected to be obtained at
the time in an arms-length transaction with a Person who
was not an Affiliate;
(8) any agreement as in effect on the Issue Date or any
renewals or extensions of any such agreement (so long as such
renewals or extensions are not less favorable to the Company or
the Restricted Subsidiaries in any material respect) and the
transactions evidenced thereby; and
(9) any transaction with a Receivables Subsidiary pursuant
to a Qualified Receivables Transaction.
Limitation
on Line of Business
The Company will not, and will not permit any Restricted
Subsidiary, to engage in any business other than a Related
Business, except to the extent as would not be material to the
Company and its Subsidiaries taken as a whole.
Limitation
on Liens
The Company will not, and will not permit any Restricted
Subsidiary to, directly or indirectly, Incur or permit to exist
any Lien (the Initial Lien) of any nature whatsoever
on any of its properties (including Capital Stock of a
Restricted Subsidiary), whether owned at the Issue Date or
thereafter acquired, securing any Indebtedness, other than
Permitted Liens, without effectively providing that the Notes
shall be secured equally and ratably with (or prior to) the
obligations so secured for so long as such obligations are so
secured.
Any Lien created for the benefit of the Holders of the Notes
pursuant to the preceding sentence shall provide by its terms
that such Lien shall be automatically and unconditionally
released and discharged upon the release and discharge of the
Initial Lien.
Limitation
on Sale/Leaseback Transactions
The Company will not, and will not permit any Restricted
Subsidiary to, enter into any Sale/Leaseback Transaction with
respect to any property unless:
(1) the Company or such Restricted Subsidiary would be
entitled to (A) Incur Indebtedness in an amount equal to
the Attributable Debt with respect to such Sale/Leaseback
Transaction pursuant to the covenant described under
Limitation on Indebtedness and
(B) create a Lien on such property securing such
Attributable Debt without equally and ratably securing the Notes
pursuant to the covenant described under
Limitation on Liens;
98
(2) the net proceeds received by the Company or any
Restricted Subsidiary in connection with such Sale/Leaseback
Transaction are at least equal to the fair market value (as
determined by the Board of Directors) of such property; and
(3) the Company applies the proceeds of such transaction in
compliance with the covenant described under
Limitation on Sale of Assets and Subsidiary
Stock.
Merger
and Consolidation
(a) The Company will not consolidate with or merge with or
into, or convey, transfer or lease, in one transaction or a
series of transactions, directly or indirectly, all or
substantially all its assets to, any Person, unless:
(1) the resulting, surviving or transferee Person (the
Successor Company) shall be a Person organized and
existing under the laws of the United States of America, any
State thereof or the District of Columbia, and the Successor
Company (if not the Company) shall expressly assume, by an
indenture supplemental thereto, executed and delivered to the
Trustee, in form satisfactory to the Trustee, all the
obligations of the Company under the Notes and the Indenture;
(2) immediately after giving pro forma effect to such
transaction (and treating any Indebtedness which becomes an
obligation of the Successor Company or any Subsidiary as a
result of such transaction as having been Incurred by such
Successor Company or such Subsidiary at the time of such
transaction), no Default shall have occurred and be continuing;
(3) immediately after giving pro forma effect to such
transaction, (A) the Successor Company would be able to
Incur an additional $1.00 of Indebtedness pursuant to paragraph
(a) of the covenant described under
Limitation on Indebtedness or
(B) the Consolidated Coverage Ratio for the Successor
Company and its Restricted Subsidiaries would be greater than
such ratio for the Company and its Restricted Subsidiaries
immediately prior to such transaction; and
(4) the Company shall have delivered to the Trustee an
Officers Certificate and an Opinion of Counsel, each
stating that such consolidation, merger or transfer and such
supplemental indenture (if any) comply with the Indenture;
provided, however, that clauses (2) and (3) will not
be applicable to (A) a Restricted Subsidiary consolidating
with, merging into or transferring all or part of its properties
and assets to the Company (so long as no Capital Stock of the
Company is distributed to any Person) or to another Restricted
Subsidiary or (B) the Company merging with an Affiliate of
the Company solely for the purpose of reincorporating the
Company in another jurisdiction.
For purposes of this covenant, the sale, lease, conveyance,
assignment, transfer or other disposition of all or
substantially all of the properties and assets of one or more
Subsidiaries of the Company, which properties and assets, if
held by the Company instead of such Subsidiaries, would
constitute all or substantially all of the properties and assets
of the Company on a consolidated basis, shall be deemed to be
the transfer of all or substantially all of the properties and
assets of the Company.
The Successor Company will be the successor to the Company and
shall succeed to, and be substituted for, and may exercise every
right and power of, the Company under the Indenture, and the
predecessor Company, except in the case of a lease, shall be
released from all obligations under the Indenture and to pay the
principal of and interest on the Notes.
(b) The Company will not permit any Subsidiary Guarantor to
consolidate with or merge with or into, or convey, transfer or
lease, in one transaction or a series of transactions, all or
substantially all of its assets to any Person unless:
(1) the resulting, surviving or transferee Person (if not
such Subsidiary) shall be a Person organized and existing under
the laws of the jurisdiction under which such Subsidiary was
organized or under the laws of the United States of America, or
any State thereof or the District of Columbia, and such Person
99
shall expressly assume, by a Guaranty Agreement, in a form
satisfactory to the Trustee, all the obligations of such
Subsidiary, if any, under its Subsidiary Guaranty; provided,
however, that the foregoing shall not apply in the case of a
Subsidiary Guarantor (x) that has been disposed of in its
entirety to another Person (other than to the Company or a
Subsidiary of the Company), whether through a merger,
consolidation or sale of Capital Stock or assets or
(y) that, as a result of the disposition of all or a
portion of its Capital Stock, ceases to be a Subsidiary, in both
cases, if in connection therewith the Company provides an
Officers Certificate to the Trustee to the effect that the
Company will comply with its obligations under the covenant
described under Limitation on Sales of Assets
and Subsidiary Stock in respect of such disposition;
(2) immediately after giving effect to such transaction or
transactions on a pro forma basis (and treating any Indebtedness
which becomes an obligation of the resulting, surviving or
transferee Person as a result of such transaction as having been
issued by such Person at the time of such transaction), no
Default shall have occurred and be continuing; and
(3) the Company delivers to the Trustee an Officers
Certificate and an Opinion of Counsel, each stating that such
consolidation, merger or transfer and such Guaranty Agreement,
if any, complies with the Indenture;
provided, however, that clause (2) will not be applicable
to (A) a Restricted Subsidiary consolidating with, merging
into or transferring all or part of its properties and assets to
a Subsidiary Guarantor (so long as no Capital Stock of the
Subsidiary Guarantor is distributed to any Person) or to another
Restricted Subsidiary or (B) a Subsidiary Guarantor merging
with an Affiliate of the Company solely for the purpose of
reincorporating the Subsidiary Guarantor in another jurisdiction.
(c) Parent will not consolidate with or merge with or into,
or convey, transfer or lease, in one transaction or a series of
transactions, all or substantially all of its assets to any
Person unless:
(1) the resulting, surviving or transferee Person (if not
Parent) shall be a Person organized and existing under the laws
of the jurisdiction under which Parent was organized or under
the laws of the United States of America, or any State thereof
or the District of Columbia, and such Person shall expressly
assume, by a Guaranty Agreement, in a form satisfactory to the
Trustee, all the obligations of Parent, if any, under the Parent
Guaranty;
(2) immediately after giving effect to such transaction or
transactions on a pro forma basis (and treating any Indebtedness
which becomes an obligation of the resulting, surviving or
transferee Person as a result of such transaction as having been
issued by such Person at the time of such transaction), no
Default shall have occurred and be continuing; and
(3) the Company delivers to the Trustee an Officers
Certificate and an Opinion of Counsel, each stating that such
consolidation, merger or transfer and such Guaranty Agreement,
if any, complies with the Indenture;
provided, however, that clause (2) will not be applicable
to (A) a Restricted Subsidiary consolidating with, merging
into or transferring all or part of its properties and assets to
Parent (so long as no Capital Stock of Parent is distributed to
any Person) or to another Restricted Subsidiary or
(B) Parent merging with an Affiliate of the Company solely
for the purpose of reincorporating Parent in another
jurisdiction.
Future
Guarantors
The Company will cause each Domestic Restricted Subsidiary that
Incurs any Indebtedness (other than Indebtedness permitted to be
Incurred pursuant to clause (2), (7), (8), (9), (12),
(13) or (14) of paragraph (b) of the covenant
described under Limitation on
Indebtedness) to, and each Foreign Subsidiary that enters
into a Guarantee of any Senior Indebtedness (other than
Indebtedness permitted to be Incurred pursuant to clause (2),
(7), (8), (9), (12), (13) or (14) of paragraph
(b) of the covenant described under Limitation
on Indebtedness and other than a Foreign Subsidiary that
Guarantees Senior Indebtedness Incurred by another Foreign
Subsidiary) to, in each case, within 10 Business Days, execute
and deliver to the Trustee a Guaranty
100
Agreement pursuant to which such Restricted Subsidiary will
Guarantee payment of the Notes on the same terms and conditions
as those set forth in the Indenture.
SEC
Reports
Whether or not the Company is subject to the reporting
requirements of Section 13 or 15(d) of the Exchange Act,
the Company will file with the SEC subject to the next sentence
and provide the Trustee and Noteholders with such annual and
other reports as are specified in Sections 13 and 15(d) of
the Exchange Act and applicable to a U.S. corporation
subject to such Sections, such reports to be so filed and
provided at the times specified for the filings of such reports
under such Sections and containing all the information, audit
reports and exhibits required for such reports. If, at any time,
the Company is not subject to the periodic reporting
requirements of the Exchange Act for any reason, the Company
will nevertheless continue filing the reports specified in the
preceding sentence with the SEC within the time periods required
unless the SEC will not accept such a filing. The Company agrees
that it will not take any action for the purpose of causing the
SEC not to accept such filings. If, notwithstanding the
foregoing, the SEC will not accept such filings for any reason,
the Company will post the reports specified in the preceding
sentence on its website within the time periods that would apply
if the Company were required to file those reports with the SEC.
At any time that any of the Companys Subsidiaries are
Unrestricted Subsidiaries, then the quarterly and annual
financial information required by the preceding paragraph will
include a reasonably detailed presentation, either on the face
of the financial statements or in the footnotes thereto, and in
Managements Discussion and Analysis of Financial
Condition and Results of Operations, of the financial
condition and results of operations of the Company and its
Restricted Subsidiaries separate from the financial condition
and results of operations of the Unrestricted Subsidiaries of
the Company.
In addition, the Company will furnish to the Holders of the
Notes and to prospective investors, upon the requests of such
Holders, any information required to be delivered pursuant to
Rule 144A(d)(4) under the Securities Act so long as the
Notes are not freely transferable under the Securities Act.
In addition, at any time that Parent holds no material assets
other than cash, Temporary Cash Investments and the Capital
Stock of the Company or any other direct or indirect
intermediate holding company parent of the Company (and performs
the related incidental activities associated with such
ownership) and complies with the requirements of
Rule 3-10
of
Regulation S-X
promulgated by the SEC (or any successor provision), the
reports, information and other documents required to be filed
and furnished to holders of the Notes pursuant to this covenant
may, at the option of the Company, be filed by and be those of
Parent rather than of the Company; provided, however, that the
issuance by Parent of any Indebtedness or Capital Stock shall
not be deemed to prevent the Company from exercising its option
described in this paragraph to file and furnish reports,
information and other documents of Parent to satisfy the
requirements of this covenant.
Notwithstanding the foregoing, such requirements shall be deemed
satisfied prior to the commencement of the exchange offer or the
effectiveness of a shelf registration statement relating to the
registration of the Notes under the Securities Act (as described
under Registered Exchange Offer; Registration
Rights) by the filing with the SEC of an exchange offer
registration statement or a shelf registration statement, and
any amendments thereto, with such financial information that
satisfies
Regulation S-X
of the Securities Act within the time periods and in accordance
with the other provisions of the Registration Rights Agreement.
Defaults
Each of the following is an Event of Default:
(1) a default in the payment of interest on the Notes when
due, continued for 30 days;
(2) a default in the payment of principal of any Note when
due at its Stated Maturity, upon optional redemption, upon
required purchase, upon declaration of acceleration or otherwise;
(3) the failure by the Company or Parent to comply with its
obligations under Certain
Covenants Merger and Consolidation above;
101
(4) the failure by the Company or any Subsidiary Guarantor
to comply for 60 days after notice with its other
agreements contained in the Indenture;
(5) Indebtedness of the Company, any Subsidiary Guarantor
or any Significant Subsidiary is not paid within any applicable
grace period after final maturity or is accelerated by the
holders thereof because of a default and the total amount of
such Indebtedness unpaid or accelerated exceeds
$100 million (the cross acceleration provision);
(6) certain events of bankruptcy, insolvency or
reorganization of the Company or any Significant Subsidiary (the
bankruptcy provisions);
(7) any judgment or decree for the payment of money in
excess of $100 million (other than a judgment or decree
covered by indemnities or insurance policies issued be reputable
and creditworthy companies to the extent coverage has not been
disclaimed) is entered against the Company or any Significant
Subsidiary, remains outstanding for a period of 60 consecutive
days following such judgment and is not discharged, waived or
stayed (the judgment default provision); or
(8) any Guaranty ceases to be in full force and effect
(other than in accordance with the terms of such Guaranty) or
any Guarantor denies or disaffirms its obligations under its
Guaranty.
However, a default under clause (4) will not constitute an
Event of Default until the Trustee or the holders of 25% in
principal amount of the outstanding Notes notify the Company of
the default and the Company does not cure such default within
the time specified after receipt of such notice.
If an Event of Default occurs and is continuing, the Trustee or
the holders of at least 25% in principal amount of the
outstanding Notes may declare the principal of and accrued but
unpaid interest on all the Notes to be due and payable. Upon
such a declaration, such principal and interest shall be due and
payable immediately. If an Event of Default relating to certain
events of bankruptcy, insolvency or reorganization of the
Company occurs and is continuing, the principal of and interest
on all the Notes will ipso facto become and be immediately due
and payable without any declaration or other act on the part of
the Trustee or any holders of the Notes. Under certain
circumstances, the holders of a majority in principal amount of
the outstanding Notes may rescind any such acceleration with
respect to the Notes and its consequences.
Subject to the provisions of the Indenture relating to the
duties of the Trustee, in case an Event of Default occurs and is
continuing, the Trustee will be under no obligation to exercise
any of the rights or powers under the Indenture at the request
or direction of any of the holders of the Notes unless such
holders have offered to the Trustee reasonable indemnity or
security against any loss, liability or expense. Except to
enforce the right to receive payment of principal, premium (if
any) or interest when due, no holder of a Note may pursue any
remedy with respect to the Indenture or the Notes unless:
(1) such holder has previously given the Trustee notice
that an Event of Default is continuing;
(2) holders of at least 25% in principal amount of the
outstanding Notes have requested the Trustee to pursue the
remedy;
(3) such holders have offered the Trustee reasonable
security or indemnity against any loss, liability or expense;
(4) the Trustee has not complied with such request within
60 days after the receipt thereof and the offer of security
or indemnity; and
(5) holders of a majority in principal amount of the
outstanding Notes have not given the Trustee a direction
inconsistent with such request within such
60-day
period.
Subject to certain restrictions, the holders of a majority in
principal amount of the outstanding Notes are given the right to
direct the time, method and place of conducting any proceeding
for any remedy available to the Trustee or of exercising any
trust or power conferred on the Trustee. The Trustee, however,
may refuse to follow any direction that conflicts with law or
the Indenture or that the Trustee determines is unduly
prejudicial to the rights of any other holder of a Note or that
would involve the Trustee in personal liability.
102
In the event of any Event of Default under the cross
acceleration provision, such Event of Default and all
consequences thereof (excluding, however, any resulting payment
default) will be annulled, waived and rescinded, automatically
and without any action by the Trustee or the holders of the
Notes, if within 20 Business Days after such Event of
Default arose the Company delivers an Officers Certificate
to the Trustee stating that (x) the Indebtedness or
guarantee that is the basis for such Event of Default has been
discharged or (y) the holders thereof have rescinded or
waived the acceleration, notice or action (as the case may be)
giving rise to such Event of Default or (z) the default
that is the basis for such Event of Default has been cured, it
being understood that in no event shall an acceleration of the
principal amount of the Notes as described above be annulled,
waived or rescinded upon the happening of any such events.
In the event that the Company or any of its Restricted
Subsidiaries had previously taken an action (or failed to take
an action) that was prohibited (or required) by the Indenture
solely because of the continuance of a Default (the
Initial Default), then upon the cure or waiver of
the Initial Default, any Default or Event of Default arising
from the taking of such action (or failure to take such action)
and all consequences thereof (excluding any resulting payment
Default, other than as a result of acceleration of the Notes)
will be annulled, waived and rescinded, automatically and
without any action by the Trustee or the Holders.
If a Default occurs, is continuing and is known to the Trustee,
the Trustee must mail to each holder of the Notes notice of the
Default within 90 days after it occurs. Except in the case
of a Default in the payment of principal of or interest on any
Note, the Trustee may withhold notice if and so long as a
committee of its Trust Officers in good faith determines
that withholding notice is not opposed to the interest of the
holders of the Notes. In addition, we are required to deliver to
the Trustee, within 120 days after the end of each fiscal
year, a certificate indicating whether the signers thereof know
of any Default that occurred during the previous year. We are
required to deliver to the Trustee, within 30 days after
the occurrence thereof, written notice of any event which would
constitute certain Defaults, their status and what action we are
taking or propose to take in respect thereof.
Amendments
and Waivers
Subject to certain exceptions, the Indenture may be amended with
the consent of the holders of a majority in principal amount of
the Notes then outstanding (including consents obtained in
connection with a tender offer or exchange for the Notes) and
any past default or compliance with any provisions may also be
waived with the consent of the holders of a majority in
principal amount of the Notes then outstanding. However, without
the consent of each holder of an outstanding Note affected
thereby, an amendment or waiver may not, among other things:
(1) reduce the amount of Notes whose holders must consent
to an amendment;
(2) reduce the rate of or extend the time for payment of
interest on any Note;
(3) reduce the principal of or change the Stated Maturity
of any Note;
(4) change the provisions applicable to the redemption of
any Note as described under Optional
Redemption above;
(5) make any Note payable in money other than that stated
in the Note;
(6) impair the right of any holder of the Notes to receive
payment of principal of and interest on such holders Notes
on or after the due dates therefor or to institute suit for the
enforcement of any payment on or with respect to such
holders Notes;
(7) make any change in the amendment provisions that
require each holders consent or in the waiver provisions;
(8) make any change in the ranking or priority of any Note
that would adversely affect the Noteholders; or
(9) make any change in, or release other than in accordance
with the Indenture or any Guaranty that would adversely affect
the Noteholders.
103
Notwithstanding the preceding, without the consent of any holder
of the Notes, the Company, the Guarantors and Trustee may amend
the Indenture:
(1) to cure any ambiguity, omission, mistake, defect or
inconsistency;
(2) to provide for the assumption by a successor
corporation of the obligations of the Company or any Guarantor
under the Indenture;
(3) to provide for uncertificated Notes in addition to or
in place of certificated Notes (provided that the uncertificated
Notes are issued in registered form for purposes of
Section 163(f) of the Code, or in a manner such that the
uncertificated Notes are described in Section 163(f)(2)(B)
of the Code);
(4) to add Guarantees with respect to the Notes, including
any Subsidiary Guaranties, or to secure the Notes;
(5) to add to the covenants of the Company or any Guarantor
for the benefit of the holders of the Notes or to surrender any
right or power conferred upon the Company or any Subsidiary
Guarantor;
(6) to make any change that does not adversely affect the
rights of any holder of the Notes;
(7) to comply with any requirement of the SEC in connection
with the qualification of the Indenture under the
Trust Indenture Act;
(8) to conform the text of the Indenture, the Notes and the
Subsidiary Guaranties to any provision of this Description
of the Notes to the extent that such provision in this
Description of the Notes was intended to be a
verbatim recitation of a provision of the Indenture, the Notes
and the Guaranties; or
(9) to make any amendment to the provisions of the
Indenture relating to the transfer and legending of Notes;
provided, however, that (a) compliance with the Indenture
as so amended would not result in Notes being transferred in
violation of the Securities Act or any other applicable
securities law and (b) such amendment does not materially
and adversely affect the rights of Holders to transfer Notes.
The consent of the holders of the Notes is not necessary under
the Indenture to approve the particular form of any proposed
amendment. It is sufficient if such consent approves the
substance of the proposed amendment.
After an amendment under the Indenture becomes effective, we are
required to mail to holders of the Notes a notice briefly
describing such amendment. However, the failure to give such
notice to all holders of the Notes, or any defect therein, will
not impair or affect the validity of the amendment.
Neither the Company nor any Affiliate of the Company may,
directly or indirectly, pay or cause to be paid any
consideration, whether by way of interest, fee or otherwise, to
any Holder for or as an inducement to any consent, waiver or
amendment of any of the terms or provisions of the Indenture or
the Notes unless such consideration is offered to all Holders
and is paid to all Holders that so consent, waive or agree to
amend in the time frame set forth in solicitation documents
relating to such consent, waiver or agreement.
Transfer
The Notes will be issued in registered form and will be
transferable only upon the surrender of the Notes being
transferred for registration of transfer. We may require payment
of a sum sufficient to cover any tax, assessment or other
governmental charge payable in connection with certain transfers
and exchanges.
Satisfaction
and Discharge
When we (1) deliver to the Trustee all outstanding Notes
for cancellation or (2) all outstanding Notes have become
due and payable, whether at maturity or on a redemption date as
a result of the mailing of notice of redemption, and, in the
case of clause (2), we irrevocably deposit with the Trustee
funds sufficient to pay at maturity or upon redemption all
outstanding Notes, including interest thereon to maturity or
such redemption date, and if in either case we pay all other
sums payable under the Indenture by us, then the Indenture
shall, subject to certain exceptions, cease to be of further
effect.
104
Defeasance
At any time, we may terminate all our obligations under the
Notes and the Indenture (legal defeasance), except
for certain obligations, including those respecting the
defeasance trust and obligations to register the transfer or
exchange of the Notes, to replace mutilated, destroyed, lost or
stolen Notes and to maintain a registrar and paying agent in
respect of the Notes.
In addition, at any time we may terminate our obligations under
Change of Control and under the
covenants described under Certain
Covenants (other than the covenant described under
Merger and Consolidation), the operation
of the cross acceleration provision, the bankruptcy provisions
with respect to Significant Subsidiaries and Guarantors and the
judgment default provision described under
Defaults above and the limitation
contained in clause (3) of the first paragraph under
Certain Covenants Merger and
Consolidation above (covenant defeasance).
We may exercise our legal defeasance option notwithstanding our
prior exercise of our covenant defeasance option. If we exercise
our legal defeasance option, payment of the Notes may not be
accelerated because of an Event of Default with respect thereto.
If we exercise our covenant defeasance option, payment of the
Notes may not be accelerated because of an Event of Default
specified in clause (4), (5), (6) (with respect only to
Significant Subsidiaries and Subsidiary Guarantors) or
(7) or (9) under
Defaults above or because of the
failure of the Company to comply with clause (3) of the
first paragraph under Certain
Covenants Merger and Consolidation above. If
we exercise our legal defeasance option or our covenant
defeasance option, each Guarantor will be released from all of
its obligations with respect to its Guaranty.
In order to exercise either of our defeasance options, we must
irrevocably deposit in trust (the defeasance trust)
with the Trustee money or U.S. Government Obligations for
the payment of principal and interest on the Notes to redemption
or maturity, as the case may be, and must comply with certain
other conditions, including delivery to the Trustee of an
Opinion of Counsel to the effect that holders of the Notes will
not recognize income, gain or loss for Federal income tax
purposes as a result of such deposit and defeasance and will be
subject to Federal income tax on the same amounts and in the
same manner and at the same times as would have been the case if
such deposit and defeasance had not occurred (and, in the case
of legal defeasance only, such Opinion of Counsel must be based
on a ruling of the Internal Revenue Service or other change in
applicable Federal income tax law).
Concerning
the Trustee
U.S. Bank National Association is to be the Trustee under
the Indenture. We have appointed U.S. Bank National
Association as Registrar and Paying Agent with regard to the
Notes.
The Indenture contains certain limitations on the rights of the
Trustee, should it become a creditor of the Company, to obtain
payment of claims in certain cases, or to realize on certain
property received in respect of any such claim as security or
otherwise. The Trustee will be permitted to engage in other
transactions; provided, however, if it acquires any conflicting
interest it must either eliminate such conflict within
90 days, apply to the SEC for permission to continue or
resign.
The Holders of a majority in principal amount of the outstanding
Notes will have the right to direct the time, method and place
of conducting any proceeding for exercising any remedy available
to the Trustee, subject to certain exceptions. If an Event of
Default occurs (and is not cured), the Trustee will be required,
in the exercise of its power, to use the degree of care of a
prudent man in the conduct of his own affairs. Subject to such
provisions, the Trustee will be under no obligation to exercise
any of its rights or powers under the Indenture at the request
of any Holder of Notes, unless such Holder shall have offered to
the Trustee security and indemnity satisfactory to it against
any loss, liability or expense and then only to the extent
required by the terms of the Indenture.
No
Personal Liability of Directors, Officers, Employees and
Stockholders
No director, officer, employee, incorporator or stockholder of
the Company or any Guarantor will have any liability for any
obligations of the Company or any Guarantor under the Notes, any
Guaranty or the
105
Indenture or for any claim based on, in respect of, or by reason
of such obligations or their creation. Each Holder of the Notes
by accepting a Note waives and releases all such liability. The
waiver and release are part of the consideration for issuance of
the Notes. Such waiver and release may not be effective to waive
liabilities under the U.S. Federal securities laws, and it
is the view of the SEC that such a waiver is against public
policy.
Governing
Law
The Indenture and the Notes will be governed by, and construed
in accordance with, the laws of the State of New York.
Certain
Definitions
Additional Assets means:
(1) any property, plant or equipment or other assets or
capital expenditures used in a Related Business or that replace
the assets that were the subject of the Asset Disposition;
(2) the Capital Stock of a Person that becomes a Restricted
Subsidiary as a result of the acquisition of such Capital Stock
by the Company or another Restricted Subsidiary; or
(3) Capital Stock constituting a minority interest in any
Person that at such time is a Restricted Subsidiary;
provided, however, that any such Restricted Subsidiary described
in clause (2) or (3) above is primarily engaged in a
Related Business or replaces the assets that were the subject of
the Asset Disposition.
Affiliate of any specified Person means any
other Person, directly or indirectly, controlling or controlled
by or under direct or indirect common control with such
specified Person. For the purposes of this definition,
control when used with respect to any Person means
the power to direct the management and policies of such Person,
directly or indirectly, whether through the ownership of voting
securities, by contract or otherwise; and the terms
controlling and controlled have meanings
correlative to the foregoing.
Applicable Premium means with respect to any
Note on any applicable redemption date, the excess of:
(a) the present value at such redemption date of
(i) the redemption price at July 15, 2011 (such
redemption price being set forth under the caption
Optional Redemption) plus (ii) all
required interest payments due on the Notes through
July 15, 2011 (excluding accrued but unpaid interest to the
date of redemption), computed using a discount rate equal to the
Treasury Rate as of such redemption date plus 50 basis
points; over (b) the then outstanding principal amount of
the Notes.
Asset Disposition means any sale, lease,
transfer or other voluntary disposition (or series of related
sales, leases, transfers or dispositions) by the Company or any
Restricted Subsidiary, including any disposition by means of a
merger, consolidation or similar transaction (each referred to
for the purposes of this definition as a
disposition), of:
(1) any shares of Capital Stock of a Restricted Subsidiary
(other than directors qualifying shares or shares required
by applicable law to be held by a Person other than the Company
or a Restricted Subsidiary);
(2) all or substantially all the assets of any division or
line of business of the Company or any Restricted
Subsidiary; or
(3) any other assets of the Company or any Restricted
Subsidiary outside of the ordinary course of business of the
Company or such Restricted Subsidiary
other than, in the case of clauses (1), (2) and
(3) above,
(A) a disposition by a Restricted Subsidiary to the Company
or by the Company or a Restricted Subsidiary to a Restricted
Subsidiary;
106
(B) for purposes of the covenant described under
Certain Covenants Limitation on
Sales of Assets and Subsidiary Stock only, (x) a
disposition that constitutes a Restricted Payment (or would
constitute a Restricted Payment but for the exclusions from the
definition thereof, including the exclusion for Permitted
Investments) and that is not prohibited by the covenant
described under Certain Covenants
Limitation on Restricted Payments and (y) a
disposition of all or substantially all the assets of the
Company in accordance with the covenant described under
Certain Covenants Merger and
Consolidation or any disposition that constitutes a Change
of Control;
(C) a disposition of assets with a fair market value of
less than $75.0 million;
(D) a disposition of cash or Temporary Cash Investments;
(E) the creation of a Lien (but not the sale or other
disposition of the property subject to such Lien);
(F) (F) a Hospital Swap;
(G) long-term leases of Hospitals to another Person;
provided that the aggregate book value of the properties subject
to such leases at any one time outstanding does not exceed 10%
of the Total Assets at the time any such lease is entered into;
(H) a disposition of property no longer used or useful in
the conduct of the business of the Company and its Restricted
Subsidiaries;
(I) a disposition of Capital Stock, or Indebtedness or
other securities of, an Unrestricted Subsidiary;
(J) foreclosures on assets or transfers by reason of
eminent domain;
(K) a disposition of an account receivable in connection
with the collection or compromise thereof; and
(L) sales of accounts receivables and related assets of the
type specified in the definition of Qualified Receivables
Transaction to or by a Receivables Subsidiary for the fair
market value thereof or the creation of a Lien on any such
accounts receivable or related assets in connection with a
Qualified Receivables Transaction.
Attributable Debt in respect of a
Sale/Leaseback Transaction means, as at the time of
determination, the present value (discounted at the interest
rate borne by the Notes, compounded annually) of the total
obligations of the lessee for rental payments during the
remaining term of the lease included in such Sale/Leaseback
Transaction (including any period for which such lease has been
extended); provided, however, that if such Sale/Leaseback
Transaction results in a Capital Lease Obligation, the amount of
Indebtedness represented thereby will be determined in
accordance with the definition of Capital Lease
Obligation.
Average Life means, as of the date of
determination, with respect to any Indebtedness, the quotient
obtained by dividing:
(1) the sum of the products of the numbers of years from
the date of determination to the dates of each successive
scheduled principal payment of or redemption or similar payment
with respect to such Indebtedness multiplied by the amount of
such payment by
(2) the sum of all such payments.
Board of Directors means the Board of
Directors of the Company or any committee thereof duly
authorized to act on behalf of such Board.
Business Day means each day which is not a
Legal Holiday.
Capital Lease Obligation means an obligation
that is required to be classified and accounted for as a capital
lease for financial reporting purposes in accordance with GAAP,
and the amount of Indebtedness
107
represented by such obligation shall be the capitalized amount
of such obligation determined in accordance with GAAP; and the
Stated Maturity thereof shall be the date of the last payment of
rent or any other amount due under such lease prior to the first
date upon which such lease may be terminated by the lessee
without payment of a penalty. For purposes of the covenant
described under Certain Covenants
Limitation on Liens, a Capital Lease Obligation will be
deemed to be secured by a Lien on the property being leased.
Capital Stock of any Person means any and all
shares, interests (including partnership interests), rights to
purchase, warrants, options, participations or other equivalents
of or interests in (however designated) equity of such Person,
including any Preferred Stock, but excluding any debt securities
convertible into such equity.
Code means the Internal Revenue Code of 1986,
as amended.
Consolidated Coverage Ratio as of any date of
determination means the ratio of (x) the aggregate amount
of EBITDA for the period of the most recent four consecutive
fiscal quarters for which internal financial statements are
available to (y) Consolidated Interest Expense for such
four fiscal quarters; provided, however, that:
(3) if the Company or any Restricted Subsidiary has
Incurred any Indebtedness since the beginning of such period
that remains outstanding or if the transaction giving rise to
the need to calculate the Consolidated Coverage Ratio is an
Incurrence of Indebtedness, or both, EBITDA and Consolidated
Interest Expense for such period shall be calculated after
giving effect on a pro forma basis to such Indebtedness (but
excluding any Indebtedness Incurred on or after such date of
determination under paragraph (b) of the covenant described
under Limitation on Indebtedness) as if
such Indebtedness had been Incurred on the first day of such
period;
(4) if the Company or any Restricted Subsidiary has repaid,
repurchased, defeased or otherwise discharged any Indebtedness
since the beginning of such period or if any Indebtedness is to
be repaid, repurchased, defeased or otherwise discharged (in
each case other than Indebtedness Incurred under any revolving
credit facility unless such Indebtedness has been permanently
repaid and has not been replaced) on the date of the transaction
giving rise to the need to calculate the Consolidated Coverage
Ratio, EBITDA and Consolidated Interest Expense for such period
shall be calculated on a pro forma basis as if such discharge
had occurred on the first day of such period and as if the
Company or such Restricted Subsidiary had not earned the
interest income actually earned during such period in respect of
cash or Temporary Cash Investments used to repay, repurchase,
defease or otherwise discharge such Indebtedness;
(5) if since the beginning of such period the Company or
any Restricted Subsidiary shall have made any Asset Disposition,
EBITDA for such period shall be reduced by an amount equal to
EBITDA (if positive) directly attributable to the assets which
are the subject of such Asset Disposition for such period, or
increased by an amount equal to EBITDA (if negative), directly
attributable thereto for such period and Consolidated Interest
Expense for such period shall be reduced by an amount equal to
the Consolidated Interest Expense directly attributable to any
Indebtedness of the Company or any Restricted Subsidiary repaid,
repurchased, defeased or otherwise discharged with respect to
the Company and its continuing Restricted Subsidiaries in
connection with such Asset Disposition for such period (or, if
the Capital Stock of any Restricted Subsidiary is sold, the
Consolidated Interest Expense for such period directly
attributable to the Indebtedness of such Restricted Subsidiary
to the extent the Company and its continuing Restricted
Subsidiaries are no longer liable for such Indebtedness after
such sale);
(6) if since the beginning of such period the Company or
any Restricted Subsidiary (by merger or otherwise) shall have
made an Investment in any Restricted Subsidiary (or any Person
which becomes a Restricted Subsidiary) or an acquisition of
assets, including any acquisition of assets occurring in
connection with a transaction requiring a calculation to be made
hereunder, which constitutes all or substantially all of an
operating unit of a business, EBITDA and Consolidated Interest
Expense for such period shall be calculated after giving pro
forma effect thereto (including the Incurrence of any
Indebtedness) as if such Investment or acquisition had occurred
on the first day of such period; and
(7) if since the beginning of such period any Person (that
subsequently became a Restricted Subsidiary or was merged with
or into the Company or any Restricted Subsidiary since the
beginning of
108
such period) shall have made any Asset Disposition, any
Investment or acquisition of assets that would have required an
adjustment pursuant to clause (3) or (4) above if made
by the Company or a Restricted Subsidiary during such period,
EBITDA and Consolidated Interest Expense for such period shall
be calculated after giving pro forma effect thereto as if such
Asset Disposition, Investment or acquisition had occurred on the
first day of such period.
For purposes of this definition, whenever pro forma effect is to
be given to an acquisition of assets, the amount of income or
earnings relating thereto and the amount of Consolidated
Interest Expense associated with any Indebtedness Incurred in
connection therewith, the pro forma calculations shall be
determined in good faith by a responsible financial or
accounting Officer of the Company. If any Indebtedness bears a
floating rate of interest and is being given pro forma effect,
the interest on such Indebtedness shall be calculated as if the
rate in effect on the date of determination had been the
applicable rate for the entire period (taking into account any
Interest Rate Agreement applicable to such Indebtedness if such
Interest Rate Agreement has a remaining term in excess of
12 months). If any Indebtedness is incurred under a
revolving credit facility and is being given pro forma effect,
the interest on such Indebtedness shall be calculated based on
the average daily balance of such Indebtedness for the four
fiscal quarters subject to the pro forma calculation to the
extent that such Indebtedness was incurred solely for working
capital purposes.
Consolidated Current Liabilities as of the
date of determination means the aggregate amount of liabilities
of the Company and its consolidated Restricted Subsidiaries
which may properly be classified as current liabilities
(including taxes accrued as estimated), on a consolidated basis,
after eliminating:
(1) all intercompany items between the Company and any
Restricted Subsidiary; and
(2) all current maturities of long-term Indebtedness, all
as determined in accordance with GAAP consistently applied.
Consolidated Interest Expense means, for any
period, the total interest expense of the Company and its
consolidated Restricted Subsidiaries, plus, to the extent not
included in such total interest expense, and to the extent
incurred by the Company or its Restricted Subsidiaries, without
duplication (but excluding, in each case amortization of
deferred financing fees, any loss on early extinguishment of
Indebtedness and any fees related to a Qualified Receivables
Transaction):
(1) interest expense attributable to Capital Lease
Obligations;
(2) amortization of debt discount;
(3) capitalized interest;
(4) non-cash interest expense (other than imputed interest
as a result of purchase accounting);
(5) commissions, discounts and other fees and charges owed
with respect to letters of credit and bankers acceptance
financing;
(6) net payments pursuant to Hedging Obligations;
(7) dividends paid in respect of all Disqualified Stock of
the Company and all Preferred Stock of any Restricted
Subsidiary, in each case, held by Persons other than the Company
or a Wholly Owned Subsidiary (other than dividends payable
solely in Capital Stock (other than Disqualified Stock) of the
Company);
(8) interest incurred in connection with Investments in
discontinued operations;
(9) interest accruing on any Indebtedness of any other
Person to the extent such Indebtedness is Guaranteed by (or
secured by the assets of) the Company or any Restricted
Subsidiary; and
(10) the cash contributions to any employee stock ownership
plan or similar trust to the extent such contributions are used
by such plan or trust to pay interest or fees to any Person
(other than the Company) in connection with Indebtedness
Incurred by such plan or trust.
109
Consolidated Net Income means, for any
period, the net income of the Company and its consolidated
Subsidiaries; provided, however, that there shall not be
included in such Consolidated Net Income:
(1) any net income of any Person (other than the Company)
if such Person is not a Restricted Subsidiary, except that:
(A) subject to the exclusion contained in clause (4)
below, the Companys equity in the net income of any such
Person for such period shall be included in such Consolidated
Net Income up to the aggregate amount of cash actually
distributed by such Person during such period to the Company or
a Restricted Subsidiary as a dividend or other distribution
(subject, in the case of a dividend or other distribution paid
to a Restricted Subsidiary, to the limitations contained in
clause (3) below); and
(B) the Companys equity in a net loss of any such
Person for such period shall be included in determining such
Consolidated Net Income to the extent actually funded with cash;
(2) any net income (or loss) of any Person acquired by the
Company or a Subsidiary in a pooling of interests transaction
(or any transaction accounted for in a manner similar to a
pooling of interests) for any period prior to the date of such
acquisition;
(3) any net income of any Restricted Subsidiary if such
Restricted Subsidiary is subject to restrictions, directly or
indirectly, on the payment of dividends or the making of
distributions by such Restricted Subsidiary, directly or
indirectly, to the Company, except that:
(A) subject to the exclusion contained in clause (4)
below, the Companys equity in the net income of any such
Restricted Subsidiary for such period shall be included in such
Consolidated Net Income up to the aggregate amount of cash that
could have been distributed by such Restricted Subsidiary during
such period to the Company or another Restricted Subsidiary as a
dividend or other distribution (subject, in the case of a
dividend or other distribution paid to another Restricted
Subsidiary, to the limitation contained in this clause); and
(B) the Companys equity in a net loss of any such
Restricted Subsidiary for such period shall be included in
determining such Consolidated Net Income to the extent actually
funded in cash;
(4) any gain (or loss) realized upon the sale or other
disposition of any assets of the Company, its consolidated
Subsidiaries or any other Person (including pursuant to any
sale-and-leaseback
arrangement) which is not sold or otherwise disposed of in the
ordinary course of business and any gain (or loss) realized upon
the sale or other disposition of any Capital Stock of any Person;
(5) extraordinary, unusual or nonrecurring gains, losses,
costs, charges or expenses (including severance, relocation,
transition and other restructuring costs and litigation
settlements or losses);
(6) the cumulative effect of a change in accounting
principles;
(7) non-cash compensation charges, including any such
charges arising from stock options, restricted stock grants or
other equity-incentive programs;
(8) any net after-tax gains or losses and all fees and
expenses or charges relating thereto attributable to the early
extinguishment of Indebtedness;
(9) the effect of any non-cash items resulting from any
amortization,
write-up,
write-down or write-off of assets (including intangible assets,
goodwill and deferred financing costs in connection with the
Transactions or any future acquisition, disposition, merger,
consolidation or similar transaction or any other non-cash
impairment charges incurred subsequent to the Issue Date
resulting from the application at SFAS Nos. 141, 142 or 144
(excluding any such non-cash item to the extent that it
represents an accrual of or reserve for cash expenditures in any
future period except to the extent such item is subsequently
reversed);
(10) any net gain or loss resulting from Hedging
Obligations (including pursuant to the application of
SFAS No. 133); and
110
(11) any net after-tax income or loss from discontinued
operations and any net after-tax gains or losses on disposal of
discontinued operations;
in each case, for such period. Notwithstanding the foregoing,
for the purposes of the covenant described under Certain
Covenants Limitation on Restricted Payments
only, there shall be excluded from Consolidated Net Income any
repurchases, repayments or redemptions of Investments, proceeds
realized on the sale of Investments or return of capital to the
Company or a Restricted Subsidiary to the extent such
repurchases, repayments, redemptions, proceeds or returns
increase the amount of Restricted Payments permitted under such
covenant pursuant to clause (a)(3)(D) thereof.
Consolidated Tangible Assets as of any date
of determination, means the total amount of assets (less
accumulated depreciation and amortization, allowances for
doubtful receivables, other applicable reserves and other
properly deductible items) which would appear on a consolidated
balance sheet of the Company and its consolidated Restricted
Subsidiaries, determined on a consolidated basis in accordance
with GAAP, and after giving effect to purchase accounting and
after deducting therefrom, to the extent otherwise included, the
amounts of:
(1) minority interests in consolidated Subsidiaries held by
Persons other than the Company or a Restricted Subsidiary;
(2) excess of cost over fair value of assets of businesses
acquired, as determined in good faith by the Board of Directors;
(3) any revaluation or other
write-up in
book value of assets subsequent to the Issue Date as a result of
a change in the method of valuation in accordance with GAAP
consistently applied;
(4) unamortized debt discount and expenses and other
unamortized deferred charges, goodwill, patents, trademarks,
service marks, trade names, copyrights, licenses, organization
or developmental expenses and other intangible items;
(5) treasury stock;
(6) cash set apart and held in a sinking or other analogous
fund established for the purpose of redemption or other
retirement of Capital Stock to the extent such obligation is not
reflected in Consolidated Current Liabilities; and
(7) Investments in and assets of Unrestricted Subsidiaries.
Contingent Obligations means, with respect to
any Person, any obligation of such Person guaranteeing any
leases or other obligations that do not constitute Indebtedness
(primary obligations) of any other Person (the
primary obligor) in any manner, whether directly or
indirectly, including any obligation of such Person, whether or
not contingent, (i) to purchase any such primary obligation
or any property constituting direct or indirect security
therefor, (ii) to advance or supply funds (A) for the
purchase or payment of any such primary obligation or
(B) to maintain working capital or equity capital of the
primary obligor or otherwise to maintain the net worth or
solvency of the primary obligor or (iii) to purchase
property, securities or services primarily for the purpose of
assuring the owner of any such primary obligation of the ability
of the primary obligor to make payment of such primary
obligation against loss in respect thereof.
Credit Agreement means the Credit Agreement
to be entered into by and among, Parent, the Company, certain of
its Subsidiaries identified therein as guarantors, the lenders
from time to time thereto, Credit Suisse, as Administrative
Agent and collateral agent, together with the related documents
thereto (including the term loans and revolving loans
thereunder, any letters of credit and reimbursement obligations
related thereto, any guarantees and security documents), as
amended, extended, renewed, restated, refunded, replaced,
refinanced, supplemented, modified or otherwise changed (in
whole or in part, and without limitation as to amount, terms,
conditions, covenants and other provisions) from time to time,
and any one or more other agreements (and related documents)
governing Indebtedness, including indentures, incurred to
Refinance, substitute, supplement, replace or add to (including
increasing the amount available for borrowing or adding or
removing any Person as a borrower, issuer or guarantor
thereunder), in whole or in part, the borrowings and
111
commitments then outstanding or permitted to be outstanding
under such Credit Agreement or one or more successors to the
Credit Agreement or one or more new credit agreements.
Credit Facilities means one or more debt
facilities (including the Credit Agreement and indentures or
debt securities) or commercial paper facilities, in each case
with banks or other institutional lenders or investors providing
for revolving credit loans, term debt, receivables financing
(including through the sale of receivables to such lenders or to
special purpose entities formed to borrow from such lenders
against such receivables), debt securities or letters of credit,
in each case, as amended, restated, modified, renewed, refunded,
replaced or refinanced in whole or in part from time to time,
including any refunding, replacement or refinancing thereof
through the issuance of debt securities.
Currency Agreement means any foreign exchange
contract, currency swap agreement or other similar agreement
with respect to currency values.
Default means any event which is, or after
notice or passage of time or both would be, an Event of Default.
Designated Noncash Consideration means the
fair market value of noncash consideration received by the
Company or one of its Restricted Subsidiaries in connection with
an Asset Disposition that is designated as Designated Noncash
Consideration pursuant to an Officers Certificate setting
forth the basis of such valuation, less the amount of cash or
cash equivalents received in connection with a subsequent sale,
redemption or payment of, on or with respect to such Designated
Noncash Consideration.
Disqualified Stock means, with respect to any
Person, any Capital Stock which by its terms (or by the terms of
any security into which it is convertible or for which it is
exchangeable at the option of the holder) or upon the happening
of any event:
(1) matures or is mandatorily redeemable (other than
redeemable only for Capital Stock of such Person which is not
itself Disqualified Stock) pursuant to a sinking fund obligation
or otherwise;
(2) is convertible or exchangeable at the option of the
holder for Indebtedness or Disqualified Stock; or
(3) is mandatorily redeemable or must be purchased upon the
occurrence of certain events or otherwise, in whole or in part;
in each case on or prior to the date which is 91 days after
the Stated Maturity of the Notes; provided, however, that any
Capital Stock that would not constitute Disqualified Stock but
for provisions thereof giving holders thereof the right to
require such Person to purchase or redeem such Capital Stock
upon the occurrence of an asset sale or change
of control shall not constitute Disqualified Stock if:
(1) the asset sale or change of
control provisions applicable to such Capital Stock are
not more favorable in terms of price to the holders of such
Capital Stock than the terms applicable to the Notes and
described under Certain Covenants
Limitation on Sales of Assets and Subsidiary Stock and
Certain Covenants Change of
Control; and
(2) any such requirement only becomes operative after
compliance with such terms applicable to the Notes, including
the purchase of any Notes tendered pursuant thereto.
The amount of any Disqualified Stock that does not have a fixed
redemption, repayment or repurchase price will be calculated in
accordance with the terms of such Disqualified Stock as if such
Disqualified Stock were redeemed, repaid or repurchased on any
date on which the amount of such Disqualified Stock is to be
determined pursuant to the Indenture; provided, however, that if
such Disqualified Stock could not be required to be redeemed,
repaid or repurchased at the time of such determination, the
redemption, repayment or repurchase price will be the book value
of such Disqualified Stock as reflected in the most recent
financial statements of such Person.
Domestic Restricted Subsidiary means any
Restricted Subsidiary other than a Foreign Subsidiary.
112
EBITDA for any period means the sum of
Consolidated Net Income, plus the following to the extent
deducted in calculating such Consolidated Net Income:
(1) all income tax expense of the Company and its
consolidated Restricted Subsidiaries;
(2) Consolidated Interest Expense;
(3) depreciation and amortization expense of the Company
and its consolidated Restricted Subsidiaries (excluding
amortization expense attributable to a prepaid item that was
paid in cash in a prior period);
(4) all other non-cash charges of the Company and its
consolidated Restricted Subsidiaries (excluding any such
non-cash charge to the extent that it represents an accrual of
or reserve for cash expenditures in any future period) less all
non-cash items of income of the Company and its consolidated
Restricted Subsidiaries (other than accruals of revenue by the
Company and its consolidated Restricted Subsidiaries in the
ordinary course of business); and
(5) fees related to a Qualified Receivables Transaction;
in each case for such period. Notwithstanding the foregoing, the
provision for taxes based on the income or profits of, and the
depreciation and amortization and non-cash charges of, a
Restricted Subsidiary shall be added to Consolidated Net Income
to compute EBITDA only to the extent (and in the same
proportion, including by reason of minority interests) that the
net income or loss of such Restricted Subsidiary was included in
calculating Consolidated Net Income and only if a corresponding
amount would be permitted at the date of determination to be
dividended to the Company by such Restricted Subsidiary without
prior approval (that has not been obtained), pursuant to the
terms of its charter and all agreements, instruments, judgments,
decrees, orders, statutes, rules and governmental regulations
applicable to such Restricted Subsidiary or its stockholders.
Exchange Act means the U.S. Securities
Exchange Act of 1934, as amended.
Exchange Notes means the debt securities of
the Company issued pursuant to the Indenture in exchange for,
and in an aggregate principal amount equal to, the Notes, in
compliance with the terms of the Registration Rights Agreement.
Foreign Subsidiary means any Restricted
Subsidiary of the Company that is not organized under the laws
of the United States of America or any State thereof or the
District of Columbia or any Subsidiary of such Person.
GAAP means generally accepted accounting
principles in the United States of America as in effect as of
the Issue Date, including those set forth in:
(1) the opinions and pronouncements of the Accounting
Principles Board of the American Institute of Certified Public
Accountants;
(2) statements and pronouncements of the Financial
Accounting Standards Board; and
(3) such other statements by such other entity as approved
by a significant segment of the accounting profession.
Guarantee means any obligation, contingent or
otherwise, of any Person directly or indirectly guaranteeing any
Indebtedness of any Person and any obligation, direct or
indirect, contingent or otherwise, of such Person:
(1) to purchase or pay (or advance or supply funds for the
purchase or payment of) such Indebtedness of such Person
(whether arising by virtue of partnership arrangements, or by
agreements to keep-well, to purchase assets, goods, securities
or services, to take-or-pay or to maintain financial statement
conditions or otherwise); or
(2) entered into for the purpose of assuring in any other
manner the obligee of such Indebtedness of the payment thereof
or to protect such obligee against loss in respect thereof (in
whole or in part);
113
provided, however, that the term Guarantee shall not
include endorsements for collection or deposit in the ordinary
course of business. The term Guarantee used as a
verb has a corresponding meaning.
Guarantor means Parent and each Subsidiary
Guarantor, as applicable.
Guaranty means the Parent Guaranty and each
Subsidiary Guaranty, as applicable.
Guaranty Agreement means a supplemental
indenture, in a form reasonably satisfactory to the Trustee,
pursuant to which a Subsidiary Guarantor or a successor to
Parent guarantees the Companys obligations with respect to
the Notes on the terms provided for in the Indenture.
Hedging Obligations of any Person means the
obligations of such Person pursuant to any Interest Rate
Agreement or Currency Agreement or agreement intended to hedge
against fluctuations in commodity prices.
Holder or Noteholder means
the Person in whose name a Note is registered on the
Registrars books.
Hospital means a hospital, outpatient clinic,
outpatient surgical center, long-term care facility, medical
office building or other facility or business that is used or
useful in or related to the provision of healthcare services.
Hospital Swap means an exchange of assets
and, to the extent necessary to equalize the value of the assets
being exchanged, cash by the Company or a Restricted Subsidiary
for one or more Hospitals
and/or one
or more Related Businesses, or for 100% of the Capital Stock of
any Person owning or operating one or more Hospitals
and/or one
or more Related Businesses; provided that cash does not exceed
30% of the sum of the amount of the cash and the fair market
value of the Capital Stock or assets received or given by the
Company or a Restricted Subsidiary in such transaction.
Notwithstanding the foregoing, the Company and its Restricted
Subsidiaries may consummate two Hospital Swaps in any
12-month
period without regard to the requirements of the proviso in the
previous sentence.
Incur means issue, assume, Guarantee, incur
or otherwise become liable for; provided, however, that any
Indebtedness of a Person existing at the time such Person
becomes a Restricted Subsidiary (whether by merger,
consolidation, acquisition or otherwise) shall be deemed to be
Incurred by such Person at the time it becomes a Restricted
Subsidiary. The term Incurrence when used as a noun
shall have a correlative meaning. Solely for purposes of
determining compliance with Certain
Covenants Limitation on Indebtedness and
Certain Covenants Limitation on
Liens:
(1) amortization of debt discount or the accretion of
principal with respect to a non-interest bearing or other
discount security;
(2) the payment of regularly scheduled interest in the form
of additional Indebtedness of the same instrument or the payment
of regularly scheduled dividends on Capital Stock in the form of
additional Capital Stock of the same class and with the same
terms; and
(3) the obligation to pay a premium in respect of
Indebtedness arising in connection with the issuance of a notice
of redemption or the making of a mandatory offer to purchase
such Indebtedness will not be deemed to be the Incurrence of
Indebtedness or Liens.
Indebtedness means, with respect to any
Person on any date of determination (without duplication):
(1) the principal in respect of (A) indebtedness of
such Person for money borrowed and (B) indebtedness
evidenced by notes, debentures, bonds or other similar
instruments for the payment of which such Person is responsible
or liable;
(2) all Capital Lease Obligations of such Person and all
Attributable Debt in respect of Sale/Leaseback Transactions
entered into by such Person;
(3) all obligations of such Person issued or assumed as the
deferred purchase price of property, all conditional sale
obligations of such Person and all obligations of such Person
under any title retention
114
agreement (but excluding any accounts payable or other liability
to trade creditors arising in the ordinary course of business);
(4) all obligations of such Person for the reimbursement of
any obligor on any letter of credit, bankers acceptance or
similar credit transaction (other than obligations with respect
to letters of credit securing obligations (other than
obligations described in clauses (1) through
(3) above) entered into in the ordinary course of business
of such Person to the extent such letters of credit are not
drawn upon or, if and to the extent drawn upon, such drawing is
reimbursed no later than the tenth Business Day following
payment on the letter of credit);
(5) the amount of all obligations of such Person with
respect to the redemption, repayment or other repurchase of any
Disqualified Stock of such Person or, with respect to any
Preferred Stock of any Subsidiary of such Person, the principal
amount of such Preferred Stock to be determined in accordance
with the Indenture (but excluding, in each case, any accrued
dividends);
(6) all obligations of the type referred to in
clauses (1) through (5) of other Persons and all
dividends of other Persons for the payment of which, in either
case, such Person is responsible or liable, directly or
indirectly, as obligor, guarantor or otherwise, including by
means of any Guarantee;
(7) all obligations of the type referred to in
clauses (1) through (6) of other Persons secured by
any Lien on any property or asset of such Person (whether or not
such obligation is assumed by such Person), the amount of such
obligation being deemed to be the lesser of the fair market
value of such property or assets and the amount of the
obligation so secured; and
(8) to the extent not otherwise included in this
definition, Hedging Obligations of such Person.
Notwithstanding the foregoing, (A) in connection with the
purchase by the Company or any Restricted Subsidiary of any
business, the term Indebtedness will exclude
post-closing payment adjustments to which the seller may become
entitled to the extent such payment is determined by a final
closing balance sheet or such payment depends on the performance
of such business after the closing; provided, however, that, at
the time of closing, the amount of any such payment is not
determinable and, to the extent such payment thereafter becomes
fixed and determined, the amount is paid within 30 days
thereafter and (B) the term Indebtedness will
exclude Contingent Obligations Incurred in the ordinary course
of business and not in respect of Indebtedness.
The amount of Indebtedness of any Person at any date shall be
the outstanding balance at such date of all unconditional
obligations as described above; provided, however, that in the
case of Indebtedness sold at a discount, the amount of such
Indebtedness at any time will be the accreted value thereof at
such time.
Independent Qualified Party means an
investment banking firm, accounting firm or appraisal firm of
national standing; provided, however, that such firm is not an
Affiliate of the Company.
Interest Rate Agreement means any interest
rate swap agreement, interest rate cap agreement or other
financial agreement or arrangement with respect to exposure to
interest rates.
Investment in any Person means any direct or
indirect advance, loan (other than advances to customers in the
ordinary course of business that are recorded as accounts
receivable on the balance sheet of the lender) or other
extensions of credit (including by way of Guarantee or similar
arrangement) or capital contribution to (by means of any
transfer of cash or other property to others or any payment for
property or services for the account or use of others), or any
purchase or acquisition of Capital Stock, Indebtedness or other
similar instruments issued by such Person, in each case by any
other Person. If the Company or any Restricted Subsidiary
issues, sells or otherwise disposes of any Capital Stock of a
Person that is a Restricted Subsidiary such that, after giving
effect thereto, such Person is no longer a Restricted
Subsidiary, any Investment by the Company or any Restricted
Subsidiary in such Person remaining after giving effect thereto
will be deemed to be a new Investment at such time. The
acquisition by the Company or any Restricted Subsidiary of a
Person that holds an Investment in a third Person will be deemed
to be an Investment by the Company or such Restricted Subsidiary
in such third Person at such time. Except as otherwise provided
for herein, the amount
115
of an Investment shall be its fair market value at the time the
Investment is made and without giving effect to subsequent
changes in value.
For purposes of the definition of Unrestricted
Subsidiary, the definition of Restricted
Payment and the covenant described under
Certain Covenants Limitation on
Restricted Payments:
(1) Investment shall include the portion
(proportionate to the Companys equity interest in such
Subsidiary) of the fair market value of the net assets of any
Subsidiary of the Company at the time that such Subsidiary is
designated an Unrestricted Subsidiary; provided, however, that
upon a redesignation of such Subsidiary as a Restricted
Subsidiary, the Company shall be deemed to continue to have a
permanent Investment in an Unrestricted Subsidiary
equal to an amount (if positive) equal to (A) the
Companys Investment in such Subsidiary at the
time of such redesignation less (B) the portion
(proportionate to the Companys equity interest in such
Subsidiary) of the fair market value of the net assets of such
Subsidiary at the time of such redesignation; and
(2) any property transferred to or from an Unrestricted
Subsidiary shall be valued at its fair market value at the time
of such transfer, in each case as determined in good faith by
the Board of Directors.
Issue Date means the date on which the Notes
are originally issued.
Legal Holiday means a Saturday, a Sunday or a
day on which banking institutions are not required to be open in
the State of New York.
Lien means any mortgage, pledge, security
interest, encumbrance, lien or charge of any kind (including any
conditional sale or other title retention agreement or lease in
the nature thereof).
Net Available Cash from an Asset Disposition
means cash payments received therefrom (including any cash
payments received by way of deferred payment of principal
pursuant to a note or installment receivable or otherwise and
proceeds from the sale or other disposition of any securities
received as consideration, but only as and when received, but
excluding any other consideration received in the form of
assumption by the acquiring Person of Indebtedness or other
obligations relating to such properties or assets or received in
any other non-cash form), in each case net of:
(1) all legal, title and recording tax expenses,
commissions and other fees and expenses incurred, and all
Federal, state, provincial, foreign and local taxes required to
be accrued as a liability under GAAP, as a consequence of such
Asset Disposition;
(2) all payments made on any Indebtedness which is secured
by any assets subject to such Asset Disposition, in accordance
with the terms of any Lien upon or other security agreement of
any kind with respect to such assets, or which must by its
terms, or in order to obtain a necessary consent to such Asset
Disposition, or by applicable law, be repaid out of the proceeds
from such Asset Disposition;
(3) all distributions and other payments required to be
made to minority interest holders in Restricted Subsidiaries as
a result of such Asset Disposition;
(4) the deduction of appropriate amounts provided by the
seller as a reserve, in accordance with GAAP, against any
liabilities associated with the property or other assets
disposed in such Asset Disposition and retained by the Company
or any Restricted Subsidiary after such Asset
Disposition; and
(5) any portion of the purchase price from an Asset
Disposition placed in escrow, whether as a reserve for
adjustment of the purchase price, for satisfaction of
indemnities in respect of such Asset Disposition or otherwise in
connection with that Asset Disposition; provided, however, that
upon the termination of that escrow, Net Available Cash will be
increased by any portion of funds in the escrow that are
released to the Company or any Restricted Subsidiary.
Net Cash Proceeds, with respect to any
issuance or sale of Capital Stock or Indebtedness, means the
cash proceeds of such issuance or sale net of attorneys
fees, accountants fees, underwriters or placement
agents fees, discounts or commissions and brokerage,
consultant and other fees actually incurred in connection with
such issuance or sale and net of taxes paid or payable as a
result thereof.
116
Non-Recourse Indebtedness of a Person means
Indebtedness:
(1) as to which neither the Company nor any Subsidiary
Guarantor:
(A) provides credit support of any kind (including any
undertaking, agreement or instrument that would constitute
Indebtedness);
(B) is directly or indirectly liable as a guarantor or
otherwise; or
(C) constitutes the lender; and
(2) no default with respect to which would permit upon
notice, lapse of time or both any holder of any other
Indebtedness of the Company or any Subsidiary Guarantor to
declare a default on such other Indebtedness or cause the
payment thereof to be accelerated or payable prior to its stated
maturity.
Obligations means, with respect to any
Indebtedness, all obligations for principal, premium, interest,
penalties, fees, indemnifications, reimbursements and other
amounts payable pursuant to the documentation governing such
Indebtedness.
Officer means the Chairman of the Board, the
President, any Vice President, the Treasurer or the Secretary of
the Company.
Officers Certificate means a
certificate signed by two Officers.
Opinion of Counsel means a written opinion
from legal counsel who is acceptable to the Trustee. The counsel
may be an employee of or counsel to the Company or the Trustee.
Parent means Community Health Systems, Inc.,
a Delaware corporation, and its successors or any other direct
or indirect parent of the Company.
Parent Board means the Board of Directors of
Parent or any committee thereof duly authorized to act on behalf
of such Board.
Parent Guaranty means the Guarantee by Parent
of the Companys obligations with respect to the Notes.
Permitted Investment means an Investment by
the Company or any Restricted Subsidiary in:
(1) the Company, a Restricted Subsidiary or a Person that
will, upon the making of such Investment, become a Restricted
Subsidiary;
(2) another Person if, as a result of such Investment, such
other Person is merged or consolidated with or into, or
transfers or conveys all or substantially all its assets to, the
Company or a Restricted Subsidiary;
(3) cash and Temporary Cash Investments;
(4) receivables owing to the Company or any Restricted
Subsidiary if created or acquired in the ordinary course of
business and payable or dischargeable in accordance with
customary trade terms; provided, however, that such trade terms
may include such concessionary trade terms as the Company or any
such Restricted Subsidiary deems reasonable under the
circumstances;
(5) payroll, travel and similar advances to cover matters
that are expected at the time of such advances ultimately to be
treated as expenses for accounting purposes and that are made in
the ordinary course of business;
(6) loans or advances to employees made in the ordinary
course of business consistent with past practices of the Company
or such Restricted Subsidiary, but in any event not to exceed
$25 million in the aggregate outstanding at any one time;
(7) stock, obligations or securities received in settlement
of debts created in the ordinary course of business and owing to
the Company or any Restricted Subsidiary or in satisfaction of
judgments;
117
(8) any Person to the extent such Investment represents the
non-cash portion of the consideration received for (i) an
Asset Disposition as permitted pursuant to the covenant
described under Certain Covenants
Limitation on Sales of Assets and Subsidiary Stock or
(ii) a disposition of assets not constituting an Asset
Disposition;
(9) any Person where such Investment was acquired by the
Company or any of its Restricted Subsidiaries (a) in
exchange for any other Investment or accounts receivable held by
the Company or any such Restricted Subsidiary in connection with
or as a result of a bankruptcy, workout, reorganization or
recapitalization of the issuer of such other Investment or
accounts receivable or (b) as a result of a foreclosure by
the Company or any of its Restricted Subsidiaries with respect
to any secured Investment or other transfer of title with
respect to any secured Investment in default;
(10) any Person to the extent such Investments consist of
prepaid expenses, negotiable instruments held for collection and
lease, utility and workers compensation, performance and
other similar deposits made in the ordinary course of business
by the Company or any Restricted Subsidiary;
(11) any Person to the extent such Investments consist of
Hedging Obligations otherwise permitted under the covenant
described under Certain Covenants
Limitation on Indebtedness;
(12) any Person to the extent such Investment exists on the
Issue Date, and any extension, modification or renewal of any
such Investments existing on the Issue Date, but only to the
extent not involving additional advances, contributions or other
Investments of cash or other assets or other increases thereof
(other than as a result of the accrual or accretion of interest
or original issue discount or the issuance of
pay-in-kind
securities, in each case, pursuant to the terms of such
Investment as in effect on the Issue Date);
(13) (a) any Investment in any captive insurance
subsidiary in existence on the Issue Date or (b) in event
the Company or a Restricted Subsidiary shall establish a
Subsidiary for the purpose of insuring the healthcare business
or facilities owned or operated by the Company, any Subsidiary
or any physician employed by or on the medical staff of any such
business or facility (the Insurance Subsidiary),
Investments in an amount that do not exceed 125% of the minimum
amount of capital required under the laws of the jurisdiction in
which the Insurance Subsidiary is formed (other than any excess
capital that would result in any unfavorable tax or
reimbursement impact if distributed), and any Investment by such
Insurance Subsidiary that is a legal investment for an insurance
company under the laws of the jurisdiction in which the
Insurance Subsidiary is formed and made in the ordinary course
of business and rated in one of the four highest rating
categories;
(14) Physician Support Obligations incurred by the Company
or any Restricted Subsidiary;
(15) Investments made in connection with Hospital Swaps;
(16) any Investment by the Company or a Restricted
Subsidiary in a Receivables Subsidiary, or any Investment by a
Receivables Subsidiary in another Person, in each case in
connection with a Qualified Receivables Transaction;
(17) Investments the payment for which consists of Capital
Stock of the Company or Parent (other than Disqualified Stock);
(18) the Incurrence of Guarantees of Indebtedness not
prohibited by the covenant described under
Limitation on Indebtedness and
performance guarantees;
(19) Investments consisting of earnest money deposits
required in connection a purchase agreement or other
acquisition; and
(20) Persons to the extent such Investments, when taken
together with all other Investments made pursuant to this
clause (20) and outstanding on the date such Investment is
made, do not exceed 5% of the Total Assets (with the fair market
value of each Investment being measured at the time made and
without giving effect to subsequent changes in value); provided,
however, that if such Investment is in Capital Stock of a Person
that subsequently becomes a Restricted Subsidiary, such
Investment shall
118
thereafter be deemed permitted under clause (1) above and
shall not be included as having been made pursuant to this
clause (20).
Permitted Liens means, with respect to any
Person:
(1) pledges or deposits by such Person under workers
compensation laws, unemployment insurance laws or similar
legislation, or good faith deposits in connection with bids,
tenders, contracts (other than for the payment of Indebtedness)
or leases to which such Person is a party, or deposits to secure
public or statutory obligations of such Person or deposits of
cash or United States government bonds to secure surety or
appeal bonds to which such Person is a party, or deposits as
security for contested taxes or import duties or for the payment
of rent, in each case Incurred in the ordinary course of
business;
(2) Liens imposed by law, such as carriers,
warehousemens and mechanics Liens, in each case for
sums not yet due or being contested in good faith by appropriate
proceedings or other Liens arising out of judgments or awards
against such Person with respect to which such Person shall then
be proceeding with an appeal or other proceedings for review and
Liens arising solely by virtue of any statutory or common law
provision relating to bankers Liens, rights of set-off or
similar rights and remedies as to deposit accounts or other
funds maintained with a creditor depository institution;
provided, however, that (A) such deposit account is not a
dedicated cash collateral account and is not subject to
restrictions against access by the Company in excess of those
set forth by regulations promulgated by the Federal Reserve
Board and (B) such deposit account is not intended by the
Company or any Restricted Subsidiary to provide collateral to
the depository institution;
(3) Liens for property taxes not yet subject to penalties
for non-payment or which are being contested in good faith by
appropriate proceedings;
(4) Liens in favor of issuers of surety bonds or letters of
credit issued pursuant to the request of and for the account of
such Person in the ordinary course of its business; provided,
however, that such letters of credit do not constitute
Indebtedness;
(5) minor survey exceptions, minor encumbrances, easements
or reservations of, or rights of others for, licenses,
rights-of-way, sewers, electric lines, telegraph and telephone
lines and other similar purposes, or zoning or other
restrictions as to the use of real property or Liens incidental
to the conduct of the business of such Person or to the
ownership of its properties which were not Incurred in
connection with Indebtedness and which do not in the aggregate
materially adversely affect the value of said properties or
materially impair their use in the operation of the business of
such Person;
(6) Liens securing Indebtedness Incurred to finance the
construction, purchase or lease of, or repairs, improvements or
additions to, property, plant or equipment of such Person;
provided, however, that the Lien may not extend to any other
property owned by such Person or any of its Restricted
Subsidiaries at the time the Lien is Incurred (other than assets
and property affixed or appurtenant thereto), and the
Indebtedness (other than any interest thereon) secured by the
Lien may not be Incurred more than 180 days after the later
of the acquisition, completion of construction, repair,
improvement, addition or commencement of full operation of the
property subject to the Lien;
(7) Liens to secure Indebtedness permitted under the
provisions described in clause (b)(1) and (b)(16) under
Certain Covenants Limitation on
Indebtedness;
(8) Liens existing on the Issue Date;
(9) Liens on property or shares of Capital Stock of another
Person at the time such other Person becomes a Subsidiary of
such Person; provided, however, that the Liens may not extend to
any other property owned by such Person or any of its Restricted
Subsidiaries (other than assets and property affixed or
appurtenant thereto);
(10) Liens on property at the time such Person or any of
its Subsidiaries acquires the property, including any
acquisition by means of a merger or consolidation with or into
such Person or a Subsidiary of such Person; provided, however,
that the Liens may not extend to any other property owned by
such
119
Person or any of its Restricted Subsidiaries (other than assets
and property affixed or appurtenant thereto);
(11) Liens securing Indebtedness or other obligations of a
Subsidiary of such Person owing to such Person or a Restricted
Subsidiary of such Person;
(12) Liens securing Hedging Obligations so long as such
Hedging Obligations are permitted to be Incurred under the
Indenture;
(13) Liens to secure any Refinancing (or successive
Refinancings) as a whole, or in part, of any Indebtedness
secured by any Lien referred to in the foregoing clause (6),
(8), (9), (10) or (15); provided, however, that:
(A) such new Lien shall be limited to all or part of the
same property and assets that secured or, under the written
agreements pursuant to which the original Lien arose, could
secure the original Lien (plus improvements and accessions to,
such property or proceeds or distributions thereof); and
(B) the Indebtedness secured by such Lien at such time is
not increased to any amount greater than the sum of (x) the
outstanding principal amount or, if greater, committed amount of
the Indebtedness described under clause (6), (8), (9),
(10) or (15) at the time the original Lien became a
Permitted Lien and (y) an amount necessary to pay any fees
and expenses, including premiums, related to such refinancing,
refunding, extension, renewal or replacement;
(14) Liens on accounts receivable and related assets of the
type specified in the definition of Qualified Receivables
Transaction Incurred in connection with a Qualified
Receivables Transaction; and
(15) Liens Incurred to secure Obligations in respect of any
Indebtedness permitted to be incurred pursuant to the covenant
described under Certain Covenants
Limitation on Indebtedness; provided, however, that at the
time of Incurrence and after giving pro forma effect thereto,
the ratio of (x) the aggregate amount of Secured
Indebtedness as of such date of determination to (y) EBITDA
(determined on a pro forma basis consistent with the calculation
of Consolidated Coverage Ratio) for the most recent four
consecutive fiscal quarters for which internal financial
statements are available would be less than 4.0 to 1.0.
Notwithstanding the foregoing, Permitted Liens will
not include any Lien described in clause (9) or
(10) above to the extent such Lien applies to any
Additional Assets acquired directly or indirectly from Net
Available Cash pursuant to the covenant described under
Certain Covenants Limitation on
Sale of Assets and Subsidiary Stock. For purposes of this
definition, the term Indebtedness shall be deemed to
include interest on such Indebtedness. For purposes of this
definition, the term Indebtedness shall be deemed to
include interest on such Indebtedness.
Person means any individual, corporation,
partnership, limited liability company, joint venture,
association, joint-stock company, trust, unincorporated
organization, government or any agency or political subdivision
thereof or any other entity.
Physician Support Obligation means:
(1) a loan to or on behalf of, or a Guarantee of
Indebtedness of or income of, a physician or healthcare
professional providing service to patients in the service area
of a Hospital operated by the Company or any of its Restricted
Subsidiaries made or given by the Company or any Subsidiary of
the Company:
(A) in the ordinary course of its business; and
(B) pursuant to a written agreement having a period not to
exceed five years; or
(2) Guarantees by the Company or any Restricted Subsidiary
of leases and loans to acquire property (real or personal) for
or on behalf of a physician or healthcare professional providing
service to patients in the service area of a Hospital operated
by the Company or any of its Restricted Subsidiaries.
120
Preferred Stock, as applied to the Capital
Stock of any Person, means Capital Stock of any class or classes
(however designated) which is preferred as to the payment of
dividends or distributions, or as to the distribution of assets
upon any voluntary or involuntary liquidation or dissolution of
such Person, over shares of Capital Stock of any other class of
such Person.
principal of a Note means the principal of
the Note plus the premium, if any, payable on the Note which is
due or overdue or is to become due at the relevant time.
Public Equity Offering means an underwritten
primary public offering of common stock of Parent or the Company
for cash pursuant to an effective registration statement under
the Securities Act.
Purchase Money Indebtedness means
Indebtedness (including Capital Lease Obligations) Incurred to
finance the acquisition by the Company or a Restricted
Subsidiary of equipment or property that is used or useful in a
Related Business (whether through the direct purchase of such
asset or the purchase of Capital Stock of any Person owning such
asset), including additions and improvements; provided, however,
that any Lien arising in connection with any such Indebtedness
shall be limited to the specific asset being financed or, in the
case of real property or fixtures, including additions and
improvements, the real property on which such asset is attached;
provided further, however, that such Indebtedness is Incurred
within 180 days after such acquisition of such assets.
Qualified Receivables Transaction means any
transaction or series of transactions that may be entered into
by the Company or any Restricted Subsidiary pursuant to which
the Company or any Restricted Subsidiary may sell, convey or
otherwise transfer pursuant to customary terms to (1) a
Receivables Subsidiary (in the case of a transfer by the Company
or any Restricted Subsidiary) and (2) any other Person (in
the case of a transfer by a Receivables Subsidiary), or grants a
security interest in, any accounts receivable (whether now
existing or arising in the future) of the Company or any of its
Restricted Subsidiaries, and any assets related thereto,
including all collateral securing such accounts receivable, all
contracts and all guarantees or other obligations in respect of
such accounts receivable, proceeds of such accounts receivable
and other assets that are customarily transferred or in respect
of which security interests are customarily granted in
connection with asset securitization transactions involving
accounts receivable.
Rating Agency means Standard &
Poors, a division of the McGraw-Hill Companies, Inc. and
Moodys Investors Service, Inc. or if Standard &
Poors, a division of the McGraw-Hill Companies, Inc., or
Moodys Investors Service, Inc. or both shall not make a
rating on the Notes publicly available, a nationally recognized
statistical rating agency or agencies, as the case may be,
selected by the Company (as certified by a resolution of the
Board of Directors) which shall be substituted for
Standard & Poors, a division of the McGraw-Hill
Companies, Inc., or Moodys Investors Service, Inc. or
both, as the case may be.
Receivables Subsidiary means a Wholly Owned
Subsidiary of the Company that engages in no activities other
than in connection with the financing of accounts receivable and
that is designated by the Board of Directors (as provided below)
as a Receivables Subsidiary (a) no portion of the
Indebtedness or any other Obligations (contingent or otherwise)
of which (i) is Guaranteed by the Company or any of its
Restricted Subsidiaries, other than contingent liabilities
pursuant to Standard Securitization Undertakings, (ii) is
recourse to or obligates the Company or any of its Restricted
Subsidiaries in any way other than pursuant to Standard
Securitization Undertakings or (iii) subjects any property
or asset of the Company or any of its Restricted Subsidiaries,
directly or indirectly, contingently or otherwise, to the
satisfaction thereof, other than pursuant to Standard
Securitization Undertakings, (b) with which neither the
Company nor any of its Restricted Subsidiaries has any contract,
agreement, arrangement or understanding other than on terms no
less favorable to the Company or such Restricted Subsidiary than
those that might be obtained at the time from Persons who are
not Affiliates of the Company, other than fees payable in the
ordinary course of business in connection with servicing
accounts receivable of such entity and (c) to which neither
the Company nor any of its Restricted Subsidiaries has any
obligation to maintain or preserve such Receivables
Subsidiarys financial condition or cause such Receivables
Subsidiary to achieve certain levels of operating results. Any
such designation by the Board of Directors will be evidenced to
the Trustee by filing with the Trustee a certified copy of the
resolution of the Board of Directors giving effect to such
designation and an Officers Certificate certifying that
such designation complied with the foregoing conditions.
121
Refinance means, in respect of any
Indebtedness, to refinance, extend, renew, refund, repay,
prepay, purchase, redeem, defease or retire, or to issue other
Indebtedness in exchange or replacement for, such Indebtedness.
Refinanced and Refinancing shall have
correlative meanings.
Refinancing Indebtedness means Indebtedness
that Refinances any Indebtedness of the Company or any
Restricted Subsidiary existing on the Issue Date or Incurred in
compliance with the Indenture, including Indebtedness that
Refinances Refinancing Indebtedness; provided, however, that:
(1) such Refinancing Indebtedness has a Stated Maturity no
earlier than the earlier of (A) the Stated Maturity of the
Indebtedness being Refinanced and (B) the 91st day
after the Stated Maturity of any Notes then outstanding;
(2) such Refinancing Indebtedness has an Average Life at
the time such Refinancing Indebtedness is Incurred that is equal
to or greater than the greater of (A) the Average Life of
the Indebtedness being Refinanced and (B) the Average Life
of any Notes then outstanding;
(3) such Refinancing Indebtedness has an aggregate
principal amount (or if Incurred with original issue discount,
an aggregate issue price) that is equal to or less than the
aggregate principal amount (or if Incurred with original issue
discount, the aggregate accreted value) then outstanding (plus
fees and expenses, including any premium and defeasance costs)
under the Indebtedness being Refinanced; and
(4) if the Indebtedness being Refinanced is subordinated in
right of payment to the Notes or a Subsidiary Guarantee, such
Refinancing Indebtedness is subordinated in right of payment to
the Notes at least to the same extent as the Indebtedness being
Refinanced;
provided further, however, that Refinancing Indebtedness shall
not include (A) Indebtedness of a Subsidiary (other than a
Subsidiary Guarantor) that Refinances Indebtedness of the
Company or (B) Indebtedness of the Company or a Restricted
Subsidiary that Refinances Indebtedness of an Unrestricted
Subsidiary.
Registration Rights Agreement means the
Registration Rights Agreement dated the Issue Date, among the
Company, the Guarantors and the Initial Purchasers.
Related Business means a business affiliated
or associated with a Hospital or any business related or
ancillary to the provision of healthcare services or information
or the investment in, or the management, leasing or operation
of, any of the foregoing.
Restricted Payment with respect to any Person
means:
(1) the declaration or payment of any dividends or any
other distributions of any sort in respect of its Capital Stock
(including any payment in connection with any merger or
consolidation involving such Person) or similar payment to the
direct or indirect holders of its Capital Stock in their
capacity as such (other than (A) dividends or distributions
payable solely in its Capital Stock (other than Disqualified
Stock), (B) dividends or distributions payable solely to
the Company or a Restricted Subsidiary and (C) pro rata
dividends or other distributions made by a Subsidiary that is
not a Wholly Owned Subsidiary to minority stockholders (or
owners of an equivalent interest in the case of a Subsidiary
that is an entity other than a corporation));
(2) the purchase, repurchase, redemption, defeasance or
other acquisition or retirement for value of any Capital Stock
of the Company held by any Person (other than by a Restricted
Subsidiary), including in connection with any merger or
consolidation and including the exercise of any option to
exchange any Capital Stock (other than into Capital Stock of the
Company that is not Disqualified Stock);
(3) the purchase, repurchase, redemption, defeasance or
other acquisition or retirement for value, prior to scheduled
maturity, scheduled repayment or scheduled sinking fund payment
of any Subordinated Obligations of the Company or any Subsidiary
Guarantor (other than (A) from the Company or a Restricted
Subsidiary or (B) the purchase, repurchase, redemption,
defeasance or other acquisition or retirement of Subordinated
Obligations purchased in anticipation of satisfying a sinking
fund obligation, principal installment or final maturity, in
each case due within one year of the date of such purchase,
repurchase, redemption, defeasance or other acquisition or
retirement); or
122
(4) the making of any Investment (other than a Permitted
Investment) in any Person.
Restricted Subsidiary means any Subsidiary of
the Company that is not an Unrestricted Subsidiary.
Sale/Leaseback Transaction means an
arrangement relating to property owned by the Company or a
Restricted Subsidiary on the Issue Date or thereafter acquired
by the Company or a Restricted Subsidiary whereby the Company or
a Restricted Subsidiary transfers such property to a Person and
the Company or a Restricted Subsidiary leases it from such
Person.
SEC means the Securities and Exchange
Commission.
Secured Indebtedness means any Indebtedness
of the Company and its Restricted Subsidiaries secured by a Lien.
Securities Act means the U.S. Securities
Act of 1933, as amended.
Senior Indebtedness means with respect to any
Person:
(1) Indebtedness of such Person, whether outstanding on the
Issue Date or thereafter Incurred; and
(2) all other Obligations of such Person (including
interest accruing on or after the filing of any petition in
bankruptcy or for reorganization relating to such Person whether
or not post-filing interest is allowed in such proceeding) in
respect of Indebtedness described in clause (1) above
unless, in the case of clauses (1) and (2), in the
instrument creating or evidencing the same or pursuant to which
the same is outstanding, it is provided that such Indebtedness
or other Obligations are subordinate in right of payment to the
Notes or the Subsidiary Guaranty of such Person, as the case may
be; provided, however, that Senior Indebtedness shall not
include:
(1) any obligation of such Person to the Company or any
Subsidiary of the Company;
(2) any liability for Federal, state, local or other taxes
owed or owing by such Person;
(3) any accounts payable or other liability to trade
creditors arising in the ordinary course of business;
(4) any Indebtedness or other Obligation of such Person
which is subordinate or junior in any respect to any other
Indebtedness or other Obligation of such Person; or
(5) that portion of any Indebtedness which at the time of
Incurrence is Incurred in violation of the Indenture.
Significant Subsidiary means any Restricted
Subsidiary that would be a Significant Subsidiary of
the Company within the meaning of
Rule 1-02
under
Regulation S-X
promulgated by the SEC.
Standard Securitization Undertakings means
all representations, warranties, covenants and indemnities
entered into by the Company or any Restricted Subsidiary which
are customary in securitization transactions involving accounts
receivable in connection with any servicing obligation assumed
by the Company or any Restricted Subsidiary in respect of such
accounts receivable.
Stated Maturity means, with respect to any
security, the date specified in such security as the fixed date
on which the final payment of principal of such security is due
and payable, including pursuant to any mandatory redemption
provision (but excluding any provision providing for the
repurchase of such security at the option of the holder thereof
upon the happening of any contingency unless such contingency
has occurred).
Subordinated Obligation means, with respect
to a Person, any Indebtedness of such Person (whether
outstanding on the Issue Date or thereafter Incurred) which is
subordinate or junior in right of payment to the Notes or a
Subsidiary Guaranty of such Person, as the case may be, pursuant
to a written agreement to that effect.
123
Subsidiary means, with respect to any Person,
any corporation, association, partnership or other business
entity of which more than 50% of the total voting power of
shares of Voting Stock is at the time owned or controlled,
directly or indirectly, by:
(1) such Person;
(2) such Person and one or more Subsidiaries of such
Person; or
(3) one or more Subsidiaries of such Person.
Subsidiary Guarantor means each Subsidiary of
the Company that executes the Indenture as a guarantor on the
Issue Date and each other Subsidiary of the Company that
thereafter guarantees the Notes pursuant to the terms of the
Indenture.
Subsidiary Guaranty means a Guarantee by a
Subsidiary Guarantor of the Companys obligations with
respect to the Notes.
Temporary Cash Investments means any of the
following:
(1) any investment in direct obligations of the United
States of America or any agency thereof or obligations
guaranteed by the United States of America or any agency thereof;
(2) investments in demand and time deposit accounts,
certificates of deposit and money market deposits maturing
within one year of the date of acquisition thereof issued by a
bank or trust company which is organized under the laws of the
United States of America, any State thereof or any foreign
country recognized by the United States of America, and which
bank or trust company has capital, surplus and undivided profits
aggregating in excess of $50.0 million (or the foreign
currency equivalent thereof) and has outstanding debt which is
rated A (or such similar equivalent rating) or
higher by at least one nationally recognized statistical rating
organization (as defined in Rule 436 under the Securities
Act) or any money-market fund sponsored by a registered broker
dealer or mutual fund distributor;
(3) repurchase obligations with a term of not more than
30 days for underlying securities of the types described in
clause (1) above entered into with a bank meeting the
qualifications described in clause (2) above;
(4) investments in commercial paper, maturing not more than
one year after the date of acquisition, issued by a corporation
(other than an Affiliate of the Company) organized and in
existence under the laws of the United States of America or any
foreign country recognized by the United States of America with
a rating at the time as of which any investment therein is made
of
P-1
(or higher) according to Moodys Investors Service, Inc. or
A-1
(or higher) according to Standard and Poors Ratings Group;
(5) investments in securities with maturities of one year
or less from the date of acquisition issued or fully guaranteed
by any state, commonwealth or territory of the United States of
America, or by any political subdivision or taxing authority
thereof, and rated at least A by
Standard & Poors Ratings Group or A
by Moodys Investors Service, Inc.; and
(6) investments in money market funds that invest
substantially all their assets in securities of the types
described in clauses (1) through (5) above.
Total Assets means, as of any date of
determination, after giving pro forma effect to any acquisition
of assets on such date, the sum of the amounts that would appear
on the consolidated balance sheet of the Company and its
Restricted Subsidiaries as the total assets of the Company and
its Restricted Subsidiaries.
Treasury Rate means, as of the applicable
redemption date, the yield to maturity as of such redemption
date of United States Treasury securities with a constant
maturity (as compiled and published in the most recent Federal
Reserve Statistical Release H.15 (519) that has become
publicly available at least two business days prior to such
redemption date (or, if such Statistical Release is no longer
published, any publicly available source of similar market
data)) most nearly equal to the period from such redemption date
to July 15, 2011; provided, however, that if the period
from such redemption date to July 15, 2011 is less than one
year,
124
the weekly average yield on actually traded United States
Treasury securities adjusted to a constant maturity of one year
will be used.
Trustee means U.S. Bank National
Association until a successor replaces it and, thereafter, means
the successor.
Trust Indenture Act means the
Trust Indenture Act of 1939 (15 U.S.C.
§§ 77aaa-77bbbb)
as in effect on the Issue Date.
Trust Officer means the Chairman of the
Board, the President or any other officer or assistant officer
of the Trustee assigned by the Trustee to administer its
corporate trust matters.
Unrestricted Subsidiary means:
(1) any Subsidiary of the Company that at the time of
determination shall be designated an Unrestricted Subsidiary by
the Board of Directors in the manner provided below; and
(2) any Subsidiary of an Unrestricted Subsidiary.
The Board of Directors may designate any Subsidiary of the
Company (including any newly acquired or newly formed
Subsidiary) to be an Unrestricted Subsidiary unless such
Subsidiary or any of its Subsidiaries owns any Capital Stock or
Indebtedness of, or holds any Lien on any property of, the
Company or any other Subsidiary of the Company that is not a
Subsidiary of the Subsidiary to be so designated; provided,
however, that either (A) the Subsidiary to be so designated
has total assets of $1,000 or less or (B) if such
Subsidiary has assets greater than $1,000, such designation
would be permitted under the covenant described under
Certain Covenants Limitation on
Restricted Payments.
The Board of Directors may designate any Unrestricted Subsidiary
to be a Restricted Subsidiary; provided, however, that
immediately after giving effect to such designation no Default
shall have occurred and be continuing. Any such designation by
the Board of Directors shall be evidenced to the Trustee by
promptly filing with the Trustee a copy of the resolution of the
Board of Directors giving effect to such designation and an
Officers Certificate certifying that such designation
complied with the foregoing provisions.
U.S. Dollar Equivalent means with
respect to any monetary amount in a currency other than
U.S. dollars, at any time for determination thereof, the
amount of U.S. dollars obtained by converting such foreign
currency involved in such computation into U.S. dollars at
the spot rate for the purchase of U.S. dollars with the
applicable foreign currency as published in The Wall Street
Journal in the Exchange Rates column under the
heading Currency Trading on the date two Business
Days prior to such determination.
Except as described under Certain Covenants
Limitation on Indebtedness, whenever it is necessary to
determine whether the Company has complied with any covenant in
the Indenture or a Default has occurred and an amount is
expressed in a currency other than U.S. dollars, such
amount will be treated as the U.S. Dollar Equivalent
determined as of the date such amount is initially determined in
such currency.
U.S. Government Obligations means direct
obligations (or certificates representing an ownership interest
in such obligations) of the United States of America (including
any agency or instrumentality thereof) for the payment of which
the full faith and credit of the United States of America is
pledged and which are not callable at the issuers option.
Voting Stock of a Person means all classes of
Capital Stock of such Person then outstanding and normally
entitled (without regard to the occurrence of any contingency)
to vote in the election of directors, managers or trustees
thereof.
Wholly Owned Subsidiary means a Restricted
Subsidiary all the Capital Stock of which (other than
directors qualifying shares) is owned by the Company or
one or more other Wholly Owned Subsidiaries.
125
CERTAIN
U.S. FEDERAL INCOME TAX CONSIDERATIONS
The following is a summary of the material U.S. federal
income tax considerations relating to the exchange of Old Notes
for Exchange Notes in the exchange offer. It does not contain a
complete analysis of all the potential tax considerations
relating to the exchange. This summary is limited to holders of
Old Notes who hold the Old Notes as capital assets
(in general, assets held for investment). Special situations,
such as the following, are not addressed:
|
|
|
|
|
tax consequences to holders who may be subject to special tax
treatment, such as tax-exempt entities, dealers in securities or
currencies, banks, other financial institutions, insurance
companies, regulated investment companies, traders in securities
that elect to use a mark-to-market method of accounting for
their securities holdings or corporations that accumulate
earnings to avoid U.S. federal income tax;
|
|
|
|
tax consequences to persons holding notes as part of a hedging,
integrated, constructive sale or conversion transaction or a
straddle or other risk reduction transaction;
|
|
|
|
tax consequences to holders whose functional
currency is not the U.S. dollar;
|
|
|
|
tax consequences to persons who hold notes through a partnership
or similar pass-through entity;
|
|
|
|
U.S. federal gift tax, estate tax (except as to
non-United
States holders) or alternative minimum tax consequences, if
any; or
|
|
|
|
any state, local or foreign tax consequences.
|
The discussion below is based upon the provisions of the
Internal Revenue Code of 1986, as amended, existing and proposed
Treasury regulations promulgated thereunder, and rulings,
judicial decisions and administrative interpretations
thereunder, as of the date hereof. Those authorities may be
changed, perhaps retroactively, so as to result in
U.S. federal income tax consequences different from those
discussed below.
Consequences
of Tendering Notes
The exchange of your Old Notes for Exchange Notes in the
exchange offer should not constitute an exchange for federal
income tax purposes. Accordingly, the exchange offer should have
no federal income tax consequences to you if you exchange your
Old Notes for Exchange Notes. For example, there should be no
change in your tax basis and your holding period should carry
over to the Exchange Notes. In addition, the federal income tax
consequences of holding and disposing of your Exchange Notes
should be the same as those applicable to your Old Notes.
The preceding discussion of certain U.S. federal income tax
considerations of the exchange offer is for general information
only and is not tax advice. Accordingly, each investor should
consult its own tax advisor as to particular tax consequences to
it of exchanging Old Notes for Exchange Notes, including the
applicability and effect of any state, local or foreign tax
laws, and of any proposed changes in applicable laws.
Each broker-dealer that receives Exchange Notes for its own
account under the exchange offer must acknowledge that it will
deliver a prospectus in connection with any resale of Exchange
Notes.
This prospectus, as it may be amended or supplemented from time
to time, may be used by a broker-dealer in connection with
resales of Exchange Notes received in exchange for Old Notes if
the Old Notes were acquired as a result of market-making
activities or other trading activities.
We have agreed to make this prospectus, as amended or
supplemented, available to any broker-dealer to use in
connection with any such resale for a period of at least
90 days after the expiration date. In addition,
until ,
all dealers effecting transactions in the Exchange Notes may be
required to deliver a prospectus.
126
We will not receive any proceeds from any sale of Exchange Notes
by broker-dealers. Exchange Notes received by broker-dealers for
their own accounts under the exchange offer may be sold from
time to time in one or more transactions;
|
|
|
|
|
in the over-the-counter market;
|
|
|
|
in negotiated transactions;
|
|
|
|
through the writing of options on the Exchange Notes or a
combination of such methods of resale;
|
|
|
|
at market prices prevailing at the time of resale;
|
|
|
|
at prices related to such prevailing market prices; or
|
|
|
|
at negotiated prices.
|
Any resale may be made directly to purchasers or to or through
brokers or dealers. Brokers or dealers may receive compensation
in the form of commissions or concessions from any broker-dealer
or the purchasers of any such Exchange Notes. An
underwriter within the meaning of the Securities Act
of 1933 includes:
|
|
|
|
|
any broker-dealer that resells Exchange Notes that were received
by it for its own account pursuant to the exchange offer; or
|
|
|
|
any broker or dealer that participates in a distribution of such
Exchange Notes.
|
Any profit on any resale of Exchange Notes and any commissions
or concessions received by any persons may be deemed to be
underwriting compensation under the Securities Act of 1933. The
letter of transmittal states that, by acknowledging that it will
deliver and by delivering a prospectus, a broker-dealer will not
be deemed to admit that it is an underwriter within
the meaning of the Securities Act of 1933.
Based on interpretations by the staff of the Securities and
Exchange Commission in no-action letters issued to third
parties, we believe that a holder or other person who receives
Exchange Notes will be allowed to resell the Exchange Notes to
the public without further registration under the Securities Act
of 1933 and without delivering to the purchasers of the Exchange
Notes a prospectus that satisfies the requirements of
Section 10 of the Securities Act of 1933. The holder (other
than a person that is an affiliate of ours within
the meaning of Rule 405 under the Securities Act of
1933) who receives Exchange Notes in exchange for Old Notes
in the ordinary course of business and who is not participating,
need not intend to participate or have an arrangement or
understanding with person to participate in the distribution of
the Exchange Notes.
However, if any holder acquires Exchange Notes in the exchange
offer for the purpose of distributing or participating in a
distribution of the Exchange Notes, the holder cannot rely on
the position of the staff of the Securities and Exchange
Commission enunciated in such no-action letters or any similar
interpretive letters. The holder must comply with the
registration and prospectus delivery requirements of the
Securities Act of 1933 in connection with any resale
transaction. A secondary resale transaction should be covered by
an effective registration statement containing the selling
security holder information required by Item 507 or 508, as
applicable, of
Regulation S-K
under the Securities Act of 1933, unless an exemption from
registration is otherwise available.
Further, each broker-dealer that receives Exchange Notes for its
own account in exchange for Old Notes, where the Old Notes were
acquired by such participating broker-dealer as a result of
market-making activities or other trading activities, must
acknowledge that it will deliver a prospectus in connection with
any resale of any Exchange Notes. We have agreed, for a period
of not less than 90 days from the consummation of the
exchange offer, to make this prospectus available to any
broker-dealer for use in connection with any such resale.
For a period of not less than 90 days after the expiration
date we will promptly send additional copies of this prospectus
and any amendment or supplement to this prospectus to any
broker-dealer that requests those documents in the letter of
transmittal. We have agreed to pay all expenses incident to the
exchange offer, including the expenses of one counsel for the
holders of the Old Notes, other than commissions or concessions
127
of any brokers or dealers. We will indemnify the holders of the
Old Notes against liabilities under the Securities Act of 1933,
including any broker-dealers.
Certain legal matters relating to this offering will be passed
upon for us by Kirkland & Ellis LLP, New York, New
York. The initial purchasers have been represented by Cravath,
Swaine & Moore LLP, New York, New York.
INDEPENDENT
REGISTERED PUBLIC ACCOUNTING FIRMS
The financial statements incorporated in this prospectus by
reference from Community Health Systems, Inc. and
subsidiaries
Form 8-K
dated September 24, 2007 and the related financial
statement schedules and managements report on the
effectiveness of internal control over financial reporting
incorporated in the prospectus by reference from the Community
Health Systems, Inc. and subsidiaries Annual Report on
Form 10-K
for the year ended December 31, 2006, have been audited by
Deloitte & Touche LLP, an independent registered
public accounting firm, as stated in their reports, which are
incorporated herein by reference, (which reports
(1) express an unqualified opinion on the financial
statements and financial statement schedules and include an
explanatory paragraph referring to the adoption of Statement of
Financial Accounting Standard No. 123 (Revised 2004),
Share Based Payment) (2) express an
unqualified opinion on managements assessment regarding
the effectiveness of internal control over financial reporting,
and (3) express an unqualified opinion on the effectiveness
of internal control over financial reporting), and have been so
incorporated in reliance upon the reports of such firm given
upon their authority as experts in accounting and auditing.
The consolidated financial statements of Triad Hospitals, Inc.
appearing in Community Health Systems Inc.s current report
on
Form 8-K
dated September 24, 2007, and Triad Hospitals, Inc.
managements assessment of the effectiveness of internal
control over financial reporting as of December 31, 2006
appearing in Triad Hospitals, Inc. Annual Report on
Form 10-K
have been audited by Ernst & Young LLP, independent
registered public accounting firm, as set forth in their reports
thereon, included therein, and incorporated herein by reference.
Such consolidated financial statements and managements
assessment are incorporated herein by reference in reliance upon
such reports given on the authority of such firm as experts in
accounting and auditing.
INCORPORATION
OF CERTAIN DOCUMENTS
This prospectus incorporates by reference the documents and
reports listed below, which have been filed with the SEC:
|
|
|
|
|
our definitive proxy statement filed on April 12, 2007
under Regulation 14A in connection with our Annual Meeting
of Stockholders;
|
|
|
|
our Annual Report on
Form 10-K
for the fiscal year ended December 31, 2006 (except for the
Report of the Independent Registered Public Accounting Firm and
consolidated financial statements included in Item 8
thereof);
|
|
|
|
Triads Annual Report on
Form 10-K
for the fiscal year ended December 31, 2006 (except for the
Report of the Independent Registered Public Accounting Firm and
consolidated financial statements included in Item 8
thereof);
|
|
|
|
our Quarterly Report on
Form 10-Q
for the quarter ended June 30, 2007 (except for our
condensed consolidated financial statements included in
Part I, Item 1 thereof);
|
|
|
|
Triads Current Report on
Form 8-K
dated as of May 30, 2007;
|
|
|
|
Triads Current Report on
Form 8-K
dated as of June 12, 2007;
|
128
|
|
|
|
|
our Current Report on Form 8-K dated as of
September 14, 2007; and
|
|
|
|
our Current Report on
Form 8-K
dated as of September 24, 2007.
|
We also incorporate by reference the information contained in
all other documents we file with the SEC pursuant to
Sections 13(a), 13(c), 14 or 15(d) of the Exchange Act
(other than portions of these documents that are furnished under
Item 2.02 or Item 7.01 of a Current Report on
Form 8-K,
unless otherwise indicated therein) after the date of this
prospectus and prior to the termination of this offering. The
information contained in any such document will be considered
part of this prospectus from the date the document is filed with
the SEC. We make available free of charge, through the investor
relations section of our website,
www.chs.net/investor.relations, annual reports on
Form 10-K,
quarterly reports on
Form 10-Q
and current reports on
Form 8-K
as well as amendments to those reports, as soon as reasonably
practical after they are filed with the SEC. You may also
request free copies of these filings by writing or telephoning
us at the following address: Community Health Systems, Inc.,
4000 Meridian Boulevard, Franklin, TN 37067, Attention: Investor
Relations.
WHERE
YOU CAN FIND ADDITIONAL INFORMATION
While any notes remain outstanding, we will make available, upon
request, to any beneficial owner and any prospective purchaser
of notes the information required pursuant to
Rule 144A(d)(4) under the Securities Act during any period
in which we are not subject to Section 13 or 15(d) of the
Exchange Act. Any such request should be directed to: Community
Health Systems, Inc., 4000 Meridian Boulevard, Franklin,
TN 37067, Attention: Investor Relations.
You will find additional information about us in our SEC
filings. Our SEC filings may also be inspected and copied at the
SECs Public Reference Room, 100 F Street, N.E.,
Washington, D.C. 20549. You may obtain information on the
operation of the Public Reference Room by calling the SEC at
1-800-SEC-0330.
The SEC also maintains an Internet site
(http://www.sec.gov)
that contains reports, proxy and information statements, and
other information regarding issuers who file electronically with
the SEC.
129
$3,021,331,000
CHS/Community Health Systems,
Inc.
87/8% Senior
Notes due 2015
PROSPECTUS
We have not authorized any dealer, salesperson or other person
to give any information or represent anything to you other than
the information contained in this prospectus. You may not rely
on unauthorized information or representations.
This prospectus does not offer to sell or ask for offers to buy
any of the securities in any jurisdiction where it is unlawful,
where the person making the offer is not qualified to do so, or
to any person who can not legally be offered the securities.
The information in this prospectus is current only as of the
date on its cover, and may change after that date. For any time
after the cover date of this prospectus, we do not represent
that our affairs are the same as described or that the
information in this prospectus is correct, nor do we imply those
things by delivering this prospectus or selling securities to
you.
Until ,
all dealers that effect transactions in these securities,
whether or not participating in the exchange offer may be
required to deliver a prospectus. This is in addition to the
dealers obligations to deliver a prospectus when acting as
underwriters and with respect to their unsold allotments or
subscriptions.
, 2007
PART II
INFORMATION
NOT REQUIRED IN PROSPECTUS
|
|
ITEM 20.
|
INDEMNIFICATION
OF DIRECTORS AND OFFICERS
|
Alabama
Centre Hospital Corporation, Cullman Hospital Corporation, Foley
Hospital Corporation, Fort Payne Hospital Corporation,
Greenville Hospital Corporation, QHG of Enterprise, Inc. and QHG
of Jacksonville, Inc. are all incorporated under the laws of the
State of Alabama.
Section 10-2B-8.50
of the Alabama Business Corporation Act allows corporations to
indemnify a director, officer, or employee, or former director,
officer, or employee against liability incurred in connection
with a proceeding, in which the director, officer or employee is
made a party by reason of being or having been a director,
officer, or employee if the individual conducted himself or
herself in good faith and reasonably believed that the conduct
was in the best interests of the corporation or at least not
opposed to its best interests; and in the case of any criminal
proceeding, the individual had no reasonable cause to believe
his or her conduct was unlawful.
The bylaws of each of Centre Hospital Corporation, Cullman
Hospital Corporation, Foley Hospital Corporation,
Fort Payne Hospital Corporation, Greenville Hospital
Corporation, QHG of Enterprise, Inc. and QHG of Jacksonville,
Inc. provide for the indemnification of directors and officers
to the fullest extent permitted by the Alabama Business
Corporation Act.
Arizona
Payson Hospital Corporation is incorporated under the laws of
the State of Arizona.
Section 10-851
of the Arizona Revised Statutes permits a corporation to
indemnify an individual made a party to a proceeding because the
individual is or was a director against liability incurred in
the proceeding if all of the following conditions exist:
(a) the individuals conduct was in good faith;
(b) the individual reasonably believed in the case of
conduct in an official capacity with the corporation, that the
conduct was in its best interests and in all other cases, that
the conduct was at least not opposed to its best interests; and
(c) in the case of any criminal proceedings, the individual
had no reasonable cause to believe the conduct was unlawful.
Section 10-851
of the Arizona Revised Statutes permits a corporation to
indemnify an individual made a party to a proceeding because the
director engaged in conduct for which broader indemnification
has been made permissible or obligatory under a provision of the
articles of incorporation pursuant to
section 10-202,
subsection B, paragraph 2 of the Arizona Revised Statutes.
The termination of a proceeding by judgment, order, settlement
or conviction or on a plea of no contest or its equivalent is
not of itself determinative that the director did not meet the
standard of conduct described in this section. Under Arizona
Revised Statutes, a corporation may not indemnify a director
under this section either: (a) in connection with a
proceeding by or in the right of the corporation in which the
director was adjudged liable to the corporation or (b) in
connection with any other proceeding charging improper financial
benefit to the director, whether or not involving action in the
directors official capacity, in which the director was
adjudged liable on the basis that financial benefit was
improperly received by the director. Indemnification permitted
under this section in connection with a proceeding by or in the
right of the corporation is limited to reasonable expenses
incurred in connection with the proceeding.
The bylaws of Payson Hospital Corporation provide for the
indemnification of directors and officers to the fullest extent
permitted by the Arizona Revised Statutes.
Arkansas
Forrest City Arkansas Hospital Company, LLC, Forrest City Clinic
Company, LLC, Forrest City Hospital Corporation, QHG of
Springdale, Inc., Triad-El Dorado, Inc. and Phillips Hospital
Corporation are incorporated under the laws of the State of
Arkansas.
II-1
Section 4-32-404
of Arkansas Small Business Entity Tax Pass Through Act
provides that a limited liability companys operating
agreement may: (a) eliminate or limit the personal
liability of a member or manager for monetary damages for breach
of any duty provided for in
Section 4-32-402
and (b) provide for indemnification of a member or manager
for judgments, settlements, penalties, fines, or expenses
incurred in a proceeding to which a person is a party because
the person is or was a member or manager.
Section 4-27-850
of the Arkansas 1987 Business Corporation Act allows a
corporation to indemnify any person who was or is a party or is
threatened to be made a party to any threatened, pending, or
completed action, suit, or proceeding, whether civil, criminal,
administrative, or investigative (other than an action by or in
the right of the corporation) by reason of the fact that he is
or was a director, officer, employee, or agent of the
corporation or is or was serving at the request of the
corporation as a director, officer, employee, or agent of
another corporation, partnership, joint venture, trust, or other
enterprise, against expenses (including attorneys fees),
judgments, fines, and amounts paid in settlement actually and
reasonably incurred by him in connection with such action, suit,
or proceeding if he acted in good faith and in a manner he
reasonably believed to be in or not opposed to the best
interests of the corporation, and, with respect to any criminal
action or proceeding, had no reasonable cause to believe his
conduct was unlawful. The termination of any action, suit, or
proceeding by judgment, order, settlement, conviction, or upon a
plea of nolo contendere or its equivalent, shall not, of itself,
create a presumption that the person did not act in good faith
and in a manner which he reasonably believed to be in or not
opposed to the best interests of the corporation, and, with
respect to any criminal action or proceeding, had reasonable
cause to believe that his conduct was unlawful.
The Limited Liability Company Agreements of each of Forrest City
Arkansas Hospital Company, LLC and Forrest City Clinic Company,
LLC provide, to the fullest extent authorized by Arkansas
Small Business Entity Tax Pass Through Act, for the
indemnification of any member, manager, officer or employee of
the company from and against any and all claims and demands
arising by reason of the fact that such person is, or was, a
member, manager, officer or employee of the company.
The bylaws of each of Forrest City Hospital Corporation and
Phillips Hospital Corporation provide for the indemnification of
all current and former directors and officers to the fullest
extent permitted by the Arkansas 1987 Business Corporation Act.
Delaware
Chesterfield/Marlboro, L.P., CHHS Holdings, LLC, CHS/Community
Health Systems, Inc., Cleveland Regional Medical Center, L.P.,
Community GP Corp., Community Health Investment Corporation,
Community Health Systems, Inc., Community LP Corp., Fallbrook
Hospital Corporation, Hallmark Healthcare Corporation, Hospital
of Barstow, Inc., Lancaster Hospital Corporation, National
Healthcare of Cleveland, Inc., National Healthcare of Cullman,
Inc., National Healthcare of Decatur, Inc., National Healthcare
of Hartselle, Inc., National Healthcare of Leesville, Inc.,
National Healthcare of Mt. Vernon, Inc., National Healthcare of
Newport, Inc., NWI Hospital Holdings, LLC, Pennsylvania Hospital
Company, LLC, Phoenixville Hospital Company, LLC, Pottstown
Hospital Company, LLC, Ruston Hospital Corporation, Watsonville
Hospital Corporation, Webb Hospital Corporation, Webb Hospital
Holdings, LLC, Abilene Hospital, LLC, Abilene Merger, LLC,
Arizona DH, LLC, ARMC, LP, Birmingham Holdings, LLC, Bluffton
Health System, LLC, Brownwood Hospital, L.P., Brownwood Medical
Center, LLC, Carlsbad Medical Center, LLC, Claremore Regional
Hospital, LLC, Clarksville , Holdings, LLC, College Station
Hospital, L.P., College Station Medical Center, LLC, College
Station Merger, LLC, CP Hospital GP, LLC, CPLP, LLC, Crestwood
Hospital LP, LLC, Crestwood Hospital, LLC, CSMC, LLC, CSRA
Holdings, LLC, Deaconess Holdings, LLC, Deaconess Hospital
Holdings, LLC, Desert Hospital Holdings, LLC, Detar Hospital,
LLC, Dukes Health System, LLC, Gadsden Regional Medical Center,
LLC, Greenbrier VMC, LLC, GRMC Holdings, LLC, Hobbs Medco, LLC,
Las Cruces Medical Center, LLC, Lea Regional Hospital, LLC,
Longview Merger, LLC, LRH, LLC, Lutheran Health Network of
Indiana, LLC, Massillon Health System, LLC , Medical Center of
Brownwood, LLC, MMC of Nevada, LLC, Navarro Hospital, L.P.,
Navarro Regional, LLC, NRH, LLC, Oregon Healthcorp, LLC,
Palmer-Wasilla Health System, LLC, Quorum Health Resources, LLC,
Regional Hospital of Longview, LLC, Russellville Holdings, LLC,
, SACMC, LLC, San Angelo Community , edical Center, LLC,
San Angelo Hospital, L.P., San Angelo Medical, LLC,
Southern Texas Medical Center, LLC, St. Joseph Health System,
II-2
LLC, Tennyson Holdings, Inc., Triad Holdings III, LLC, Triad
Holdings IV, LLC, Triad Holdings V, LLC, Triad Healthcare
Corporation, Triad of Alabama, LLC, Triad of Oregon, LLC,
Triad-ARMC, LLC,
Triad-Denton
Hospital GP, LLC, Triad-Denton Hospital, L.P., Triad-Navarro
Regional Hospital Subsidiary, LLC, VHC Medical, LLC, Vicksburg
Healthcare, LLC, Victoria Hospital, LLC, Victoria of Texas,
L.P., WHMC, LLC, Willamette Valley Medical Center, LLC,
Women & Childrens Hospital, LLC, Woodland
Heights Medical Center, LLC and Woodward Health System, LLC are
incorporated under the laws of the State of Delaware.
Section 17-108
of the Delaware Revised Uniform Limited Partnership Act provides
that a partnership may, and shall have the power to, indemnify
and hold harmless any partner or other person from and against
any and all claims and demands whatsoever.
Section 18-108
of the Delaware Limited Liability Company Act provides that a
limited liability company may, and shall have the power to,
indemnify and hold harmless any member or manager or other
person from and against any and all claims and demands
whatsoever.
Section 145 of the Delaware General Corporation Law, or the
DGCL, provides that a corporation may indemnify any person,
including an officer or director, who was or is, or is
threatened to be made, a party to any threatened, pending or
completed action, suit or proceeding, whether civil, criminal,
administrative or investigative (other than an action by or in
the right of such corporation), by reason of the fact that such
person is or was a director, officer, employee or agent of such
corporation, or is or was serving at the request of such
corporation as a director, officer, employee or agent of another
corporation, partnership, joint venture, trust or other
enterprise. The indemnity may include expenses (including
attorneys fees), judgments, fines and amounts paid in
settlement actually and reasonably incurred by such person in
connection with such action, suit or proceeding, provided such
person acted in good faith and in a manner such person
reasonably believed to be in or not opposed to the best
interests of such corporation, and, with respect to any criminal
actions and proceedings, had no reasonable cause to believe that
his conduct was unlawful. A Delaware corporation may indemnify
any person, including an officer or director, who was or is, or
is threatened to be made, a party to any threatened, pending or
contemplated action or suit by or in the right of such
corporation, under the same conditions, except that such
indemnification is limited to expenses (including
attorneys fees) actually and reasonably incurred by such
person, and except that no indemnification is permitted without
judicial approval if such person is adjudged to be liable to
such corporation. Where an officer or director of a corporation
is successful, on the merits or otherwise, in the defense of any
action, suit or proceeding referred to above, or any claim,
issue or matter therein, the corporation must indemnify that
person against the expenses (including attorneys fees)
which such officer or director actually and reasonably incurred
in connection therewith.
The Limited Liability Company Agreements of each of CHHS
Holdings, LLC, NWI Hospital Holdings, LLC, Pennsylvania Hospital
Company, LLC, Phoenixville Hospital Company, LLC, Pottstown
Hospital Company, LLC, Webb Hospital Holdings, LLC, Abilene
Hospital, LLC, Abilene Merger, LLC, Arizona DH, LLC, Birmingham
Holdings, LLC, Bluffton Health System, LLC, Brownwood Medical
Center, LLC, Carlsbad Medical Center, LLC, Claremore Regional
Hospital, LLC, Clarksville , Holdings, LLC, College Station
Medical Center, LLC, College Station Merger, LLC, CP Hospital
GP, LLC, CPLP, LLC, Crestwood Hospital LP, LLC, Crestwood
Hospital, LLC, CSMC, LLC, CSRA Holdings, LLC, Deaconess
Holdings, LLC, Deaconess Hospital Holdings, LLC, Desert Hospital
Holdings, LLC, Detar Hospital, LLC, Dukes Health System, LLC,
Gadsden Regional Medical Center, LLC, Greenbrier VMC, LLC, GRMC
Holdings, LLC, Hobbs Medco, LLC, Las Cruces Medical Center, LLC,
Lea Regional Hospital, LLC, Longview Merger, LLC, LRH, LLC,
Lutheran Health Network of Indiana, LLC, Massillon Health
System, LLC , Medical Center of Brownwood, LLC, MMC of Nevada,
LLC, Navarro Regional, LLC, NRH, LLC, Oregon Healthcorp, LLC,
Palmer-Wasilla Health System, LLC, Quorum Health Resources, LLC,
Regional Hospital of Longview, LLC, SACMC, LLC, San Angelo
Community , Medical Center, LLC, San Angelo Medical, LLC,
Southern Texas Medical Center, LLC, St. Joseph Health System,
LLC, Triad Holdings III, LLC, Triad Holdings IV, LLC, Triad
Holdings V, LLC, Triad of Alabama, LLC, Triad of Oregon,
LLC, Triad-ARMC, LLC, Triad-Denton Hospital GP, LLC,
Triad-Navarro Regional Hospital Subsidiary, LLC, VHC Medical,
LLC, Vicksburg Healthcare, LLC, Victoria Hospital, LLC, WHMC,
LLC, Willamette Valley Medical Center, LLC, Women &
Childrens Hospital, LLC, Woodland Heights Medical Center,
LLC, Woodward Health System, LLC and
II-3
Russellville Holdings, LLC provide, to the fullest extent
authorized by the Delaware Limited Liability Company Act, for
the indemnification of any member, manager, officer or employee
of the companies from and against any and all claims and demands
arising by reason of the fact that such person is, or was, a
member, manager, officer or employee of the companies.
The Bylaws of Tennyson Holdings, Inc., CHS/Community Health
Systems, Inc., Cleveland Regional Medical Center, L.P.,
Community GP Corp., Community Health Investment Corporation,
Community Health Systems, Inc., Community LP Corp., Fallbrook
Hospital Corporation, Hallmark Healthcare Corporation, Hospital
of Barstow, Inc., Lancaster Hospital Corporation, National
Healthcare of Cleveland, Inc., National Healthcare of Cullman,
Inc., National Healthcare of Decatur, Inc., National Healthcare
of Hartselle, Inc., National Healthcare of Leesville, Inc.,
National Healthcare of Mt. Vernon, Inc., National Healthcare of
Newport, Inc., Ruston Hospital Corporation, Watsonville Hospital
Corporation, Webb Hospital Corporation provide for the
indemnification of all current and former directors and officers
to the fullest extent permitted by the DGCL.
The Certificate of Incorporation of Triad Healthcare Corporation
provides for the indemnification of all directors and officers
to the fullest extent permitted by the DGCL.
The Limited Partnership Agreements of each of
Chesterfield/Marlboro, L.P., ARMC, L.P., Brownwood Hospital,
L.P., College Station Hospital, L.P., Navarro Hospital, L.P.,
San Angelo Hospital, L.P., Triad-Denton Hospital, L.P. and
Victoria of Texas, L.P. provide, to the fullest extent
authorized by the Delaware Revised Uniform Limited Partnership
Act, for the indemnification of any partner, manager, officer or
employee of the companies from and against any and all claims
and demands arising by reason of the fact that such person is,
or was, a partner, manager, officer or employee of the companies.
Georgia
Fannin Regional Hospital, Inc., QHG Georgia Holdings, Inc. and
QHG Georgia, L.P. is incorporated under the laws of the State of
Georgia.
Sections 14-2-850
through
14-2-859 of
the Georgia Business Corporation Code provides for the
indemnification of officers and directors by the corporation
under certain circumstances against expenses and liabilities
incurred in legal proceedings involving such persons because of
their being or having been an officer or director of the
corporation. Under the Georgia Business Corporation Code, a
corporation may purchase insurance on behalf of an officer or
director of the corporation incurred in his or her capacity as
an officer or director regardless of whether the person could be
indemnified under the Georgia Business Corporation Code.
Section 14-9-108
of the Georgia Revised Uniform Limited Partnership Act provides
for the indemnification of partners by the partnership from and
against any and all claims and demands whatsoever, except for
(1) intentional misconduct or a knowing violation of law;
or (2) any transaction for which the Indemnitee received a
personal benefit in violation or breach of any provision of the
partnership agreement.
The bylaws of each of Fannin Regional Hospital, Inc., QHG
Georgia Holdings, Inc. and QHG Georgia, L.P. provide for the
indemnification of directors and officers to the fullest extent
permitted by the Georgia Business Corporation Code.
The Agreement of Limited Partnership of QHG Georgia, L.P.
provides for the indemnification of directors and officers to
the fullest extent permitted by the Georgia Revised Uniform
Limited Partnership Act.
Illinois
Anna Hospital Corporation, Galesburg Hospital Corporation,
Granite City Hospital Corporation, Granite City Illinois
Hospital Company, LLC, Marion Hospital Corporation, Red Bud
Hospital Corporation, Red Bud Illinois Hospital Company, LLC,
Waukegan Hospital Corporation and Waukegan Illinois Hospital
Company, LLC are incorporated under the laws of the State of
Illinois.
II-4
Section 15-7
of the Illinois Limited Liability Company Act states that a
limited liability company shall reimburse a member or manager
for payments made and indemnify a member or manager for
liabilities incurred by the member or manager in the ordinary
course of the business of the company or for the preservation of
its business or property.
Section 8.75 of the Illinois Business Corporation Act of
1983 provides that a corporation may indemnify any person,
including an officer or director, who was or is, or is
threatened to be made, a party to any threatened, pending or
completed action, suit or proceeding, whether civil, criminal,
administrative or investigative (other than an action by or in
the right of such corporation), by reason of the fact that such
person is or was a director, officer, employee or agent of such
corporation, or is or was serving at the request of such
corporation as a director, officer, employee or agent of another
corporation, partnership, joint venture, trust or other
enterprise. The indemnity may include expenses (including
attorneys fees), judgments, fines and amounts paid in
settlement actually and reasonably incurred by such person in
connection with such action, suit or proceeding, provided such
person acted in good faith and in a manner such person
reasonably believed to be in or not opposed to the best
interests of such corporation, and, with respect to any criminal
actions and proceedings, had no reasonable cause to believe that
his conduct was unlawful. An Illinois corporation may indemnify
any person, including an officer or director, who was or is, or
is threatened to be made, a party to any threatened, pending or
contemplated action or suit by or in the right of such
corporation, under the same conditions, except that such
indemnification is limited to expenses (including
attorneys fees) actually and reasonably incurred by such
person, and except that no indemnification is permitted without
judicial approval if such person is adjudged to be liable to
such corporation. Where an officer or director of a corporation
is successful, on the merits or otherwise, in the defense of any
action, suit or proceeding referred to above, or any claim,
issue or matter therein, the corporation must indemnify that
person against the expenses (including attorneys fees)
which such officer or director actually and reasonably incurred
in connection therewith.
The Limited Liability Company Agreement of each of Granite City
Illinois Hospital Company, LLC, Red Bud Illinois Hospital
Company, LLC and Waukegan Illinois Hospital Company, LLC,
provide, to the fullest extent authorized by the Illinois
Limited Liability Company Act, for the indemnification of any
member, manager, officer or employee of the company from and
against any and all claims and demands arising by reason of the
fact that such person is, or was, a member, manager, officer or
employee of the company.
The bylaws of each of Anna Hospital Corporation, Galesburg
Hospital Corporation, Granite City Hospital Corporation, Marion
Hospital Corporation, Waukegan Hospital Corporation and Red Bud
Hospital Corporation provide for the indemnification of
directors and officers to the fullest extent permitted by the
Illinois Business Corporation Act of 1983.
Indiana
Frankfort Health Partner, Inc., IOM Health System, L.P., QHG of
Bluffton, Inc., QHG of Clinton County, Inc., QHG of
Fort Wayne, Inc. and QHG of Warsaw, Inc. are incorporated
under the laws of the State of Indiana.
Under
Section 23-1-37-8
of the Indiana Business Corporation Law, a corporation may
indemnify an individual made a party to a proceeding because the
individual is or was a director against liability incurred in
the proceeding if: (1) the individuals conduct was in
good faith; and (2) the individual reasonably believed:
(A) in the case of conduct in the individuals
official capacity with the corporation, that the
individuals conduct was in its best interests; and
(B) in all other cases, that the individuals conduct
was at least not opposed to its best interests; and (3) in
the case of any criminal proceeding, the individual either:
(A) had reasonable cause to believe the individuals
conduct was lawful; or (B) had no reasonable cause to
believe the individuals conduct was unlawful. A
directors conduct with respect to an employee benefit plan
for a purpose the director reasonably believed to be in the
interests of the participants in and beneficiaries of the plan
is conduct that satisfies the requirement of subsection
(a)(2)(B).
Section 23-16-2-9
of the Indiana Revised Uniform Limited Partnership Act provides
that a partnership may indemnify a former or current partner,
employee, officer, or agent of the partnership against liability
if the persons conduct was in good faith and the person
reasonably believed that (A) in the case of conduct in
II-5
the persons capacity as a partner, that the persons
conduct was in the best interests of the partnership; and
(B) in all other cases that the persons conduct was
at least not opposed to the best interests of the partnership;
subject to any other indemnification rights the person may have
under the partnership agreement or with the written consent of
all partners.
The bylaws of Frankfort Health Partner, Inc., QHG of Bluffton,
Inc., QHG of Clinton County, Inc., QHG of Fort Wayne, Inc.
and QHG of Warsaw, Inc. provide for the indemnification of
directors and officers to the fullest extent permitted by the
Indiana Business Corporation Law.
The Agreement of Limited Partnership of IOM Health System, L.P
provides for the indemnification of directors and officers to
the fullest extent permitted by the Indiana Revised Uniform
Limited Partnership Act.
Kentucky
Hospital of Fulton, Inc., Hospital of Louisa, Inc. and Jackson
Hospital Corporation are incorporated under the laws of the
State of Kentucky.
Section 271B.8-510
of the Kentucky Business Corporation Act permits a corporation
to indemnify an individual who is a party to a proceeding
because he is a director against liability incurred in the
proceeding if: (1) (a) he conducted himself in good faith;
(b) he reasonably believed (i) in the case of conduct
in his official capacity, that his conduct was in the best
interests of the corporation; and (ii) in all other cases,
that his conduct was at least not opposed to the best interests
of the corporation; and (c) in the case of any criminal
proceeding, he had no reasonable cause to believe his conduct
was unlawful. A directors conduct with respect to an
employee benefit plan for a purpose he reasonably believed to be
in the interests of the participants in and beneficiaries of the
plan is conduct that satisfies the requirement of subsection
(1)(b)2 of this section.
The bylaws of each of Hospital of Fulton, Inc., Hospital of
Louisa, Inc. and Jackson Hospital Corporation provide for the
indemnification of directors and officers to the fullest extent
permitted by the Kentucky Business Corporation Act.
Louisiana
Ruston Louisiana Hospital Company, LLC is incorporated under the
laws of the State of Louisiana.
Section 1315 of the Louisiana Limited Liability Company Act
provides for indemnification of a member or members, or a
manager or managers, for judgments, settlements, penalties,
fines, or expenses incurred because he is or was a member or
manager.
The Ruston Louisiana Hospital Company, LLC Limited Liability
Company Agreement provides, to the fullest extent authorized by
law, for the indemnification of any member, manager, officer or
employee of the company from and against any and all claims and
demands arising by reason of the fact that such person is, or
was, a member, manager, officer or employee of the company.
Mississippi
QHG of Forrest County, Inc., QHG of Hattiesburg, Inc. and River
Region Medical Corporation are incorporated under the laws of
the State of Mississippi.
Sections 79-4-8.50
through
79-4-8.59 of
the Mississippi Business Corporation Act provides that a
corporation may indemnify any person, including an officer or
director, who was or is, or is threatened to be made, a party to
any threatened, pending or completed action, suit or proceeding,
whether civil, criminal, administrative or investigative (other
than an action by or in the right of such corporation), by
reason of the fact that such person is or was a director,
officer, employee or agent of such corporation, if the
persons conduct was in good faith and reasonably believed:
(1) in the case of conduct in the persons official
capacity, that (A) the conduct was in the best interests of
the corporation; and (B) in all other cases that the
persons conduct was at least not opposed to the best
interests of the corporation; and (2) in the case of any
criminal
II-6
action, the person either (A) had reasonable cause to
believe the persons conduct was lawful; or (B) had no
reasonable cause to believe the persons conduct was
unlawful.
The bylaws of each of QHG of Forrest County, Inc., QHG of
Hattiesburg, Inc. and River Region Medical Corporation provide
for the indemnification of directors and officers to the fullest
extent permitted by the Mississippi Business Corporation Act.
Missouri
Farmington Hospital Corporation, Farmington Missouri Hospital
Company, LLC, Kirksville Hospital Corporation, Moberly Hospital,
Inc. are incorporated under the laws of the State of Missouri.
The Missouri Limited Liability Company Act is silent as to
indemnification.
Section 351-355
of the General and Business Corporation Law of Missouri,
provides that a corporation may indemnify any person, including
an officer or director, who was or is, or is threatened to be
made, a party to any threatened, pending or completed action,
suit or proceeding, whether civil, criminal, administrative or
investigative (other than an action by or in the right of such
corporation), by reason of the fact that such person is or was a
director, officer, employee or agent of such corporation, or is
or was serving at the request of such corporation as a director,
officer, employee or agent of another corporation, partnership,
joint venture, trust or other enterprise. The indemnity may
include expenses (including attorneys fees), judgments,
fines and amounts paid in settlement actually and reasonably
incurred by such person in connection with such action, suit or
proceeding, provided such person acted in good faith and in a
manner such person reasonably believed to be in or not opposed
to the best interests of such corporation, and, with respect to
any criminal actions and proceedings, had no reasonable cause to
believe that his conduct was unlawful. A Missouri corporation
may indemnify any person, including an officer or director, who
was or is, or is threatened to be made, a party to any
threatened, pending or contemplated action or suit by or in the
right of such corporation, under the same conditions, except
that such indemnification is limited to expenses (including
attorneys fees) actually and reasonably incurred by such
person, and except that no indemnification is permitted without
judicial approval if such person is adjudged to be liable to
such corporation. Where an officer or director of a corporation
is successful, on the merits or otherwise, in the defense of any
action, suit or proceeding referred to above, or any claim,
issue or matter therein, the corporation must indemnify that
person against the expenses (including attorneys fees)
which such officer or director actually and reasonably incurred
in connection therewith.
The Farmington Missouri Hospital Company, LLC Limited Liability
Company Agreement provides, to the fullest extent authorized by
the Missouri Limited Liability Company Act, for the
indemnification of any member, manager, officer or employee of
the company from and against any and all claims and demands
arising by reason of the fact that such person is, or was, a
member, manager, officer or employee of the company.
The bylaws of Farmington Hospital Corporation, Kirksville
Hospital Corporation and Moberly Hospital, Inc. provide for the
indemnification of directors and officers to the fullest extent
permitted by the General and Business Corporation Law of
Missouri.
Nevada
NC-DSH, Inc. is incorporated under the laws of the State of
Nevada.
Under Nevada General Corporation Law, to the extent that an
Indemnitee is successful on the merits in defense of a suit or
proceeding brought against him or her by reason of the fact that
he or she is or was a director, officer, or agent of the
registrant, or serves or served any other enterprise or
organization at the request of the registrant, the registrant
shall indemnify him or her against expenses (including
attorneys fees) actually and reasonably incurred in
connection with such action.
If unsuccessful in defense of a third-party civil suit or a
criminal suit, or if such a suit is settled, an Indemnitee may
be indemnified under Nevada law against both (i) expenses,
including attorneys fees, and (ii) judgments, fines,
and amounts paid in settlement if he or she acted in good faith
and in a manner he or
II-7
she reasonably believed to be in, or not opposed to, the best
interests of the registrant, and, with respect to any criminal
action, had no reasonable cause to believe his or her conduct
was unlawful.
If unsuccessful in defense of a suit brought by or in the right
of the registrant, where the suit is settled, an Indemnitee may
be indemnified under Nevada law only against expenses (including
attorneys fees) actually and reasonably incurred in the
defense or settlement of the suit if he or she acted in good
faith and in a manner he or she reasonably believed to be in, or
not opposed to, the best interests of the registrant except that
if the Indemnitee is adjudged to be liable for a breach of
fiduciary duty or misconduct, fraud, or a knowing violation of
law in the performance of his or her duty to the registrant, he
or she cannot be made whole even for expenses unless a court
determines that he or she is fully and reasonably entitled to
indemnification for such expenses.
Also under Nevada law, expenses incurred by an officer or
director in defending a civil or criminal action, suit, or
proceeding may be paid by the registrant in advance of the final
disposition of the suit, action, or proceeding upon receipt of
an undertaking by or on behalf of the officer or director to
repay such amount if it is ultimately determined that he or she
is not entitled to be indemnified by the registrant. The
registrant may also advance expenses incurred by other employees
and agents of the registrant upon such terms and conditions, if
any, that the board of directors of the registrant deems
appropriate.
The By-laws of NC-DSH, Inc. provide for the indemnification of
directors and officers to the fullest extent permitted by the
Nevada General Corporation Law.
New
Jersey
Salem Hospital Corporation is incorporated under the laws of the
State of New Jersey.
Section 14A: 3-5 of the New Jersey Business Corporation Act
provides that any corporation organized for any purpose under
any general or special law of this State shall have the power to
indemnify a corporate agent against his expenses and liabilities
in connection with any proceeding involving the corporate agent
by reason of his being or having been such a corporate agent,
other than a proceeding by or in the right of the corporation,
if: (a) such corporate agent acted in good faith and in a
manner he reasonably believed to be in or not opposed to the
best interests of the corporation; and (b) with respect to
any criminal proceeding, such corporate agent had no reasonable
cause to believe his conduct was unlawful. Any corporation
organized for any purpose under any general or special law of
this New Jersey shall have the power to indemnify a corporate
agent against his expenses in connection with any proceeding by
or in the right of the corporation to procure a judgment in its
favor which involves the corporate agent by reason of his being
or having been such corporate agent, if he acted in good faith
and in a manner he reasonably believed to be in or not opposed
to the best interests of the corporation.
The bylaws of Salem Hospital Corporation provide for the
indemnification of directors and officers to the fullest extent
permitted by the New Jersey Business Corporation Act.
New
Mexico
Deming Hospital Corporation, Roswell Hospital Corporation and
San Miguel Hospital Corporation are incorporated under the
laws of the State of New Mexico.
Section 53-11-4.1
of the New Mexico Business Corporation Act permits a corporation
to indemnify any person made a part to any proceeding by reason
of the fact that the person is or was a director, officer, or
employer if the person acted in good faith and reasonably
believed the persons conduct was in the best interests of
the corporation or at least not opposed to its best interests;
and in the case of any criminal proceeding, the person had no
reasonable cause to believe the persons conduct was
unlawful. Indemnification may be made against judgments,
penalties, fines, settlements and reasonable expenses, actually
incurred by the person in connection with the proceeding; except
that if the proceeding was by or in the right of the
corporation, indemnification may be made only against such
reasonable expenses and shall not be made in respect of any
proceeding in which the person shall have been adjudged to be
liable to the corporation. The termination of any proceeding by
judgment, order, settlement, conviction or upon a plea of nolo
contendere or its equivalent,
II-8
shall not, of itself, be determinative that the person did not
meet the requisite standard of conduct set forth in this
subsection.
The bylaws of each of Deming Hospital Corporation, Roswell
Hospital Corporation and San Miguel Hospital Corporation
provide for the indemnification of directors and officers to the
fullest extent permitted by the New Mexico Business Corporation
Act.
New
York
CHS Holdings Corp. and Hallmark Holdings Corp. are incorporated
under the laws of the State of New York.
Section 722 of the New York Business Corporation Law
permits a corporation to indemnify any person made, or
threatened to be made, a party to an action or proceeding (
other than one by or in the right of the corporation to procure
a judgment in its favor), whether civil or criminal, including
an action by or in the right of any other corporation of any
type or kind, domestic or foreign, or any partnership, joint
venture, trust, employee benefit plan or other enterprise, which
any director or officer of the corporation served in any
capacity at the request of the corporation, by reason of the
fact that he, his testator or intestate, was a director or
officer of the corporation, or served such other corporation,
partnership, joint venture, trust, employee benefit plan or
other enterprise in any capacity, against judgments, fines,
amounts paid in settlement and reasonable expenses, including
attorneys fees actually and necessarily incurred as a
result of such action or proceeding, or any appeal therein, if
such director or officer acted, in good faith, for a purpose
which he reasonably believed to be in, or, in the case of
service for any other corporation or any partnership, joint
venture, trust, employee benefit plan or other enterprise, not
opposed to, the best interests of the corporation and, in
criminal actions or proceedings, in addition, had no reasonable
cause to believe that his conduct was unlawful.
New York Business Corporation Law also provides that a
corporation may indemnify any person made, or threatened to be
made, a party to an action by or in the right of the corporation
to procure a judgment in its favor by reason of the fact that
he, his testator or intestate, is or was a director or officer
of the corporation, or is or was serving at the request of the
corporation as a director or officer of any other corporation of
any type or kind, domestic or foreign, of any partnership, joint
venture, trust, employee benefit plan or other enterprise,
against amounts paid in settlement and reasonable expenses,
including attorneys fees, actually and necessarily
incurred by him in connection with the defense or settlement of
such action, or in connection with an appeal therein, if such
director or officer acted, in good faith, for a purpose which he
reasonably believed to be in, or, in the case of service for any
other corporation or any partnership, joint venture, trust,
employee benefit plan or other enterprise, not opposed to, the
best interests of the corporation, except that no
indemnification under this paragraph shall be made in respect of
(1) a threatened action, or a pending action which is
settled or otherwise disposed of, or (2) any claim, issue
or matter as to which such person shall have been adjudged to be
liable to the corporation, unless and only to the extent that
the court in which the action was brought, or, if no action was
brought, any court of competent jurisdiction, determines upon
application that, in view of all the circumstances of the case,
the person is fairly and reasonably entitled to indemnity for
such portion of the settlement amount and expenses as the court
deems proper.
The bylaws of each of CHS Holdings Corp. and Hallmark Holdings
Corp. provide for the indemnification of directors and officers
to the fullest extent permitted by the New York Business
Corporation Law.
North
Carolina
Williamston Hospital Corporation is incorporated under the laws
of the State of North Carolina.
Sections 55-8-50
through
55-8-58 of
the North Carolina Business Corporation Act permit
indemnification of directors and officers in a variety of
circumstances which may include liabilities under the Securities
Act of 1933, as amended (the Securities Act). In
addition, a corporation may purchase insurance under the law of
North Carolina on behalf of directors, officers, employees or
agents, which may cover liabilities under the Securities Act.
II-9
The bylaws of Williamston Hospital Corporation provide for the
indemnification of directors and officers to the fullest extent
permitted by the North Carolina Business Corporation Act.
Ohio
QHG of Barberton, Inc. and QHG of Massillon, Inc. are
incorporated under the laws of the State of Ohio.
Under Section 1701.13(E) of the Ohio General Corporation
Law, generally, a corporation may indemnify any current or
former director, officer, employee or agent for reasonable
expenses incurred in connection with the defense or settlement
of any threatened, pending or completed litigation related to
the persons position with the corporation or related to
the persons service (as a director, trustee, officer,
employee, member, manager, or agent) to another corporation at
the request of the indemnifying corporation, if he or she acted
in good faith and in a manner he or she reasonably believed to
be in or not opposed to the best interests of the corporation.
If the litigation involved a criminal action or proceeding, the
person must also have had no reasonable cause to believe his or
her conduct was unlawful. Ohio law requires indemnification for
reasonable expenses incurred if the person was successful in the
defense of the litigation.
The bylaws of QHG of Barberton, Inc. and QHG of Massillon, Inc.
provide for the indemnification of directors and officers to the
fullest extent permitted by the Ohio General Corporation Law.
Oklahoma
Kay County Hospital Corporation, Kay County Oklahoma Hospital
Company, LLC, SouthCrest L.L.C., Triad-South Tulsa Hospital
Company, Inc. are incorporated under the laws of the State of
Oklahoma.
Section 1031 of the Oklahoma General Corporation Act
authorizes the indemnification of directors and officers under
certain circumstances. The Oklahoma General Corporation Act
provides for indemnification of each of the companys
officers and directors against (a) expenses, including
attorneys fees, judgments, fines and amounts paid in
settlement actually and reasonably incurred by them in
connection with any action, suit or proceeding brought by reason
of such person being or having been a director, officer,
employee or agent of the company, or of any other corporation,
partnership, joint venture, trust or other enterprise at the
request of the company, other than an action by or in the right
of company. To be entitled to indemnification, the individual
must have acted in good faith and in a manner he reasonably
believed to be in or not opposed to the best interest of the
company, and with respect to any criminal action, the person
seeking indemnification had no reasonable cause to believe that
the conduct was unlawful and (b) expenses, including
attorneys fees, actually and reasonably incurred in
connection with the defense or settlement of any action or suit
by or in the right of the company brought by reason of the
person seeking indemnification being or having been a director,
officer, employee or agent of the company, or any other
corporation, partnership, joint venture, trust or other
enterprise at the request of the company, provided the actions
were in good faith and were reasonably believed to be in or not
opposed to the best interest of the company, except that no
indemnification shall be made in respect of any claim, issue or
matter as to which the individual shall have been adjudged
liable to the company, unless and only to the extent that the
court in which such action was decided has determined that the
person is fairly and reasonably entitled to indemnity for such
expenses which the court deems proper.
Section 2003 of the Oklahoma Limited Liability Company Act
provides that a limited liability company may indemnify and hold
harmless any member, agent, or employee from and against any and
all claims and demands whatsoever, except in the case of action
or failure to act by the member, agent, or employee which
constitutes willful misconduct or recklessness, and subject to
the standards and restrictions, if any, set forth in the
articles of organization or operating agreement.
The bylaws of Kay County Hospital Corporation provide for the
indemnification of directors and officers to the fullest extent
permitted by the Oklahoma General Corporation Law.
The bylaws of Triad-South Tulsa Hospital Company, Inc. provide
for the indemnification of directors and officers except in
cases of gross negligence or willful misconduct in the
performance of their duties.
II-10
The SouthCrest L.L.C. Limited Liability Company Agreement
provides, to the fullest extent authorized by Ohio Limited
Liability Company Act, for the indemnification of any member,
manager, officer or employee of the company from and against any
and all claims and demands arising by reason of the fact that
such person is, or was, a member, manager, officer or employee
of the company.
Pennsylvania
CHS Berwick Hospital Corporation, Clinton Hospital Corporation,
Coatesville Hospital Corporation, Northampton Hospital
Corporation, Sunbury Hospital Corporation and West Grove
Hospital Corporation are incorporated under the laws of the
State of Pennsylvania.
Sections 1741 through 1750 of the Pennsylvania Business
Corporation Law of 1988, as amended, permits, and in some cases
requires, the indemnification of officers, directors and
employees of the Company. Section 3.1 of our bylaws
provides that we shall indemnify any director or officer of the
Company who is or was a party or is threatened to be made a
party to any threatened, pending or completed action, suit or
proceeding, whether civil, criminal, administrative or
investigative, including actions or suits by or in the right of
the Company, its shareholders or otherwise, by reason of the
fact that he or she is or was a director or officer of the
Company or is or was serving at the request of the Company as a
director, officer, partner, fiduciary or trustee of another
corporation, partnership, joint venture, trust, employee benefit
plan or other enterprise to the fullest extent permitted by law,
including, without limitation, against expenses (including legal
fees), damages, punitive damages, judgments, penalties, fines
and amounts paid in settlement, actually and reasonably incurred
by him or her in connection with such proceedings unless the act
or failure to act giving rise to the claim is finally determined
by a court to have constituted willful misconduct or
recklessness. Section 3.1 also provides that, if an
authorized representative is not entitled to indemnification for
a portion of liabilities to which he or she may be subject, the
Company will indemnify the person to the maximum extent
permitted for the remaining portion of the liabilities.
The bylaws of each of CHS Berwick Hospital Corporation, Clinton
Hospital Corporation, Coatesville Hospital Corporation,
Northampton Hospital Corporation, Sunbury Hospital Corporation
and West Grove Hospital Corporation provide for the
indemnification of directors and officers to the fullest extent
permitted by the Pennsylvania Business Corporation Law of 1988.
South
Carolina
QHG of South Carolina, Inc. and QHG of Spartanburg, Inc. are
incorporated under the laws of the State of South Carolina.
Reference is made to Chapter 8, Article 5 of
Title 33 of the 1976 Code of Laws of South Carolina as
amended, which provides for indemnification of officers and
directors of South Carolina corporations in certain instances in
connection with legal proceedings involving any such persons
because of being or having been an officer or director.
The bylaws of QHG of South Carolina, Inc. and QHG of
Spartanburg, Inc. provide for the indemnification of directors
and officers to the fullest extent permitted by the 1976 Code of
Laws of South Carolina as amended.
Tennessee
Brownsville Hospital Corporation, Cleveland Hospital
Corporation, Dyersburg Hospital Corporation, Hospital of
Morristown, Inc., Jackson Hospital Corporation, Jackson,
Tennessee Hospital Company, LLC, Lakeway Hospital Corporation,
Lexington Hospital Corporation, Martin Hospital Corporation,
McKenzie Hospital Corporation, McNairy Hospital Corporation,
Shelbyville Hospital Corporation and Sparta Hospital Corporation
are incorporated under the laws of the State of Tennessee.
Section 48-18-507
of the Tennessee Business Corporation Act permits a corporation
to indemnify: (1) an officer of the corporation who is not
a director is entitled to mandatory indemnification and is
entitled to apply for court-ordered indemnification, in each
case to the same extent as a director; (2) the corporation
may
II-11
indemnify and advance expenses under this part to an officer,
employee, or agent of the corporation who is not a director to
the same extent as to a director; and (3) a corporation may
also indemnify and advance expenses to an officer, employee, or
agent who is not a director to the extent, consistent with
public policy, that may be provided by its charter, bylaws,
general or specific action of its board of directors, or
contract.
Section 48-243-101
of the Tennessee Limited Liability Company Act permits an LLC to
indemnify an individual made a party to a proceeding because
such individual is or was a responsible person against liability
incurred in the proceeding if the individual acted in good faith
and reasonably believed that such individuals conduct was
in the best interest of the LLC or at least not opposed to its
best interests; and in the case of any criminal proceeding, had
no reasonable cause to believe such conduct was unlawful.
The bylaws of each of each of Brownsville Hospital Corporation,
Cleveland Hospital Corporation, Dyersburg Hospital Corporation,
Hospital of Morristown, Inc., Jackson Hospital Corporation,
Lakeway Hospital Corporation, Lexington Hospital Corporation,
Martin Hospital Corporation, McKenzie Hospital Corporation,
McNairy Hospital Corporation, Shelbyville Hospital Corporation
and Sparta Hospital Corporation provide for the indemnification
of directors and officers to the fullest extent permitted by the
Tennessee Business Corporation Act.
The Jackson, Tennessee Hospital Company, LLC Limited Liability
Company Agreement provides, to the fullest extent authorized by
the Tennessee Limited Liability Company Act, for the
indemnification of any member, manager, officer or employee of
the company from and against any and all claims and demands
arising by reason of the fact that such person is, or was, a
member, manager, officer or employee of the company.
Texas
Big Bend Hospital Corporation, Big Spring Hospital Corporation,
Granbury Hospital Corporation, Jourdanton Hospital Corporation,
NHCI of Hillsboro, Inc., Weatherford Hospital Corporation and
Weatherford Texas Hospital Company, LLC are incorporated under
the laws of the State of Texas.
Section 2.20 of the Texas Limited Liability Company Act
permits a limited liability company to indemnify members,
managers, officers and other persons and purchase and maintain
liability insurance for such persons, subject to such standards,
and restrictions, if any, as are set forth in its articles of
organization or in its regulation.
Under
Article 2.02-1
of the Texas Business Corporation Act, a corporation may
indemnify a person who was, is, or is threatened to be made a
named defendant or respondent in a proceeding because the person
is or was a director only if it is determined in accordance with
Section F of this article that the person:
(1) conducted himself in good faith; (2) reasonably
believed: (a) in the case of conduct in his official
capacity as a director of the corporation, that his conduct was
in the corporations best interests; and (b) in all
other cases, that his conduct was at least not opposed to the
corporations best interests; and (3) in the case of
any criminal proceeding, had no reasonable cause to believe his
conduct was unlawful.
The Limited Liability Company Agreement of Weatherford Texas
Hospital Company, LLC provides for the indemnification of any
member, manager, officer or employee to the fullest extent
permitted by the Texas Limited Liability Company Act.
The bylaws of Big Bend Hospital Corporation, Big Spring Hospital
Corporation, Granbury Hospital Corporation, Jourdanton Hospital
Corporation, NHCI of Hillsboro, Inc., Weatherford Hospital
Corporation provide for the indemnification of directors and
officers to the fullest extent permitted by the Texas Business
Corporation Act.
Utah
Tooele Hospital Corporation is incorporated under the laws of
the State of Utah.
Section 16-10a-902
of the Utah Revised Business Corporation Act (the Revised
Act) provides that a corporation may indemnify any
individual who was, is, or is threatened to be made a named
defendant or
II-12
respondent (a Party) in any threatened, pending or
completed action, suit or proceeding, whether civil, criminal,
administrative or investigative and whether formal or informal
(a Proceeding), because he or she is or was a
director of the corporation or, while a director of the
corporation, is or was serving at its request as a director,
officer, partner, trustee, employee, fiduciary or agent of
another corporation or other person or of an employee benefit
plan (an Indemnifiable Director), against any
obligation incurred with respect to a Proceeding, including any
judgment, settlement, penalty, fine or reasonable expenses
(including attorneys fees), incurred in the Proceeding if
his or her conduct was in good faith, he or she reasonably
believed that his or her conduct was in, or not opposed to, the
best interests of the corporation, and, in the case of any
criminal Proceeding, had no reasonable cause to believe such
conduct was unlawful; provided, however, that pursuant to
Subsection 902(4): (i) indemnification under
Section 902 in connection with a Proceeding by or in the
right of the corporation is limited to payment of reasonable
expenses (including attorneys fees) incurred in connection
with the Proceeding and (ii) the corporation may not
indemnify an Indemnifiable Director in connection with a
Proceeding by or in the right of the corporation in which the
Indemnifiable Director was adjudged liable to the corporation,
or in connection with any other Proceeding charging that the
Indemnifiable Director derived an improper personal benefit,
whether or not involving action in his or her official capacity,
in which Proceeding he or she was adjudged liable on the basis
that he or she derived an improper personal benefit.
Section 16-10a-903
of the Revised Act provides that, unless limited by its articles
of incorporation, a corporation shall indemnify an Indemnifiable
Director who was successful, on the merits or otherwise, in the
defense of any Proceeding, or in the defense of any claim, issue
or matter in the Proceeding, to which he or she was a Party
because he or she is or was an Indemnifiable Director of the
corporation, against reasonable expenses (including
attorneys fees) incurred in connection with the Proceeding
or claim with respect to which he or she has been successful.
The Certificate of Incorporation of Tooele Hospital Corporation,
provides, to the fullest extent authorized by the Utah Revised
Business Corporation Act, for the indemnification of any member,
manager, officer or employee of the company from and against any
and all claims and demands arising by reason of the fact that
such person is, or was, a member, manager, officer or employee
of the company.
Virginia
Emporia Hospital Corporation, Franklin Hospital Corporation,
Petersburg Hospital Company, LLC, Russell County Medical Center,
Inc., Virginia Hospital Company, LLC are incorporated under the
laws of State of Virginia.
Section 13.1-1009
of the Virginia Limited Liability Company Act permits a limited
liability company to indemnify and hold harmless any member or
manager or other person from and against any and all claims and
demands whatsoever, and to pay for or reimburse any member or
manager or other person for reasonable expenses incurred by such
a person who is a party to a proceeding in advance of final
disposition of the proceeding.
Article 10 of Chapter 9 of Title 13.1 of the Code
of Virginia, as amended, permits a Virginia corporation to
indemnify any director or officer for reasonable expenses
incurred in any legal proceeding in advance of final disposition
of the proceeding, if the director or officer furnishes the
corporation with a written statement of his or her good faith
belief that he or she has met the standard of conduct prescribed
by the Code of Virginia and furnishes the corporation with a
written undertaking to repay any funds advanced if it is
ultimately determined that he or she did not meet the relevant
standard of conduct. In addition, a corporation is permitted to
indemnify a director or officer against liability incurred in a
proceeding if a determination has been made by the disinterested
members of the board of directors, special legal counsel or
shareholders that the director or officer conducted himself or
herself in good faith and otherwise met the required standard of
conduct. In a proceeding by or in the right of the corporation,
no indemnification shall be made in respect of any matter as to
which a director or officer is adjudged to be liable to the
corporation, except for reasonable expenses incurred in
connection with the proceeding if it is determined that the
director or officer has met the relevant standard of conduct. In
any other proceeding, no indemnification shall be made if the
director or
II-13
officer is adjudged liable to the corporation on the basis that
he or she improperly received a personal benefit. Corporations
are given the power to make any other or further indemnity,
including advance of expenses, to any director or officer that
may be authorized by the articles of incorporation or any bylaw
made by the shareholders, or any resolution adopted, before or
after the event, by the shareholders, except an indemnity
against willful misconduct or a knowing violation of the
criminal law. Unless limited by its articles of incorporation,
indemnification against the reasonable expenses incurred by a
director or officer is mandatory when he or she entirely
prevails in the defense of any proceeding to which he or she is
a party because he or she is or was a director or officer.
The Limited Liability Company Agreements of each of Petersburg
Hospital Company, LLC and Virginia Hospital Company, LLC
provide, to the fullest extent authorized by the Virginia
Limited Liability Company Act, for the indemnification of any
member, manager, officer or employee of the companies from and
against any and all claims and demands arising by reason of the
fact that such person is, or was, a member, manager, officer or
employee of the companies.
The bylaws of each of Emporia Hospital Corporation, Franklin
Hospital Corporation and Russell County Medical Center, Inc.
provide for the indemnification of directors and officers to the
fullest extent permitted by the Code of Virginia.
West
Virginia
Oak Hill Hospital Corporation is incorporated under the laws of
the State of West Virginia.
Section 31D-8-851
permits a corporation to indemnify an individual who is a party
to a proceeding because he or she is a director or officer
against liability incurred in the proceeding if He or she
conducted himself or herself in good faith and reasonably
believed that his or her conduct was in the best interests of
the corporation or at least not opposed to the best interests of
the corporation; and in the case of any criminal
proceeding, he or she had no reasonable cause to believe his or
her conduct was unlawful; or engaged in conduct for which
broader indemnification has been made permissible or obligatory
under a provision of the articles of incorporation.
The bylaws of Oak Hill Hospital Corporation provide for the
indemnification of directors and officers to the fullest extent
permitted by the West Virginia Business Corporation Act.
Wyoming
Evanston Hospital Corporation is incorporated under the laws of
the State of Wyoming.
Section 17-16-851
of the Wyoming Business Corporation Act permits a corporation to
indemnify an individual who is a party to a proceeding because
he is a director or officer against liability incurred in the
proceeding if he conducted himself in good faith and reasonably
believed that his conduct was in or at least not opposed to the
corporations best interests; and in the case of any
criminal proceeding, he had no reasonable cause to believe his
conduct was unlawful; or engaged in conduct for which broader
indemnification has been made permissible or obligatory under a
provision of the articles of incorporation.
The bylaws of Evanston Hospital Corporation provide for the
indemnification of directors and officers to the fullest extent
permitted by the Wyoming Business Corporation Act.
II-14
|
|
Item 21.
|
Exhibits
and Financial Statement Schedules
|
|
|
|
|
|
Exhibit
|
|
|
No.
|
|
Description
|
|
|
1
|
.1
|
|
Purchase Agreement between the
Registrant, Credit Suisse Securities (USA) LLC, Wachovia Capital
Markets, LLC and Community Health Systems, Inc., dated on June
27, 2007 (incorporated by reference to Exhibit 1.1 to the
Companys Current Report on Form 8-K (No. 001-15925)).
|
|
2
|
.1
|
|
Agreement and Plan of Merger
between the Registrant, FLCH Acquisition Corp. and Community
Health Systems, Inc., dated on June 9, 1996 (incorporated by
reference to Exhibit 2.1 to the Companys Registration
Statement on Form S-1 (No. 333-31790))
|
|
3
|
.1
|
|
Form of Restated Certificate of
Incorporation of the Registrant (incorporated by reference to
Exhibit 3.1 to the Companys Registration Statement on Form
S-1 (No. 333-31790))
|
|
3
|
.2
|
|
Form of Restated By laws of the
Registrant (incorporated by reference to Exhibit 3.2 to the
Registrants Annual Report on Form 10-K for the year ended
December 31, 2000)
|
|
3
|
.3.
|
|
Certificate of Incorporation of
Centre Hospital Corporation
|
|
3
|
.4.
|
|
By-laws of Centre Hospital
Corporation
|
|
3
|
.5.
|
|
Certificate of Incorporation of
Cullman Hospital Corporation
|
|
3
|
.6.
|
|
By-laws of Cullman Hospital
Corporation
|
|
3
|
.7.
|
|
Certificate of Incorporation of
Foley Hospital Corporation
|
|
3
|
.8.
|
|
By-laws of Foley Hospital
Corporation
|
|
3
|
.9.
|
|
Certificate of Incorporation of
Fort Payne Hospital Corporation
|
|
3
|
.10.
|
|
By-laws of Fort Payne
Hospital Corporation
|
|
3
|
.11.
|
|
Certificate of Incorporation of
Greenville Hospital Corporation
|
|
3
|
.12.
|
|
By-laws of Greenville Hospital
Corporation
|
|
3
|
.13.
|
|
Certificate of Formation of
Forrest City Arkansas Hospital Company, LLC
|
|
3
|
.14.
|
|
Limited Liability Company
Agreement of Forrest City Arkansas Hospital Company, LLC
|
|
3
|
.15.
|
|
Certificate of Formation of
Forrest City Clinic Company, LLC
|
|
3
|
.16.
|
|
Limited Liability Company
Agreement Forrest City Clinic Company, LLC
|
|
3
|
.17.
|
|
Certificate of Incorporation of
Forrest City Hospital Corporation
|
|
3
|
.18.
|
|
By-laws of Forrest City Hospital
Corporation
|
|
3
|
.19.
|
|
Certificate of Incorporation of
Phillips Hospital Corporation
|
|
3
|
.20.
|
|
By-laws of Phillips Hospital
Corporation
|
|
3
|
.21.
|
|
Certificate of Incorporation of
Payson Hospital Corporation
|
|
3
|
.22.
|
|
By-laws of Payson Hospital
Corporation
|
|
3
|
.23.
|
|
Certificate of Limited Partnership
of Chesterfield/Marlboro, L.P.
|
|
3
|
.24.
|
|
Limited Partnership Agreement of
Chesterfield/Marlboro, L.P.
|
|
3
|
.25.
|
|
Certificate of Formation of CHHS
Holdings, LLC
|
|
3
|
.26.
|
|
Limited Liability Company
Agreement of CHHS Holdings, LLC
|
|
3
|
.27.
|
|
Certificate of Incorporation of
CHS/Community Health Systems, Inc.
|
|
3
|
.28.
|
|
By-laws of CHS/Community Health
Systems, Inc.
|
|
3
|
.29.
|
|
Certificate of Limited Partnership
of Cleveland Regional Medical Center, L.P.
|
|
3
|
.30.
|
|
Limited Partnership Agreement of
Cleveland Regional Medical Center, L.P.
|
|
3
|
.31.
|
|
Certificate of Incorporation of
Community GP Corp.
|
|
3
|
.32.
|
|
By-laws of Community GP Corp.
|
|
3
|
.33.
|
|
Certificate of Incorporation of
Community Health Investment Corporation
|
|
3
|
.34.
|
|
By-laws of Community Health
Investment Corporation
|
|
3
|
.35.
|
|
Certificate of Incorporation of
Community Health Systems, Inc.
|
|
3
|
.36.
|
|
By-laws of Community Health
Systems, Inc.
|
II-15
|
|
|
|
|
Exhibit
|
|
|
No.
|
|
Description
|
|
|
3
|
.37.
|
|
Certificate of Incorporation of
Community LP Corp.
|
|
3
|
.38.
|
|
By-laws of Community LP Corp.
|
|
3
|
.39.
|
|
Certificate of Incorporation of
Fallbrook Hospital Corporation
|
|
3
|
.40.
|
|
By-laws of Fallbrook Hospital
Corporation
|
|
3
|
.41.
|
|
Certificate of Incorporation of
Hallmark Healthcare Corporation
|
|
3
|
.42.
|
|
By-laws of Hallmark Healthcare
Corporation
|
|
3
|
.43.
|
|
Certificate of Incorporation of
Hospital of Barstow, Inc.
|
|
3
|
.44.
|
|
By-laws of Hospital of Barstow,
Inc.
|
|
3
|
.45.
|
|
Certificate of Incorporation of
Lancaster Hospital Corporation
|
|
3
|
.46.
|
|
By-laws of Lancaster Hospital
Corporation
|
|
3
|
.47.
|
|
Certificate of Incorporation of
National Healthcare of Cleveland, Inc.
|
|
3
|
.48.
|
|
By-laws of National Healthcare of
Cleveland, Inc.
|
|
3
|
.49.
|
|
Certificate of Incorporation of
National Healthcare of Cullman, Inc.
|
|
3
|
.50.
|
|
By-laws of National Healthcare of
Cullman, Inc.
|
|
3
|
.51.
|
|
Certificate of Incorporation of
National Healthcare of Decatur, Inc.
|
|
3
|
.52.
|
|
By-laws of National Healthcare of
Decatur, Inc.
|
|
3
|
.53.
|
|
Certificate of Incorporation of
National Healthcare of Hartselle, Inc.
|
|
3
|
.54.
|
|
By-laws of National Healthcare of
Hartselle, Inc.
|
|
3
|
.55.
|
|
Certificate of Incorporation of
National Healthcare of Leesville, Inc.
|
|
3
|
.56.
|
|
By-laws of National Healthcare of
Leesville, Inc.
|
|
3
|
.57.
|
|
Certificate of Incorporation of
National Healthcare of Mt. Vernon, Inc.
|
|
3
|
.58.
|
|
By-laws of National Healthcare of
Mt. Vernon, Inc.
|
|
3
|
.59.
|
|
Certificate of Incorporation of
National Healthcare of Newport, Inc.
|
|
3
|
.60.
|
|
By-laws of National Healthcare of
Newport, Inc.
|
|
3
|
.61.
|
|
Certificate of Formation of NWI
Hospital Holdings, LLC
|
|
3
|
.62.
|
|
Limited Liability Company
Agreement of NWI Hospital Holdings, LLC
|
|
3
|
.63.
|
|
Certificate of Formation of
Pennsylvania Hospital Company, LLC
|
|
3
|
.64.
|
|
Limited Liability Company
Agreement of Pennsylvania Hospital Company, LLC
|
|
3
|
.65.
|
|
Certificate of Formation of
Phoenixville Hospital Company, LLC
|
|
3
|
.66.
|
|
Limited Liability Company
Agreement of Phoenixville Hospital Company, LLC
|
|
3
|
.67.
|
|
Certificate of Formation of
Pottstown Hospital Company, LLC
|
|
3
|
.68.
|
|
Limited Liability Company
Agreement of Pottstown Hospital Company, LLC
|
|
3
|
.69.
|
|
Certificate of Incorporation of
Ruston Hospital Corporation
|
|
3
|
.70.
|
|
By-laws of Ruston Hospital
Corporation
|
|
3
|
.71.
|
|
Certificate of Incorporation of
Watsonville Hospital Corporation
|
|
3
|
.72.
|
|
By-laws of Watsonville Hospital
Corporation
|
|
3
|
.73.
|
|
Certificate of Incorporation of
Webb Hospital Corporation
|
|
3
|
.74.
|
|
By-laws of Webb Hospital
Corporation
|
|
3
|
.75.
|
|
Certificate of Formation of Webb
Hospital Holdings, LLC
|
|
3
|
.76.
|
|
Limited Liability Company
Agreement of Webb Hospital Holdings, LLC
|
|
3
|
.77.
|
|
Certificate of Incorporation of
Fannin Regional Hospital, Inc.
|
|
3
|
.78.
|
|
By-laws of Fannin Regional
Hospital, Inc.
|
|
3
|
.79.
|
|
Certificate of Incorporation of
Anna Hospital Corporation
|
|
3
|
.80.
|
|
By-laws of Anna Hospital
Corporation
|
II-16
|
|
|
|
|
Exhibit
|
|
|
No.
|
|
Description
|
|
|
3
|
.81.
|
|
Certificate of Incorporation of
Galesburg Hospital Corporation
|
|
3
|
.82.
|
|
By-laws of Galesburg Hospital
Corporation
|
|
3
|
.83.
|
|
Certificate of Incorporation of
Granite City Hospital Corporation
|
|
3
|
.84.
|
|
By-laws of Granite City Hospital
Corporation
|
|
3
|
.85.
|
|
Certificate of Formation of
Granite City Illinois Hospital Company, LLC
|
|
3
|
.86.
|
|
Limited Liability Company
Agreement of Granite City Illinois Hospital Company, LLC
|
|
3
|
.87.
|
|
Certificate of Incorporation of
Marion Hospital Corporation
|
|
3
|
.88.
|
|
By-laws of Marion Hospital
Corporation
|
|
3
|
.89.
|
|
Certificate of Incorporation of
Red Bud Hospital Corporation
|
|
3
|
.90.
|
|
By-laws of Red Bud Hospital
Corporation
|
|
3
|
.91.
|
|
Certificate of Formation of Red
Bud Illinois Hospital Company, LLC
|
|
3
|
.92.
|
|
Limited Liability Company
Agreement of Red Bud Illinois Hospital Company, LLC
|
|
3
|
.93.
|
|
Certificate of Incorporation of
Waukegan Hospital Corporation
|
|
3
|
.94.
|
|
By-laws of Waukegan Hospital
Corporation
|
|
3
|
.95.
|
|
Certificate of Formation of
Waukegan Illinois Hospital Company, LLC
|
|
3
|
.96.
|
|
Limited Liability Company
Agreement of Waukegan Illinois Hospital Company, LLC
|
|
3
|
.97.
|
|
Certificate of Incorporation of
Hospital of Fulton, Inc.
|
|
3
|
.98.
|
|
By-laws of Hospital of Fulton,
Inc.
|
|
3
|
.99.
|
|
Certificate of Incorporation of
Hospital of Louisa, Inc.
|
|
3
|
.100.
|
|
By-laws of Hospital of Louisa,
Inc.
|
|
3
|
.101.
|
|
Certificate of Incorporation of
Jackson Hospital Corporation
|
|
3
|
.102.
|
|
By-laws of Jackson Hospital
Corporation
|
|
3
|
.103.
|
|
Certificate of Formation of Ruston
Louisiana Hospital Company, LLC
|
|
3
|
.104.
|
|
Limited Liability Company
Agreement of Ruston Louisiana Hospital Company, LLC
|
|
3
|
.105.
|
|
Certificate of Incorporation of
Farmington Hospital Corporation
|
|
3
|
.106.
|
|
By-laws of Farmington Hospital
Corporation
|
|
3
|
.107.
|
|
Certificate of Formation of
Farmington Missouri Hospital Company, LLC
|
|
3
|
.108.
|
|
Limited Liability Company
Agreement of Farmington Missouri Hospital Company, LLC
|
|
3
|
.109.
|
|
Certificate of Incorporation of
Kirksville Hospital Corporation
|
|
3
|
.110.
|
|
By-laws of Kirksville Hospital
Corporation
|
|
3
|
.111.
|
|
Certificate of Incorporation of
Moberly Hospital, Inc.
|
|
3
|
.112.
|
|
By-laws of Moberly Hospital,
Inc.
|
|
3
|
.113.
|
|
Certificate of Incorporation of
Williamston Hospital Corporation
|
|
3
|
.114.
|
|
By-laws of Williamston Hospital
Corporation
|
|
3
|
.115.
|
|
Certificate of Incorporation of
Salem Hospital Corporation
|
|
3
|
.116.
|
|
By-laws of Salem Hospital
Corporation
|
|
3
|
.117.
|
|
Certificate of Incorporation of
Deming Hospital Corporation
|
|
3
|
.118.
|
|
By-laws of Deming Hospital
Corporation
|
|
3
|
.119.
|
|
Certificate of Incorporation of
Roswell Hospital Corporation
|
|
3
|
.120.
|
|
By-laws of Roswell Hospital
Corporation
|
|
3
|
.121.
|
|
Certificate of Incorporation of
San Miguel Hospital Corporation
|
|
3
|
.122.
|
|
By-laws of San Miguel
Hospital Corporation
|
|
3
|
.123.
|
|
Certificate of Incorporation of
CHS Holdings Corp.
|
|
3
|
.124.
|
|
By-laws of CHS Holdings
Corp.
|
II-17
|
|
|
|
|
Exhibit
|
|
|
No.
|
|
Description
|
|
|
3
|
.125.
|
|
Certificate of Incorporation of
Hallmark Holdings Corp.
|
|
3
|
.126.
|
|
By-laws of Hallmark Holdings
Corp.
|
|
3
|
.127.
|
|
Certificate of Incorporation of
Kay County Hospital Corporation
|
|
3
|
.128.
|
|
By-laws of Kay County Hospital
Corporation
|
|
3
|
.129.
|
|
Certificate of Formation of Kay
County Oklahoma Hospital Company, LLC
|
|
3
|
.130.
|
|
Limited Liability Company
Agreement of Kay County Oklahoma Hospital Company, LLC
|
|
3
|
.131.
|
|
Certificate of Incorporation of
CHS Berwick Hospital Corporation
|
|
3
|
.132.
|
|
By-laws of CHS Berwick Hospital
Corporation
|
|
3
|
.133.
|
|
Certificate of Incorporation of
Clinton Hospital Corporation
|
|
3
|
.134.
|
|
By-laws of Clinton Hospital
Corporation
|
|
3
|
.135.
|
|
Certificate of Incorporation of
Coatesville Hospital Corporation
|
|
3
|
.136.
|
|
By-laws of Coatesville Hospital
Corporation
|
|
3
|
.137.
|
|
Certificate of Incorporation of
Northampton Hospital Corporation
|
|
3
|
.138.
|
|
By-laws of Northampton Hospital
Corporation
|
|
3
|
.139.
|
|
Certificate of Incorporation of
Sunbury Hospital Corporation
|
|
3
|
.140.
|
|
By-laws of Sunbury Hospital
Corporation
|
|
3
|
.141.
|
|
Certificate of Incorporation of
West Grove Hospital Corporation
|
|
3
|
.142.
|
|
By-laws of West Grove Hospital
Corporation
|
|
3
|
.143.
|
|
Certificate of Incorporation of
Brownsville Hospital Corporation
|
|
3
|
.144.
|
|
By-laws of Brownsville Hospital
Corporation
|
|
3
|
.145.
|
|
Certificate of Incorporation of
Cleveland Hospital Corporation
|
|
3
|
.146.
|
|
By-laws of Cleveland Hospital
Corporation
|
|
3
|
.147.
|
|
Certificate of Incorporation of
Dyersburg Hospital Corporation
|
|
3
|
.148.
|
|
By-laws of Dyersburg Hospital
Corporation
|
|
3
|
.149.
|
|
Certificate of Incorporation of
Hospital of Morristown, Inc.
|
|
3
|
.150.
|
|
By-laws of Hospital of Morristown,
Inc.
|
|
3
|
.151.
|
|
Certificate of Incorporation of
Jackson Hospital Corporation
|
|
3
|
.152.
|
|
By-laws of Jackson Hospital
Corporation
|
|
3
|
.153.
|
|
Certificate of Formation of
Jackson, Tennessee Hospital Company, LLC
|
|
3
|
.154.
|
|
Limited Liability Company
Agreement of Jackson, Tennessee Hospital Company, LLC
|
|
3
|
.155.
|
|
Certificate of Incorporation of
Lakeway Hospital Corporation
|
|
3
|
.156.
|
|
By-laws of Lakeway Hospital
Corporation
|
|
3
|
.157.
|
|
Certificate of Incorporation of
Lexington Hospital Corporation
|
|
3
|
.158.
|
|
By-laws of Lexington Hospital
Corporation
|
|
3
|
.159.
|
|
Certificate of Incorporation of
Martin Hospital Corporation
|
|
3
|
.160.
|
|
By-laws of Martin Hospital
Corporation
|
|
3
|
.161.
|
|
Certificate of Incorporation of
McKenzie Hospital Corporation
|
|
3
|
.162.
|
|
By-laws of McKenzie Hospital
Corporation
|
|
3
|
.163.
|
|
Certificate of Incorporation of
McNairy Hospital Corporation
|
|
3
|
.164.
|
|
By-laws of McNairy Hospital
Corporation
|
|
3
|
.165.
|
|
Certificate of Incorporation of
Shelbyville Hospital Corporation
|
|
3
|
.166.
|
|
By-laws of Shelbyville Hospital
Corporation
|
|
3
|
.167.
|
|
Certificate of Incorporation of
Sparta Hospital Corporation
|
|
3
|
.168.
|
|
By-laws of Sparta Hospital
Corporation
|
II-18
|
|
|
|
|
Exhibit
|
|
|
No.
|
|
Description
|
|
|
3
|
.169.
|
|
Certificate of Incorporation of
Big Bend Hospital Corporation
|
|
3
|
.170.
|
|
By-laws of Big Bend Hospital
Corporation
|
|
3
|
.171.
|
|
Certificate of Incorporation of
Big Spring Hospital Corporation
|
|
3
|
.172.
|
|
By-laws of Big Spring Hospital
Corporation
|
|
3
|
.173.
|
|
Certificate of Incorporation of
Granbury Hospital Corporation
|
|
3
|
.174.
|
|
By-laws of Granbury Hospital
Corporation
|
|
3
|
.175.
|
|
Certificate of Incorporation of
Jourdanton Hospital Corporation
|
|
3
|
.176.
|
|
By-laws of Jourdanton Hospital
Corporation
|
|
3
|
.177.
|
|
Certificate of Incorporation of
NHCI of Hillsboro, Inc.
|
|
3
|
.178.
|
|
By-laws of NHCI of Hillsboro,
Inc.
|
|
3
|
.179.
|
|
Certificate of Incorporation of
Weatherford Hospital Corporation
|
|
3
|
.180.
|
|
By-laws of Weatherford Hospital
Corporation
|
|
3
|
.181.
|
|
Certificate of Formation of
Weatherford Texas Hospital Company, LLC
|
|
3
|
.182.
|
|
Limited Liability Company
Agreement of Weatherford Texas Hospital Company, LLC
|
|
3
|
.183.
|
|
Certificate of Incorporation of
Tooele Hospital Corporation
|
|
3
|
.184.
|
|
By-laws of Tooele Hospital
Corporation
|
|
3
|
.185.
|
|
Certificate of Incorporation of
Emporia Hospital Corporation
|
|
3
|
.186.
|
|
By-laws of Emporia Hospital
Corporation
|
|
3
|
.187.
|
|
Certificate of Incorporation of
Franklin Hospital Corporation
|
|
3
|
.188.
|
|
By-laws of Franklin Hospital
Corporation
|
|
3
|
.189.
|
|
Certificate of Formation of
Petersburg Hospital Company, LLC
|
|
3
|
.190.
|
|
Limited Liability Company
Agreement of Petersburg Hospital Company, LLC
|
|
3
|
.191.
|
|
Certificate of Incorporation of
Russell County Medical Center, Inc.
|
|
3
|
.192.
|
|
By-laws of Russell County Medical
Center, Inc.
|
|
3
|
.193.
|
|
Certificate of Formation of
Virginia Hospital Company, LLC
|
|
3
|
.194.
|
|
Limited Liability Company
Agreement of Virginia Hospital Company, LLC
|
|
3
|
.195.
|
|
Certificate of Incorporation of
Oak Hill Hospital Corporation
|
|
3
|
.196.
|
|
By-laws of Oak Hill Hospital
Corporation
|
|
3
|
.197.
|
|
Certificate of Incorporation of
Evanston Hospital Corporation
|
|
3
|
.198.
|
|
By-laws of Evanston Hospital
Corporation
|
|
3
|
.199.
|
|
Certificate of Incorporation of
QHG of Enterprise, Inc.
|
|
3
|
.200.
|
|
By-laws of QHG of Enterprise,
Inc.
|
|
3
|
.201.
|
|
Certificate of Incorporation of
QHG of Jacksonville, Inc.
|
|
3
|
.202.
|
|
By-laws of QHG of Jacksonville,
Inc.
|
|
3
|
.203.
|
|
Certificate of Incorporation of
QHG of Springdale, Inc.
|
|
3
|
.204.
|
|
By-laws of QHG of Springdale,
Inc.
|
|
3
|
.205.
|
|
Certificate of Incorporation of
Triad-El Dorado, Inc.
|
|
3
|
.206.
|
|
By-laws of Triad-El Dorado,
Inc.
|
|
3
|
.207.
|
|
Certificate of Formation of
Abilene Hospital, LLC
|
|
3
|
.208.
|
|
Limited Liability Company
Agreement of Abilene Hospital, LLC
|
|
3
|
.209.
|
|
Certificate of Formation of
Abilene Merger, LLC
|
|
3
|
.210.
|
|
Limited Liability Company
Agreement of Abilene Merger, LLC
|
|
3
|
.211.
|
|
Certificate of Formation of
Arizona DH, LLC
|
|
3
|
.212.
|
|
Limited Liability Company
Agreement of Arizona DH, LLC
|
II-19
|
|
|
|
|
Exhibit
|
|
|
No.
|
|
Description
|
|
|
3
|
.213.
|
|
Certificate of Limited Partnership
of ARMC, L.P.
|
|
3
|
.214.
|
|
Amended and Restated Limited
Partnership Agreement of ARMC, L.P.
|
|
3
|
.215.
|
|
Certificate of Formation of
Birmingham Holdings, LLC
|
|
3
|
.216.
|
|
Limited Liability Company
Agreement of Birmingham Holdings, LLC
|
|
3
|
.217.
|
|
Certificate of Formation of
Bluffton Health System, LLC
|
|
3
|
.218.
|
|
Limited Liability Company
Agreement of Bluffton Health System, LLC
|
|
3
|
.219.
|
|
Certificate of Limited Partnership
of Brownwood Hospital, L.P.
|
|
3
|
.220.
|
|
Limited Partnership Agreement of
Brownwood Hospital, L.P.
|
|
3
|
.221.
|
|
Certificate of Formation of
Brownwood Medical Center, LLC
|
|
3
|
.222.
|
|
Amended and Restated Limited
Liability Company Agreement of Brownwood Medical Center,
LLC
|
|
3
|
.223.
|
|
Certificate of Formation of
Carlsbad Medical Center, LLC
|
|
3
|
.224.
|
|
Second Amended and Restated
Limited Liability Company Agreement of Carlsbad Medical Center,
LLC
|
|
3
|
.225.
|
|
Certificate of Formation of
Claremore Regional Hospital, LLC
|
|
3
|
.226.
|
|
Amended and Restated Limited
Liability Company Agreement of Claremore Regional Hospital,
LLC
|
|
3
|
.227.
|
|
Certificate of Formation of
Clarksville Holdings, LLC
|
|
3
|
.228.
|
|
Limited Liability Company
Agreement of Clarksville Holdings, LLC
|
|
3
|
.229.
|
|
Certificate of Limited Partnership
of College Station Hospital, L.P.
|
|
3
|
.230.
|
|
Amended and Restated Limited
Partnership Agreement of College Station Hospital, L.P.
|
|
3
|
.231.
|
|
Certificate of Formation of
College Station Medical Center, LLC
|
|
3
|
.232.
|
|
Limited Liability Company
Agreement of College Station Medical Center, LLC
|
|
3
|
.233.
|
|
Certificate of Formation of
College Station Merger, LLC
|
|
3
|
.234.
|
|
Limited Liability Company
Agreement of College Station Merger, LLC
|
|
3
|
.235.
|
|
Certificate of Formation of CP
Hospital GP, LLC
|
|
3
|
.236.
|
|
Limited Liability Company
Agreement of CP Hospital GP, LLC
|
|
3
|
.237.
|
|
Certificate of Formation of CPLP,
LLC
|
|
3
|
.238.
|
|
Limited Liability Company
Agreement of CPLP, LLC
|
|
3
|
.239.
|
|
Certificate of Formation of
Crestwood Hospital LP, LLC
|
|
3
|
.240.
|
|
Amended and Restated Limited
Liability Company Agreement of Crestwood Hospital LP, LLC
|
|
3
|
.241.
|
|
Certificate of Formation of
Crestwood Hospital, LLC
|
|
3
|
.242.
|
|
Second Amended and Restated
Limited Liability Company Agreement of Crestwood Hospital,
LLC
|
|
3
|
.243.
|
|
Certificate of Formation of CSMC,
LLC
|
|
3
|
.244.
|
|
Amended and Restated Limited
Liability Company Agreement of CSMC, LLC
|
|
3
|
.245.
|
|
Certificate of Formation of CSRA
Holdings, LLC
|
|
3
|
.246.
|
|
Limited Liability Company
Agreement of CSRA Holdings, LLC
|
|
3
|
.247.
|
|
Certificate of Formation of
Deaconess Holdings, LLC
|
|
3
|
.248.
|
|
Amended and Restated Limited
Liability Company Agreement of Deaconess Holdings, LLC
|
|
3
|
.249.
|
|
Certificate of Formation of
Deaconess Hospital Holdings, LLC
|
|
3
|
.250.
|
|
Second Amended and Restated
Limited Liability Company Agreement of Deaconess Hospital
Holdings, LLC
|
|
3
|
.251.
|
|
Certificate of Formation of Desert
Hospital Holdings, LLC
|
|
3
|
.252.
|
|
Limited Liability Company
Agreement of Desert Hospital Holdings, LLC
|
II-20
|
|
|
|
|
Exhibit
|
|
|
No.
|
|
Description
|
|
|
3
|
.253.
|
|
Certificate of Formation of Detar
Hospital, LLC
|
|
3
|
.254.
|
|
Limited Liability Company
Agreement of Detar Hospital, LLC
|
|
3
|
.255.
|
|
Certificate of Formation of Dukes
Health System, LLC
|
|
3
|
.256.
|
|
Amended and Restated Limited
Liability Company Agreement of Dukes Health System, LLC
|
|
3
|
.257.
|
|
Certificate of Formation of
Gadsden Regional Medical Center, LLC
|
|
3
|
.258.
|
|
Limited Liability Company
Agreement of Gadsden Regional Medical Center, LLC
|
|
3
|
.259.
|
|
Certificate of Formation of
Greenbrier VMC, LLC
|
|
3
|
.260.
|
|
Limited Liability Company
Agreement of Greenbrier VMC, LLC
|
|
3
|
.261.
|
|
Certificate of Formation of GRMC
Holdings, LLC
|
|
3
|
.262.
|
|
Limited Liability Company
Agreement of GRMC Holdings, LLC
|
|
3
|
.263.
|
|
Certificate of Formation of Hobbs
Medco, LLC
|
|
3
|
.264.
|
|
Limited Liability Company
Agreement of Hobbs Medco, LLC
|
|
3
|
.265.
|
|
Certificate of Formation of Las
Cruces Medical Center, LLC
|
|
3
|
.266.
|
|
Amended and Restated Limited
Liability Company Agreement of Las Cruces Medical Center,
LLC
|
|
3
|
.267.
|
|
Certificate of Formation of Lea
Regional Hospital, LLC
|
|
3
|
.268.
|
|
Amended and Restated Limited
Liability Company Agreement of Lea Regional Hospital, LLC
|
|
3
|
.269.
|
|
Certificate of Formation of
Longview Merger, LLC
|
|
3
|
.270.
|
|
Limited Liability Company
Agreement of Longview Merger, LLC
|
|
3
|
.271.
|
|
Certificate of Formation of LRH,
LLC
|
|
3
|
.272.
|
|
Amended and Restated Limited
Liability Company Agreement of LRH, LLC
|
|
3
|
.273.
|
|
Certificate of Formation of
Lutheran Health Network of Indiana, LLC
|
|
3
|
.274.
|
|
Second Amended and Restated
Limited Liability Company Agreement of Lutheran Health Network
of Indiana, LLC
|
|
3
|
.275.
|
|
Certificate of Formation of
Massillon Health System, LLC
|
|
3
|
.276.
|
|
Second Amended and Restated
Operating Agreement of Massillon Health System, LLC
|
|
3
|
.277.
|
|
Certificate of Formation of
Medical Center of Brownwood, LLC
|
|
3
|
.278.
|
|
Limited Liability Company
Agreement of Medical Center of Brownwood, LLC
|
|
3
|
.279.
|
|
Certificate of Formation of MMC of
Nevada, LLC
|
|
3
|
.280.
|
|
Limited Liability Company
Agreement of MMC of Nevada, LLC
|
|
3
|
.281.
|
|
Certificate of Limited Partnership
of Navarro Hospital, L.P.
|
|
3
|
.282.
|
|
Limited Partnership Agreement of
Navarro Hospital, L.P.
|
|
3
|
.283.
|
|
Certificate of Formation of
Navarro Regional, LLC
|
|
3
|
.284.
|
|
Amended and Restated Limited
Liability Company Agreement of Navarro Regional, LLC
|
|
3
|
.285.
|
|
Certificate of Formation of NRH,
LLC
|
|
3
|
.286.
|
|
Amended and Restated Limited
Liability Company Agreement of NRH, LLC
|
|
3
|
.287.
|
|
Certificate of Formation of Oregon
Healthcorp, LLC
|
|
3
|
.288.
|
|
Limited Liability Company
Agreement of Oregon Healthcorp, LLC
|
|
3
|
.289.
|
|
Certificate of Formation of
Palmer-Wasilla Health System, LLC
|
|
3
|
.290.
|
|
Amended and Restated Limited
Liability Company Agreement of Palmer-Wasilla Health System,
LLC
|
|
3
|
.291.
|
|
Certificate of Formation of Quorum
Health Resources, LLC
|
|
3
|
.292.
|
|
Limited Liability Company
Agreement of Quorum Health Resources, LLC
|
|
3
|
.293.
|
|
Certificate of Formation of
Regional Hospital of Longview, LLC
|
|
3
|
.294.
|
|
Amended and Restated Limited
Liability Company Agreement of Regional Hospital of Longview,
LLC
|
|
3
|
.295.
|
|
Certificate of Formation of
Russellville Holdings, LLC
|
II-21
|
|
|
|
|
Exhibit
|
|
|
No.
|
|
Description
|
|
|
3
|
.296.
|
|
Limited Liability Company
Agreement of Russellville Holdings, LLC
|
|
3
|
.297.
|
|
Certificate of Formation of SACMC,
LLC
|
|
3
|
.298.
|
|
Amended and Restated Limited
Liability Company Agreement of SACMC, LLC
|
|
3
|
.299.
|
|
Certificate of Formation of
San Angelo Community Medical Center, LLC
|
|
3
|
.300.
|
|
Limited Liability Company
Agreement of San Angelo Community Medical Center, LLC
|
|
3
|
.301.
|
|
Certificate of Limited Partnership
of San Angelo Hospital, L.P.
|
|
3
|
.302.
|
|
Limited Partnership Agreement of
San Angelo Hospital, L.P.
|
|
3
|
.303.
|
|
Certificate of Formation of
San Angelo Medical, LLC
|
|
3
|
.304.
|
|
Limited Liability Company
Agreement of San Angelo Medical, LLC
|
|
3
|
.305.
|
|
Certificate of Formation of
Southern Texas Medical Center, LLC
|
|
3
|
.306.
|
|
Limited Liability Company
Agreement of Southern Texas Medical Center, LLC
|
|
3
|
.307.
|
|
Certificate of Formation of St.
Joseph Health System, LLC
|
|
3
|
.308.
|
|
Limited Liability Company
Agreement of St. Joseph Health System, LLC
|
|
3
|
.309.
|
|
Certificate of Incorporation of
Tennyson Holdings, Inc.
|
|
3
|
.310.
|
|
By-laws of Tennyson Holdings,
Inc.
|
|
3
|
.311.
|
|
Certificate of Formation of Triad
Holdings III, LLC
|
|
3
|
.312.
|
|
By-laws of Triad Holdings III,
LLC
|
|
3
|
.313.
|
|
Certificate of Formation of Triad
Holdings IV, LLC
|
|
3
|
.314.
|
|
Second Amended and Restated
Limited Liability Company Agreement of Triad Holdings IV,
LLC
|
|
3
|
.315.
|
|
Certificate of Formation of Triad
Holdings V, LLC
|
|
3
|
.316.
|
|
Limited Liability Company
Agreement of Triad Holdings V, LLC
|
|
3
|
.317.
|
|
Certificate of Incorporation of
Triad Healthcare Corporation
|
|
3
|
.318.
|
|
By-laws of Triad Healthcare
Corporation
|
|
3
|
.319.
|
|
Certificate of Formation of Triad
of Alabama, LLC
|
|
3
|
.320.
|
|
Amended and Restated Limited
Liability Company Agreement of Triad of Alabama, LLC
|
|
3
|
.321.
|
|
Certificate of Formation of Triad
of Oregon, LLC
|
|
3
|
.322.
|
|
Amended and Restated Limited
Liability Company Agreement of Triad of Oregon, LLC
|
|
3
|
.323.
|
|
Certificate of Formation of
Triad-ARMC, LLC
|
|
3
|
.324.
|
|
Limited Liability Company
Agreement of Triad-ARMC, LLC
|
|
3
|
.325.
|
|
Certificate of Formation of
Triad-Denton Hospital GP, LLC
|
|
3
|
.326.
|
|
Amended and Restated Limited
Liability Company Agreement of Triad-Denton Hospital GP,
LLC
|
|
3
|
.327.
|
|
Certificate of Limited Partnership
of Triad-Denton Hospital, L.P.
|
|
3
|
.328.
|
|
Limited Partnership Agreement of
Triad-Denton Hospital, L.P.
|
|
3
|
.329.
|
|
Certificate of Formation of
Triad-Navarro Regional Hospital Subsidiary, LLC
|
|
3
|
.330.
|
|
Limited Liability Company
Agreement of Triad-Navarro Regional Hospital Subsidiary,
LLC
|
|
3
|
.331.
|
|
Certificate of Formation of VHC
Medical, LLC
|
|
3
|
.332.
|
|
Limited Liability Company
Agreement of VHC Medical, LLC
|
|
3
|
.333.
|
|
Certificate of Formation of
Vicksburg Healthcare, LLC
|
|
3
|
.334.
|
|
Second Amended and Restated
Operating Agreement of Vicksburg Healthcare, LLC
|
|
3
|
.335.
|
|
Certificate of Formation of
Victoria Hospital, LLC
|
|
3
|
.336.
|
|
Limited Liability Company
Agreement of Victoria Hospital, LLC
|
|
3
|
.337.
|
|
Certificate of Limited Partnership
of Victoria of Texas, L.P.
|
|
3
|
.338.
|
|
Limited Partnership Agreement of
Victoria of Texas, L.P.
|
|
3
|
.339.
|
|
Certificate of Formation of WHMC,
LLC
|
II-22
|
|
|
|
|
Exhibit
|
|
|
No.
|
|
Description
|
|
|
3
|
.340.
|
|
Limited Liability Company
Agreement of WHMC, LLC
|
|
3
|
.341.
|
|
Certificate of Formation of
Willamette Valley Medical Center, LLC
|
|
3
|
.342.
|
|
Amended and Restated Limited
Liability Company Agreement of Willamette Valley Medical
Center, LLC
|
|
3
|
.343.
|
|
Certificate of Formation of Women
& Childrens Hospital, LLC
|
|
3
|
.344.
|
|
Amended and Restated Limited
Liability Company Agreement of Women & Childrens
Hospital, LLC
|
|
3
|
.345.
|
|
Certificate of Formation of
Woodland Heights Medical Center, LLC
|
|
3
|
.346.
|
|
Amended and Restated Limited
Liability Company Agreement of Woodland Heights Medical
Center, LLC
|
|
3
|
.347.
|
|
Certificate of Formation of
Woodward Health System, LLC
|
|
3
|
.348.
|
|
Limited Liability Company
Agreement of Woodward Health System, LLC
|
|
3
|
.349.
|
|
Certificate of Incorporation of
QHG Georgia Holdings, Inc.
|
|
3
|
.350.
|
|
By-laws of QHG Georgia Holdings,
Inc.
|
|
3
|
.351.
|
|
Certificate of Limited Partnership
of QHG Georgia, L.P.
|
|
3
|
.352.
|
|
Limited Partnership Agreement of
QHG Georgia, L.P.
|
|
3
|
.353.
|
|
Certificate of Incorporation of
Frankfort Health Partner, Inc.
|
|
3
|
.354.
|
|
By-laws of Frankfort Health
Partner, Inc.
|
|
3
|
.355.
|
|
Certificate of Limited Partnership
of IOM Health System, L.P.
|
|
3
|
.356.
|
|
Limited Partnership Agreement of
IOM Health System, L.P.
|
|
3
|
.357.
|
|
Certificate of Incorporation of
QHG of Bluffton, Inc.
|
|
3
|
.358.
|
|
By-laws of QHG of Bluffton,
Inc.
|
|
3
|
.359.
|
|
Certificate of Incorporation of
QHG of Clinton County, Inc.
|
|
3
|
.360.
|
|
By-laws of QHG of Clinton County,
Inc.
|
|
3
|
.361.
|
|
Certificate of Incorporation of
QHG of Fort Wayne, Inc.
|
|
3
|
.362.
|
|
By-laws of QHG of Fort Wayne,
Inc.
|
|
3
|
.363.
|
|
Certificate of Incorporation of
QHG of Warsaw, Inc.
|
|
3
|
.364.
|
|
By-laws of QHG of Warsaw,
Inc.
|
|
3
|
.365.
|
|
Certificate of Incorporation of
QHG of Forrest County, Inc.
|
|
3
|
.366.
|
|
By-laws of QHG of Forrest County,
Inc.
|
|
3
|
.367.
|
|
Certificate of Incorporation of
QHG of Hattiesburg, Inc.
|
|
3
|
.368.
|
|
By-laws of QHG of Hattiesburg,
Inc.
|
|
3
|
.369.
|
|
Certificate of Incorporation of
River Region Medical Corporation
|
|
3
|
.370.
|
|
Amended and Restated By-laws of
River Region Medical Corporation
|
|
3
|
.371.
|
|
Certificate of Incorporation of
NC-DSH, Inc.
|
|
3
|
.372.
|
|
By-laws of NC-DSH, Inc.
|
|
3
|
.373.
|
|
Certificate of Incorporation of
QHG of Barberton, Inc.
|
|
3
|
.374.
|
|
By-laws of QHG of Barberton,
Inc.
|
|
3
|
.375.
|
|
Certificate of Incorporation of
QHG of Massillon, Inc.
|
|
3
|
.376.
|
|
By-laws of QHG of Massillon,
Inc.
|
|
3
|
.377.
|
|
Certificate of Formation of
SouthCrest, L.L.C.
|
|
3
|
.378.
|
|
Second Amended and Restated
Operating Agreement of SouthCrest, L.L.C.
|
|
3
|
.379.
|
|
Certificate of Incorporation of
Triad-South Tulsa Hospital Company, Inc.
|
|
3
|
.380.
|
|
By-laws of Triad-South Tulsa
Hospital Company, Inc.
|
|
3
|
.381.
|
|
Certificate of Incorporation of
QHG of South Carolina, Inc.
|
II-23
|
|
|
|
|
Exhibit
|
|
|
No.
|
|
Description
|
|
|
3
|
.382.
|
|
By-laws of QHG of South Carolina,
Inc.
|
|
3
|
.383.
|
|
Certificate of Incorporation of
QHG of Spartanburg, Inc.
|
|
3
|
.384.
|
|
By-laws of QHG of Spartanburg,
Inc.
|
|
4
|
.1
|
|
Senior Notes Indenture, dated as
of July 25, 2007, by and among CHS/Community Health Systems,
Inc., the Guarantors party thereto and U.S. Bank National
Association, as Trustee (incorporated by reference to
Exhibit 4.3 to the Companys Current Report on
Form 8-K filed July 24, 2007
(No. 001-15925))
|
|
4
|
.2
|
|
Registration Rights Agreement,
dated as of July 25, 2007, by and among CHS/Community Health
Systems, Inc., the Guarantors party thereto and the Initial
Purchasers (incorporated by reference to Exhibit 4.1 to the
Companys Current Report on Form 8-K filed
July 24, 2007
(No. 001-15925))
|
|
4
|
.3
|
|
Form of
87/8% Senior
Note due 2015 (included in Exhibit 4.1)
|
|
5
|
.1
|
|
Opinion of Kirkland & Ellis
LLP
|
|
10
|
.1
|
|
Amended and Restated Credit
Agreement dated as of August 19, 2004, among, CHS/Community
Health Systems, Inc., Community Health Systems, Inc., JPMorgan
Chase Bank, as Administrative Agent, Wachovia Bank, National
Association, as Syndication Agent, Bank of America, N.A., as
Documentation Agent and JP Morgan Securities Inc. and Banc of
America Securities LLC as Joint Lead Arrangers and Joint
Bookrunners and the other lender party thereto (incorporated by
reference to Exhibit 10.1 to the Registrants Quarterly
Report on Form 10-Q for the quarter ended June 30, 2002)
|
|
10
|
.2
|
|
First Amendment and Waiver, dated
as of December 16, 2004 representing an amendment to the Amended
and Restated Wachovia Credit Agreement dated as of August 19,
2004, among CHS/Community Health Systems, Inc., Community Health
Systems, Inc., JPMorgan Chase Bank, as Administrative Agent,
Wachovia Bank, National Association, as Syndication Agent Bank
of America, N.A., as Documentation Agent and JP Morgan
Securities Inc. and Banc of America Securities LLC as Joint Lead
Arrangers and Joint Bookrunners and the other lenders party
thereto (incorporated by reference to Exhibit 10.10 to the
Companys Annual Report on Form 10-K for the year ended
December 31, 2004)
|
|
10
|
.3
|
|
Second Amendment dated as of July
8, 2005, to the Amended and Restated Credit Agreement dated as
of August 19, 2004, among CHS/Community Health Systems, Inc.,
Community Health Systems, Inc., the several lenders thereto, JP
Morgan Chase Bank, as Administrative Agent, Wachovia Bank,
National Association, as Syndication Agent, and Bank of America,
N.A., as Documentation Agent (incorporated by reference to
Exhibit 10.1 to the Companys Current Report on Form 8-K
filed July 13, 2005 (No. 001-15925))
|
|
10
|
.4
|
|
Third Amendment, dated December
13, 2006, among CHS/CHS Community Health Systems, Inc.,
Community Health Systems, Inc., the several banks and other
financial institutions lenders parties thereto, JP Morgan Chase
Bank, as Administrative Agent, Wachovia Bank, National
Association, as Syndication Agent, and Bank of America, National
Association, as Documentation Agent (incorporated by reference
to Exhibit 10.2 to the Companys Current Report on Form 8-K
filed December 13, 2006 (No. 001-15925))
|
|
10
|
.5
|
|
First Incremental Facility
Amendment, dated as of December 13, 2006, among CHS/CHS
Community Health Systems, Inc., Community Health Systems, Inc.,
the several banks and other financial institutions lenders
parties thereto, JP Morgan Chase Bank, as Administrative Agent,
Wachovia Bank, National Association, as Syndication Agent, and
Bank of America, National Association, as Documentation Agent
(incorporated by reference to Exhibit 10.1 to the Companys
Current Report on Form 8-K filed December 13, 2006 (No.
001-15925))
|
|
10
|
.6
|
|
Form of outside director Stock
Option Agreement (incorporated by reference to Exhibit 10.1 to
the Companys Registration Statement on Form S-1 (No.
333-31790))
|
|
10
|
.7
|
|
Form of Amendment No. 1 to the
Director Stock Option Agreement (incorporated by reference to
the Companys Registration Statement on Form S-8 (No.
333-10034977))
|
II-24
|
|
|
|
|
Exhibit
|
|
|
No.
|
|
Description
|
|
|
10
|
.8
|
|
Community Health Systems, Inc.
Amended and Restated 2000 Stock Option and Award Plan, as
amended and restated on February 23, 2005 (incorporated by
reference to Exhibit 10.1 to the Companys Current Report
on Form 8-K filed February 28, 2005 (No. 001-15925))
|
|
10
|
.9
|
|
Form of Amendment No. 1 to the
Community Health Systems, Inc. Amended and Restated 2000 Stock
Option and Award Plan (incorporated by reference to Exhibit 99.1
to the Companys Current Report on Form 8-K dated December
20, 2005)
|
|
10
|
.10
|
|
Form of Restricted Stock Award
Agreement (Directors) (incorporated by reference to Exhibit 99.2
to the Companys Current Report on Form 8-K dated December
20, 2005)
|
|
10
|
.11
|
|
Community Health Systems Deferred
Compensation Plan Trust, Amended and Restated Effective February
26, 1999 (incorporated by reference to Exhibit 10.18 to the
Companys Annual Report on Form 10-K for the year ended
December 31, 2002)
|
|
10
|
.12
|
|
Community Health Systems Deferred
Compensation Plan, as amended effective October 1, 1993; January
1, 1994; January 1, 1998; April 1, 1999; July 1, 2000; and June
1, 2001 (incorporated by reference to Exhibit 10.19 to the
Companys Annual Report on Form 10-K for the year ended
December 31, 2002)
|
|
10
|
.13
|
|
Community Health Systems, Inc.
Directors Fees Deferral Plan (incorporated by reference to
Exhibit 10.18 to the Companys Annual Report on Form 10-K
for the year ended December 31, 2004)
|
|
10
|
.14
|
|
Form of Restricted Stock Award
Agreement (incorporated by reference to Exhibit 10.2 to the
Companys Current Report on Form 8-K filed February 28,
2005 (No. 001-15925))
|
|
10
|
.15
|
|
Form of Indemnification Agreement
between the Registrant and its directors and executive officers
(incorporated by reference to Exhibit 10.8 to the Companys
Current Report on Form 8-K filed February 28, 2005 (No.
001-15925))
|
|
10
|
.16
|
|
Community Health Systems, Inc.
Supplemental Executive Retirement Plan (incorporated by
reference to Exhibit 10.17 to the Companys Annual Report
on Form 10-K for the year ended December 31, 2002)
|
|
10
|
.17
|
|
Amendment No. 2 to the Community
Health Systems, Inc. Supplemental Executive Retirement Plan
dated December 10, 2002 (incorporated by reference to Exhibit
10.2 to the Companys Current Report on Form 8-K filed June
1, 2005 (No. 001-15925))
|
|
10
|
.18
|
|
Supplemental Executive Retirement
Plan Trust, dated June 1, 2005, by and between CHS/Community
Health Systems, Inc., as grantor, and Wachovia Bank, N.A., as
trustee (incorporated by reference to Exhibit 10.3 to the
Companys Current Report on Form 8-K filed June 1, 2005
(No. 001-15925))
|
|
10
|
.19
|
|
Participation Agreement entered
into as of January 1, 2005, by and between Community Health
Systems Professional Services Corporation and HealthTrust
Purchasing Group, L.P. (incorporated by reference to Exhibit
10.19 to the Companys Annual Report on Form 10-K for the
year ended December 31, 2004)
|
|
10
|
.20
|
|
Form of Performance Based
Restricted Stock Award Agreement between Registrant and its
executive officers (incorporated by reference to Exhibit 10.1 to
the Companys Current Report on Form 8-K filed March 3,
2006 (No. 001-15925))
|
|
12
|
.1
|
|
Statement re Computation of Ratio
of Earnings to Fixed Charges
|
|
21
|
|
|
List of subsidiaries
|
|
23
|
.1
|
|
Consent of Deloitte & Touche
LLP
|
|
23
|
.2
|
|
Consent of Ernst & Young LLP
|
|
24
|
.1
|
|
Power of Attorney (included in the
signature pages hereto)
|
|
25
|
.1
|
|
Statement of Eligibility of
Trustee
|
|
99
|
.1
|
|
Form of Letter of
Transmittal
|
|
|
|
* |
|
Management Contract or Compensation Plan or Arrangement |
|
|
|
To be filed by amendment. |
II-25
The undersigned registrants hereby undertake:
(a) To file, during any period in which offers or sales are
being made, a post-effective amendment to this registration
statement:
(i) to include any prospectus required by
Section 10(a)(3) of the Securities Act of 1933;
(ii) to reflect in the prospectus any facts or events
arising after the effective date of the registration statement
(or the most recent post-effective amendment thereof) which
individually or in the aggregate, represent a fundamental change
in the information set forth in the registration statement.
Notwithstanding the foregoing, any increase or decrease in the
volume of securities offered (if the total dollar value of
securities offered would not exceed that which was registered)
and any deviation from the low or high end of the estimated
maximum offering range may be reflected in the form of
prospectus filed with the Commission pursuant to
Rule 424(b) if, in the aggregate, the changes in volume and
price represent no more than 20 percent change in the
maximum aggregate offering price set forth in the
Calculation of Registration Fee table in the
effective registration statement; and
(iii) to include any material information with respect to
the plan of distribution not previously disclosed in the
registration statement or any material change to such
information in the registration statement;
(b) That, for the purpose of determining any liability
under the Securities Act, each such post-effective amendment
shall be deemed to be a new registration statement relating to
the securities offered therein, and the offering of such
securities at that time shall be deemed to be the initial
bona fide offering thereof.
(c) To remove from the registration by means of a
post-effective amendment any of the securities being registered
which remain unsold at the termination of the offering.
(d) That, for purposes of determining liability under the
Securities Act of 1933 to any purchaser, each prospectus filed
pursuant to Rule 424(b) as part of a registration statement
relating to an offering, other than registration statements
relying on Rule 430B or other than prospectuses filed in
reliance on Rule 430A, shall be deemed to be part of and
included in the registration statement as of the date it is
first used after effectiveness. Provided, however, that no
statement made in a registration statement or prospectus that is
part of the registration statement or made in a document
incorporated or deemed incorporated by reference into the
registration statement or prospectus that is part of the
registration statement will, as to a purchaser with a time of
contract of sale prior to such first use, supersede or modify
any statement that was made in the registration statement or
prospectus that was part of the registration statement or made
in any such document immediately prior to such date of first use.
(e) That, for the purpose of determining liability of the
registrants under the Securities Act to any purchaser in the
initial distribution of the securities: The undersigned
registrants undertake that in a primary offering of securities
of the undersigned registrants pursuant to this registration
statement, regardless of the underwriting method used to sell
the securities to the purchaser, if the securities are offered
or sold to such purchaser by means of any of the following
communications, the undersigned registrants will each be a
seller to the purchaser and will be considered to offer or sell
such securities to such purchaser:
(i) any preliminary prospectus or prospectus of the
undersigned registrants relating to the offering required to be
filed pursuant to Rule 424;
(ii) any free writing prospectus relating to the offering
prepared by or on behalf of the undersigned registrant or used
or referred to by the undersigned registrants;
II-26
(iii) the portion of any other free writing prospectus
relating to the offering containing material information about
the undersigned registrant or its securities provided by or on
behalf of the undersigned registrants; and
(iv) any other communication that is an offer in the
offering made by the undersigned registrants to the purchaser.
(f) Insofar as indemnification for liabilities arising
under the Securities Act may be permitted to directors, officers
and controlling persons of the registrants pursuant to the
provisions described in Item 20, or otherwise, the registrant
has been advised that in the opinion of the Securities and
Exchange Commission such indemnification is against public
policy as expressed in the Securities Act and is, therefore,
unenforceable. In the event that a claim for indemnification
against such liabilities (other than the payment by the
registrant of expenses incurred or paid by a director, officer
or controlling person of the registrant in the successful
defense of any action, suit or proceeding) is asserted by such
director, officer or controlling person in connection with the
securities being registered, the registrant will, unless in the
opinion of its counsel the matter has been settled by
controlling precedent, submit to a court of appropriate
jurisdiction the question whether such indemnification by it is
against public policy as expressed in the Securities Act and
will be governed by the final adjudication of such issue.
(g) To respond to requests for information that is
incorporated by reference into the prospectus pursuant to
Items 4, 10(b), or 11 or 13 of this form, within one
business day of receipt of such request, and to send the
incorporated documents by first class mail or other equally
prompt means. This includes information contained in documents
filed subsequent to the date of the registration statement
through the date of responding to the request.
(h) To supply by means of a post-effective amendment all
information concerning a transaction, and the company being
acquired involved therein, that was not the subject of and
included in the registration statement when it became effective.
II-27
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the
registrant has duly caused this registration statement to be
signed on its behalf by the undersigned, thereunto duly
authorized, in the City of Franklin, State of Tennessee, on
September 24, 2007.
CHS/COMMUNITY HEALTH SYSTEMS, INC.
(Registrant)
Wayne T. Smith
Chairman of the Board,
President and Chief Executive Officer
POWER OF
ATTORNEY
Each person whose signature appears below constitutes and
appoints Wayne T. Smith, W. Larry Cash and Rachel A. Seifert,
and each of them singly, his or her true and lawful
attorneys-in-fact and agents, with full power of substitution
and resubstitution, for him or her and in his or her name, place
and stead, in any and all capacities, to sign any and all
amendments (including post-effective amendments) to this
registration statement and any and all additional registration
statements pursuant to Rule 462(b) of the Securities Act of
1933, as amended, and to file the same, with all exhibits
thereto, and all other documents in connection therewith, with
the Securities and Exchange Commission, granting unto each said
attorney-in-fact and agents full power and authority to do and
perform each and every act in person, hereby ratifying and
confirming all that said attorneys-in-fact and agents or either
of them or their or his or her substitute or substitutes may
lawfully do or cause to be done by virtue hereof.
Pursuant to the requirements of the Securities Act of 1933, this
registration statement has been signed by the following persons
in the capacities and on the dates indicated.
|
|
|
|
|
|
|
Name
|
|
Title
|
|
Date
|
|
|
|
|
|
|
/s/ Wayne
T. Smith
Wayne
T. Smith
|
|
Chairman of the Board,
President, Chief Executive Officer
and Director
(Principal Executive Officer)
|
|
September 24, 2007
|
|
|
|
|
|
/s/ W.
Larry Cash
W.
Larry Cash
|
|
Executive Vice President,
Chief Financial Officer and Director (Principal Financial
Officer)
|
|
September 24, 2007
|
|
|
|
|
|
/s/ T.
Mark Buford
T.
Mark Buford
|
|
Vice President and Corporate
Controller
(Principal Accounting Officer)
|
|
September 24, 2007
|
|
|
|
|
|
/s/ Rachel
A. Seifert
Rachel
A. Seifert
|
|
Director
|
|
September 24, 2007
|
II-28
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the
registrant has duly caused this registration statement to be
signed on its behalf by the undersigned, thereunto duly
authorized, in the City of Franklin, State of Tennessee, on
September 24, 2007.
COMMUNITY HEALTH SYSTEMS, INC.
(Registrant)
Wayne T. Smith
Chairman of the Board,
President and Chief Executive Officer
POWER OF
ATTORNEY
Each person whose signature appears below constitutes and
appoints Wayne T. Smith, W. Larry Cash and Rachel A. Seifert,
and each of them singly, his or her true and lawful
attorneys-in-fact and agents, with full power of substitution
and resubstitution, for him or her and in his or her name, place
and stead, in any and all capacities, to sign any and all
amendments (including post-effective amendments) to this
registration statement and any and all additional registration
statements pursuant to Rule 462(b) of the Securities Act of
1933, as amended, and to file the same, with all exhibits
thereto, and all other documents in connection therewith, with
the Securities and Exchange Commission, granting unto each said
attorney-in-fact and agents full power and authority to do and
perform each and every act in person, hereby ratifying and
confirming all that said attorneys-in-fact and agents or either
of them or their or his or her substitute or substitutes may
lawfully do or cause to be done by virtue hereof.
Pursuant to the requirements of the Securities Act of 1933, this
registration statement has been signed by the following persons
in the capacities and on the dates indicated.
|
|
|
|
|
|
|
Name
|
|
Title
|
|
Date
|
|
|
|
|
|
|
/s/ Wayne
T. Smith
Wayne
T. Smith
|
|
Chairman of the Board,
President and Chief Executive Officer
(Principal Executive Officer)
|
|
September 24, 2007
|
|
|
|
|
|
/s/ W.
Larry Cash
W.
Larry Cash
|
|
Executive Vice President,
Chief Financial Officer and Director (Principal Financial
Officer)
|
|
September 24, 2007
|
|
|
|
|
|
/s/ T.
Mark Buford
T.
Mark Buford
|
|
Vice President and Corporate
Controller
(Principal Accounting Officer)
|
|
September 24, 2007
|
|
|
|
|
|
/s/ Harvey
Klein, M.D.
Harvey
Klein, M.D.
|
|
Director
|
|
September 24, 2007
|
|
|
|
|
|
/s/ H.
Mitchell Watson,
Jr.
H.
Mitchell Watson, Jr.
|
|
Director
|
|
September 24, 2007
|
II-29
|
|
|
|
|
|
|
Name
|
|
Title
|
|
Date
|
|
|
|
|
|
|
/s/ Dale
F. Frey
Dale
F. Frey
|
|
Director
|
|
September 24, 2007
|
|
|
|
|
|
/s/ John
A. Fry
John
A. Fry
|
|
Director
|
|
September 24, 2007
|
|
|
|
|
|
/s/ John
A. Clerico
John
A. Clerico
|
|
Director
|
|
September 24, 2007
|
|
|
|
|
|
/s/ Julia
B. North
Julia
B. North
|
|
Director
|
|
September 24, 2007
|
II-30
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, each
of the Registrants listed on
Schedule A-1
hereto has duly caused this registration statement to be signed
on its behalf by the undersigned, thereunto duly authorized, in
the City of Franklin, State of Tennessee, on September 24,
2007.
Each of the Registrants Named on
Schedule A-1
Hereto
|
|
|
|
By:
|
/s/ Martin
G. Schweinhart
|
Martin G. Schweinhart
President
POWER OF
ATTORNEY
Each of the undersigned officers and directors of each of the
Registrants listed on
Schedule A-1
hereto hereby constitutes and appoints W. Larry Cash and Rachel
A. Seifert, and each of them singly, his or her true and lawful
attorneys-in-fact and agents, with full power of substitution
and resubstitution, for him or her and in his or her name, place
and stead, in any and all capacities, to sign any and all
amendments (including
post-effective
amendments) to this registration statement and any and all
additional registration statements pursuant to Rule 462(b)
of the Securities Act of 1933, as amended, and to file the same,
with all exhibits thereto, and all other documents in connection
therewith, with the Securities and Exchange Commission, granting
unto each said attorney-in-fact and agents full power and
authority to do and perform each and every act in person, hereby
ratifying and confirming all that said attorneys-in-fact and
agents or either of them or their or his or her substitute or
substitutes may lawfully do or cause to be done by virtue hereof.
Pursuant to the requirements of the Securities Act of 1933, this
registration statement has been signed by the following persons
in the capacities and on the dates indicated.
|
|
|
|
|
|
|
Name
|
|
Title
|
|
Date
|
|
|
|
|
|
|
/s/ Martin
G.
Schweinhart
Martin
G. Schweinhart
|
|
President and Director
(Principal Executive Officer)
|
|
September 24, 2007
|
|
|
|
|
|
/s/ W.
Larry Cash
W.
Larry Cash
|
|
Executive Vice President
and Director
(Principal Financial Officer)
|
|
September 24, 2007
|
|
|
|
|
|
/s/ T.
Mark Buford
T.
Mark Buford
|
|
Vice President
(Principal Accounting Officer)
|
|
September 24, 2007
|
|
|
|
|
|
/s/ Rachel
A. Seifert
Rachel
A. Seifert
|
|
Director
|
|
September 24, 2007
|
II-31
Schedule A-1
Registrants
Centre Hospital Corporation
Cullman Hospital Corporation
Foley Hospital Corporation
Fort Payne Hospital Corporation
Greenville Hospital Corporation
Forrest City Arkansas Hospital Company, LLC
Forrest City Hospital Corporation
Phillips Hospital Corporation
Payson Hospital Corporation
CHHS Holdings, LLC
Community GP Corp.
Community Health Investment Corporation
Community LP Corp.
Fallbrook Hospital Corporation
Hallmark Healthcare Corporation
Hospital of Barstow, Inc.
Lancaster Hospital Corporation
National Healthcare of Cleveland, Inc.
National Healthcare of Cullman, Inc.
National Healthcare of Decatur, Inc.
National Healthcare of Hartselle, Inc.
National Healthcare of Leesville, Inc.
National Healthcare of Mt. Vernon, Inc.
National Healthcare of Newport, Inc.
Pennsylvania Hospital Company, LLC
Phoenixville Hospital Company, LLC
Pottstown Hospital Company, LLC
Ruston Hospital Corporation
Watsonville Hospital Corporation
Webb Hospital Corporation\
Webb Hospital Holdings, LLC
Fannin Regional Hospital, Inc.
Anna Hospital Corporation
Galesburg Hospital Corporation
Granite City Hospital Corporation
Granite City Illinois Hospital Company, LLC
Marion Hospital Corporation
Red Bud Hospital Corporation
Red Bud Illinois Hospital Company, LLC
Waukegan Hospital Corporation
Waukegan Illinois Hospital Company, LLC
Hospital of Fulton, Inc.
Hospital of Louisa, Inc.
Jackson Hospital Corporation
Emporia Hospital Corporation
Ruston Louisiana Hospital Company, LLC
Farmington Hospital Corporation
Farmington Missouri Hospital Company, LLC
Kirksville Hospital Corporation
Moberly Hospital, Inc.
Williamston Hospital Corporation
Salem Hospital Corporation
Deming Hospital Corporation
Roswell Hospital Corporation
San Miguel Hospital Corporation
Kay County Hospital Corporation
Kay County Oklahoma Hospital Company, LLC
CHS Berwick Hospital Corporation
Clinton Hospital Corporation
Coatesville Hospital Corporation
Northampton Hospital Corporation
Sunbury Hospital Corporation
West Grove Hospital Corporation
Brownsville Hospital Corporation
Cleveland Hospital Corporation
Dyersburg Hospital Corporation
Hospital of Morristown, Inc.
Jackson Hospital Corporation
Jackson, Tennessee Hospital Company, LLC
Lakeway Hospital Corporation
Lexington Hospital Corporation
Martin Hospital Corporation
McKenzie Hospital Corporation
McNairy Hospital Corporation
Shelbyville Hospital Corporation
Sparta Hospital Corporation
Big Bend Hospital Corporation
Big Spring Hospital Corporation
Granbury Hospital Corporation
Jourdanton Hospital Corporation
NHCI of Hillsboro, Inc.
Weatherford Hospital Corporation
Weatherford Texas Hospital Company, LLC
Tooele Hospital Corporation
Franklin Hospital Corporation
Petersburg Hospital Company, LLC
Russell County Medical Center, Inc.
Virginia Hospital Company, LLC
Oak Hill Hospital Corporation
Evanston Hospital Corporation
Forrest City Clinic Company, LLC
QHG of Enterprise, Inc.
QHG of Jacksonville, Inc.
QHG of Springdale, Inc.
Triad El Dorado, Inc.
Abilene Hospital, LLC
Abilene Merger, LLC
Arizona DH, LLC
Birmingham Holdings, LLC
Bluffton Health System, LLC
Brownwood Medical Center, LLC
Carlsbad Medical Center, LLC
Claremore Regional Hospital, LLC
Clarksville Holdings, LLC
College Station Medical Center, LLC
College Station Merger, LLC
CP Hospital GP, LLC
CPLP, LLC
Crestwood Hospital LP, LLC
Crestwood Hospital, LLC
CSMC, LLC
CSRA Holdings, LLC
Deaconess Holdings, LLC
Deaconess Hospital Holdings, LLC
Desert Hospital Holdings, LLC
Detar Hospital, LLC
Dukes Health System, LLC
Gadsden Regional Medical Center, LLC
Greenbrier VMC, LLC
GRMC Holdings, LLC
Hobbs Medco, LLC
Las Cruces Medical Center, LLC
Lea Regional Hospital, LLC
Longview Merger, LLC
LRH, LLC
Lutheran Health Network of Indiana, LLC
Massillon Health System, LLC
Medical Center of Brownwood, LLC
MMC of Nevada, LLC
Navarro Regional, LLC
NRH, LLC
Oregon Healthcorp, LLC
Palmer-Wasilla Health System, LLC
Regional Hospital of Longview, LLC
Russellville Holdings, LLC
SACMC, LLC
San Angelo Community Medical Center, LLC
San Angelo Medical, LLC
Southern Texas Medical Center, LLC
St. Joseph Health System, LLC
Tennyson Holdings, Inc.
Triad Holdings III, LLC
Triad Holdings IV, LLC
Triad Holdings V, LLC
Triad Healthcare Corporation
(f/k/a Triad Hospitals, Inc.)
Triad of Alabama, LLC
Triad of Oregon, LLC
Triad-ARMC, LLC
Triad-Denton Hospital GP, LLC
Triad-Navarro Regional Hospital Subsidiary, LLC
VHC Medical, LLC
Vicksburg Healthcare, LLC
Victoria Hospital, LLC
WHMC, LLC
Willamette Valley Medical Center, LLC
Women & Childrens Hospital, LLC
Woodland Heights Medical Center, LLC
Woodward Health System, LLC
QHG Georgia Holdings, Inc.
Frankfort Health Partner, Inc.
QHG of Bluffton, Inc.
QHG of Clinton County, Inc.
QHG of Fort Wayne, Inc.
QHG of Warsaw, Inc.
QHG of Forrest County, Inc.
QHG of Hattiesburg, Inc.
River Region Medical Corporation
NC-DSH, Inc.
QHG of Barberton, Inc.
QHG of Massillon, Inc.
SouthCrest, L.L.C.
Triad-South Tulsa Hospital Company, Inc.
QHG of South Carolina, Inc.
QHG of Spartanburg, Inc.
Quorum Health Resources, LLC
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the
registrants listed below have duly caused this registration
statement to be signed on its behalf by the undersigned,
thereunto duly authorized, in the City of Franklin, State of
Tennessee, on September 24, 2007.
Chesterfield/Marlboro, L.P.
Its General Partner
Cleveland Regional Medical Center, L.P.
Its: General Partner
ARMC, L.P.
Its: General Partner
Brownwood Hospital, L.P.
|
|
|
|
|
By: Brownwood Medical Center, LLC
|
Its: General Partner
College Station Hospital, L.P.
|
|
|
|
|
By: College Station Medical Center, LLC
|
Its: General Partner
Navarro Hospital, L.P.
|
|
|
|
|
By: Navarro Regional, LLC
|
Its: General Partner
San Angelo Hospital, L.P.
|
|
|
|
|
By: San Angelo Community Medical Center, LLC
|
Its: General Partner
Triad-Denton Hospital, L.P.
|
|
|
|
|
By: Triad-Denton Hospital GP, LLC
|
Its: General Partner
Victoria of Texas, L.P.
Its: General Partner
QHG Georgia, LP
|
|
|
|
|
By: QHG Georgia Holdings, Inc.
|
Its: General Partner
IOM Health System, L.P.
|
|
|
|
|
By: Lutheran Health Network of Indiana, LLC
|
Its: General Partner
|
|
|
|
By:
|
/s/ Martin
G. Schweinhart
|
Martin G. Schweinhart
President
POWER OF
ATTORNEY
Each of the undersigned officers and directors of each of the
Registrants listed above hereby constitutes and appoints W.
Larry Cash and Rachel A. Seifert, and each of them singly, his
or her true and lawful attorneys-in-fact and agents, with full
power of substitution and resubstitution, for him or her and in
his or her name, place and stead, in any and all capacities, to
sign any and all amendments (including post-effective
amendments) to this registration statement and any and all
additional registration statements pursuant to Rule 462(b)
of the Securities Act of 1933, as amended, and to file the same,
with all exhibits thereto, and all other documents in connection
therewith, with the Securities and Exchange Commission, granting
unto each said attorney-in-fact and agents full power and
authority to do and perform each and every act in person, hereby
ratifying and confirming all that said attorneys-in-fact and
agents or either of them or their or his or her substitute or
substitutes may lawfully do or cause to be done by virtue hereof.
Pursuant to the requirements of the Securities Act of 1933, this
registration statement has been signed by the following persons
in the capacities and on the dates indicated.
|
|
|
|
|
|
|
Name
|
|
Title
|
|
Date
|
|
|
|
|
|
|
/s/ Martin
G.
Schweinhart
Martin
G. Schweinhart
|
|
President and Director
(Principal Executive Officer)
|
|
September 24, 2007
|
|
|
|
|
|
/s/ W.
Larry Cash
W.
Larry Cash
|
|
Executive Vice President and
Director (Principal Financial Officer)
|
|
September 24, 2007
|
|
|
|
|
|
/s/ T.
Mark Buford
T.
Mark Buford
|
|
Vice President
(Principal Accounting Officer)
|
|
September 24, 2007
|
|
|
|
|
|
/s/ Rachel
A. Seifert
Rachel
A. Seifert
|
|
Director
|
|
September 24, 2007
|
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, each
of the Registrants listed below have duly caused this
registration statement to be signed on its behalf by the
undersigned, thereunto duly authorized, in the City of Franklin,
State of Tennessee, on September 24, 2007.
CHS HOLDINGS CORP.
HALLMARK HOLDINGS CORP.
Kathleen Fritz
President
POWER OF
ATTORNEY
Each of the undersigned officers and directors of each of the
Registrants listed on
Schedule A-1
hereto hereby constitutes and appoints W. Larry Cash and Rachel
A. Seifert, and each of them singly, his or her true and lawful
attorneys-in-fact and agents, with full power of substitution
and resubstitution, for him or her and in his or her name, place
and stead, in any and all capacities, to sign any and all
amendments (including
post-effective
amendments) to this registration statement and any and all
additional registration statements pursuant to Rule 462(b)
of the Securities Act of 1933, as amended, and to file the same,
with all exhibits thereto, and all other documents in connection
therewith, with the Securities and Exchange Commission, granting
unto each said attorney-in-fact and agents full power and
authority to do and perform each and every act in person, hereby
ratifying and confirming all that said attorneys-in-fact and
agents or either of them or their or his or her substitute or
substitutes may lawfully do or cause to be done by virtue hereof.
Pursuant to the requirements of the Securities Act of 1933, this
registration statement has been signed by the following persons
in the capacities and on the dates indicated.
|
|
|
|
|
|
|
Name
|
|
Title
|
|
Date
|
|
|
|
|
|
|
/s/ Kathleen
Fritz
Kathleen
Fritz
|
|
President and Director
(Principal Executive Officer)
|
|
September 24, 2007
|
|
|
|
|
|
/s/ Cathleen
Danielsson
Cathleen
Danielsson
|
|
Vice President, Secretary,
Treasurer and Director (Principal Financial Officer and
Principal Accounting Officer)
|
|
September 24, 2007
|
Ex-23.1 - Consent of Deloitte & Touche LLP
Exhibit
23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in this Registration Statement on Form S-4
of our report dated February 20, 2007 (September 20, 2007 as to Notes 13 and 15) relating to
the consolidated financial statements of Community Health Systems, Inc. appearing in the
current report on Form 8-K dated September 20, 2007 (which report expresses an unqualified
opinion and includes and explanatory paragraph referring to the Company adopting the fair
value recognition provisions of Statement of Financial Accounting Standards No. 123 (Revised
2004), Share Based Payment effective January 1, 2006). We also consent to the incorporation
by reference in this Registration Statement on Form S-4 of our reports dated February 20, 2007
relating to the financial statement schedule(s) of Community Health Systems, Inc. and
managements report on the effectiveness of internal control over financial reporting included
in Item 9 and Item 15 of the Annual Report on the Companys Form 10-K for the fiscal year
ended December 31, 2006. We also consent to the reference to us under the heading Experts in
the Prospectus, which is part of this Registration Statement.
/s/ Deloitte & Touche LLP
Nashville, Tennessee
September 20, 2007
Ex-23.2 Consent of Ernst & Young, LLP
Exhibit 23.2
Consent of Independent Registered Public Accounting Firm
We consent
to the reference to our firm under the caption Independent
Registered Public Accounting Firms in the Registration Statement
(Form S-4) for the registration of $3,021,331,000 CHS/Community Health Systems, Inc. 8 7/8% Senior
Notes due 2015 and to the incorporation by reference therein of our report dated February 27, 2007
(except for Note 22, as to which the date is September 21, 2007), with respect to the consolidated
financial statements of Triad Hospitals, Inc., for the year ended December 31, 2006, included in
the current report on Form 8-K, dated September 24, 2007, filed by Community Health Systems, Inc.
with the Securities and Exchange Commission.
We also consent to the incorporation by reference in the Registration Statement of our report
dated February 27, 2007, with respect to Triad Hospitals Inc. managements assessment of internal control over financial
reporting, and the effectiveness of internal control over financial reporting of Triad Hospitals,
Inc. included in Item 9A in the Triad Hospitals, Inc. Annual Report on Form 10-K for the year ended
December 31, 2006, filed with the Securities and Exchange Commission.
/s/ ERNST & YOUNG, LLP
Dallas, Texas
September 21, 2007